{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pickle\n",
    "import pandas as pd\n",
    "import os\n",
    "from transformers import GPT2Tokenizer\n",
    "import openai\n",
    "import numpy as np\n",
    "import ipdb\n",
    "import re\n",
    "import tqdm\n",
    "from sklearn import metrics\n",
    "import conlleval\n",
    "\n",
    "tokenizer = GPT2Tokenizer.from_pretrained(\"gpt2\")\n",
    "import spacy\n",
    "\n",
    "nlp = spacy.load(\"en_core_web_sm\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "pd.set_option('max_rows',500,'max_colwidth',5000)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 289,
   "metadata": {},
   "outputs": [],
   "source": [
    "data_name = 'ddi'\n",
    "seed = 33\n",
    "few_shot_num = 5\n",
    "number_of_test_samples = 50\n",
    "selection_strategy = 'random'\n",
    "sep = None\n",
    "engine='davinci'\n",
    "permutation = 4\n",
    "verbalizer = 'natural'\n",
    "\n",
    "if verbalizer == '':\n",
    "    if permutation == 0:\n",
    "        prompt_filename = '../data/{}_test_prompts_{}_{}.{}.{}'.format(data_name, selection_strategy,seed,few_shot_num,number_of_test_samples,permutation, verbalizer)\n",
    "    else:\n",
    "        prompt_filename = '../data/{}_test_prompts_{}_{}.{}.{}.perm_{}{}'.format(data_name, selection_strategy,seed,few_shot_num,number_of_test_samples,permutation, verbalizer)\n",
    "else:\n",
    "    prompt_filename = '../data/{}_test_prompts_{}_{}.{}.{}.perm_{}.{}'.format(data_name, selection_strategy,seed,few_shot_num,number_of_test_samples,permutation, verbalizer)\n",
    "filename_root = prompt_filename.split('/')[-1]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 290,
   "metadata": {},
   "outputs": [],
   "source": [
    "preds_filename = '../outputs/'+filename_root+'.preds.{}'.format(engine)\n",
    "df = pickle.load(open(preds_filename,'rb'))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {},
   "outputs": [],
   "source": [
    "preds_filename = '../data/ddi_test_prompts_random_42.5.50.perm_4.KNN.preds'\n",
    "df = pickle.load(open(preds_filename,'rb'))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {},
   "outputs": [],
   "source": [
    "filename_root = 'ddi_test_prompts_random_42.5.50.perm_0.'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 292,
   "metadata": {},
   "outputs": [],
   "source": [
    "if (seed==42 or seed==33) and (permutation <2) and verbalizer == '':\n",
    "    df[filename_root] = [e['choices'][0]['text'].strip() for e in df['gpt3_output_'+filename_root]]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Sentence: The use of antacids should be considered in place of H2 blockers or proton pump inhibitors in patients receiving SPRYCEL therapy.\n",
      "Drug 1: antacids\n",
      "Drug 2: H2 blockers\n",
      "Interaction: none\n",
      "\n",
      "Sentence: The use of antacids should be considered in place of H2 blockers or proton pump inhibitors in patients receiving SPRYCEL therapy.\n",
      "Drug 1: antacids\n",
      "Drug 2: proton pump inhibitors\n",
      "Interaction: none\n",
      "\n",
      "Sentence: The use of antacids should be considered in place of H2 blockers or proton pump inhibitors in patients receiving SPRYCEL therapy.\n",
      "Drug 1: antacids\n",
      "Drug 2: SPRYCEL\n",
      "Interaction: none\n",
      "\n",
      "Sentence: The use of antacids should be considered in place of H2 blockers or proton pump inhibitors in patients receiving SPRYCEL therapy.\n",
      "Drug 1: H2 blockers\n",
      "Drug 2: proton pump inhibitors\n",
      "Interaction: none\n",
      "\n",
      "Sentence: The use of antacids should be considered in place of H2 blockers or proton pump inhibitors in patients receiving SPRYCEL therapy.\n",
      "Drug 1: H2 blockers\n",
      "Drug 2: SPRYCEL\n",
      "Interaction: advice\n",
      "\n",
      "Sentence: The concomitant use of H2 blockers or proton pump inhibitors with SPRYCEL is not recommended.\n",
      "Drug1: proton pump inhibitors\n",
      "Drug2: SPRYCEL\n",
      "Interaction:\n"
     ]
    }
   ],
   "source": [
    "print(df.test_ready_prompt.values[0])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 294,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array(['Recommendation', 'Effect Alteration', 'Metabolic Mechanism ',\n",
       "       'No Interaction', 'Unspecified'], dtype=object)"
      ]
     },
     "execution_count": 294,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.labels.unique()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [],
   "source": [
    "new_preds = []\n",
    "\n",
    "for pred in df[filename_root]:\n",
    "    for label in df.labels.unique():\n",
    "        if label.lower().startswith(pred):            \n",
    "            new_preds.append(label)\n",
    "            break"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array(['advice', 'effect', 'mechanism', 'none', 'other'], dtype=object)"
      ]
     },
     "execution_count": 27,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.labels.unique()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [],
   "source": [
    "df[filename_root] = new_preds"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {},
   "outputs": [],
   "source": [
    "def evaluate_re_preds(df, pred_name, unique_label_dict):\n",
    "    true_labels = [unique_label_dict[lab] for lab in df.labels]\n",
    "    pred_labels = [unique_label_dict[lab] for lab in df[pred_name]]\n",
    "    \n",
    "    print(metrics.f1_score(true_labels, pred_labels, labels=list(unique_label_dict.values()), average=None))\n",
    "    print(metrics.f1_score(true_labels, pred_labels, labels=list(unique_label_dict.values()), average='macro'))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'advice': 0, 'mechanism': 1, 'none': 2, 'effect': 3, 'other': 4}"
      ]
     },
     "execution_count": 29,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "unique_label_dict"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[0.28571429 0.77777778 0.66666667 0.63157895 0.        ]\n",
      "0.4723475355054303\n"
     ]
    }
   ],
   "source": [
    "unique_label_dict = {lab : i for lab,i in zip(df.unique_labels.values[0], range(len(df.unique_labels.values[0])))}\n",
    "evaluate_re_preds(df, filename_root, unique_label_dict)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Unnamed: 0</th>\n",
       "      <th>index</th>\n",
       "      <th>sentence</th>\n",
       "      <th>label</th>\n",
       "      <th>doc</th>\n",
       "      <th>split</th>\n",
       "      <th>entity1</th>\n",
       "      <th>entity2</th>\n",
       "      <th>prompts</th>\n",
       "      <th>empty_prompts</th>\n",
       "      <th>labels</th>\n",
       "      <th>unique_labels</th>\n",
       "      <th>test_ready_prompt</th>\n",
       "      <th>ddi_test_prompts_random_42.5.50.perm_0.</th>\n",
       "      <th>gpt3_output_ddi_test_prompts_random_42.5.50.perm_0.</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>1065</th>\n",
       "      <td>4386</td>\n",
       "      <td>DDI-DrugBank.d48.s12.p2</td>\n",
       "      <td>The concomitant use of H2 blockers or proton pump inhibitors with SPRYCEL is not recommended.</td>\n",
       "      <td>DDI-advise</td>\n",
       "      <td>DDI-DrugBank.d48</td>\n",
       "      <td>dev</td>\n",
       "      <td>proton pump inhibitors</td>\n",
       "      <td>SPRYCEL</td>\n",
       "      <td>Sentence: The concomitant use of H2 blockers or proton pump inhibitors with SPRYCEL is not recommended.\\nDrug 1: proton pump inhibitors\\nDrug 2: SPRYCEL\\nInteraction: advice</td>\n",
       "      <td>Sentence: The concomitant use of H2 blockers or proton pump inhibitors with SPRYCEL is not recommended.\\nDrug1: proton pump inhibitors\\nDrug2: SPRYCEL\\nInteraction:</td>\n",
       "      <td>advice</td>\n",
       "      <td>{advice, mechanism, none, effect, other}</td>\n",
       "      <td>Sentence: The use of antacids should be considered in place of H2 blockers or proton pump inhibitors in patients receiving SPRYCEL therapy.\\nDrug 1: antacids\\nDrug 2: H2 blockers\\nInteraction: none\\n\\nSentence: The use of antacids should be considered in place of H2 blockers or proton pump inhibitors in patients receiving SPRYCEL therapy.\\nDrug 1: antacids\\nDrug 2: proton pump inhibitors\\nInteraction: none\\n\\nSentence: The use of antacids should be considered in place of H2 blockers or proton pump inhibitors in patients receiving SPRYCEL therapy.\\nDrug 1: antacids\\nDrug 2: SPRYCEL\\nInteraction: none\\n\\nSentence: The use of antacids should be considered in place of H2 blockers or proton pump inhibitors in patients receiving SPRYCEL therapy.\\nDrug 1: H2 blockers\\nDrug 2: proton pump inhibitors\\nInteraction: none\\n\\nSentence: The use of antacids should be considered in place of H2 blockers or proton pump inhibitors in patients receiving SPRYCEL therapy.\\nDrug 1: H2 blockers\\nDrug 2: SPRYCEL\\nInteraction: advice\\n\\nSentence: The concomitant use of H2 blockers or proton pump inhibitors with SPRYCEL is not recommended.\\nDrug1: proton pump inhibitors\\nDrug2: SPRYCEL\\nInteraction:</td>\n",
       "      <td>none</td>\n",
       "      <td>({'id': 'cmpl-4IU8yuPU9WAmvuVcrvDxgoAnQtZKU', 'object': 'text_completion', 'created': 1640311124, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      1163\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.23378392\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" none\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" none\": -0.23378392\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" none\"\n",
       "}]}, Sentence: The use of antacids should be considered in place of H2 blockers or proton pump inhibitors in patients receiving SPRYCEL therapy.\\nDrug 1: antacids\\nDrug 2: H2 blockers\\nInteraction: none\\n\\nSentence: The use of antacids should be considered in place of H2 blockers or proton pump inhibitors in patients receiving SPRYCEL therapy.\\nDrug 1: antacids\\nDrug 2: proton pump inhibitors\\nInteraction: none\\n\\nSentence: The use of antacids should be considered in place of H2 blockers or proton pump inhibitors in patients receiving SPRYCEL therapy.\\nDrug 1: antacids\\nDrug 2: SPRYCEL\\nInteraction: none\\n\\nSentence: The use of antacids should be considered in place of H2 blockers or proton pump inhibitors in patients receiving SPRYCEL therapy.\\nDrug 1: H2 blockers\\nDrug 2: proton pump inhibitors\\nInteraction: none\\n\\nSentence: The use of antacids should be considered in place of H2 blockers or proton pump inhibitors in patients receiving SPRYCEL therapy.\\nDrug 1: H2 blockers\\nDrug 2: SPRYCEL\\nInteraction: advice\\n\\nSentence: The concomitant use of H2 blockers or proton pump inhibitors with SPRYCEL is not recommended.\\nDrug1: proton pump inhibitors\\nDrug2: SPRYCEL\\nInteraction:,  effect other mechanism none advice )</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1157</th>\n",
       "      <td>17780</td>\n",
       "      <td>DDI-DrugBank.d31.s0.p0</td>\n",
       "      <td>MAO inhibitors should be used with caution in patients receiving hydralazine.</td>\n",
       "      <td>DDI-advise</td>\n",
       "      <td>DDI-DrugBank.d31</td>\n",
       "      <td>dev</td>\n",
       "      <td>MAO inhibitors</td>\n",
       "      <td>hydralazine</td>\n",
       "      <td>Sentence: MAO inhibitors should be used with caution in patients receiving hydralazine.\\nDrug 1: MAO inhibitors\\nDrug 2: hydralazine\\nInteraction: advice</td>\n",
       "      <td>Sentence: MAO inhibitors should be used with caution in patients receiving hydralazine.\\nDrug1: MAO inhibitors\\nDrug2: hydralazine\\nInteraction:</td>\n",
       "      <td>advice</td>\n",
       "      <td>{advice, mechanism, none, effect, other}</td>\n",
       "      <td>Sentence: Cevimeline should be administered with caution to patients taking beta adrenergic antagonists, because of the possibility of conduction disturbances.\\nDrug 1: Cevimeline\\nDrug 2: beta adrenergic antagonists\\nInteraction: advice\\n\\nSentence: All vasopressors should be used cautiously in patients taking monoamine oxidase (MAO) inhibitors.\\nDrug 1: vasopressors\\nDrug 2: monoamine oxidase (MAO) inhibitors\\nInteraction: advice\\n\\nSentence: DISULFIRAM SHOULD BE USED WITH CAUTION IN THOSE PATIENTS REVEIVING PHENYTOIN AND ITS CONGENERS.\\nDrug 1: DISULFIRAM\\nDrug 2: PHENYTOIN\\nInteraction: advice\\n\\nSentence: NSAIDs should be used with caution in patients taking cyclosporine, and renal function should be carefully monitored.\\nDrug 1: NSAIDs\\nDrug 2: cyclosporine\\nInteraction: advice\\n\\nSentence: NSAIDs should be used with caution in patients taking cyclosporine, and renal function should be carefully monitored.\\nDrug 1: NSAIDs\\nDrug 2: cyclosporine\\nInteraction: advice\\n\\nSentence: MAO inhibitors should be used with caution in patients receiving hydralazine.\\nDrug1: MAO inhibitors\\nDrug2: hydralazine\\nInteraction:</td>\n",
       "      <td>advice</td>\n",
       "      <td>({'id': 'cmpl-4IU8ym4u4Kyep29mBPWYn6dKI0xjE', 'object': 'text_completion', 'created': 1640311124, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      1104\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.004028529\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" advice\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" advice\": -0.004028529\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" advice\"\n",
       "}]}, Sentence: Cevimeline should be administered with caution to patients taking beta adrenergic antagonists, because of the possibility of conduction disturbances.\\nDrug 1: Cevimeline\\nDrug 2: beta adrenergic antagonists\\nInteraction: advice\\n\\nSentence: All vasopressors should be used cautiously in patients taking monoamine oxidase (MAO) inhibitors.\\nDrug 1: vasopressors\\nDrug 2: monoamine oxidase (MAO) inhibitors\\nInteraction: advice\\n\\nSentence: DISULFIRAM SHOULD BE USED WITH CAUTION IN THOSE PATIENTS REVEIVING PHENYTOIN AND ITS CONGENERS.\\nDrug 1: DISULFIRAM\\nDrug 2: PHENYTOIN\\nInteraction: advice\\n\\nSentence: NSAIDs should be used with caution in patients taking cyclosporine, and renal function should be carefully monitored.\\nDrug 1: NSAIDs\\nDrug 2: cyclosporine\\nInteraction: advice\\n\\nSentence: NSAIDs should be used with caution in patients taking cyclosporine, and renal function should be carefully monitored.\\nDrug 1: NSAIDs\\nDrug 2: cyclosporine\\nInteraction: advice\\n\\nSentence: MAO inhibitors should be used with caution in patients receiving hydralazine.\\nDrug1: MAO inhibitors\\nDrug2: hydralazine\\nInteraction:,  effect other mechanism none advice )</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1096</th>\n",
       "      <td>9530</td>\n",
       "      <td>DDI-DrugBank.d165.s16.p2</td>\n",
       "      <td>Cyclosporine, tacrolimus and digoxin concentrations should be monitored at the initiation of Itraconazole therapy and frequently thereafter, and the dose of these three drug products adjusted appropriately.</td>\n",
       "      <td>DDI-advise</td>\n",
       "      <td>DDI-DrugBank.d165</td>\n",
       "      <td>dev</td>\n",
       "      <td>Cyclosporine</td>\n",
       "      <td>Itraconazole</td>\n",
       "      <td>Sentence: Cyclosporine, tacrolimus and digoxin concentrations should be monitored at the initiation of Itraconazole therapy and frequently thereafter, and the dose of these three drug products adjusted appropriately.\\nDrug 1: Cyclosporine\\nDrug 2: Itraconazole\\nInteraction: advice</td>\n",
       "      <td>Sentence: Cyclosporine, tacrolimus and digoxin concentrations should be monitored at the initiation of Itraconazole therapy and frequently thereafter, and the dose of these three drug products adjusted appropriately.\\nDrug1: Cyclosporine\\nDrug2: Itraconazole\\nInteraction:</td>\n",
       "      <td>advice</td>\n",
       "      <td>{advice, mechanism, none, effect, other}</td>\n",
       "      <td>Sentence: For patients receiving both therapies, standard monitoring of tacrolimus blood concentrations and appropriate tacrolimus dosage adjustments are recommended.\\nDrug 1: tacrolimus\\nDrug 2: tacrolimus\\nInteraction: none\\n\\nSentence: The physician is advised to monitor the plasma concentrations of itraconazole when any of these drugs is taken concurrently, and to increase the dose of Itraconazole if necessary.\\nDrug 1: itraconazole\\nDrug 2: Itraconazole\\nInteraction: none\\n\\nSentence: Therefore, cyclosporine serum levels should be monitored and appropriate cyclosporine dosage adjustments made when these drugs are used concomitantly.\\nDrug 1: cyclosporine\\nDrug 2: cyclosporine\\nInteraction: none\\n\\nSentence: Therefore, cyclosporine serum levels should be monitored and appropriate cyclosporine dosage adjustments made when these drugs are used concomitantly.\\nDrug 1: cyclosporine\\nDrug 2: cyclosporine\\nInteraction: none\\n\\nSentence: Coadministration of Itraconazole and cyclosporine, tacrolimus or digoxin has led to increased plasma concentrations of the latter three drugs.\\nDrug 1: Itraconazole\\nDrug 2: cyclosporine\\nInteraction: mechanism\\n\\nSentence: Cyclosporine, tacrolimus and digoxin concentrations should be monitored at the initiation of Itraconazole therapy and frequently thereafter, and the dose of these three drug products adjusted appropriately.\\nDrug1: Cyclosporine\\nDrug2: Itraconazole\\nInteraction:</td>\n",
       "      <td>none</td>\n",
       "      <td>({'id': 'cmpl-4IU8zW6xaSCy1WxGEXwYUqbQNKIwO', 'object': 'text_completion', 'created': 1640311125, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      1407\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.3778825\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" none\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" none\": -0.3778825\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" none\"\n",
       "}]}, Sentence: For patients receiving both therapies, standard monitoring of tacrolimus blood concentrations and appropriate tacrolimus dosage adjustments are recommended.\\nDrug 1: tacrolimus\\nDrug 2: tacrolimus\\nInteraction: none\\n\\nSentence: The physician is advised to monitor the plasma concentrations of itraconazole when any of these drugs is taken concurrently, and to increase the dose of Itraconazole if necessary.\\nDrug 1: itraconazole\\nDrug 2: Itraconazole\\nInteraction: none\\n\\nSentence: Therefore, cyclosporine serum levels should be monitored and appropriate cyclosporine dosage adjustments made when these drugs are used concomitantly.\\nDrug 1: cyclosporine\\nDrug 2: cyclosporine\\nInteraction: none\\n\\nSentence: Therefore, cyclosporine serum levels should be monitored and appropriate cyclosporine dosage adjustments made when these drugs are used concomitantly.\\nDrug 1: cyclosporine\\nDrug 2: cyclosporine\\nInteraction: none\\n\\nSentence: Coadministration of Itraconazole and cyclosporine, tacrolimus or digoxin has led to increased plasma concentrations of the latter three drugs.\\nDrug 1: Itraconazole\\nDrug 2: cyclosporine\\nInteraction: mechanism\\n\\nSentence: Cyclosporine, tacrolimus and digoxin concentrations should be monitored at the initiation of Itraconazole therapy and frequently thereafter, and the dose of these three drug products adjusted appropriately.\\nDrug1: Cyclosporine\\nDrug2: Itraconazole\\nInteraction:,  effect other mechanism none advice )</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1164</th>\n",
       "      <td>19325</td>\n",
       "      <td>DDI-DrugBank.d297.s5.p0</td>\n",
       "      <td>There is insufficient experience to assess the safety and efficacy of ORENCIA administered concurrently with anakinra, and therefore such use is not recommended.</td>\n",
       "      <td>DDI-advise</td>\n",
       "      <td>DDI-DrugBank.d297</td>\n",
       "      <td>dev</td>\n",
       "      <td>ORENCIA</td>\n",
       "      <td>anakinra</td>\n",
       "      <td>Sentence: There is insufficient experience to assess the safety and efficacy of ORENCIA administered concurrently with anakinra, and therefore such use is not recommended.\\nDrug 1: ORENCIA\\nDrug 2: anakinra\\nInteraction: advice</td>\n",
       "      <td>Sentence: There is insufficient experience to assess the safety and efficacy of ORENCIA administered concurrently with anakinra, and therefore such use is not recommended.\\nDrug1: ORENCIA\\nDrug2: anakinra\\nInteraction:</td>\n",
       "      <td>advice</td>\n",
       "      <td>{advice, mechanism, none, effect, other}</td>\n",
       "      <td>Sentence: Although there is little published information on concomitant administration of lidocaine and Bretylium Tosylate, these drugs are often administered concurrently without any evidence of interactions resulting in adverse effects or diminished efficacy.\\nDrug 1: lidocaine\\nDrug 2: Bretylium Tosylate\\nInteraction: none\\n\\nSentence: The safety and efficacy of anakinra used in combination with HUMIRA has not been studied.\\nDrug 1: anakinra\\nDrug 2: HUMIRA\\nInteraction: none\\n\\nSentence: Aspirin: As with other NSAIDs, concomitant administration of Ponstel and aspirin is not generally recommended because of the potential of increased adverse effects.\\nDrug 1: Aspirin\\nDrug 2: NSAIDs\\nInteraction: none\\n\\nSentence: Aspirin: As with other NSAIDs, concomitant administration of Ponstel and aspirin is not generally recommended because of the potential of increased adverse effects.\\nDrug 1: Aspirin\\nDrug 2: Ponstel\\nInteraction: none\\n\\nSentence: Aspirin: As with other NSAIDs, concomitant administration of Ponstel and aspirin is not generally recommended because of the potential of increased adverse effects.\\nDrug 1: Aspirin\\nDrug 2: aspirin\\nInteraction: none\\n\\nSentence: There is insufficient experience to assess the safety and efficacy of ORENCIA administered concurrently with anakinra, and therefore such use is not recommended.\\nDrug1: ORENCIA\\nDrug2: anakinra\\nInteraction:</td>\n",
       "      <td>none</td>\n",
       "      <td>({'id': 'cmpl-4IU8zd0FzOR9XmIoT2I4tqglCkWdy', 'object': 'text_completion', 'created': 1640311125, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      1369\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.00047064314\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" none\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" none\": -0.00047064314\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" none\"\n",
       "}]}, Sentence: Although there is little published information on concomitant administration of lidocaine and Bretylium Tosylate, these drugs are often administered concurrently without any evidence of interactions resulting in adverse effects or diminished efficacy.\\nDrug 1: lidocaine\\nDrug 2: Bretylium Tosylate\\nInteraction: none\\n\\nSentence: The safety and efficacy of anakinra used in combination with HUMIRA has not been studied.\\nDrug 1: anakinra\\nDrug 2: HUMIRA\\nInteraction: none\\n\\nSentence: Aspirin: As with other NSAIDs, concomitant administration of Ponstel and aspirin is not generally recommended because of the potential of increased adverse effects.\\nDrug 1: Aspirin\\nDrug 2: NSAIDs\\nInteraction: none\\n\\nSentence: Aspirin: As with other NSAIDs, concomitant administration of Ponstel and aspirin is not generally recommended because of the potential of increased adverse effects.\\nDrug 1: Aspirin\\nDrug 2: Ponstel\\nInteraction: none\\n\\nSentence: Aspirin: As with other NSAIDs, concomitant administration of Ponstel and aspirin is not generally recommended because of the potential of increased adverse effects.\\nDrug 1: Aspirin\\nDrug 2: aspirin\\nInteraction: none\\n\\nSentence: There is insufficient experience to assess the safety and efficacy of ORENCIA administered concurrently with anakinra, and therefore such use is not recommended.\\nDrug1: ORENCIA\\nDrug2: anakinra\\nInteraction:,  effect other mechanism none advice )</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1133</th>\n",
       "      <td>14414</td>\n",
       "      <td>DDI-DrugBank.d364.s10.p1</td>\n",
       "      <td>Coadministration of alosetron and strong CYP3A4 inhibitors, such as clarithromycin, telithromycin, protease inhibitors, voriconazole, and itraconazole has not been evaluated but should be undertaken with caution because of similar potential drug interactions.</td>\n",
       "      <td>DDI-advise</td>\n",
       "      <td>DDI-DrugBank.d364</td>\n",
       "      <td>dev</td>\n",
       "      <td>alosetron</td>\n",
       "      <td>telithromycin</td>\n",
       "      <td>Sentence: Coadministration of alosetron and strong CYP3A4 inhibitors, such as clarithromycin, telithromycin, protease inhibitors, voriconazole, and itraconazole has not been evaluated but should be undertaken with caution because of similar potential drug interactions.\\nDrug 1: alosetron\\nDrug 2: telithromycin\\nInteraction: advice</td>\n",
       "      <td>Sentence: Coadministration of alosetron and strong CYP3A4 inhibitors, such as clarithromycin, telithromycin, protease inhibitors, voriconazole, and itraconazole has not been evaluated but should be undertaken with caution because of similar potential drug interactions.\\nDrug1: alosetron\\nDrug2: telithromycin\\nInteraction:</td>\n",
       "      <td>advice</td>\n",
       "      <td>{advice, mechanism, none, effect, other}</td>\n",
       "      <td>Sentence: Concomitant administration of alosetron and moderate CYP1A2 inhibitors, including quinolone antibiotics and cimetidine, has not been evaluated, but should be avoided unless clinically necessary because of similar potential drug interactions.\\nDrug 1: alosetron\\nDrug 2: quinolone antibiotics\\nInteraction: advice\\n\\nSentence: Concomitant administration of alosetron and moderate CYP1A2 inhibitors, including quinolone antibiotics and cimetidine, has not been evaluated, but should be avoided unless clinically necessary because of similar potential drug interactions.\\nDrug 1: alosetron\\nDrug 2: cimetidine\\nInteraction: advice\\n\\nSentence: Concomitant administration of alosetron and moderate CYP1A2 inhibitors, including quinolone antibiotics and cimetidine, has not been evaluated, but should be avoided unless clinically necessary because of similar potential drug interactions.\\nDrug 1: quinolone antibiotics\\nDrug 2: cimetidine\\nInteraction: none\\n\\nSentence: Consequently, concomitant administration of Aprepitant with strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, nefazodone, troleandomycin, clarithromycin, ritonavir, nelfinavir) should be approached with caution.\\nDrug 1: Aprepitant\\nDrug 2: ketoconazole\\nInteraction: advice\\n\\nSentence: Consequently, concomitant administration of Aprepitant with strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, nefazodone, troleandomycin, clarithromycin, ritonavir, nelfinavir) should be approached with caution.\\nDrug 1: Aprepitant\\nDrug 2: itraconazole\\nInteraction: advice\\n\\nSentence: Coadministration of alosetron and strong CYP3A4 inhibitors, such as clarithromycin, telithromycin, protease inhibitors, voriconazole, and itraconazole has not been evaluated but should be undertaken with caution because of similar potential drug interactions.\\nDrug1: alosetron\\nDrug2: telithromycin\\nInteraction:</td>\n",
       "      <td>none</td>\n",
       "      <td>({'id': 'cmpl-4IU8zi6Lp7opAJ8VVBb868IfkA8Ao', 'object': 'text_completion', 'created': 1640311125, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      1857\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.6837042\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" none\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" none\": -0.6837042\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" none\"\n",
       "}]}, Sentence: Concomitant administration of alosetron and moderate CYP1A2 inhibitors, including quinolone antibiotics and cimetidine, has not been evaluated, but should be avoided unless clinically necessary because of similar potential drug interactions.\\nDrug 1: alosetron\\nDrug 2: quinolone antibiotics\\nInteraction: advice\\n\\nSentence: Concomitant administration of alosetron and moderate CYP1A2 inhibitors, including quinolone antibiotics and cimetidine, has not been evaluated, but should be avoided unless clinically necessary because of similar potential drug interactions.\\nDrug 1: alosetron\\nDrug 2: cimetidine\\nInteraction: advice\\n\\nSentence: Concomitant administration of alosetron and moderate CYP1A2 inhibitors, including quinolone antibiotics and cimetidine, has not been evaluated, but should be avoided unless clinically necessary because of similar potential drug interactions.\\nDrug 1: quinolone antibiotics\\nDrug 2: cimetidine\\nInteraction: none\\n\\nSentence: Consequently, concomitant administration of Aprepitant with strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, nefazodone, troleandomycin, clarithromycin, ritonavir, nelfinavir) should be approached with caution.\\nDrug 1: Aprepitant\\nDrug 2: ketoconazole\\nInteraction: advice\\n\\nSentence: Consequently, concomitant administration of Aprepitant with strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, nefazodone, troleandomycin, clarithromycin, ritonavir, nelfinavir) should be approached with caution.\\nDrug 1: Aprepitant\\nDrug 2: itraconazole\\nInteraction: advice\\n\\nSentence: Coadministration of alosetron and strong CYP3A4 inhibitors, such as clarithromycin, telithromycin, protease inhibitors, voriconazole, and itraconazole has not been evaluated but should be undertaken with caution because of similar potential drug interactions.\\nDrug1: alosetron\\nDrug2: telithromycin\\nInteraction:,  effect other mechanism none advice )</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>930</td>\n",
       "      <td>DDI-DrugBank.d246.s0.p4</td>\n",
       "      <td>Concurrent use of butorphanol with central nervous system depressants (e.g., alcohol, barbiturates, tranquilizers, and antihistamines) may result in increased central nervous system depressant effects.</td>\n",
       "      <td>DDI-effect</td>\n",
       "      <td>DDI-DrugBank.d246</td>\n",
       "      <td>dev</td>\n",
       "      <td>butorphanol</td>\n",
       "      <td>antihistamines</td>\n",
       "      <td>Sentence: Concurrent use of butorphanol with central nervous system depressants (e.g., alcohol, barbiturates, tranquilizers, and antihistamines) may result in increased central nervous system depressant effects.\\nDrug 1: butorphanol\\nDrug 2: antihistamines\\nInteraction: effect</td>\n",
       "      <td>Sentence: Concurrent use of butorphanol with central nervous system depressants (e.g., alcohol, barbiturates, tranquilizers, and antihistamines) may result in increased central nervous system depressant effects.\\nDrug1: butorphanol\\nDrug2: antihistamines\\nInteraction:</td>\n",
       "      <td>effect</td>\n",
       "      <td>{advice, mechanism, none, effect, other}</td>\n",
       "      <td>Sentence: Antihistamines may have additive effects with alcohol and other CNS depressants, e.g., hypnotics, sedatives, tranquilizers, antianxiety agents.\\nDrug 1: Antihistamines\\nDrug 2: alcohol\\nInteraction: effect\\n\\nSentence: Antihistamines may have additive effects with alcohol and other CNS depressants, e.g., hypnotics, sedatives, tranquilizers, antianxiety agents.\\nDrug 1: Antihistamines\\nDrug 2: CNS depressants\\nInteraction: effect\\n\\nSentence: Antihistamines may have additive effects with alcohol and other CNS depressants, e.g., hypnotics, sedatives, tranquilizers, antianxiety agents.\\nDrug 1: Antihistamines\\nDrug 2: hypnotics\\nInteraction: effect\\n\\nSentence: Antihistamines may have additive effects with alcohol and other CNS depressants, e.g., hypnotics, sedatives, tranquilizers, antianxiety agents.\\nDrug 1: Antihistamines\\nDrug 2: sedatives\\nInteraction: effect\\n\\nSentence: Antihistamines may have additive effects with alcohol and other CNS depressants, e.g., hypnotics, sedatives, tranquilizers, antianxiety agents.\\nDrug 1: Antihistamines\\nDrug 2: tranquilizers\\nInteraction: effect\\n\\nSentence: Concurrent use of butorphanol with central nervous system depressants (e.g., alcohol, barbiturates, tranquilizers, and antihistamines) may result in increased central nervous system depressant effects.\\nDrug1: butorphanol\\nDrug2: antihistamines\\nInteraction:</td>\n",
       "      <td>effect</td>\n",
       "      <td>({'id': 'cmpl-4IU8zfDqpsak0mEPlNNqQ6P7sD9kO', 'object': 'text_completion', 'created': 1640311125, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      1353\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.027719622\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" effect\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" effect\": -0.027719622\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" effect\"\n",
       "}]}, Sentence: Antihistamines may have additive effects with alcohol and other CNS depressants, e.g., hypnotics, sedatives, tranquilizers, antianxiety agents.\\nDrug 1: Antihistamines\\nDrug 2: alcohol\\nInteraction: effect\\n\\nSentence: Antihistamines may have additive effects with alcohol and other CNS depressants, e.g., hypnotics, sedatives, tranquilizers, antianxiety agents.\\nDrug 1: Antihistamines\\nDrug 2: CNS depressants\\nInteraction: effect\\n\\nSentence: Antihistamines may have additive effects with alcohol and other CNS depressants, e.g., hypnotics, sedatives, tranquilizers, antianxiety agents.\\nDrug 1: Antihistamines\\nDrug 2: hypnotics\\nInteraction: effect\\n\\nSentence: Antihistamines may have additive effects with alcohol and other CNS depressants, e.g., hypnotics, sedatives, tranquilizers, antianxiety agents.\\nDrug 1: Antihistamines\\nDrug 2: sedatives\\nInteraction: effect\\n\\nSentence: Antihistamines may have additive effects with alcohol and other CNS depressants, e.g., hypnotics, sedatives, tranquilizers, antianxiety agents.\\nDrug 1: Antihistamines\\nDrug 2: tranquilizers\\nInteraction: effect\\n\\nSentence: Concurrent use of butorphanol with central nervous system depressants (e.g., alcohol, barbiturates, tranquilizers, and antihistamines) may result in increased central nervous system depressant effects.\\nDrug1: butorphanol\\nDrug2: antihistamines\\nInteraction:,  effect other mechanism none advice )</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>299</th>\n",
       "      <td>19162</td>\n",
       "      <td>DDI-DrugBank.d222.s0.p0</td>\n",
       "      <td>When atropine and pralidoxime are used together, the signs of atropinization (flushing, mydriasis, tachycardia, dryness of the mouth and nose) may occur earlier than might be expected than when atropine is used alone because pralidoxime may potentiate the effect of atropine.</td>\n",
       "      <td>DDI-effect</td>\n",
       "      <td>DDI-DrugBank.d222</td>\n",
       "      <td>dev</td>\n",
       "      <td>atropine</td>\n",
       "      <td>pralidoxime</td>\n",
       "      <td>Sentence: When atropine and pralidoxime are used together, the signs of atropinization (flushing, mydriasis, tachycardia, dryness of the mouth and nose) may occur earlier than might be expected than when atropine is used alone because pralidoxime may potentiate the effect of atropine.\\nDrug 1: atropine\\nDrug 2: pralidoxime\\nInteraction: effect</td>\n",
       "      <td>Sentence: When atropine and pralidoxime are used together, the signs of atropinization (flushing, mydriasis, tachycardia, dryness of the mouth and nose) may occur earlier than might be expected than when atropine is used alone because pralidoxime may potentiate the effect of atropine.\\nDrug1: atropine\\nDrug2: pralidoxime\\nInteraction:</td>\n",
       "      <td>effect</td>\n",
       "      <td>{advice, mechanism, none, effect, other}</td>\n",
       "      <td>Sentence: Particular caution is necessary when using ROMAZICON in cases of mixed drug overdosage since the toxic effects (such as convulsions and cardiac dysrhythmias) of other drugs taken in overdose (especially cyclic antidepressants) may emerge with the reversal of the benzodiazepine effect by flumazenil.\\nDrug 1: ROMAZICON\\nDrug 2: cyclic antidepressants\\nInteraction: effect\\n\\nSentence: Particular caution is necessary when using ROMAZICON in cases of mixed drug overdosage since the toxic effects (such as convulsions and cardiac dysrhythmias) of other drugs taken in overdose (especially cyclic antidepressants) may emerge with the reversal of the benzodiazepine effect by flumazenil.\\nDrug 1: ROMAZICON\\nDrug 2: benzodiazepine\\nInteraction: none\\n\\nSentence: Particular caution is necessary when using ROMAZICON in cases of mixed drug overdosage since the toxic effects (such as convulsions and cardiac dysrhythmias) of other drugs taken in overdose (especially cyclic antidepressants) may emerge with the reversal of the benzodiazepine effect by flumazenil.\\nDrug 1: ROMAZICON\\nDrug 2: flumazenil\\nInteraction: none\\n\\nSentence: Particular caution is necessary when using ROMAZICON in cases of mixed drug overdosage since the toxic effects (such as convulsions and cardiac dysrhythmias) of other drugs taken in overdose (especially cyclic antidepressants) may emerge with the reversal of the benzodiazepine effect by flumazenil.\\nDrug 1: cyclic antidepressants\\nDrug 2: benzodiazepine\\nInteraction: none\\n\\nSentence: Particular caution is necessary when using ROMAZICON in cases of mixed drug overdosage since the toxic effects (such as convulsions and cardiac dysrhythmias) of other drugs taken in overdose (especially cyclic antidepressants) may emerge with the reversal of the benzodiazepine effect by flumazenil.\\nDrug 1: cyclic antidepressants\\nDrug 2: flumazenil\\nInteraction: none\\n\\nSentence: When atropine and pralidoxime are used together, the signs of atropinization (flushing, mydriasis, tachycardia, dryness of the mouth and nose) may occur earlier than might be expected than when atropine is used alone because pralidoxime may potentiate the effect of atropine.\\nDrug1: atropine\\nDrug2: pralidoxime\\nInteraction:</td>\n",
       "      <td>none</td>\n",
       "      <td>({'id': 'cmpl-4IU90xeGU5nqC6ovMrbi47RslkRo8', 'object': 'text_completion', 'created': 1640311126, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      2211\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.4597337\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" none\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" none\": -0.4597337\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" none\"\n",
       "}]}, Sentence: Particular caution is necessary when using ROMAZICON in cases of mixed drug overdosage since the toxic effects (such as convulsions and cardiac dysrhythmias) of other drugs taken in overdose (especially cyclic antidepressants) may emerge with the reversal of the benzodiazepine effect by flumazenil.\\nDrug 1: ROMAZICON\\nDrug 2: cyclic antidepressants\\nInteraction: effect\\n\\nSentence: Particular caution is necessary when using ROMAZICON in cases of mixed drug overdosage since the toxic effects (such as convulsions and cardiac dysrhythmias) of other drugs taken in overdose (especially cyclic antidepressants) may emerge with the reversal of the benzodiazepine effect by flumazenil.\\nDrug 1: ROMAZICON\\nDrug 2: benzodiazepine\\nInteraction: none\\n\\nSentence: Particular caution is necessary when using ROMAZICON in cases of mixed drug overdosage since the toxic effects (such as convulsions and cardiac dysrhythmias) of other drugs taken in overdose (especially cyclic antidepressants) may emerge with the reversal of the benzodiazepine effect by flumazenil.\\nDrug 1: ROMAZICON\\nDrug 2: flumazenil\\nInteraction: none\\n\\nSentence: Particular caution is necessary when using ROMAZICON in cases of mixed drug overdosage since the toxic effects (such as convulsions and cardiac dysrhythmias) of other drugs taken in overdose (especially cyclic antidepressants) may emerge with the reversal of the benzodiazepine effect by flumazenil.\\nDrug 1: cyclic antidepressants\\nDrug 2: benzodiazepine\\nInteraction: none\\n\\nSentence: Particular caution is necessary when using ROMAZICON in cases of mixed drug overdosage since the toxic effects (such as convulsions and cardiac dysrhythmias) of other drugs taken in overdose (especially cyclic antidepressants) may emerge with the reversal of the benzodiazepine effect by flumazenil.\\nDrug 1: cyclic antidepressants\\nDrug 2: flumazenil\\nInteraction: none\\n\\nSentence: When atropine and pralidoxime are used together, the signs of atropinization (flushing, mydriasis, tachycardia, dryness of the mouth and nose) may occur earlier than might be expected than when atropine is used alone because pralidoxime may potentiate the effect of atropine.\\nDrug1: atropine\\nDrug2: pralidoxime\\nInteraction:,  effect other mechanism none advice )</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>177</th>\n",
       "      <td>10039</td>\n",
       "      <td>DDI-DrugBank.d176.s6.p9</td>\n",
       "      <td>Lithium: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ACE inhibitors during therapy with lithium.</td>\n",
       "      <td>DDI-effect</td>\n",
       "      <td>DDI-DrugBank.d176</td>\n",
       "      <td>dev</td>\n",
       "      <td>ACE inhibitors</td>\n",
       "      <td>lithium</td>\n",
       "      <td>Sentence: Lithium: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ACE inhibitors during therapy with lithium.\\nDrug 1: ACE inhibitors\\nDrug 2: lithium\\nInteraction: effect</td>\n",
       "      <td>Sentence: Lithium: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ACE inhibitors during therapy with lithium.\\nDrug1: ACE inhibitors\\nDrug2: lithium\\nInteraction:</td>\n",
       "      <td>effect</td>\n",
       "      <td>{advice, mechanism, none, effect, other}</td>\n",
       "      <td>Sentence: Lithium: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ACE inhibitors during therapy with lithium.\\nDrug 1: Lithium\\nDrug 2: lithium\\nInteraction: none\\n\\nSentence: Lithium: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ACE inhibitors during therapy with lithium.\\nDrug 1: Lithium\\nDrug 2: lithium\\nInteraction: none\\n\\nSentence: Lithium: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ACE inhibitors during therapy with lithium.\\nDrug 1: Lithium\\nDrug 2: ACE inhibitors\\nInteraction: none\\n\\nSentence: Lithium: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ACE inhibitors during therapy with lithium.\\nDrug 1: Lithium\\nDrug 2: lithium\\nInteraction: none\\n\\nSentence: Lithium: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ACE inhibitors during therapy with lithium.\\nDrug 1: lithium\\nDrug 2: lithium\\nInteraction: none\\n\\nSentence: Lithium: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ACE inhibitors during therapy with lithium.\\nDrug1: ACE inhibitors\\nDrug2: lithium\\nInteraction:</td>\n",
       "      <td>none</td>\n",
       "      <td>({'id': 'cmpl-4IU90jfZkOKzbVibrfvxlp5JNx3yY', 'object': 'text_completion', 'created': 1640311126, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      1319\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.0018755054\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" none\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" none\": -0.0018755054\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" none\"\n",
       "}]}, Sentence: Lithium: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ACE inhibitors during therapy with lithium.\\nDrug 1: Lithium\\nDrug 2: lithium\\nInteraction: none\\n\\nSentence: Lithium: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ACE inhibitors during therapy with lithium.\\nDrug 1: Lithium\\nDrug 2: lithium\\nInteraction: none\\n\\nSentence: Lithium: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ACE inhibitors during therapy with lithium.\\nDrug 1: Lithium\\nDrug 2: ACE inhibitors\\nInteraction: none\\n\\nSentence: Lithium: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ACE inhibitors during therapy with lithium.\\nDrug 1: Lithium\\nDrug 2: lithium\\nInteraction: none\\n\\nSentence: Lithium: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ACE inhibitors during therapy with lithium.\\nDrug 1: lithium\\nDrug 2: lithium\\nInteraction: none\\n\\nSentence: Lithium: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ACE inhibitors during therapy with lithium.\\nDrug1: ACE inhibitors\\nDrug2: lithium\\nInteraction:,  effect other mechanism none advice )</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>204</th>\n",
       "      <td>12858</td>\n",
       "      <td>DDI-DrugBank.d335.s3.p4</td>\n",
       "      <td>The actions of the benzodiazepines may be potentiated by barbiturates, narcotics, phenothiazines, monoamine oxidase inhibitors or other antidepressants.</td>\n",
       "      <td>DDI-effect</td>\n",
       "      <td>DDI-DrugBank.d335</td>\n",
       "      <td>dev</td>\n",
       "      <td>benzodiazepines</td>\n",
       "      <td>antidepressants</td>\n",
       "      <td>Sentence: The actions of the benzodiazepines may be potentiated by barbiturates, narcotics, phenothiazines, monoamine oxidase inhibitors or other antidepressants.\\nDrug 1: benzodiazepines\\nDrug 2: antidepressants\\nInteraction: effect</td>\n",
       "      <td>Sentence: The actions of the benzodiazepines may be potentiated by barbiturates, narcotics, phenothiazines, monoamine oxidase inhibitors or other antidepressants.\\nDrug1: benzodiazepines\\nDrug2: antidepressants\\nInteraction:</td>\n",
       "      <td>effect</td>\n",
       "      <td>{advice, mechanism, none, effect, other}</td>\n",
       "      <td>Sentence: The action of the benzodiazepines may be potentiated by anticonvulsants, antihistamines, alcohol, barbiturates, monoamine oxidase inhibitors, narcotics, phenothiazines, psychotropic medications, or other drugs that produce CNS depression.\\nDrug 1: benzodiazepines\\nDrug 2: anticonvulsants\\nInteraction: effect\\n\\nSentence: The action of the benzodiazepines may be potentiated by anticonvulsants, antihistamines, alcohol, barbiturates, monoamine oxidase inhibitors, narcotics, phenothiazines, psychotropic medications, or other drugs that produce CNS depression.\\nDrug 1: benzodiazepines\\nDrug 2: antihistamines\\nInteraction: effect\\n\\nSentence: The action of the benzodiazepines may be potentiated by anticonvulsants, antihistamines, alcohol, barbiturates, monoamine oxidase inhibitors, narcotics, phenothiazines, psychotropic medications, or other drugs that produce CNS depression.\\nDrug 1: benzodiazepines\\nDrug 2: alcohol\\nInteraction: effect\\n\\nSentence: The action of the benzodiazepines may be potentiated by anticonvulsants, antihistamines, alcohol, barbiturates, monoamine oxidase inhibitors, narcotics, phenothiazines, psychotropic medications, or other drugs that produce CNS depression.\\nDrug 1: benzodiazepines\\nDrug 2: barbiturates\\nInteraction: effect\\n\\nSentence: The action of the benzodiazepines may be potentiated by anticonvulsants, antihistamines, alcohol, barbiturates, monoamine oxidase inhibitors, narcotics, phenothiazines, psychotropic medications, or other drugs that produce CNS depression.\\nDrug 1: benzodiazepines\\nDrug 2: monoamine oxidase inhibitors\\nInteraction: effect\\n\\nSentence: The actions of the benzodiazepines may be potentiated by barbiturates, narcotics, phenothiazines, monoamine oxidase inhibitors or other antidepressants.\\nDrug1: benzodiazepines\\nDrug2: antidepressants\\nInteraction:</td>\n",
       "      <td>effect</td>\n",
       "      <td>({'id': 'cmpl-4IU903C7EzxX7sFulCKkf9Beo4mzL', 'object': 'text_completion', 'created': 1640311126, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      1812\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.008146561\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" effect\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" effect\": -0.008146561\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" effect\"\n",
       "}]}, Sentence: The action of the benzodiazepines may be potentiated by anticonvulsants, antihistamines, alcohol, barbiturates, monoamine oxidase inhibitors, narcotics, phenothiazines, psychotropic medications, or other drugs that produce CNS depression.\\nDrug 1: benzodiazepines\\nDrug 2: anticonvulsants\\nInteraction: effect\\n\\nSentence: The action of the benzodiazepines may be potentiated by anticonvulsants, antihistamines, alcohol, barbiturates, monoamine oxidase inhibitors, narcotics, phenothiazines, psychotropic medications, or other drugs that produce CNS depression.\\nDrug 1: benzodiazepines\\nDrug 2: antihistamines\\nInteraction: effect\\n\\nSentence: The action of the benzodiazepines may be potentiated by anticonvulsants, antihistamines, alcohol, barbiturates, monoamine oxidase inhibitors, narcotics, phenothiazines, psychotropic medications, or other drugs that produce CNS depression.\\nDrug 1: benzodiazepines\\nDrug 2: alcohol\\nInteraction: effect\\n\\nSentence: The action of the benzodiazepines may be potentiated by anticonvulsants, antihistamines, alcohol, barbiturates, monoamine oxidase inhibitors, narcotics, phenothiazines, psychotropic medications, or other drugs that produce CNS depression.\\nDrug 1: benzodiazepines\\nDrug 2: barbiturates\\nInteraction: effect\\n\\nSentence: The action of the benzodiazepines may be potentiated by anticonvulsants, antihistamines, alcohol, barbiturates, monoamine oxidase inhibitors, narcotics, phenothiazines, psychotropic medications, or other drugs that produce CNS depression.\\nDrug 1: benzodiazepines\\nDrug 2: monoamine oxidase inhibitors\\nInteraction: effect\\n\\nSentence: The actions of the benzodiazepines may be potentiated by barbiturates, narcotics, phenothiazines, monoamine oxidase inhibitors or other antidepressants.\\nDrug1: benzodiazepines\\nDrug2: antidepressants\\nInteraction:,  effect other mechanism none advice )</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>354</th>\n",
       "      <td>21838</td>\n",
       "      <td>DDI-DrugBank.d558.s8.p0</td>\n",
       "      <td>In an analysis of the supraventricular arrhythmia and DIAMOND patient populations, the concomitant administration of verapamil with dofetilide was associated with a higher occurrence of torsade de pointes.</td>\n",
       "      <td>DDI-effect</td>\n",
       "      <td>DDI-DrugBank.d558</td>\n",
       "      <td>dev</td>\n",
       "      <td>verapamil</td>\n",
       "      <td>dofetilide</td>\n",
       "      <td>Sentence: In an analysis of the supraventricular arrhythmia and DIAMOND patient populations, the concomitant administration of verapamil with dofetilide was associated with a higher occurrence of torsade de pointes.\\nDrug 1: verapamil\\nDrug 2: dofetilide\\nInteraction: effect</td>\n",
       "      <td>Sentence: In an analysis of the supraventricular arrhythmia and DIAMOND patient populations, the concomitant administration of verapamil with dofetilide was associated with a higher occurrence of torsade de pointes.\\nDrug1: verapamil\\nDrug2: dofetilide\\nInteraction:</td>\n",
       "      <td>effect</td>\n",
       "      <td>{advice, mechanism, none, effect, other}</td>\n",
       "      <td>Sentence: In patients, the concomitant administration of digoxin with dofetilide was associated with a higher occurrence of torsade de pointes.\\nDrug 1: digoxin\\nDrug 2: dofetilide\\nInteraction: effect\\n\\nSentence: In clinical trials in patients undergoing PTCA/PCI, co-administration of Angiomax with heparin, warfarin, thrombolytics or glycoprotein IIb/IIIa inhibitors was associated with increased risks of major bleeding events compared to patients not receiving these concomitant medications.\\nDrug 1: Angiomax\\nDrug 2: heparin\\nInteraction: effect\\n\\nSentence: In clinical trials in patients undergoing PTCA/PCI, co-administration of Angiomax with heparin, warfarin, thrombolytics or glycoprotein IIb/IIIa inhibitors was associated with increased risks of major bleeding events compared to patients not receiving these concomitant medications.\\nDrug 1: Angiomax\\nDrug 2: warfarin\\nInteraction: effect\\n\\nSentence: In clinical trials in patients undergoing PTCA/PCI, co-administration of Angiomax with heparin, warfarin, thrombolytics or glycoprotein IIb/IIIa inhibitors was associated with increased risks of major bleeding events compared to patients not receiving these concomitant medications.\\nDrug 1: Angiomax\\nDrug 2: thrombolytics\\nInteraction: effect\\n\\nSentence: In clinical trials in patients undergoing PTCA/PCI, co-administration of Angiomax with heparin, warfarin, thrombolytics or glycoprotein IIb/IIIa inhibitors was associated with increased risks of major bleeding events compared to patients not receiving these concomitant medications.\\nDrug 1: heparin\\nDrug 2: warfarin\\nInteraction: none\\n\\nSentence: In an analysis of the supraventricular arrhythmia and DIAMOND patient populations, the concomitant administration of verapamil with dofetilide was associated with a higher occurrence of torsade de pointes.\\nDrug1: verapamil\\nDrug2: dofetilide\\nInteraction:</td>\n",
       "      <td>effect</td>\n",
       "      <td>({'id': 'cmpl-4IU91N7Sk5Bs398xpFdRwwDvzGRjS', 'object': 'text_completion', 'created': 1640311127, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      1856\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.020413725\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" effect\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" effect\": -0.020413725\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" effect\"\n",
       "}]}, Sentence: In patients, the concomitant administration of digoxin with dofetilide was associated with a higher occurrence of torsade de pointes.\\nDrug 1: digoxin\\nDrug 2: dofetilide\\nInteraction: effect\\n\\nSentence: In clinical trials in patients undergoing PTCA/PCI, co-administration of Angiomax with heparin, warfarin, thrombolytics or glycoprotein IIb/IIIa inhibitors was associated with increased risks of major bleeding events compared to patients not receiving these concomitant medications.\\nDrug 1: Angiomax\\nDrug 2: heparin\\nInteraction: effect\\n\\nSentence: In clinical trials in patients undergoing PTCA/PCI, co-administration of Angiomax with heparin, warfarin, thrombolytics or glycoprotein IIb/IIIa inhibitors was associated with increased risks of major bleeding events compared to patients not receiving these concomitant medications.\\nDrug 1: Angiomax\\nDrug 2: warfarin\\nInteraction: effect\\n\\nSentence: In clinical trials in patients undergoing PTCA/PCI, co-administration of Angiomax with heparin, warfarin, thrombolytics or glycoprotein IIb/IIIa inhibitors was associated with increased risks of major bleeding events compared to patients not receiving these concomitant medications.\\nDrug 1: Angiomax\\nDrug 2: thrombolytics\\nInteraction: effect\\n\\nSentence: In clinical trials in patients undergoing PTCA/PCI, co-administration of Angiomax with heparin, warfarin, thrombolytics or glycoprotein IIb/IIIa inhibitors was associated with increased risks of major bleeding events compared to patients not receiving these concomitant medications.\\nDrug 1: heparin\\nDrug 2: warfarin\\nInteraction: none\\n\\nSentence: In an analysis of the supraventricular arrhythmia and DIAMOND patient populations, the concomitant administration of verapamil with dofetilide was associated with a higher occurrence of torsade de pointes.\\nDrug1: verapamil\\nDrug2: dofetilide\\nInteraction:,  effect other mechanism none advice )</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>265</th>\n",
       "      <td>17981</td>\n",
       "      <td>DDI-DrugBank.d396.s0.p18</td>\n",
       "      <td>Patients receiving other narcotic analgesics, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with hydrocodone and acetaminophen tablets may exhibit an additive CNS depression.</td>\n",
       "      <td>DDI-effect</td>\n",
       "      <td>DDI-DrugBank.d396</td>\n",
       "      <td>dev</td>\n",
       "      <td>alcohol</td>\n",
       "      <td>hydrocodone</td>\n",
       "      <td>Sentence: Patients receiving other narcotic analgesics, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with hydrocodone and acetaminophen tablets may exhibit an additive CNS depression.\\nDrug 1: alcohol\\nDrug 2: hydrocodone\\nInteraction: effect</td>\n",
       "      <td>Sentence: Patients receiving other narcotic analgesics, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with hydrocodone and acetaminophen tablets may exhibit an additive CNS depression.\\nDrug1: alcohol\\nDrug2: hydrocodone\\nInteraction:</td>\n",
       "      <td>effect</td>\n",
       "      <td>{advice, mechanism, none, effect, other}</td>\n",
       "      <td>Sentence: Patients receiving other narcotic analgesics, general anesthetics, phenothiazines, tranquilizers, sedative-hypnotics, tricyclic antidepressants or other CNS depressants (including alcohol) concomitantly with DILAUDID may exhibit an additive CNS depression.\\nDrug 1: narcotic analgesic\\nDrug 2: anesthetics\\nInteraction: none\\n\\nSentence: Patients receiving other narcotic analgesics, general anesthetics, phenothiazines, tranquilizers, sedative-hypnotics, tricyclic antidepressants or other CNS depressants (including alcohol) concomitantly with DILAUDID may exhibit an additive CNS depression.\\nDrug 1: narcotic analgesic\\nDrug 2: phenothiazines\\nInteraction: none\\n\\nSentence: Patients receiving other narcotic analgesics, general anesthetics, phenothiazines, tranquilizers, sedative-hypnotics, tricyclic antidepressants or other CNS depressants (including alcohol) concomitantly with DILAUDID may exhibit an additive CNS depression.\\nDrug 1: narcotic analgesic\\nDrug 2: tranquilizers\\nInteraction: none\\n\\nSentence: Patients receiving other narcotic analgesics, general anesthetics, phenothiazines, tranquilizers, sedative-hypnotics, tricyclic antidepressants or other CNS depressants (including alcohol) concomitantly with DILAUDID may exhibit an additive CNS depression.\\nDrug 1: narcotic analgesic\\nDrug 2: sedative-hypnotics\\nInteraction: none\\n\\nSentence: Patients receiving other narcotic analgesics, general anesthetics, phenothiazines, tranquilizers, sedative-hypnotics, tricyclic antidepressants or other CNS depressants (including alcohol) concomitantly with DILAUDID may exhibit an additive CNS depression.\\nDrug 1: narcotic analgesic\\nDrug 2: tricyclic antidepressants\\nInteraction: none\\n\\nSentence: Patients receiving other narcotic analgesics, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with hydrocodone and acetaminophen tablets may exhibit an additive CNS depression.\\nDrug1: alcohol\\nDrug2: hydrocodone\\nInteraction:</td>\n",
       "      <td>none</td>\n",
       "      <td>({'id': 'cmpl-4IU91IOnl7d0F6Hoh6giSD0zUZ0x8', 'object': 'text_completion', 'created': 1640311127, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      1971\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.007345331\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" none\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" none\": -0.007345331\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" none\"\n",
       "}]}, Sentence: Patients receiving other narcotic analgesics, general anesthetics, phenothiazines, tranquilizers, sedative-hypnotics, tricyclic antidepressants or other CNS depressants (including alcohol) concomitantly with DILAUDID may exhibit an additive CNS depression.\\nDrug 1: narcotic analgesic\\nDrug 2: anesthetics\\nInteraction: none\\n\\nSentence: Patients receiving other narcotic analgesics, general anesthetics, phenothiazines, tranquilizers, sedative-hypnotics, tricyclic antidepressants or other CNS depressants (including alcohol) concomitantly with DILAUDID may exhibit an additive CNS depression.\\nDrug 1: narcotic analgesic\\nDrug 2: phenothiazines\\nInteraction: none\\n\\nSentence: Patients receiving other narcotic analgesics, general anesthetics, phenothiazines, tranquilizers, sedative-hypnotics, tricyclic antidepressants or other CNS depressants (including alcohol) concomitantly with DILAUDID may exhibit an additive CNS depression.\\nDrug 1: narcotic analgesic\\nDrug 2: tranquilizers\\nInteraction: none\\n\\nSentence: Patients receiving other narcotic analgesics, general anesthetics, phenothiazines, tranquilizers, sedative-hypnotics, tricyclic antidepressants or other CNS depressants (including alcohol) concomitantly with DILAUDID may exhibit an additive CNS depression.\\nDrug 1: narcotic analgesic\\nDrug 2: sedative-hypnotics\\nInteraction: none\\n\\nSentence: Patients receiving other narcotic analgesics, general anesthetics, phenothiazines, tranquilizers, sedative-hypnotics, tricyclic antidepressants or other CNS depressants (including alcohol) concomitantly with DILAUDID may exhibit an additive CNS depression.\\nDrug 1: narcotic analgesic\\nDrug 2: tricyclic antidepressants\\nInteraction: none\\n\\nSentence: Patients receiving other narcotic analgesics, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with hydrocodone and acetaminophen tablets may exhibit an additive CNS depression.\\nDrug1: alcohol\\nDrug2: hydrocodone\\nInteraction:,  effect other mechanism none advice )</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>41</th>\n",
       "      <td>2563</td>\n",
       "      <td>DDI-DrugBank.d132.s14.p0</td>\n",
       "      <td>Concomitant administration of diflunisal and acetaminophen in dogs, but not in rats, at approximately 2 times the recommended maximum human therapeutic dose of each (40 to 52 mg/kg/day of diflunisal/acetaminophen) resulted in greater gastrointestinal toxicity than when either drug was administered alone.</td>\n",
       "      <td>DDI-effect</td>\n",
       "      <td>DDI-DrugBank.d132</td>\n",
       "      <td>dev</td>\n",
       "      <td>diflunisal</td>\n",
       "      <td>acetaminophen</td>\n",
       "      <td>Sentence: Concomitant administration of diflunisal and acetaminophen in dogs, but not in rats, at approximately 2 times the recommended maximum human therapeutic dose of each (40 to 52 mg/kg/day of diflunisal/acetaminophen) resulted in greater gastrointestinal toxicity than when either drug was administered alone.\\nDrug 1: diflunisal\\nDrug 2: acetaminophen\\nInteraction: effect</td>\n",
       "      <td>Sentence: Concomitant administration of diflunisal and acetaminophen in dogs, but not in rats, at approximately 2 times the recommended maximum human therapeutic dose of each (40 to 52 mg/kg/day of diflunisal/acetaminophen) resulted in greater gastrointestinal toxicity than when either drug was administered alone.\\nDrug1: diflunisal\\nDrug2: acetaminophen\\nInteraction:</td>\n",
       "      <td>effect</td>\n",
       "      <td>{advice, mechanism, none, effect, other}</td>\n",
       "      <td>Sentence: Diclofenac: Administration of morning and lunch doses of Starlix 120 mg in combination with a single 75-mg dose of diclofenac in healthy volunteers resulted in no significant changes to the pharmacokinetics of either agent.\\nDrug 1: Diclofenac\\nDrug 2: Starlix\\nInteraction: none\\n\\nSentence: Diclofenac: Administration of morning and lunch doses of Starlix 120 mg in combination with a single 75-mg dose of diclofenac in healthy volunteers resulted in no significant changes to the pharmacokinetics of either agent.\\nDrug 1: Diclofenac\\nDrug 2: diclofenac\\nInteraction: none\\n\\nSentence: Diclofenac: Administration of morning and lunch doses of Starlix 120 mg in combination with a single 75-mg dose of diclofenac in healthy volunteers resulted in no significant changes to the pharmacokinetics of either agent.\\nDrug 1: Starlix\\nDrug 2: diclofenac\\nInteraction: none\\n\\nSentence: Warfarin: In a study in healthy volunteers, no clinically relevant pharmacokinetic or pharmacodynamic interaction between isradipine and racemic warfarin was seen when two single oral doses of warfarin (0.7 mg/kg body weight) were administered during 11 days of multipledose treatment with 5 mg b.i.d. isradipine.\\nDrug 1: Warfarin\\nDrug 2: isradipine\\nInteraction: none\\n\\nSentence: Warfarin: In a study in healthy volunteers, no clinically relevant pharmacokinetic or pharmacodynamic interaction between isradipine and racemic warfarin was seen when two single oral doses of warfarin (0.7 mg/kg body weight) were administered during 11 days of multipledose treatment with 5 mg b.i.d. isradipine.\\nDrug 1: Warfarin\\nDrug 2: warfarin\\nInteraction: none\\n\\nSentence: Concomitant administration of diflunisal and acetaminophen in dogs, but not in rats, at approximately 2 times the recommended maximum human therapeutic dose of each (40 to 52 mg/kg/day of diflunisal/acetaminophen) resulted in greater gastrointestinal toxicity than when either drug was administered alone.\\nDrug1: diflunisal\\nDrug2: acetaminophen\\nInteraction:</td>\n",
       "      <td>none</td>\n",
       "      <td>({'id': 'cmpl-4IU91cqSSKVbT2QXgi7Ue30Unb1vt', 'object': 'text_completion', 'created': 1640311127, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      1990\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.008622842\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" none\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" none\": -0.008622842\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" none\"\n",
       "}]}, Sentence: Diclofenac: Administration of morning and lunch doses of Starlix 120 mg in combination with a single 75-mg dose of diclofenac in healthy volunteers resulted in no significant changes to the pharmacokinetics of either agent.\\nDrug 1: Diclofenac\\nDrug 2: Starlix\\nInteraction: none\\n\\nSentence: Diclofenac: Administration of morning and lunch doses of Starlix 120 mg in combination with a single 75-mg dose of diclofenac in healthy volunteers resulted in no significant changes to the pharmacokinetics of either agent.\\nDrug 1: Diclofenac\\nDrug 2: diclofenac\\nInteraction: none\\n\\nSentence: Diclofenac: Administration of morning and lunch doses of Starlix 120 mg in combination with a single 75-mg dose of diclofenac in healthy volunteers resulted in no significant changes to the pharmacokinetics of either agent.\\nDrug 1: Starlix\\nDrug 2: diclofenac\\nInteraction: none\\n\\nSentence: Warfarin: In a study in healthy volunteers, no clinically relevant pharmacokinetic or pharmacodynamic interaction between isradipine and racemic warfarin was seen when two single oral doses of warfarin (0.7 mg/kg body weight) were administered during 11 days of multipledose treatment with 5 mg b.i.d. isradipine.\\nDrug 1: Warfarin\\nDrug 2: isradipine\\nInteraction: none\\n\\nSentence: Warfarin: In a study in healthy volunteers, no clinically relevant pharmacokinetic or pharmacodynamic interaction between isradipine and racemic warfarin was seen when two single oral doses of warfarin (0.7 mg/kg body weight) were administered during 11 days of multipledose treatment with 5 mg b.i.d. isradipine.\\nDrug 1: Warfarin\\nDrug 2: warfarin\\nInteraction: none\\n\\nSentence: Concomitant administration of diflunisal and acetaminophen in dogs, but not in rats, at approximately 2 times the recommended maximum human therapeutic dose of each (40 to 52 mg/kg/day of diflunisal/acetaminophen) resulted in greater gastrointestinal toxicity than when either drug was administered alone.\\nDrug1: diflunisal\\nDrug2: acetaminophen\\nInteraction:,  effect other mechanism none advice )</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>643</td>\n",
       "      <td>DDI-DrugBank.d238.s4.p0</td>\n",
       "      <td>Several tricyclic antidepressants have been reported to block the pharmacologic effects of guanethidine, clonidine, or similar agents, and such an effect may be anticipated with CMI because of its structural similarity to other tricyclic antidepressants.</td>\n",
       "      <td>DDI-effect</td>\n",
       "      <td>DDI-DrugBank.d238</td>\n",
       "      <td>dev</td>\n",
       "      <td>tricyclic antidepressants</td>\n",
       "      <td>guanethidine</td>\n",
       "      <td>Sentence: Several tricyclic antidepressants have been reported to block the pharmacologic effects of guanethidine, clonidine, or similar agents, and such an effect may be anticipated with CMI because of its structural similarity to other tricyclic antidepressants.\\nDrug 1: tricyclic antidepressants\\nDrug 2: guanethidine\\nInteraction: effect</td>\n",
       "      <td>Sentence: Several tricyclic antidepressants have been reported to block the pharmacologic effects of guanethidine, clonidine, or similar agents, and such an effect may be anticipated with CMI because of its structural similarity to other tricyclic antidepressants.\\nDrug1: tricyclic antidepressants\\nDrug2: guanethidine\\nInteraction:</td>\n",
       "      <td>effect</td>\n",
       "      <td>{advice, mechanism, none, effect, other}</td>\n",
       "      <td>Sentence: Tricyclic antidepressants have been reported to blunt the hypotensive effect of systemic clonidine.It is not known whether the concurrent use of these agents with ALPHAGAN P in humans can lead to resulting interference with the IOP lowering effect.\\nDrug 1: Tricyclic antidepressants\\nDrug 2: clonidine\\nInteraction: effect\\n\\nSentence: Tricyclic antidepressants have been reported to blunt the hypotensive effect of systemic clonidine.It is not known whether the concurrent use of these agents with ALPHAGAN P in humans can lead to resulting interference with the IOP lowering effect.\\nDrug 1: Tricyclic antidepressants\\nDrug 2: ALPHAGAN P\\nInteraction: none\\n\\nSentence: Tricyclic antidepressants have been reported to blunt the hypotensive effect of systemic clonidine.It is not known whether the concurrent use of these agents with ALPHAGAN P in humans can lead to resulting interference with the IOP lowering effect.\\nDrug 1: clonidine\\nDrug 2: ALPHAGAN P\\nInteraction: none\\n\\nSentence: Due to their similar mechanism of action, it is expected that the neuromuscular blockade produced by any of the non-depolarizing muscle relaxants could be prolonged in the presence of piperacillin.\\nDrug 1: non-depolarizing muscle relaxants\\nDrug 2: piperacillin\\nInteraction: effect\\n\\nSentence: Avoid the use of preparations such as decongestants and local anesthetics which contain any sympathomimetic amine (e.g., epinephrine, norepinephrine), since it has been reported that tricyclic antidepressants can potentiate the effects of catecholamines.\\nDrug 1: decongestants\\nDrug 2: anesthetics\\nInteraction: none\\n\\nSentence: Several tricyclic antidepressants have been reported to block the pharmacologic effects of guanethidine, clonidine, or similar agents, and such an effect may be anticipated with CMI because of its structural similarity to other tricyclic antidepressants.\\nDrug1: tricyclic antidepressants\\nDrug2: guanethidine\\nInteraction:</td>\n",
       "      <td>none</td>\n",
       "      <td>({'id': 'cmpl-4IU927UqzTrtLVSqJBXOINZ8XaxE0', 'object': 'text_completion', 'created': 1640311128, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      1926\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.58492255\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" none\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" none\": -0.58492255\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" none\"\n",
       "}]}, Sentence: Tricyclic antidepressants have been reported to blunt the hypotensive effect of systemic clonidine.It is not known whether the concurrent use of these agents with ALPHAGAN P in humans can lead to resulting interference with the IOP lowering effect.\\nDrug 1: Tricyclic antidepressants\\nDrug 2: clonidine\\nInteraction: effect\\n\\nSentence: Tricyclic antidepressants have been reported to blunt the hypotensive effect of systemic clonidine.It is not known whether the concurrent use of these agents with ALPHAGAN P in humans can lead to resulting interference with the IOP lowering effect.\\nDrug 1: Tricyclic antidepressants\\nDrug 2: ALPHAGAN P\\nInteraction: none\\n\\nSentence: Tricyclic antidepressants have been reported to blunt the hypotensive effect of systemic clonidine.It is not known whether the concurrent use of these agents with ALPHAGAN P in humans can lead to resulting interference with the IOP lowering effect.\\nDrug 1: clonidine\\nDrug 2: ALPHAGAN P\\nInteraction: none\\n\\nSentence: Due to their similar mechanism of action, it is expected that the neuromuscular blockade produced by any of the non-depolarizing muscle relaxants could be prolonged in the presence of piperacillin.\\nDrug 1: non-depolarizing muscle relaxants\\nDrug 2: piperacillin\\nInteraction: effect\\n\\nSentence: Avoid the use of preparations such as decongestants and local anesthetics which contain any sympathomimetic amine (e.g., epinephrine, norepinephrine), since it has been reported that tricyclic antidepressants can potentiate the effects of catecholamines.\\nDrug 1: decongestants\\nDrug 2: anesthetics\\nInteraction: none\\n\\nSentence: Several tricyclic antidepressants have been reported to block the pharmacologic effects of guanethidine, clonidine, or similar agents, and such an effect may be anticipated with CMI because of its structural similarity to other tricyclic antidepressants.\\nDrug1: tricyclic antidepressants\\nDrug2: guanethidine\\nInteraction:,  effect other mechanism none advice )</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>55</th>\n",
       "      <td>3227</td>\n",
       "      <td>DDI-DrugBank.d564.s0.p7</td>\n",
       "      <td>The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension.</td>\n",
       "      <td>DDI-effect</td>\n",
       "      <td>DDI-DrugBank.d564</td>\n",
       "      <td>dev</td>\n",
       "      <td>norepinephrine</td>\n",
       "      <td>monoamine oxidase inhibitors</td>\n",
       "      <td>Sentence: The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension.\\nDrug 1: norepinephrine\\nDrug 2: monoamine oxidase inhibitors\\nInteraction: effect</td>\n",
       "      <td>Sentence: The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension.\\nDrug1: norepinephrine\\nDrug2: monoamine oxidase inhibitors\\nInteraction:</td>\n",
       "      <td>effect</td>\n",
       "      <td>{advice, mechanism, none, effect, other}</td>\n",
       "      <td>Sentence: The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension.\\nDrug 1: anesthetic solutions\\nDrug 2: epinephrine\\nInteraction: none\\n\\nSentence: The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension.\\nDrug 1: anesthetic solutions\\nDrug 2: norepinephrine\\nInteraction: none\\n\\nSentence: The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension.\\nDrug 1: anesthetic solutions\\nDrug 2: monoamine oxidase inhibitors\\nInteraction: none\\n\\nSentence: The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension.\\nDrug 1: anesthetic solutions\\nDrug 2: tricyclic antidepressants\\nInteraction: none\\n\\nSentence: The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension.\\nDrug 1: epinephrine\\nDrug 2: norepinephrine\\nInteraction: none\\n\\nSentence: The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension.\\nDrug1: norepinephrine\\nDrug2: monoamine oxidase inhibitors\\nInteraction:</td>\n",
       "      <td>none</td>\n",
       "      <td>({'id': 'cmpl-4IU923UYZaYlfV7EwXb8LRjgKs3qa', 'object': 'text_completion', 'created': 1640311128, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      1782\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.0006991211\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" none\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" none\": -0.0006991211\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" none\"\n",
       "}]}, Sentence: The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension.\\nDrug 1: anesthetic solutions\\nDrug 2: epinephrine\\nInteraction: none\\n\\nSentence: The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension.\\nDrug 1: anesthetic solutions\\nDrug 2: norepinephrine\\nInteraction: none\\n\\nSentence: The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension.\\nDrug 1: anesthetic solutions\\nDrug 2: monoamine oxidase inhibitors\\nInteraction: none\\n\\nSentence: The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension.\\nDrug 1: anesthetic solutions\\nDrug 2: tricyclic antidepressants\\nInteraction: none\\n\\nSentence: The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension.\\nDrug 1: epinephrine\\nDrug 2: norepinephrine\\nInteraction: none\\n\\nSentence: The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension.\\nDrug1: norepinephrine\\nDrug2: monoamine oxidase inhibitors\\nInteraction:,  effect other mechanism none advice )</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>196</th>\n",
       "      <td>12582</td>\n",
       "      <td>DDI-DrugBank.d485.s10.p2</td>\n",
       "      <td>Anticoagulants: Combination hormonal contraceptives may increase or decrease the effects of coumarin derivatives.</td>\n",
       "      <td>DDI-effect</td>\n",
       "      <td>DDI-DrugBank.d485</td>\n",
       "      <td>dev</td>\n",
       "      <td>hormonal contraceptives</td>\n",
       "      <td>coumarin derivatives</td>\n",
       "      <td>Sentence: Anticoagulants: Combination hormonal contraceptives may increase or decrease the effects of coumarin derivatives.\\nDrug 1: hormonal contraceptives\\nDrug 2: coumarin derivatives\\nInteraction: effect</td>\n",
       "      <td>Sentence: Anticoagulants: Combination hormonal contraceptives may increase or decrease the effects of coumarin derivatives.\\nDrug1: hormonal contraceptives\\nDrug2: coumarin derivatives\\nInteraction:</td>\n",
       "      <td>effect</td>\n",
       "      <td>{advice, mechanism, none, effect, other}</td>\n",
       "      <td>Sentence: Warfarin: Quinolones have been reported to enhance the effects of the oral anticoagulant warfarin or its derivatives.\\nDrug 1: Warfarin\\nDrug 2: Quinolones\\nInteraction: none\\n\\nSentence: Warfarin: Quinolones have been reported to enhance the effects of the oral anticoagulant warfarin or its derivatives.\\nDrug 1: Warfarin\\nDrug 2: anticoagulant\\nInteraction: none\\n\\nSentence: Warfarin: Quinolones have been reported to enhance the effects of the oral anticoagulant warfarin or its derivatives.\\nDrug 1: Warfarin\\nDrug 2: warfarin\\nInteraction: none\\n\\nSentence: Warfarin: Quinolones have been reported to enhance the effects of the oral anticoagulant warfarin or its derivatives.\\nDrug 1: Quinolones\\nDrug 2: anticoagulant\\nInteraction: none\\n\\nSentence: Warfarin: Quinolones have been reported to enhance the effects of the oral anticoagulant warfarin or its derivatives.\\nDrug 1: Quinolones\\nDrug 2: warfarin\\nInteraction: effect\\n\\nSentence: Anticoagulants: Combination hormonal contraceptives may increase or decrease the effects of coumarin derivatives.\\nDrug1: hormonal contraceptives\\nDrug2: coumarin derivatives\\nInteraction:</td>\n",
       "      <td>effect</td>\n",
       "      <td>({'id': 'cmpl-4IU920kULeqcOLjZDnZnmRLy0d7Mu', 'object': 'text_completion', 'created': 1640311128, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      1118\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.6050804\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" effect\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" effect\": -0.6050804\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" effect\"\n",
       "}]}, Sentence: Warfarin: Quinolones have been reported to enhance the effects of the oral anticoagulant warfarin or its derivatives.\\nDrug 1: Warfarin\\nDrug 2: Quinolones\\nInteraction: none\\n\\nSentence: Warfarin: Quinolones have been reported to enhance the effects of the oral anticoagulant warfarin or its derivatives.\\nDrug 1: Warfarin\\nDrug 2: anticoagulant\\nInteraction: none\\n\\nSentence: Warfarin: Quinolones have been reported to enhance the effects of the oral anticoagulant warfarin or its derivatives.\\nDrug 1: Warfarin\\nDrug 2: warfarin\\nInteraction: none\\n\\nSentence: Warfarin: Quinolones have been reported to enhance the effects of the oral anticoagulant warfarin or its derivatives.\\nDrug 1: Quinolones\\nDrug 2: anticoagulant\\nInteraction: none\\n\\nSentence: Warfarin: Quinolones have been reported to enhance the effects of the oral anticoagulant warfarin or its derivatives.\\nDrug 1: Quinolones\\nDrug 2: warfarin\\nInteraction: effect\\n\\nSentence: Anticoagulants: Combination hormonal contraceptives may increase or decrease the effects of coumarin derivatives.\\nDrug1: hormonal contraceptives\\nDrug2: coumarin derivatives\\nInteraction:,  effect other mechanism none advice )</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>137</th>\n",
       "      <td>8035</td>\n",
       "      <td>DDI-DrugBank.d522.s23.p3</td>\n",
       "      <td>Ergotamine: Concurrent use of erythromycin and ergotamine or dihydroergotamine has been associated in some patients with acute ergot toxicity characterized by severe peripheral vasospasm and dysesthesia.</td>\n",
       "      <td>DDI-effect</td>\n",
       "      <td>DDI-DrugBank.d522</td>\n",
       "      <td>dev</td>\n",
       "      <td>erythromycin</td>\n",
       "      <td>ergotamine</td>\n",
       "      <td>Sentence: Ergotamine: Concurrent use of erythromycin and ergotamine or dihydroergotamine has been associated in some patients with acute ergot toxicity characterized by severe peripheral vasospasm and dysesthesia.\\nDrug 1: erythromycin\\nDrug 2: ergotamine\\nInteraction: effect</td>\n",
       "      <td>Sentence: Ergotamine: Concurrent use of erythromycin and ergotamine or dihydroergotamine has been associated in some patients with acute ergot toxicity characterized by severe peripheral vasospasm and dysesthesia.\\nDrug1: erythromycin\\nDrug2: ergotamine\\nInteraction:</td>\n",
       "      <td>effect</td>\n",
       "      <td>{advice, mechanism, none, effect, other}</td>\n",
       "      <td>Sentence: Concurrent use of erythromycin and ergotamine or dihydroergotamine has been associated in some patients with acute ergot toxicity characterized by severe peripheral vasospasm and dysesthesia.\\nDrug 1: erythromycin\\nDrug 2: ergotamine\\nInteraction: effect\\n\\nSentence: Concurrent use of erythromycin and ergotamine or dihydroergotamine has been associated in some patients with acute ergot toxicity characterized by severe peripheral vasospasm and dysesthesia.\\nDrug 1: erythromycin\\nDrug 2: dihydroergotamine\\nInteraction: effect\\n\\nSentence: Concurrent use of erythromycin and ergotamine or dihydroergotamine has been associated in some patients with acute ergot toxicity characterized by severe peripheral vasospasm and dysesthesia.\\nDrug 1: ergotamine\\nDrug 2: dihydroergotamine\\nInteraction: none\\n\\nSentence: Sumatriptan - There have been rare postmarketing reports describing patients with weakness, hyperreflexia, and incoordination following the use of a selective serotonin reuptake inhibitor (SSRI) and sumatriptan.\\nDrug 1: Sumatriptan\\nDrug 2: selective serotonin reuptake inhibitor\\nInteraction: none\\n\\nSentence: Sumatriptan - There have been rare postmarketing reports describing patients with weakness, hyperreflexia, and incoordination following the use of a selective serotonin reuptake inhibitor (SSRI) and sumatriptan.\\nDrug 1: Sumatriptan\\nDrug 2: SSRI\\nInteraction: none\\n\\nSentence: Ergotamine: Concurrent use of erythromycin and ergotamine or dihydroergotamine has been associated in some patients with acute ergot toxicity characterized by severe peripheral vasospasm and dysesthesia.\\nDrug1: erythromycin\\nDrug2: ergotamine\\nInteraction:</td>\n",
       "      <td>effect</td>\n",
       "      <td>({'id': 'cmpl-4IU93tGLDIRJPofMzuI3g0kQTtD7P', 'object': 'text_completion', 'created': 1640311129, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      1645\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.23617452\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" effect\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" effect\": -0.23617452\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" effect\"\n",
       "}]}, Sentence: Concurrent use of erythromycin and ergotamine or dihydroergotamine has been associated in some patients with acute ergot toxicity characterized by severe peripheral vasospasm and dysesthesia.\\nDrug 1: erythromycin\\nDrug 2: ergotamine\\nInteraction: effect\\n\\nSentence: Concurrent use of erythromycin and ergotamine or dihydroergotamine has been associated in some patients with acute ergot toxicity characterized by severe peripheral vasospasm and dysesthesia.\\nDrug 1: erythromycin\\nDrug 2: dihydroergotamine\\nInteraction: effect\\n\\nSentence: Concurrent use of erythromycin and ergotamine or dihydroergotamine has been associated in some patients with acute ergot toxicity characterized by severe peripheral vasospasm and dysesthesia.\\nDrug 1: ergotamine\\nDrug 2: dihydroergotamine\\nInteraction: none\\n\\nSentence: Sumatriptan - There have been rare postmarketing reports describing patients with weakness, hyperreflexia, and incoordination following the use of a selective serotonin reuptake inhibitor (SSRI) and sumatriptan.\\nDrug 1: Sumatriptan\\nDrug 2: selective serotonin reuptake inhibitor\\nInteraction: none\\n\\nSentence: Sumatriptan - There have been rare postmarketing reports describing patients with weakness, hyperreflexia, and incoordination following the use of a selective serotonin reuptake inhibitor (SSRI) and sumatriptan.\\nDrug 1: Sumatriptan\\nDrug 2: SSRI\\nInteraction: none\\n\\nSentence: Ergotamine: Concurrent use of erythromycin and ergotamine or dihydroergotamine has been associated in some patients with acute ergot toxicity characterized by severe peripheral vasospasm and dysesthesia.\\nDrug1: erythromycin\\nDrug2: ergotamine\\nInteraction:,  effect other mechanism none advice )</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>929</td>\n",
       "      <td>DDI-DrugBank.d246.s0.p3</td>\n",
       "      <td>Concurrent use of butorphanol with central nervous system depressants (e.g., alcohol, barbiturates, tranquilizers, and antihistamines) may result in increased central nervous system depressant effects.</td>\n",
       "      <td>DDI-effect</td>\n",
       "      <td>DDI-DrugBank.d246</td>\n",
       "      <td>dev</td>\n",
       "      <td>butorphanol</td>\n",
       "      <td>tranquilizers</td>\n",
       "      <td>Sentence: Concurrent use of butorphanol with central nervous system depressants (e.g., alcohol, barbiturates, tranquilizers, and antihistamines) may result in increased central nervous system depressant effects.\\nDrug 1: butorphanol\\nDrug 2: tranquilizers\\nInteraction: effect</td>\n",
       "      <td>Sentence: Concurrent use of butorphanol with central nervous system depressants (e.g., alcohol, barbiturates, tranquilizers, and antihistamines) may result in increased central nervous system depressant effects.\\nDrug1: butorphanol\\nDrug2: tranquilizers\\nInteraction:</td>\n",
       "      <td>effect</td>\n",
       "      <td>{advice, mechanism, none, effect, other}</td>\n",
       "      <td>Sentence: Antihistamines may have additive effects with alcohol and other CNS depressants, e.g., hypnotics, sedatives, tranquilizers, antianxiety agents.\\nDrug 1: Antihistamines\\nDrug 2: alcohol\\nInteraction: effect\\n\\nSentence: Antihistamines may have additive effects with alcohol and other CNS depressants, e.g., hypnotics, sedatives, tranquilizers, antianxiety agents.\\nDrug 1: Antihistamines\\nDrug 2: CNS depressants\\nInteraction: effect\\n\\nSentence: Antihistamines may have additive effects with alcohol and other CNS depressants, e.g., hypnotics, sedatives, tranquilizers, antianxiety agents.\\nDrug 1: Antihistamines\\nDrug 2: hypnotics\\nInteraction: effect\\n\\nSentence: Antihistamines may have additive effects with alcohol and other CNS depressants, e.g., hypnotics, sedatives, tranquilizers, antianxiety agents.\\nDrug 1: Antihistamines\\nDrug 2: sedatives\\nInteraction: effect\\n\\nSentence: Antihistamines may have additive effects with alcohol and other CNS depressants, e.g., hypnotics, sedatives, tranquilizers, antianxiety agents.\\nDrug 1: Antihistamines\\nDrug 2: tranquilizers\\nInteraction: effect\\n\\nSentence: Concurrent use of butorphanol with central nervous system depressants (e.g., alcohol, barbiturates, tranquilizers, and antihistamines) may result in increased central nervous system depressant effects.\\nDrug1: butorphanol\\nDrug2: tranquilizers\\nInteraction:</td>\n",
       "      <td>effect</td>\n",
       "      <td>({'id': 'cmpl-4IU93mG6UxSJgsqJqiedRrFrIbLiG', 'object': 'text_completion', 'created': 1640311129, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      1352\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.026047714\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" effect\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" effect\": -0.026047714\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" effect\"\n",
       "}]}, Sentence: Antihistamines may have additive effects with alcohol and other CNS depressants, e.g., hypnotics, sedatives, tranquilizers, antianxiety agents.\\nDrug 1: Antihistamines\\nDrug 2: alcohol\\nInteraction: effect\\n\\nSentence: Antihistamines may have additive effects with alcohol and other CNS depressants, e.g., hypnotics, sedatives, tranquilizers, antianxiety agents.\\nDrug 1: Antihistamines\\nDrug 2: CNS depressants\\nInteraction: effect\\n\\nSentence: Antihistamines may have additive effects with alcohol and other CNS depressants, e.g., hypnotics, sedatives, tranquilizers, antianxiety agents.\\nDrug 1: Antihistamines\\nDrug 2: hypnotics\\nInteraction: effect\\n\\nSentence: Antihistamines may have additive effects with alcohol and other CNS depressants, e.g., hypnotics, sedatives, tranquilizers, antianxiety agents.\\nDrug 1: Antihistamines\\nDrug 2: sedatives\\nInteraction: effect\\n\\nSentence: Antihistamines may have additive effects with alcohol and other CNS depressants, e.g., hypnotics, sedatives, tranquilizers, antianxiety agents.\\nDrug 1: Antihistamines\\nDrug 2: tranquilizers\\nInteraction: effect\\n\\nSentence: Concurrent use of butorphanol with central nervous system depressants (e.g., alcohol, barbiturates, tranquilizers, and antihistamines) may result in increased central nervous system depressant effects.\\nDrug1: butorphanol\\nDrug2: tranquilizers\\nInteraction:,  effect other mechanism none advice )</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1560</th>\n",
       "      <td>21139</td>\n",
       "      <td>DDI-DrugBank.d413.s20.p9</td>\n",
       "      <td>Chlorpropamide: Chlorpropamides plasma half-life may be prolonged by allopurinol, since allopurinol and chlorpropamide may compete for excretion in the renal tubule.</td>\n",
       "      <td>DDI-mechanism</td>\n",
       "      <td>DDI-DrugBank.d413</td>\n",
       "      <td>dev</td>\n",
       "      <td>allopurinol</td>\n",
       "      <td>chlorpropamide</td>\n",
       "      <td>Sentence: Chlorpropamide: Chlorpropamides plasma half-life may be prolonged by allopurinol, since allopurinol and chlorpropamide may compete for excretion in the renal tubule.\\nDrug 1: allopurinol\\nDrug 2: chlorpropamide\\nInteraction: mechanism</td>\n",
       "      <td>Sentence: Chlorpropamide: Chlorpropamides plasma half-life may be prolonged by allopurinol, since allopurinol and chlorpropamide may compete for excretion in the renal tubule.\\nDrug1: allopurinol\\nDrug2: chlorpropamide\\nInteraction:</td>\n",
       "      <td>mechanism</td>\n",
       "      <td>{advice, mechanism, none, effect, other}</td>\n",
       "      <td>Sentence: Aspirin: Concomitant administration of diclofenac and aspirin is not recommended because diclofenac is displaced from its binding sites during the concomitant administration of aspirin, resulting in lower plasma concentrations, peak plasma levels, and AUC values.\\nDrug 1: Aspirin\\nDrug 2: diclofenac\\nInteraction: none\\n\\nSentence: Aspirin: Concomitant administration of diclofenac and aspirin is not recommended because diclofenac is displaced from its binding sites during the concomitant administration of aspirin, resulting in lower plasma concentrations, peak plasma levels, and AUC values.\\nDrug 1: Aspirin\\nDrug 2: aspirin\\nInteraction: none\\n\\nSentence: Aspirin: Concomitant administration of diclofenac and aspirin is not recommended because diclofenac is displaced from its binding sites during the concomitant administration of aspirin, resulting in lower plasma concentrations, peak plasma levels, and AUC values.\\nDrug 1: Aspirin\\nDrug 2: diclofenac\\nInteraction: none\\n\\nSentence: Aspirin: Concomitant administration of diclofenac and aspirin is not recommended because diclofenac is displaced from its binding sites during the concomitant administration of aspirin, resulting in lower plasma concentrations, peak plasma levels, and AUC values.\\nDrug 1: Aspirin\\nDrug 2: aspirin\\nInteraction: none\\n\\nSentence: Aspirin: Concomitant administration of diclofenac and aspirin is not recommended because diclofenac is displaced from its binding sites during the concomitant administration of aspirin, resulting in lower plasma concentrations, peak plasma levels, and AUC values.\\nDrug 1: diclofenac\\nDrug 2: aspirin\\nInteraction: advice\\n\\nSentence: Chlorpropamide: Chlorpropamides plasma half-life may be prolonged by allopurinol, since allopurinol and chlorpropamide may compete for excretion in the renal tubule.\\nDrug1: allopurinol\\nDrug2: chlorpropamide\\nInteraction:</td>\n",
       "      <td>none</td>\n",
       "      <td>({'id': 'cmpl-4IU93kBZdiYjlFcIdAfisMwAE6Wff', 'object': 'text_completion', 'created': 1640311129, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      1865\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.678508\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" none\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" none\": -0.678508\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" none\"\n",
       "}]}, Sentence: Aspirin: Concomitant administration of diclofenac and aspirin is not recommended because diclofenac is displaced from its binding sites during the concomitant administration of aspirin, resulting in lower plasma concentrations, peak plasma levels, and AUC values.\\nDrug 1: Aspirin\\nDrug 2: diclofenac\\nInteraction: none\\n\\nSentence: Aspirin: Concomitant administration of diclofenac and aspirin is not recommended because diclofenac is displaced from its binding sites during the concomitant administration of aspirin, resulting in lower plasma concentrations, peak plasma levels, and AUC values.\\nDrug 1: Aspirin\\nDrug 2: aspirin\\nInteraction: none\\n\\nSentence: Aspirin: Concomitant administration of diclofenac and aspirin is not recommended because diclofenac is displaced from its binding sites during the concomitant administration of aspirin, resulting in lower plasma concentrations, peak plasma levels, and AUC values.\\nDrug 1: Aspirin\\nDrug 2: diclofenac\\nInteraction: none\\n\\nSentence: Aspirin: Concomitant administration of diclofenac and aspirin is not recommended because diclofenac is displaced from its binding sites during the concomitant administration of aspirin, resulting in lower plasma concentrations, peak plasma levels, and AUC values.\\nDrug 1: Aspirin\\nDrug 2: aspirin\\nInteraction: none\\n\\nSentence: Aspirin: Concomitant administration of diclofenac and aspirin is not recommended because diclofenac is displaced from its binding sites during the concomitant administration of aspirin, resulting in lower plasma concentrations, peak plasma levels, and AUC values.\\nDrug 1: diclofenac\\nDrug 2: aspirin\\nInteraction: advice\\n\\nSentence: Chlorpropamide: Chlorpropamides plasma half-life may be prolonged by allopurinol, since allopurinol and chlorpropamide may compete for excretion in the renal tubule.\\nDrug1: allopurinol\\nDrug2: chlorpropamide\\nInteraction:,  effect other mechanism none advice )</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1283</th>\n",
       "      <td>4216</td>\n",
       "      <td>DDI-DrugBank.d487.s1.p7</td>\n",
       "      <td>Drugs that induce hepatic enzymes such as phenobarbital, phenytoin and rifampin may increase the clearance of corticosteroids and may require increases in corticosteroid dose to achieve the desired response.</td>\n",
       "      <td>DDI-mechanism</td>\n",
       "      <td>DDI-DrugBank.d487</td>\n",
       "      <td>dev</td>\n",
       "      <td>rifampin</td>\n",
       "      <td>corticosteroids</td>\n",
       "      <td>Sentence: Drugs that induce hepatic enzymes such as phenobarbital, phenytoin and rifampin may increase the clearance of corticosteroids and may require increases in corticosteroid dose to achieve the desired response.\\nDrug 1: rifampin\\nDrug 2: corticosteroids\\nInteraction: mechanism</td>\n",
       "      <td>Sentence: Drugs that induce hepatic enzymes such as phenobarbital, phenytoin and rifampin may increase the clearance of corticosteroids and may require increases in corticosteroid dose to achieve the desired response.\\nDrug1: rifampin\\nDrug2: corticosteroids\\nInteraction:</td>\n",
       "      <td>mechanism</td>\n",
       "      <td>{advice, mechanism, none, effect, other}</td>\n",
       "      <td>Sentence: Drugs which inhibit CYP 3A4 (e.g., ketoconazole, macrolide antibiotics such as erythromycin) have the potential to result in increased plasma concentrations of corticosteroids.\\nDrug 1: ketoconazole\\nDrug 2: macrolide antibiotics\\nInteraction: none\\n\\nSentence: Drugs which inhibit CYP 3A4 (e.g., ketoconazole, macrolide antibiotics such as erythromycin) have the potential to result in increased plasma concentrations of corticosteroids.\\nDrug 1: ketoconazole\\nDrug 2: erythromycin\\nInteraction: none\\n\\nSentence: Drugs which inhibit CYP 3A4 (e.g., ketoconazole, macrolide antibiotics such as erythromycin) have the potential to result in increased plasma concentrations of corticosteroids.\\nDrug 1: ketoconazole\\nDrug 2: corticosteroids\\nInteraction: mechanism\\n\\nSentence: Drugs which inhibit CYP 3A4 (e.g., ketoconazole, macrolide antibiotics such as erythromycin) have the potential to result in increased plasma concentrations of corticosteroids.\\nDrug 1: macrolide antibiotics\\nDrug 2: erythromycin\\nInteraction: none\\n\\nSentence: Drugs which inhibit CYP 3A4 (e.g., ketoconazole, macrolide antibiotics such as erythromycin) have the potential to result in increased plasma concentrations of corticosteroids.\\nDrug 1: macrolide antibiotics\\nDrug 2: corticosteroids\\nInteraction: mechanism\\n\\nSentence: Drugs that induce hepatic enzymes such as phenobarbital, phenytoin and rifampin may increase the clearance of corticosteroids and may require increases in corticosteroid dose to achieve the desired response.\\nDrug1: rifampin\\nDrug2: corticosteroids\\nInteraction:</td>\n",
       "      <td>mechanism</td>\n",
       "      <td>({'id': 'cmpl-4IU93OJiZV0Pcty6bu1Kcd7rhAfK1', 'object': 'text_completion', 'created': 1640311129, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      1552\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.24739274\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" mechanism\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" mechanism\": -0.24739274\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" mechanism\"\n",
       "}]}, Sentence: Drugs which inhibit CYP 3A4 (e.g., ketoconazole, macrolide antibiotics such as erythromycin) have the potential to result in increased plasma concentrations of corticosteroids.\\nDrug 1: ketoconazole\\nDrug 2: macrolide antibiotics\\nInteraction: none\\n\\nSentence: Drugs which inhibit CYP 3A4 (e.g., ketoconazole, macrolide antibiotics such as erythromycin) have the potential to result in increased plasma concentrations of corticosteroids.\\nDrug 1: ketoconazole\\nDrug 2: erythromycin\\nInteraction: none\\n\\nSentence: Drugs which inhibit CYP 3A4 (e.g., ketoconazole, macrolide antibiotics such as erythromycin) have the potential to result in increased plasma concentrations of corticosteroids.\\nDrug 1: ketoconazole\\nDrug 2: corticosteroids\\nInteraction: mechanism\\n\\nSentence: Drugs which inhibit CYP 3A4 (e.g., ketoconazole, macrolide antibiotics such as erythromycin) have the potential to result in increased plasma concentrations of corticosteroids.\\nDrug 1: macrolide antibiotics\\nDrug 2: erythromycin\\nInteraction: none\\n\\nSentence: Drugs which inhibit CYP 3A4 (e.g., ketoconazole, macrolide antibiotics such as erythromycin) have the potential to result in increased plasma concentrations of corticosteroids.\\nDrug 1: macrolide antibiotics\\nDrug 2: corticosteroids\\nInteraction: mechanism\\n\\nSentence: Drugs that induce hepatic enzymes such as phenobarbital, phenytoin and rifampin may increase the clearance of corticosteroids and may require increases in corticosteroid dose to achieve the desired response.\\nDrug1: rifampin\\nDrug2: corticosteroids\\nInteraction:,  effect other mechanism none advice )</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1458</th>\n",
       "      <td>14400</td>\n",
       "      <td>DDI-DrugBank.d157.s1.p0</td>\n",
       "      <td>(See CLINICAL PHARMACOLOGY) Coadministration of Femara and tamoxifen 20 mg daily resulted in a reduction of letrozole plasma levels by 38% on average.</td>\n",
       "      <td>DDI-mechanism</td>\n",
       "      <td>DDI-DrugBank.d157</td>\n",
       "      <td>dev</td>\n",
       "      <td>Femara</td>\n",
       "      <td>tamoxifen</td>\n",
       "      <td>Sentence: (See CLINICAL PHARMACOLOGY) Coadministration of Femara and tamoxifen 20 mg daily resulted in a reduction of letrozole plasma levels by 38% on average.\\nDrug 1: Femara\\nDrug 2: tamoxifen\\nInteraction: mechanism</td>\n",
       "      <td>Sentence: (See CLINICAL PHARMACOLOGY) Coadministration of Femara and tamoxifen 20 mg daily resulted in a reduction of letrozole plasma levels by 38% on average.\\nDrug1: Femara\\nDrug2: tamoxifen\\nInteraction:</td>\n",
       "      <td>mechanism</td>\n",
       "      <td>{advice, mechanism, none, effect, other}</td>\n",
       "      <td>Sentence: Rifampin: Co-administration of VIOXX with rifampin 600 mg daily, a potent inducer of hepatic metabolism, produced an approximate 50% decrease in rofecoxib plasma concentrations.\\nDrug 1: Rifampin\\nDrug 2: VIOXX\\nInteraction: none\\n\\nSentence: Rifampin: Co-administration of VIOXX with rifampin 600 mg daily, a potent inducer of hepatic metabolism, produced an approximate 50% decrease in rofecoxib plasma concentrations.\\nDrug 1: Rifampin\\nDrug 2: rifampin\\nInteraction: none\\n\\nSentence: Rifampin: Co-administration of VIOXX with rifampin 600 mg daily, a potent inducer of hepatic metabolism, produced an approximate 50% decrease in rofecoxib plasma concentrations.\\nDrug 1: Rifampin\\nDrug 2: rofecoxib\\nInteraction: none\\n\\nSentence: Rifampin: Co-administration of VIOXX with rifampin 600 mg daily, a potent inducer of hepatic metabolism, produced an approximate 50% decrease in rofecoxib plasma concentrations.\\nDrug 1: VIOXX\\nDrug 2: rifampin\\nInteraction: mechanism\\n\\nSentence: Rifampin: Co-administration of VIOXX with rifampin 600 mg daily, a potent inducer of hepatic metabolism, produced an approximate 50% decrease in rofecoxib plasma concentrations.\\nDrug 1: VIOXX\\nDrug 2: rofecoxib\\nInteraction: none\\n\\nSentence: (See CLINICAL PHARMACOLOGY) Coadministration of Femara and tamoxifen 20 mg daily resulted in a reduction of letrozole plasma levels by 38% on average.\\nDrug1: Femara\\nDrug2: tamoxifen\\nInteraction:</td>\n",
       "      <td>mechanism</td>\n",
       "      <td>({'id': 'cmpl-4IU940JPgGvVuIy87rHlTgE157C88', 'object': 'text_completion', 'created': 1640311130, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      1407\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.17020744\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" mechanism\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" mechanism\": -0.17020744\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" mechanism\"\n",
       "}]}, Sentence: Rifampin: Co-administration of VIOXX with rifampin 600 mg daily, a potent inducer of hepatic metabolism, produced an approximate 50% decrease in rofecoxib plasma concentrations.\\nDrug 1: Rifampin\\nDrug 2: VIOXX\\nInteraction: none\\n\\nSentence: Rifampin: Co-administration of VIOXX with rifampin 600 mg daily, a potent inducer of hepatic metabolism, produced an approximate 50% decrease in rofecoxib plasma concentrations.\\nDrug 1: Rifampin\\nDrug 2: rifampin\\nInteraction: none\\n\\nSentence: Rifampin: Co-administration of VIOXX with rifampin 600 mg daily, a potent inducer of hepatic metabolism, produced an approximate 50% decrease in rofecoxib plasma concentrations.\\nDrug 1: Rifampin\\nDrug 2: rofecoxib\\nInteraction: none\\n\\nSentence: Rifampin: Co-administration of VIOXX with rifampin 600 mg daily, a potent inducer of hepatic metabolism, produced an approximate 50% decrease in rofecoxib plasma concentrations.\\nDrug 1: VIOXX\\nDrug 2: rifampin\\nInteraction: mechanism\\n\\nSentence: Rifampin: Co-administration of VIOXX with rifampin 600 mg daily, a potent inducer of hepatic metabolism, produced an approximate 50% decrease in rofecoxib plasma concentrations.\\nDrug 1: VIOXX\\nDrug 2: rofecoxib\\nInteraction: none\\n\\nSentence: (See CLINICAL PHARMACOLOGY) Coadministration of Femara and tamoxifen 20 mg daily resulted in a reduction of letrozole plasma levels by 38% on average.\\nDrug1: Femara\\nDrug2: tamoxifen\\nInteraction:,  effect other mechanism none advice )</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1462</th>\n",
       "      <td>14502</td>\n",
       "      <td>DDI-DrugBank.d198.s22.p3</td>\n",
       "      <td>In vivo studies: Nitrates: The blood pressure lowering effects of sublingual nitrates (0.4 mg) taken 1 and 4 hours after vardenafil and increases in heart rate when taken at 1, 4 and 8 hours were potentiated by a 20 mg dose of Vardenafil in healthy middle-aged subjects.</td>\n",
       "      <td>DDI-mechanism</td>\n",
       "      <td>DDI-DrugBank.d198</td>\n",
       "      <td>dev</td>\n",
       "      <td>nitrates</td>\n",
       "      <td>vardenafil</td>\n",
       "      <td>Sentence: In vivo studies: Nitrates: The blood pressure lowering effects of sublingual nitrates (0.4 mg) taken 1 and 4 hours after vardenafil and increases in heart rate when taken at 1, 4 and 8 hours were potentiated by a 20 mg dose of Vardenafil in healthy middle-aged subjects.\\nDrug 1: nitrates\\nDrug 2: vardenafil\\nInteraction: mechanism</td>\n",
       "      <td>Sentence: In vivo studies: Nitrates: The blood pressure lowering effects of sublingual nitrates (0.4 mg) taken 1 and 4 hours after vardenafil and increases in heart rate when taken at 1, 4 and 8 hours were potentiated by a 20 mg dose of Vardenafil in healthy middle-aged subjects.\\nDrug1: nitrates\\nDrug2: vardenafil\\nInteraction:</td>\n",
       "      <td>mechanism</td>\n",
       "      <td>{advice, mechanism, none, effect, other}</td>\n",
       "      <td>Sentence: Alpha-blockers: When Vardenafil 10 or 20 mg was given to healthy volunteers either simultaneously or 6 hours after a 10 mg dose of terazosin, significant hypotension developed in a substantial number of subjects.\\nDrug 1: Alpha-blockers\\nDrug 2: Vardenafil\\nInteraction: none\\n\\nSentence: Alpha-blockers: When Vardenafil 10 or 20 mg was given to healthy volunteers either simultaneously or 6 hours after a 10 mg dose of terazosin, significant hypotension developed in a substantial number of subjects.\\nDrug 1: Alpha-blockers\\nDrug 2: terazosin\\nInteraction: none\\n\\nSentence: Alpha-blockers: When Vardenafil 10 or 20 mg was given to healthy volunteers either simultaneously or 6 hours after a 10 mg dose of terazosin, significant hypotension developed in a substantial number of subjects.\\nDrug 1: Vardenafil\\nDrug 2: terazosin\\nInteraction: effect\\n\\nSentence: Cimetidine: In a study in healthy volunteers, a one-week course of cimetidine at 400 mg b.i.d. with a single 5 mg dose of isradipine on the sixth day showed an increase in isradipine mean peak plasma concentrations (36%) and significant increase in area under the curve (50%).\\nDrug 1: Cimetidine\\nDrug 2: cimetidine\\nInteraction: none\\n\\nSentence: Cimetidine: In a study in healthy volunteers, a one-week course of cimetidine at 400 mg b.i.d. with a single 5 mg dose of isradipine on the sixth day showed an increase in isradipine mean peak plasma concentrations (36%) and significant increase in area under the curve (50%).\\nDrug 1: Cimetidine\\nDrug 2: isradipine\\nInteraction: none\\n\\nSentence: In vivo studies: Nitrates: The blood pressure lowering effects of sublingual nitrates (0.4 mg) taken 1 and 4 hours after vardenafil and increases in heart rate when taken at 1, 4 and 8 hours were potentiated by a 20 mg dose of Vardenafil in healthy middle-aged subjects.\\nDrug1: nitrates\\nDrug2: vardenafil\\nInteraction:</td>\n",
       "      <td>none</td>\n",
       "      <td>({'id': 'cmpl-4IU949UpdxinXS2xEoafOHHr3xzhl', 'object': 'text_completion', 'created': 1640311130, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      1863\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.65847224\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" none\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" none\": -0.65847224\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" none\"\n",
       "}]}, Sentence: Alpha-blockers: When Vardenafil 10 or 20 mg was given to healthy volunteers either simultaneously or 6 hours after a 10 mg dose of terazosin, significant hypotension developed in a substantial number of subjects.\\nDrug 1: Alpha-blockers\\nDrug 2: Vardenafil\\nInteraction: none\\n\\nSentence: Alpha-blockers: When Vardenafil 10 or 20 mg was given to healthy volunteers either simultaneously or 6 hours after a 10 mg dose of terazosin, significant hypotension developed in a substantial number of subjects.\\nDrug 1: Alpha-blockers\\nDrug 2: terazosin\\nInteraction: none\\n\\nSentence: Alpha-blockers: When Vardenafil 10 or 20 mg was given to healthy volunteers either simultaneously or 6 hours after a 10 mg dose of terazosin, significant hypotension developed in a substantial number of subjects.\\nDrug 1: Vardenafil\\nDrug 2: terazosin\\nInteraction: effect\\n\\nSentence: Cimetidine: In a study in healthy volunteers, a one-week course of cimetidine at 400 mg b.i.d. with a single 5 mg dose of isradipine on the sixth day showed an increase in isradipine mean peak plasma concentrations (36%) and significant increase in area under the curve (50%).\\nDrug 1: Cimetidine\\nDrug 2: cimetidine\\nInteraction: none\\n\\nSentence: Cimetidine: In a study in healthy volunteers, a one-week course of cimetidine at 400 mg b.i.d. with a single 5 mg dose of isradipine on the sixth day showed an increase in isradipine mean peak plasma concentrations (36%) and significant increase in area under the curve (50%).\\nDrug 1: Cimetidine\\nDrug 2: isradipine\\nInteraction: none\\n\\nSentence: In vivo studies: Nitrates: The blood pressure lowering effects of sublingual nitrates (0.4 mg) taken 1 and 4 hours after vardenafil and increases in heart rate when taken at 1, 4 and 8 hours were potentiated by a 20 mg dose of Vardenafil in healthy middle-aged subjects.\\nDrug1: nitrates\\nDrug2: vardenafil\\nInteraction:,  effect other mechanism none advice )</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1501</th>\n",
       "      <td>15384</td>\n",
       "      <td>DDI-DrugBank.d94.s11.p27</td>\n",
       "      <td>Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.</td>\n",
       "      <td>DDI-mechanism</td>\n",
       "      <td>DDI-DrugBank.d94</td>\n",
       "      <td>dev</td>\n",
       "      <td>EQUETROTM</td>\n",
       "      <td>nortriptyline</td>\n",
       "      <td>Sentence: Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.\\nDrug 1: EQUETROTM\\nDrug 2: nortriptyline\\nInteraction: mechanism</td>\n",
       "      <td>Sentence: Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.\\nDrug1: EQUETROTM\\nDrug2: nortriptyline\\nInteraction:</td>\n",
       "      <td>mechanism</td>\n",
       "      <td>{advice, mechanism, none, effect, other}</td>\n",
       "      <td>Sentence: Agents that are CYP3A4 inhibitors that have been found, or are expected, to increase plasma levels of EQUETROTM are the following: Acetazolamide, azole antifungals, cimetidine, clarithromycin(1), dalfopristin, danazol, delavirdine, diltiazem, erythromycin(1), fluoxetine, fluvoxamine, grapefruit juice, isoniazid, itraconazole, ketoconazole, loratadine, nefazodone, niacinamide, nicotinamide, protease inhibitors, propoxyphene, quinine, quinupristin, troleandomycin, valproate(1), verapamil, zileuton.\\nDrug 1: EQUETROTM\\nDrug 2: Acetazolamide\\nInteraction: mechanism\\n\\nSentence: Agents that are CYP3A4 inhibitors that have been found, or are expected, to increase plasma levels of EQUETROTM are the following: Acetazolamide, azole antifungals, cimetidine, clarithromycin(1), dalfopristin, danazol, delavirdine, diltiazem, erythromycin(1), fluoxetine, fluvoxamine, grapefruit juice, isoniazid, itraconazole, ketoconazole, loratadine, nefazodone, niacinamide, nicotinamide, protease inhibitors, propoxyphene, quinine, quinupristin, troleandomycin, valproate(1), verapamil, zileuton.\\nDrug 1: EQUETROTM\\nDrug 2: azole antifungals\\nInteraction: mechanism\\n\\nSentence: Agents that are CYP3A4 inhibitors that have been found, or are expected, to increase plasma levels of EQUETROTM are the following: Acetazolamide, azole antifungals, cimetidine, clarithromycin(1), dalfopristin, danazol, delavirdine, diltiazem, erythromycin(1), fluoxetine, fluvoxamine, grapefruit juice, isoniazid, itraconazole, ketoconazole, loratadine, nefazodone, niacinamide, nicotinamide, protease inhibitors, propoxyphene, quinine, quinupristin, troleandomycin, valproate(1), verapamil, zileuton.\\nDrug 1: EQUETROTM\\nDrug 2: cimetidine\\nInteraction: mechanism\\n\\nSentence: Agents that are CYP3A4 inhibitors that have been found, or are expected, to increase plasma levels of EQUETROTM are the following: Acetazolamide, azole antifungals, cimetidine, clarithromycin(1), dalfopristin, danazol, delavirdine, diltiazem, erythromycin(1), fluoxetine, fluvoxamine, grapefruit juice, isoniazid, itraconazole, ketoconazole, loratadine, nefazodone, niacinamide, nicotinamide, protease inhibitors, propoxyphene, quinine, quinupristin, troleandomycin, valproate(1), verapamil, zileuton.\\nDrug 1: EQUETROTM\\nDrug 2: clarithromycin\\nInteraction: mechanism\\n\\nSentence: Agents that are CYP3A4 inhibitors that have been found, or are expected, to increase plasma levels of EQUETROTM are the following: Acetazolamide, azole antifungals, cimetidine, clarithromycin(1), dalfopristin, danazol, delavirdine, diltiazem, erythromycin(1), fluoxetine, fluvoxamine, grapefruit juice, isoniazid, itraconazole, ketoconazole, loratadine, nefazodone, niacinamide, nicotinamide, protease inhibitors, propoxyphene, quinine, quinupristin, troleandomycin, valproate(1), verapamil, zileuton.\\nDrug 1: EQUETROTM\\nDrug 2: dalfopristin\\nInteraction: mechanism\\n\\nSentence: Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.\\nDrug1: EQUETROTM\\nDrug2: nortriptyline\\nInteraction:</td>\n",
       "      <td>mechanism</td>\n",
       "      <td>({'id': 'cmpl-4IU94DzxLKaC4SBCHFkpddeik1b1h', 'object': 'text_completion', 'created': 1640311130, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      3687\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.009376137\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" mechanism\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" mechanism\": -0.009376137\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" mechanism\"\n",
       "}]}, Sentence: Agents that are CYP3A4 inhibitors that have been found, or are expected, to increase plasma levels of EQUETROTM are the following: Acetazolamide, azole antifungals, cimetidine, clarithromycin(1), dalfopristin, danazol, delavirdine, diltiazem, erythromycin(1), fluoxetine, fluvoxamine, grapefruit juice, isoniazid, itraconazole, ketoconazole, loratadine, nefazodone, niacinamide, nicotinamide, protease inhibitors, propoxyphene, quinine, quinupristin, troleandomycin, valproate(1), verapamil, zileuton.\\nDrug 1: EQUETROTM\\nDrug 2: Acetazolamide\\nInteraction: mechanism\\n\\nSentence: Agents that are CYP3A4 inhibitors that have been found, or are expected, to increase plasma levels of EQUETROTM are the following: Acetazolamide, azole antifungals, cimetidine, clarithromycin(1), dalfopristin, danazol, delavirdine, diltiazem, erythromycin(1), fluoxetine, fluvoxamine, grapefruit juice, isoniazid, itraconazole, ketoconazole, loratadine, nefazodone, niacinamide, nicotinamide, protease inhibitors, propoxyphene, quinine, quinupristin, troleandomycin, valproate(1), verapamil, zileuton.\\nDrug 1: EQUETROTM\\nDrug 2: azole antifungals\\nInteraction: mechanism\\n\\nSentence: Agents that are CYP3A4 inhibitors that have been found, or are expected, to increase plasma levels of EQUETROTM are the following: Acetazolamide, azole antifungals, cimetidine, clarithromycin(1), dalfopristin, danazol, delavirdine, diltiazem, erythromycin(1), fluoxetine, fluvoxamine, grapefruit juice, isoniazid, itraconazole, ketoconazole, loratadine, nefazodone, niacinamide, nicotinamide, protease inhibitors, propoxyphene, quinine, quinupristin, troleandomycin, valproate(1), verapamil, zileuton.\\nDrug 1: EQUETROTM\\nDrug 2: cimetidine\\nInteraction: mechanism\\n\\nSentence: Agents that are CYP3A4 inhibitors that have been found, or are expected, to increase plasma levels of EQUETROTM are the following: Acetazolamide, azole antifungals, cimetidine, clarithromycin(1), dalfopristin, danazol, delavirdine, diltiazem, erythromycin(1), fluoxetine, fluvoxamine, grapefruit juice, isoniazid, itraconazole, ketoconazole, loratadine, nefazodone, niacinamide, nicotinamide, protease inhibitors, propoxyphene, quinine, quinupristin, troleandomycin, valproate(1), verapamil, zileuton.\\nDrug 1: EQUETROTM\\nDrug 2: clarithromycin\\nInteraction: mechanism\\n\\nSentence: Agents that are CYP3A4 inhibitors that have been found, or are expected, to increase plasma levels of EQUETROTM are the following: Acetazolamide, azole antifungals, cimetidine, clarithromycin(1), dalfopristin, danazol, delavirdine, diltiazem, erythromycin(1), fluoxetine, fluvoxamine, grapefruit juice, isoniazid, itraconazole, ketoconazole, loratadine, nefazodone, niacinamide, nicotinamide, protease inhibitors, propoxyphene, quinine, quinupristin, troleandomycin, valproate(1), verapamil, zileuton.\\nDrug 1: EQUETROTM\\nDrug 2: dalfopristin\\nInteraction: mechanism\\n\\nSentence: Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.\\nDrug1: EQUETROTM\\nDrug2: nortriptyline\\nInteraction:,  effect other mechanism none advice )</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1558</th>\n",
       "      <td>21031</td>\n",
       "      <td>DDI-DrugBank.d195.s8.p0</td>\n",
       "      <td>Co-administration of anastrozole and tamoxifen resulted in a reduction of anastrozole plasma levels by 27% compared with those achieved with anastrozole alone.</td>\n",
       "      <td>DDI-mechanism</td>\n",
       "      <td>DDI-DrugBank.d195</td>\n",
       "      <td>dev</td>\n",
       "      <td>anastrozole</td>\n",
       "      <td>tamoxifen</td>\n",
       "      <td>Sentence: Co-administration of anastrozole and tamoxifen resulted in a reduction of anastrozole plasma levels by 27% compared with those achieved with anastrozole alone.\\nDrug 1: anastrozole\\nDrug 2: tamoxifen\\nInteraction: mechanism</td>\n",
       "      <td>Sentence: Co-administration of anastrozole and tamoxifen resulted in a reduction of anastrozole plasma levels by 27% compared with those achieved with anastrozole alone.\\nDrug1: anastrozole\\nDrug2: tamoxifen\\nInteraction:</td>\n",
       "      <td>mechanism</td>\n",
       "      <td>{advice, mechanism, none, effect, other}</td>\n",
       "      <td>Sentence: Co-administration of TIKOSYN with verapamil resulted in increases in dofetilide peak plasma levels of 42%, although overall exposure to dofetilide was not significantly increased.\\nDrug 1: TIKOSYN\\nDrug 2: verapamil\\nInteraction: mechanism\\n\\nSentence: Co-administration of TIKOSYN with verapamil resulted in increases in dofetilide peak plasma levels of 42%, although overall exposure to dofetilide was not significantly increased.\\nDrug 1: TIKOSYN\\nDrug 2: dofetilide\\nInteraction: none\\n\\nSentence: Co-administration of TIKOSYN with verapamil resulted in increases in dofetilide peak plasma levels of 42%, although overall exposure to dofetilide was not significantly increased.\\nDrug 1: TIKOSYN\\nDrug 2: dofetilide\\nInteraction: none\\n\\nSentence: Co-administration of TIKOSYN with verapamil resulted in increases in dofetilide peak plasma levels of 42%, although overall exposure to dofetilide was not significantly increased.\\nDrug 1: verapamil\\nDrug 2: dofetilide\\nInteraction: none\\n\\nSentence: Co-administration of TIKOSYN with verapamil resulted in increases in dofetilide peak plasma levels of 42%, although overall exposure to dofetilide was not significantly increased.\\nDrug 1: verapamil\\nDrug 2: dofetilide\\nInteraction: none\\n\\nSentence: Co-administration of anastrozole and tamoxifen resulted in a reduction of anastrozole plasma levels by 27% compared with those achieved with anastrozole alone.\\nDrug1: anastrozole\\nDrug2: tamoxifen\\nInteraction:</td>\n",
       "      <td>mechanism</td>\n",
       "      <td>({'id': 'cmpl-4IU95CQN5l9BvOQfemmEHSZDf1L7x', 'object': 'text_completion', 'created': 1640311131, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      1446\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.34936067\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" mechanism\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" mechanism\": -0.34936067\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" mechanism\"\n",
       "}]}, Sentence: Co-administration of TIKOSYN with verapamil resulted in increases in dofetilide peak plasma levels of 42%, although overall exposure to dofetilide was not significantly increased.\\nDrug 1: TIKOSYN\\nDrug 2: verapamil\\nInteraction: mechanism\\n\\nSentence: Co-administration of TIKOSYN with verapamil resulted in increases in dofetilide peak plasma levels of 42%, although overall exposure to dofetilide was not significantly increased.\\nDrug 1: TIKOSYN\\nDrug 2: dofetilide\\nInteraction: none\\n\\nSentence: Co-administration of TIKOSYN with verapamil resulted in increases in dofetilide peak plasma levels of 42%, although overall exposure to dofetilide was not significantly increased.\\nDrug 1: TIKOSYN\\nDrug 2: dofetilide\\nInteraction: none\\n\\nSentence: Co-administration of TIKOSYN with verapamil resulted in increases in dofetilide peak plasma levels of 42%, although overall exposure to dofetilide was not significantly increased.\\nDrug 1: verapamil\\nDrug 2: dofetilide\\nInteraction: none\\n\\nSentence: Co-administration of TIKOSYN with verapamil resulted in increases in dofetilide peak plasma levels of 42%, although overall exposure to dofetilide was not significantly increased.\\nDrug 1: verapamil\\nDrug 2: dofetilide\\nInteraction: none\\n\\nSentence: Co-administration of anastrozole and tamoxifen resulted in a reduction of anastrozole plasma levels by 27% compared with those achieved with anastrozole alone.\\nDrug1: anastrozole\\nDrug2: tamoxifen\\nInteraction:,  effect other mechanism none advice )</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1490</th>\n",
       "      <td>15373</td>\n",
       "      <td>DDI-DrugBank.d94.s11.p16</td>\n",
       "      <td>Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.</td>\n",
       "      <td>DDI-mechanism</td>\n",
       "      <td>DDI-DrugBank.d94</td>\n",
       "      <td>dev</td>\n",
       "      <td>EQUETROTM</td>\n",
       "      <td>felbamate</td>\n",
       "      <td>Sentence: Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.\\nDrug 1: EQUETROTM\\nDrug 2: felbamate\\nInteraction: mechanism</td>\n",
       "      <td>Sentence: Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.\\nDrug1: EQUETROTM\\nDrug2: felbamate\\nInteraction:</td>\n",
       "      <td>mechanism</td>\n",
       "      <td>{advice, mechanism, none, effect, other}</td>\n",
       "      <td>Sentence: Agents that are CYP3A4 inhibitors that have been found, or are expected, to increase plasma levels of EQUETROTM are the following: Acetazolamide, azole antifungals, cimetidine, clarithromycin(1), dalfopristin, danazol, delavirdine, diltiazem, erythromycin(1), fluoxetine, fluvoxamine, grapefruit juice, isoniazid, itraconazole, ketoconazole, loratadine, nefazodone, niacinamide, nicotinamide, protease inhibitors, propoxyphene, quinine, quinupristin, troleandomycin, valproate(1), verapamil, zileuton.\\nDrug 1: EQUETROTM\\nDrug 2: Acetazolamide\\nInteraction: mechanism\\n\\nSentence: Agents that are CYP3A4 inhibitors that have been found, or are expected, to increase plasma levels of EQUETROTM are the following: Acetazolamide, azole antifungals, cimetidine, clarithromycin(1), dalfopristin, danazol, delavirdine, diltiazem, erythromycin(1), fluoxetine, fluvoxamine, grapefruit juice, isoniazid, itraconazole, ketoconazole, loratadine, nefazodone, niacinamide, nicotinamide, protease inhibitors, propoxyphene, quinine, quinupristin, troleandomycin, valproate(1), verapamil, zileuton.\\nDrug 1: EQUETROTM\\nDrug 2: azole antifungals\\nInteraction: mechanism\\n\\nSentence: Agents that are CYP3A4 inhibitors that have been found, or are expected, to increase plasma levels of EQUETROTM are the following: Acetazolamide, azole antifungals, cimetidine, clarithromycin(1), dalfopristin, danazol, delavirdine, diltiazem, erythromycin(1), fluoxetine, fluvoxamine, grapefruit juice, isoniazid, itraconazole, ketoconazole, loratadine, nefazodone, niacinamide, nicotinamide, protease inhibitors, propoxyphene, quinine, quinupristin, troleandomycin, valproate(1), verapamil, zileuton.\\nDrug 1: EQUETROTM\\nDrug 2: cimetidine\\nInteraction: mechanism\\n\\nSentence: Agents that are CYP3A4 inhibitors that have been found, or are expected, to increase plasma levels of EQUETROTM are the following: Acetazolamide, azole antifungals, cimetidine, clarithromycin(1), dalfopristin, danazol, delavirdine, diltiazem, erythromycin(1), fluoxetine, fluvoxamine, grapefruit juice, isoniazid, itraconazole, ketoconazole, loratadine, nefazodone, niacinamide, nicotinamide, protease inhibitors, propoxyphene, quinine, quinupristin, troleandomycin, valproate(1), verapamil, zileuton.\\nDrug 1: EQUETROTM\\nDrug 2: clarithromycin\\nInteraction: mechanism\\n\\nSentence: Agents that are CYP3A4 inhibitors that have been found, or are expected, to increase plasma levels of EQUETROTM are the following: Acetazolamide, azole antifungals, cimetidine, clarithromycin(1), dalfopristin, danazol, delavirdine, diltiazem, erythromycin(1), fluoxetine, fluvoxamine, grapefruit juice, isoniazid, itraconazole, ketoconazole, loratadine, nefazodone, niacinamide, nicotinamide, protease inhibitors, propoxyphene, quinine, quinupristin, troleandomycin, valproate(1), verapamil, zileuton.\\nDrug 1: EQUETROTM\\nDrug 2: dalfopristin\\nInteraction: mechanism\\n\\nSentence: Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.\\nDrug1: EQUETROTM\\nDrug2: felbamate\\nInteraction:</td>\n",
       "      <td>mechanism</td>\n",
       "      <td>({'id': 'cmpl-4IU951QrcyXDzJ44AaK4gLYs0nqnv', 'object': 'text_completion', 'created': 1640311131, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      3683\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.0077295625\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" mechanism\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" mechanism\": -0.0077295625\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" mechanism\"\n",
       "}]}, Sentence: Agents that are CYP3A4 inhibitors that have been found, or are expected, to increase plasma levels of EQUETROTM are the following: Acetazolamide, azole antifungals, cimetidine, clarithromycin(1), dalfopristin, danazol, delavirdine, diltiazem, erythromycin(1), fluoxetine, fluvoxamine, grapefruit juice, isoniazid, itraconazole, ketoconazole, loratadine, nefazodone, niacinamide, nicotinamide, protease inhibitors, propoxyphene, quinine, quinupristin, troleandomycin, valproate(1), verapamil, zileuton.\\nDrug 1: EQUETROTM\\nDrug 2: Acetazolamide\\nInteraction: mechanism\\n\\nSentence: Agents that are CYP3A4 inhibitors that have been found, or are expected, to increase plasma levels of EQUETROTM are the following: Acetazolamide, azole antifungals, cimetidine, clarithromycin(1), dalfopristin, danazol, delavirdine, diltiazem, erythromycin(1), fluoxetine, fluvoxamine, grapefruit juice, isoniazid, itraconazole, ketoconazole, loratadine, nefazodone, niacinamide, nicotinamide, protease inhibitors, propoxyphene, quinine, quinupristin, troleandomycin, valproate(1), verapamil, zileuton.\\nDrug 1: EQUETROTM\\nDrug 2: azole antifungals\\nInteraction: mechanism\\n\\nSentence: Agents that are CYP3A4 inhibitors that have been found, or are expected, to increase plasma levels of EQUETROTM are the following: Acetazolamide, azole antifungals, cimetidine, clarithromycin(1), dalfopristin, danazol, delavirdine, diltiazem, erythromycin(1), fluoxetine, fluvoxamine, grapefruit juice, isoniazid, itraconazole, ketoconazole, loratadine, nefazodone, niacinamide, nicotinamide, protease inhibitors, propoxyphene, quinine, quinupristin, troleandomycin, valproate(1), verapamil, zileuton.\\nDrug 1: EQUETROTM\\nDrug 2: cimetidine\\nInteraction: mechanism\\n\\nSentence: Agents that are CYP3A4 inhibitors that have been found, or are expected, to increase plasma levels of EQUETROTM are the following: Acetazolamide, azole antifungals, cimetidine, clarithromycin(1), dalfopristin, danazol, delavirdine, diltiazem, erythromycin(1), fluoxetine, fluvoxamine, grapefruit juice, isoniazid, itraconazole, ketoconazole, loratadine, nefazodone, niacinamide, nicotinamide, protease inhibitors, propoxyphene, quinine, quinupristin, troleandomycin, valproate(1), verapamil, zileuton.\\nDrug 1: EQUETROTM\\nDrug 2: clarithromycin\\nInteraction: mechanism\\n\\nSentence: Agents that are CYP3A4 inhibitors that have been found, or are expected, to increase plasma levels of EQUETROTM are the following: Acetazolamide, azole antifungals, cimetidine, clarithromycin(1), dalfopristin, danazol, delavirdine, diltiazem, erythromycin(1), fluoxetine, fluvoxamine, grapefruit juice, isoniazid, itraconazole, ketoconazole, loratadine, nefazodone, niacinamide, nicotinamide, protease inhibitors, propoxyphene, quinine, quinupristin, troleandomycin, valproate(1), verapamil, zileuton.\\nDrug 1: EQUETROTM\\nDrug 2: dalfopristin\\nInteraction: mechanism\\n\\nSentence: Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.\\nDrug1: EQUETROTM\\nDrug2: felbamate\\nInteraction:,  effect other mechanism none advice )</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1493</th>\n",
       "      <td>15376</td>\n",
       "      <td>DDI-DrugBank.d94.s11.p19</td>\n",
       "      <td>Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.</td>\n",
       "      <td>DDI-mechanism</td>\n",
       "      <td>DDI-DrugBank.d94</td>\n",
       "      <td>dev</td>\n",
       "      <td>EQUETROTM</td>\n",
       "      <td>haloperidol</td>\n",
       "      <td>Sentence: Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.\\nDrug 1: EQUETROTM\\nDrug 2: haloperidol\\nInteraction: mechanism</td>\n",
       "      <td>Sentence: Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.\\nDrug1: EQUETROTM\\nDrug2: haloperidol\\nInteraction:</td>\n",
       "      <td>mechanism</td>\n",
       "      <td>{advice, mechanism, none, effect, other}</td>\n",
       "      <td>Sentence: Agents that are CYP3A4 inhibitors that have been found, or are expected, to increase plasma levels of EQUETROTM are the following: Acetazolamide, azole antifungals, cimetidine, clarithromycin(1), dalfopristin, danazol, delavirdine, diltiazem, erythromycin(1), fluoxetine, fluvoxamine, grapefruit juice, isoniazid, itraconazole, ketoconazole, loratadine, nefazodone, niacinamide, nicotinamide, protease inhibitors, propoxyphene, quinine, quinupristin, troleandomycin, valproate(1), verapamil, zileuton.\\nDrug 1: EQUETROTM\\nDrug 2: Acetazolamide\\nInteraction: mechanism\\n\\nSentence: Agents that are CYP3A4 inhibitors that have been found, or are expected, to increase plasma levels of EQUETROTM are the following: Acetazolamide, azole antifungals, cimetidine, clarithromycin(1), dalfopristin, danazol, delavirdine, diltiazem, erythromycin(1), fluoxetine, fluvoxamine, grapefruit juice, isoniazid, itraconazole, ketoconazole, loratadine, nefazodone, niacinamide, nicotinamide, protease inhibitors, propoxyphene, quinine, quinupristin, troleandomycin, valproate(1), verapamil, zileuton.\\nDrug 1: EQUETROTM\\nDrug 2: azole antifungals\\nInteraction: mechanism\\n\\nSentence: Agents that are CYP3A4 inhibitors that have been found, or are expected, to increase plasma levels of EQUETROTM are the following: Acetazolamide, azole antifungals, cimetidine, clarithromycin(1), dalfopristin, danazol, delavirdine, diltiazem, erythromycin(1), fluoxetine, fluvoxamine, grapefruit juice, isoniazid, itraconazole, ketoconazole, loratadine, nefazodone, niacinamide, nicotinamide, protease inhibitors, propoxyphene, quinine, quinupristin, troleandomycin, valproate(1), verapamil, zileuton.\\nDrug 1: EQUETROTM\\nDrug 2: cimetidine\\nInteraction: mechanism\\n\\nSentence: Agents that are CYP3A4 inhibitors that have been found, or are expected, to increase plasma levels of EQUETROTM are the following: Acetazolamide, azole antifungals, cimetidine, clarithromycin(1), dalfopristin, danazol, delavirdine, diltiazem, erythromycin(1), fluoxetine, fluvoxamine, grapefruit juice, isoniazid, itraconazole, ketoconazole, loratadine, nefazodone, niacinamide, nicotinamide, protease inhibitors, propoxyphene, quinine, quinupristin, troleandomycin, valproate(1), verapamil, zileuton.\\nDrug 1: EQUETROTM\\nDrug 2: clarithromycin\\nInteraction: mechanism\\n\\nSentence: Agents that are CYP3A4 inhibitors that have been found, or are expected, to increase plasma levels of EQUETROTM are the following: Acetazolamide, azole antifungals, cimetidine, clarithromycin(1), dalfopristin, danazol, delavirdine, diltiazem, erythromycin(1), fluoxetine, fluvoxamine, grapefruit juice, isoniazid, itraconazole, ketoconazole, loratadine, nefazodone, niacinamide, nicotinamide, protease inhibitors, propoxyphene, quinine, quinupristin, troleandomycin, valproate(1), verapamil, zileuton.\\nDrug 1: EQUETROTM\\nDrug 2: dalfopristin\\nInteraction: mechanism\\n\\nSentence: Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.\\nDrug1: EQUETROTM\\nDrug2: haloperidol\\nInteraction:</td>\n",
       "      <td>mechanism</td>\n",
       "      <td>({'id': 'cmpl-4IU96ayh7tt8DLK8TaK3YdPQoeMcZ', 'object': 'text_completion', 'created': 1640311132, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      3685\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.010059679\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" mechanism\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" mechanism\": -0.010059679\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" mechanism\"\n",
       "}]}, Sentence: Agents that are CYP3A4 inhibitors that have been found, or are expected, to increase plasma levels of EQUETROTM are the following: Acetazolamide, azole antifungals, cimetidine, clarithromycin(1), dalfopristin, danazol, delavirdine, diltiazem, erythromycin(1), fluoxetine, fluvoxamine, grapefruit juice, isoniazid, itraconazole, ketoconazole, loratadine, nefazodone, niacinamide, nicotinamide, protease inhibitors, propoxyphene, quinine, quinupristin, troleandomycin, valproate(1), verapamil, zileuton.\\nDrug 1: EQUETROTM\\nDrug 2: Acetazolamide\\nInteraction: mechanism\\n\\nSentence: Agents that are CYP3A4 inhibitors that have been found, or are expected, to increase plasma levels of EQUETROTM are the following: Acetazolamide, azole antifungals, cimetidine, clarithromycin(1), dalfopristin, danazol, delavirdine, diltiazem, erythromycin(1), fluoxetine, fluvoxamine, grapefruit juice, isoniazid, itraconazole, ketoconazole, loratadine, nefazodone, niacinamide, nicotinamide, protease inhibitors, propoxyphene, quinine, quinupristin, troleandomycin, valproate(1), verapamil, zileuton.\\nDrug 1: EQUETROTM\\nDrug 2: azole antifungals\\nInteraction: mechanism\\n\\nSentence: Agents that are CYP3A4 inhibitors that have been found, or are expected, to increase plasma levels of EQUETROTM are the following: Acetazolamide, azole antifungals, cimetidine, clarithromycin(1), dalfopristin, danazol, delavirdine, diltiazem, erythromycin(1), fluoxetine, fluvoxamine, grapefruit juice, isoniazid, itraconazole, ketoconazole, loratadine, nefazodone, niacinamide, nicotinamide, protease inhibitors, propoxyphene, quinine, quinupristin, troleandomycin, valproate(1), verapamil, zileuton.\\nDrug 1: EQUETROTM\\nDrug 2: cimetidine\\nInteraction: mechanism\\n\\nSentence: Agents that are CYP3A4 inhibitors that have been found, or are expected, to increase plasma levels of EQUETROTM are the following: Acetazolamide, azole antifungals, cimetidine, clarithromycin(1), dalfopristin, danazol, delavirdine, diltiazem, erythromycin(1), fluoxetine, fluvoxamine, grapefruit juice, isoniazid, itraconazole, ketoconazole, loratadine, nefazodone, niacinamide, nicotinamide, protease inhibitors, propoxyphene, quinine, quinupristin, troleandomycin, valproate(1), verapamil, zileuton.\\nDrug 1: EQUETROTM\\nDrug 2: clarithromycin\\nInteraction: mechanism\\n\\nSentence: Agents that are CYP3A4 inhibitors that have been found, or are expected, to increase plasma levels of EQUETROTM are the following: Acetazolamide, azole antifungals, cimetidine, clarithromycin(1), dalfopristin, danazol, delavirdine, diltiazem, erythromycin(1), fluoxetine, fluvoxamine, grapefruit juice, isoniazid, itraconazole, ketoconazole, loratadine, nefazodone, niacinamide, nicotinamide, protease inhibitors, propoxyphene, quinine, quinupristin, troleandomycin, valproate(1), verapamil, zileuton.\\nDrug 1: EQUETROTM\\nDrug 2: dalfopristin\\nInteraction: mechanism\\n\\nSentence: Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.\\nDrug1: EQUETROTM\\nDrug2: haloperidol\\nInteraction:,  effect other mechanism none advice )</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1319</th>\n",
       "      <td>6252</td>\n",
       "      <td>DDI-DrugBank.d236.s23.p2</td>\n",
       "      <td>Phenobarbital: Amphetamines may delay intestinal absorption of phenobarbital;</td>\n",
       "      <td>DDI-mechanism</td>\n",
       "      <td>DDI-DrugBank.d236</td>\n",
       "      <td>dev</td>\n",
       "      <td>Amphetamines</td>\n",
       "      <td>phenobarbital</td>\n",
       "      <td>Sentence: Phenobarbital: Amphetamines may delay intestinal absorption of phenobarbital;\\nDrug 1: Amphetamines\\nDrug 2: phenobarbital\\nInteraction: mechanism</td>\n",
       "      <td>Sentence: Phenobarbital: Amphetamines may delay intestinal absorption of phenobarbital;\\nDrug1: Amphetamines\\nDrug2: phenobarbital\\nInteraction:</td>\n",
       "      <td>mechanism</td>\n",
       "      <td>{advice, mechanism, none, effect, other}</td>\n",
       "      <td>Sentence: Phenytoin: Amphetamines may delay intestinal absorption of phenytoin;\\nDrug 1: Phenytoin\\nDrug 2: Amphetamines\\nInteraction: none\\n\\nSentence: Phenytoin: Amphetamines may delay intestinal absorption of phenytoin;\\nDrug 1: Phenytoin\\nDrug 2: phenytoin\\nInteraction: none\\n\\nSentence: Phenytoin: Amphetamines may delay intestinal absorption of phenytoin;\\nDrug 1: Amphetamines\\nDrug 2: phenytoin\\nInteraction: mechanism\\n\\nSentence: Phenytoin: Amphetamines may delay intestinal absorption of phenytoin;\\nDrug 1: Phenytoin\\nDrug 2: Amphetamines\\nInteraction: none\\n\\nSentence: Phenytoin: Amphetamines may delay intestinal absorption of phenytoin;\\nDrug 1: Phenytoin\\nDrug 2: phenytoin\\nInteraction: none\\n\\nSentence: Phenobarbital: Amphetamines may delay intestinal absorption of phenobarbital;\\nDrug1: Amphetamines\\nDrug2: phenobarbital\\nInteraction:</td>\n",
       "      <td>none</td>\n",
       "      <td>({'id': 'cmpl-4IU96vH6rN9gevBy0fZ76Qf3L6VL7', 'object': 'text_completion', 'created': 1640311132, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      830\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.51959467\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" none\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" none\": -0.51959467\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" none\"\n",
       "}]}, Sentence: Phenytoin: Amphetamines may delay intestinal absorption of phenytoin;\\nDrug 1: Phenytoin\\nDrug 2: Amphetamines\\nInteraction: none\\n\\nSentence: Phenytoin: Amphetamines may delay intestinal absorption of phenytoin;\\nDrug 1: Phenytoin\\nDrug 2: phenytoin\\nInteraction: none\\n\\nSentence: Phenytoin: Amphetamines may delay intestinal absorption of phenytoin;\\nDrug 1: Amphetamines\\nDrug 2: phenytoin\\nInteraction: mechanism\\n\\nSentence: Phenytoin: Amphetamines may delay intestinal absorption of phenytoin;\\nDrug 1: Phenytoin\\nDrug 2: Amphetamines\\nInteraction: none\\n\\nSentence: Phenytoin: Amphetamines may delay intestinal absorption of phenytoin;\\nDrug 1: Phenytoin\\nDrug 2: phenytoin\\nInteraction: none\\n\\nSentence: Phenobarbital: Amphetamines may delay intestinal absorption of phenobarbital;\\nDrug1: Amphetamines\\nDrug2: phenobarbital\\nInteraction:,  effect other mechanism none advice )</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1312</th>\n",
       "      <td>5648</td>\n",
       "      <td>DDI-DrugBank.d506.s5.p0</td>\n",
       "      <td>Concomitant administration of Norpace and quinidine resulted in slight increases in plasma disopyramide levels and slight decreases in plasma quinidine levels.</td>\n",
       "      <td>DDI-mechanism</td>\n",
       "      <td>DDI-DrugBank.d506</td>\n",
       "      <td>dev</td>\n",
       "      <td>Norpace</td>\n",
       "      <td>quinidine</td>\n",
       "      <td>Sentence: Concomitant administration of Norpace and quinidine resulted in slight increases in plasma disopyramide levels and slight decreases in plasma quinidine levels.\\nDrug 1: Norpace\\nDrug 2: quinidine\\nInteraction: mechanism</td>\n",
       "      <td>Sentence: Concomitant administration of Norpace and quinidine resulted in slight increases in plasma disopyramide levels and slight decreases in plasma quinidine levels.\\nDrug1: Norpace\\nDrug2: quinidine\\nInteraction:</td>\n",
       "      <td>mechanism</td>\n",
       "      <td>{advice, mechanism, none, effect, other}</td>\n",
       "      <td>Sentence: Concurrent administration of cimetidine and tricyclic antidepressants can produce clinically significant increases in the plasma levels of the tricyclic antidepressants.\\nDrug 1: cimetidine\\nDrug 2: tricyclic antidepressants\\nInteraction: mechanism\\n\\nSentence: Concurrent administration of cimetidine and tricyclic antidepressants can produce clinically significant increases in the plasma levels of the tricyclic antidepressants.\\nDrug 1: cimetidine\\nDrug 2: tricyclic antidepressants\\nInteraction: none\\n\\nSentence: Concurrent administration of cimetidine and tricyclic antidepressants can produce clinically significant increases in the plasma levels of the tricyclic antidepressants.\\nDrug 1: tricyclic antidepressants\\nDrug 2: tricyclic antidepressants\\nInteraction: none\\n\\nSentence: Aspirin: In normal volunteers, a small decrease in diflunisal levels was observed when multiple doses of diflunisal and aspirin were administered concomitantly.\\nDrug 1: Aspirin\\nDrug 2: diflunisal\\nInteraction: none\\n\\nSentence: Aspirin: In normal volunteers, a small decrease in diflunisal levels was observed when multiple doses of diflunisal and aspirin were administered concomitantly.\\nDrug 1: Aspirin\\nDrug 2: diflunisal\\nInteraction: none\\n\\nSentence: Concomitant administration of Norpace and quinidine resulted in slight increases in plasma disopyramide levels and slight decreases in plasma quinidine levels.\\nDrug1: Norpace\\nDrug2: quinidine\\nInteraction:</td>\n",
       "      <td>none</td>\n",
       "      <td>({'id': 'cmpl-4IU97xpRZl62zbq8GzYBoqiYzdEqi', 'object': 'text_completion', 'created': 1640311133, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      1440\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.5518371\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" none\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" none\": -0.5518371\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" none\"\n",
       "}]}, Sentence: Concurrent administration of cimetidine and tricyclic antidepressants can produce clinically significant increases in the plasma levels of the tricyclic antidepressants.\\nDrug 1: cimetidine\\nDrug 2: tricyclic antidepressants\\nInteraction: mechanism\\n\\nSentence: Concurrent administration of cimetidine and tricyclic antidepressants can produce clinically significant increases in the plasma levels of the tricyclic antidepressants.\\nDrug 1: cimetidine\\nDrug 2: tricyclic antidepressants\\nInteraction: none\\n\\nSentence: Concurrent administration of cimetidine and tricyclic antidepressants can produce clinically significant increases in the plasma levels of the tricyclic antidepressants.\\nDrug 1: tricyclic antidepressants\\nDrug 2: tricyclic antidepressants\\nInteraction: none\\n\\nSentence: Aspirin: In normal volunteers, a small decrease in diflunisal levels was observed when multiple doses of diflunisal and aspirin were administered concomitantly.\\nDrug 1: Aspirin\\nDrug 2: diflunisal\\nInteraction: none\\n\\nSentence: Aspirin: In normal volunteers, a small decrease in diflunisal levels was observed when multiple doses of diflunisal and aspirin were administered concomitantly.\\nDrug 1: Aspirin\\nDrug 2: diflunisal\\nInteraction: none\\n\\nSentence: Concomitant administration of Norpace and quinidine resulted in slight increases in plasma disopyramide levels and slight decreases in plasma quinidine levels.\\nDrug1: Norpace\\nDrug2: quinidine\\nInteraction:,  effect other mechanism none advice )</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1337</th>\n",
       "      <td>7549</td>\n",
       "      <td>DDI-DrugBank.d382.s18.p9</td>\n",
       "      <td>Tolbutamide: Aprepitant, when given as 125 mg on Day 1 and 80 mg/day on Days 2 and 3, decreased the AUC of tolbutamide (a CYP2C9 substrate) by 23% on Day 4, 28% on Day 8, and 15% on Day 15, when a single dose of tolbutamide 500 mg was admini,stered orally prior to the administration of the 3-day regimen of Aprepitant and on Days 4,8, and 15.</td>\n",
       "      <td>DDI-mechanism</td>\n",
       "      <td>DDI-DrugBank.d382</td>\n",
       "      <td>dev</td>\n",
       "      <td>tolbutamide</td>\n",
       "      <td>Aprepitant</td>\n",
       "      <td>Sentence: Tolbutamide: Aprepitant, when given as 125 mg on Day 1 and 80 mg/day on Days 2 and 3, decreased the AUC of tolbutamide (a CYP2C9 substrate) by 23% on Day 4, 28% on Day 8, and 15% on Day 15, when a single dose of tolbutamide 500 mg was admini,stered orally prior to the administration of the 3-day regimen of Aprepitant and on Days 4,8, and 15.\\nDrug 1: tolbutamide\\nDrug 2: Aprepitant\\nInteraction: mechanism</td>\n",
       "      <td>Sentence: Tolbutamide: Aprepitant, when given as 125 mg on Day 1 and 80 mg/day on Days 2 and 3, decreased the AUC of tolbutamide (a CYP2C9 substrate) by 23% on Day 4, 28% on Day 8, and 15% on Day 15, when a single dose of tolbutamide 500 mg was admini,stered orally prior to the administration of the 3-day regimen of Aprepitant and on Days 4,8, and 15.\\nDrug1: tolbutamide\\nDrug2: Aprepitant\\nInteraction:</td>\n",
       "      <td>mechanism</td>\n",
       "      <td>{advice, mechanism, none, effect, other}</td>\n",
       "      <td>Sentence: Midazolam: Aprepitant increased the AUC of midazolam, a sensitive CYP3A4 substrate, by 2.3-fold on Day 1 and 3.3-fold on Day 5, when a single oral dose of midazolam 2 mg was coadministered on Day 1 and Day 5 of a regimen of Aprepitant 125 mg on Day 1 and 80 mg/day on Days 2 through 5.\\nDrug 1: Midazolam\\nDrug 2: Aprepitant\\nInteraction: none\\n\\nSentence: Midazolam: Aprepitant increased the AUC of midazolam, a sensitive CYP3A4 substrate, by 2.3-fold on Day 1 and 3.3-fold on Day 5, when a single oral dose of midazolam 2 mg was coadministered on Day 1 and Day 5 of a regimen of Aprepitant 125 mg on Day 1 and 80 mg/day on Days 2 through 5.\\nDrug 1: Midazolam\\nDrug 2: midazolam\\nInteraction: none\\n\\nSentence: Midazolam: Aprepitant increased the AUC of midazolam, a sensitive CYP3A4 substrate, by 2.3-fold on Day 1 and 3.3-fold on Day 5, when a single oral dose of midazolam 2 mg was coadministered on Day 1 and Day 5 of a regimen of Aprepitant 125 mg on Day 1 and 80 mg/day on Days 2 through 5.\\nDrug 1: Midazolam\\nDrug 2: midazolam\\nInteraction: none\\n\\nSentence: Midazolam: Aprepitant increased the AUC of midazolam, a sensitive CYP3A4 substrate, by 2.3-fold on Day 1 and 3.3-fold on Day 5, when a single oral dose of midazolam 2 mg was coadministered on Day 1 and Day 5 of a regimen of Aprepitant 125 mg on Day 1 and 80 mg/day on Days 2 through 5.\\nDrug 1: Midazolam\\nDrug 2: Aprepitant\\nInteraction: none\\n\\nSentence: Midazolam: Aprepitant increased the AUC of midazolam, a sensitive CYP3A4 substrate, by 2.3-fold on Day 1 and 3.3-fold on Day 5, when a single oral dose of midazolam 2 mg was coadministered on Day 1 and Day 5 of a regimen of Aprepitant 125 mg on Day 1 and 80 mg/day on Days 2 through 5.\\nDrug 1: Aprepitant\\nDrug 2: midazolam\\nInteraction: mechanism\\n\\nSentence: Tolbutamide: Aprepitant, when given as 125 mg on Day 1 and 80 mg/day on Days 2 and 3, decreased the AUC of tolbutamide (a CYP2C9 substrate) by 23% on Day 4, 28% on Day 8, and 15% on Day 15, when a single dose of tolbutamide 500 mg was admini,stered orally prior to the administration of the 3-day regimen of Aprepitant and on Days 4,8, and 15.\\nDrug1: tolbutamide\\nDrug2: Aprepitant\\nInteraction:</td>\n",
       "      <td>mechanism</td>\n",
       "      <td>({'id': 'cmpl-4IU97EaM8RxtCedc0syOs1DwFspOH', 'object': 'text_completion', 'created': 1640311133, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      2166\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.38207775\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" mechanism\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" mechanism\": -0.38207775\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" mechanism\"\n",
       "}]}, Sentence: Midazolam: Aprepitant increased the AUC of midazolam, a sensitive CYP3A4 substrate, by 2.3-fold on Day 1 and 3.3-fold on Day 5, when a single oral dose of midazolam 2 mg was coadministered on Day 1 and Day 5 of a regimen of Aprepitant 125 mg on Day 1 and 80 mg/day on Days 2 through 5.\\nDrug 1: Midazolam\\nDrug 2: Aprepitant\\nInteraction: none\\n\\nSentence: Midazolam: Aprepitant increased the AUC of midazolam, a sensitive CYP3A4 substrate, by 2.3-fold on Day 1 and 3.3-fold on Day 5, when a single oral dose of midazolam 2 mg was coadministered on Day 1 and Day 5 of a regimen of Aprepitant 125 mg on Day 1 and 80 mg/day on Days 2 through 5.\\nDrug 1: Midazolam\\nDrug 2: midazolam\\nInteraction: none\\n\\nSentence: Midazolam: Aprepitant increased the AUC of midazolam, a sensitive CYP3A4 substrate, by 2.3-fold on Day 1 and 3.3-fold on Day 5, when a single oral dose of midazolam 2 mg was coadministered on Day 1 and Day 5 of a regimen of Aprepitant 125 mg on Day 1 and 80 mg/day on Days 2 through 5.\\nDrug 1: Midazolam\\nDrug 2: midazolam\\nInteraction: none\\n\\nSentence: Midazolam: Aprepitant increased the AUC of midazolam, a sensitive CYP3A4 substrate, by 2.3-fold on Day 1 and 3.3-fold on Day 5, when a single oral dose of midazolam 2 mg was coadministered on Day 1 and Day 5 of a regimen of Aprepitant 125 mg on Day 1 and 80 mg/day on Days 2 through 5.\\nDrug 1: Midazolam\\nDrug 2: Aprepitant\\nInteraction: none\\n\\nSentence: Midazolam: Aprepitant increased the AUC of midazolam, a sensitive CYP3A4 substrate, by 2.3-fold on Day 1 and 3.3-fold on Day 5, when a single oral dose of midazolam 2 mg was coadministered on Day 1 and Day 5 of a regimen of Aprepitant 125 mg on Day 1 and 80 mg/day on Days 2 through 5.\\nDrug 1: Aprepitant\\nDrug 2: midazolam\\nInteraction: mechanism\\n\\nSentence: Tolbutamide: Aprepitant, when given as 125 mg on Day 1 and 80 mg/day on Days 2 and 3, decreased the AUC of tolbutamide (a CYP2C9 substrate) by 23% on Day 4, 28% on Day 8, and 15% on Day 15, when a single dose of tolbutamide 500 mg was admini,stered orally prior to the administration of the 3-day regimen of Aprepitant and on Days 4,8, and 15.\\nDrug1: tolbutamide\\nDrug2: Aprepitant\\nInteraction:,  effect other mechanism none advice )</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>923</th>\n",
       "      <td>1772</td>\n",
       "      <td>DDI-DrugBank.d411.s4.p167</td>\n",
       "      <td>Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.</td>\n",
       "      <td>DDI-false</td>\n",
       "      <td>DDI-DrugBank.d411</td>\n",
       "      <td>dev</td>\n",
       "      <td>perchlorate</td>\n",
       "      <td>iodine-containing compounds</td>\n",
       "      <td>Sentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug 1: perchlorate\\nDrug 2: iodine-containing compounds\\nInteraction: none</td>\n",
       "      <td>Sentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug1: perchlorate\\nDrug2: iodine-containing compounds\\nInteraction:</td>\n",
       "      <td>none</td>\n",
       "      <td>{advice, mechanism, none, effect, other}</td>\n",
       "      <td>Sentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: platelet inhibitors\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: acetylsalicylic acid\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: NSAIDs\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: ketorolac tromethamine\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: dipyridamole\\nInteraction: none\\n\\nSentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug1: perchlorate\\nDrug2: iodine-containing compounds\\nInteraction:</td>\n",
       "      <td>none</td>\n",
       "      <td>({'id': 'cmpl-4IU97Zckx8zCpplAn1dtPrJQFpkZ5', 'object': 'text_completion', 'created': 1640311133, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      2309\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.016930854\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" none\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" none\": -0.016930854\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" none\"\n",
       "}]}, Sentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: platelet inhibitors\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: acetylsalicylic acid\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: NSAIDs\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: ketorolac tromethamine\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: dipyridamole\\nInteraction: none\\n\\nSentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug1: perchlorate\\nDrug2: iodine-containing compounds\\nInteraction:,  effect other mechanism none advice )</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>667</th>\n",
       "      <td>1516</td>\n",
       "      <td>DDI-DrugBank.d411.s3.p64</td>\n",
       "      <td>Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.</td>\n",
       "      <td>DDI-false</td>\n",
       "      <td>DDI-DrugBank.d411</td>\n",
       "      <td>dev</td>\n",
       "      <td>clofibrate</td>\n",
       "      <td>5-fluorouracil</td>\n",
       "      <td>Sentence: Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.\\nDrug 1: clofibrate\\nDrug 2: 5-fluorouracil\\nInteraction: none</td>\n",
       "      <td>Sentence: Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.\\nDrug1: clofibrate\\nDrug2: 5-fluorouracil\\nInteraction:</td>\n",
       "      <td>none</td>\n",
       "      <td>{advice, mechanism, none, effect, other}</td>\n",
       "      <td>Sentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: phenytoin\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: glyburide\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: ranitidine\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: omeprazole\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: estrogens\\nInteraction: none\\n\\nSentence: Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.\\nDrug1: clofibrate\\nDrug2: 5-fluorouracil\\nInteraction:</td>\n",
       "      <td>none</td>\n",
       "      <td>({'id': 'cmpl-4IU98qfuRfakuOkwgX00eq8UNh0J5', 'object': 'text_completion', 'created': 1640311134, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      2311\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.0077649434\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" none\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" none\": -0.0077649434\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" none\"\n",
       "}]}, Sentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: phenytoin\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: glyburide\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: ranitidine\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: omeprazole\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: estrogens\\nInteraction: none\\n\\nSentence: Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.\\nDrug1: clofibrate\\nDrug2: 5-fluorouracil\\nInteraction:,  effect other mechanism none advice )</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>625</th>\n",
       "      <td>1474</td>\n",
       "      <td>DDI-DrugBank.d411.s3.p22</td>\n",
       "      <td>Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.</td>\n",
       "      <td>DDI-false</td>\n",
       "      <td>DDI-DrugBank.d411</td>\n",
       "      <td>dev</td>\n",
       "      <td>androgens</td>\n",
       "      <td>5-fluorouracil</td>\n",
       "      <td>Sentence: Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.\\nDrug 1: androgens\\nDrug 2: 5-fluorouracil\\nInteraction: none</td>\n",
       "      <td>Sentence: Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.\\nDrug1: androgens\\nDrug2: 5-fluorouracil\\nInteraction:</td>\n",
       "      <td>none</td>\n",
       "      <td>{advice, mechanism, none, effect, other}</td>\n",
       "      <td>Sentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: phenytoin\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: glyburide\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: ranitidine\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: omeprazole\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: estrogens\\nInteraction: none\\n\\nSentence: Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.\\nDrug1: androgens\\nDrug2: 5-fluorouracil\\nInteraction:</td>\n",
       "      <td>none</td>\n",
       "      <td>({'id': 'cmpl-4IU98zNfhWZpI0MvZ3EuT6IYpEVa5', 'object': 'text_completion', 'created': 1640311134, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      2310\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.009621164\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" none\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" none\": -0.009621164\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" none\"\n",
       "}]}, Sentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: phenytoin\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: glyburide\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: ranitidine\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: omeprazole\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: estrogens\\nInteraction: none\\n\\nSentence: Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.\\nDrug1: androgens\\nDrug2: 5-fluorouracil\\nInteraction:,  effect other mechanism none advice )</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>907</th>\n",
       "      <td>1756</td>\n",
       "      <td>DDI-DrugBank.d411.s4.p151</td>\n",
       "      <td>Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.</td>\n",
       "      <td>DDI-false</td>\n",
       "      <td>DDI-DrugBank.d411</td>\n",
       "      <td>dev</td>\n",
       "      <td>thiocyanate</td>\n",
       "      <td>somatostatin analogs</td>\n",
       "      <td>Sentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug 1: thiocyanate\\nDrug 2: somatostatin analogs\\nInteraction: none</td>\n",
       "      <td>Sentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug1: thiocyanate\\nDrug2: somatostatin analogs\\nInteraction:</td>\n",
       "      <td>none</td>\n",
       "      <td>{advice, mechanism, none, effect, other}</td>\n",
       "      <td>Sentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: platelet inhibitors\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: acetylsalicylic acid\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: NSAIDs\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: ketorolac tromethamine\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: dipyridamole\\nInteraction: none\\n\\nSentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug1: thiocyanate\\nDrug2: somatostatin analogs\\nInteraction:</td>\n",
       "      <td>none</td>\n",
       "      <td>({'id': 'cmpl-4IU99kPBLDyKN1UOFeNNypq2zma6t', 'object': 'text_completion', 'created': 1640311135, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      2302\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.006533926\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" none\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" none\": -0.006533926\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" none\"\n",
       "}]}, Sentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: platelet inhibitors\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: acetylsalicylic acid\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: NSAIDs\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: ketorolac tromethamine\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: dipyridamole\\nInteraction: none\\n\\nSentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug1: thiocyanate\\nDrug2: somatostatin analogs\\nInteraction:,  effect other mechanism none advice )</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>455</th>\n",
       "      <td>438</td>\n",
       "      <td>DDI-DrugBank.d561.s4.p5</td>\n",
       "      <td>Potassium-sparing diuretics (spironolactone, amiloride, triamterene, and others) or potassium supplements can increase the risk of hyperkalemia.</td>\n",
       "      <td>DDI-false</td>\n",
       "      <td>DDI-DrugBank.d561</td>\n",
       "      <td>dev</td>\n",
       "      <td>spironolactone</td>\n",
       "      <td>triamterene</td>\n",
       "      <td>Sentence: Potassium-sparing diuretics (spironolactone, amiloride, triamterene, and others) or potassium supplements can increase the risk of hyperkalemia.\\nDrug 1: spironolactone\\nDrug 2: triamterene\\nInteraction: none</td>\n",
       "      <td>Sentence: Potassium-sparing diuretics (spironolactone, amiloride, triamterene, and others) or potassium supplements can increase the risk of hyperkalemia.\\nDrug1: spironolactone\\nDrug2: triamterene\\nInteraction:</td>\n",
       "      <td>none</td>\n",
       "      <td>{advice, mechanism, none, effect, other}</td>\n",
       "      <td>Sentence: Potassium-sparing diuretics (e.g., spironolactone, triamterene, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.\\nDrug 1: Potassium-sparing diuretics\\nDrug 2: spironolactone\\nInteraction: none\\n\\nSentence: Potassium-sparing diuretics (e.g., spironolactone, triamterene, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.\\nDrug 1: Potassium-sparing diuretics\\nDrug 2: triamterene\\nInteraction: none\\n\\nSentence: Potassium-sparing diuretics (e.g., spironolactone, triamterene, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.\\nDrug 1: Potassium-sparing diuretics\\nDrug 2: amiloride\\nInteraction: none\\n\\nSentence: Potassium-sparing diuretics (e.g., spironolactone, triamterene, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.\\nDrug 1: Potassium-sparing diuretics\\nDrug 2: potassium\\nInteraction: none\\n\\nSentence: Potassium-sparing diuretics (e.g., spironolactone, triamterene, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.\\nDrug 1: Potassium-sparing diuretics\\nDrug 2: potassium\\nInteraction: none\\n\\nSentence: Potassium-sparing diuretics (spironolactone, amiloride, triamterene, and others) or potassium supplements can increase the risk of hyperkalemia.\\nDrug1: spironolactone\\nDrug2: triamterene\\nInteraction:</td>\n",
       "      <td>none</td>\n",
       "      <td>({'id': 'cmpl-4IU99dF53nQQiwGDPcvAQAQzGWwRW', 'object': 'text_completion', 'created': 1640311135, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      1615\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.0058703576\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" none\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" none\": -0.0058703576\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" none\"\n",
       "}]}, Sentence: Potassium-sparing diuretics (e.g., spironolactone, triamterene, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.\\nDrug 1: Potassium-sparing diuretics\\nDrug 2: spironolactone\\nInteraction: none\\n\\nSentence: Potassium-sparing diuretics (e.g., spironolactone, triamterene, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.\\nDrug 1: Potassium-sparing diuretics\\nDrug 2: triamterene\\nInteraction: none\\n\\nSentence: Potassium-sparing diuretics (e.g., spironolactone, triamterene, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.\\nDrug 1: Potassium-sparing diuretics\\nDrug 2: amiloride\\nInteraction: none\\n\\nSentence: Potassium-sparing diuretics (e.g., spironolactone, triamterene, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.\\nDrug 1: Potassium-sparing diuretics\\nDrug 2: potassium\\nInteraction: none\\n\\nSentence: Potassium-sparing diuretics (e.g., spironolactone, triamterene, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.\\nDrug 1: Potassium-sparing diuretics\\nDrug 2: potassium\\nInteraction: none\\n\\nSentence: Potassium-sparing diuretics (spironolactone, amiloride, triamterene, and others) or potassium supplements can increase the risk of hyperkalemia.\\nDrug1: spironolactone\\nDrug2: triamterene\\nInteraction:,  effect other mechanism none advice )</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>416</th>\n",
       "      <td>195</td>\n",
       "      <td>DDI-DrugBank.d5.s19.p1</td>\n",
       "      <td>MAO Inhibitors: Studies in animals demonstrate that the acute toxicity of bupropion is enhanced by the MAO inhibitor phenelzine .</td>\n",
       "      <td>DDI-false</td>\n",
       "      <td>DDI-DrugBank.d5</td>\n",
       "      <td>dev</td>\n",
       "      <td>MAO Inhibitors</td>\n",
       "      <td>MAO inhibitor</td>\n",
       "      <td>Sentence: MAO Inhibitors: Studies in animals demonstrate that the acute toxicity of bupropion is enhanced by the MAO inhibitor phenelzine .\\nDrug 1: MAO Inhibitors\\nDrug 2: MAO inhibitor\\nInteraction: none</td>\n",
       "      <td>Sentence: MAO Inhibitors: Studies in animals demonstrate that the acute toxicity of bupropion is enhanced by the MAO inhibitor phenelzine .\\nDrug1: MAO Inhibitors\\nDrug2: MAO inhibitor\\nInteraction:</td>\n",
       "      <td>none</td>\n",
       "      <td>{advice, mechanism, none, effect, other}</td>\n",
       "      <td>Sentence: Effect of Other Drugs on the Pharmacokinetics of Clonazepam: Literature reports suggest that ranitidine, an agent that decreases stomach acidity, does not greatly alter clonazepam pharmacokinetics.\\nDrug 1: Clonazepam\\nDrug 2: ranitidine\\nInteraction: none\\n\\nSentence: Effect of Other Drugs on the Pharmacokinetics of Clonazepam: Literature reports suggest that ranitidine, an agent that decreases stomach acidity, does not greatly alter clonazepam pharmacokinetics.\\nDrug 1: Clonazepam\\nDrug 2: clonazepam\\nInteraction: none\\n\\nSentence: Effect of Other Drugs on the Pharmacokinetics of Clonazepam: Literature reports suggest that ranitidine, an agent that decreases stomach acidity, does not greatly alter clonazepam pharmacokinetics.\\nDrug 1: ranitidine\\nDrug 2: clonazepam\\nInteraction: none\\n\\nSentence: It has been reported that results of studies in animals indicate that dopamine-induced ventricular arrhythmias during anesthesia can be reversed by propranolol.\\nDrug 1: dopamine\\nDrug 2: propranolol\\nInteraction: effect\\n\\nSentence: Inhibitors Of Endogenous Prostaglandin Synthesis It has been reported that indomethacin may reduce the antihypertensive effect of captopril, especially in cases of low renin hypertension.\\nDrug 1: indomethacin\\nDrug 2: captopril\\nInteraction: effect\\n\\nSentence: MAO Inhibitors: Studies in animals demonstrate that the acute toxicity of bupropion is enhanced by the MAO inhibitor phenelzine .\\nDrug1: MAO Inhibitors\\nDrug2: MAO inhibitor\\nInteraction:</td>\n",
       "      <td>effect</td>\n",
       "      <td>({'id': 'cmpl-4IU99he0VU11QodZAUW8DiCY9o7NV', 'object': 'text_completion', 'created': 1640311135, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      1477\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.21885142\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" effect\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" effect\": -0.21885142\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" effect\"\n",
       "}]}, Sentence: Effect of Other Drugs on the Pharmacokinetics of Clonazepam: Literature reports suggest that ranitidine, an agent that decreases stomach acidity, does not greatly alter clonazepam pharmacokinetics.\\nDrug 1: Clonazepam\\nDrug 2: ranitidine\\nInteraction: none\\n\\nSentence: Effect of Other Drugs on the Pharmacokinetics of Clonazepam: Literature reports suggest that ranitidine, an agent that decreases stomach acidity, does not greatly alter clonazepam pharmacokinetics.\\nDrug 1: Clonazepam\\nDrug 2: clonazepam\\nInteraction: none\\n\\nSentence: Effect of Other Drugs on the Pharmacokinetics of Clonazepam: Literature reports suggest that ranitidine, an agent that decreases stomach acidity, does not greatly alter clonazepam pharmacokinetics.\\nDrug 1: ranitidine\\nDrug 2: clonazepam\\nInteraction: none\\n\\nSentence: It has been reported that results of studies in animals indicate that dopamine-induced ventricular arrhythmias during anesthesia can be reversed by propranolol.\\nDrug 1: dopamine\\nDrug 2: propranolol\\nInteraction: effect\\n\\nSentence: Inhibitors Of Endogenous Prostaglandin Synthesis It has been reported that indomethacin may reduce the antihypertensive effect of captopril, especially in cases of low renin hypertension.\\nDrug 1: indomethacin\\nDrug 2: captopril\\nInteraction: effect\\n\\nSentence: MAO Inhibitors: Studies in animals demonstrate that the acute toxicity of bupropion is enhanced by the MAO inhibitor phenelzine .\\nDrug1: MAO Inhibitors\\nDrug2: MAO inhibitor\\nInteraction:,  effect other mechanism none advice )</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>834</th>\n",
       "      <td>1683</td>\n",
       "      <td>DDI-DrugBank.d411.s4.p78</td>\n",
       "      <td>Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.</td>\n",
       "      <td>DDI-false</td>\n",
       "      <td>DDI-DrugBank.d411</td>\n",
       "      <td>dev</td>\n",
       "      <td>amiodarone</td>\n",
       "      <td>heparin</td>\n",
       "      <td>Sentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug 1: amiodarone\\nDrug 2: heparin\\nInteraction: none</td>\n",
       "      <td>Sentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug1: amiodarone\\nDrug2: heparin\\nInteraction:</td>\n",
       "      <td>none</td>\n",
       "      <td>{advice, mechanism, none, effect, other}</td>\n",
       "      <td>Sentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: platelet inhibitors\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: acetylsalicylic acid\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: NSAIDs\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: ketorolac tromethamine\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: dipyridamole\\nInteraction: none\\n\\nSentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug1: amiodarone\\nDrug2: heparin\\nInteraction:</td>\n",
       "      <td>none</td>\n",
       "      <td>({'id': 'cmpl-4IU9AXHttEIhxyCl0VaDbSoqUXfEY', 'object': 'text_completion', 'created': 1640311136, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      2288\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.014599491\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" none\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" none\": -0.014599491\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" none\"\n",
       "}]}, Sentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: platelet inhibitors\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: acetylsalicylic acid\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: NSAIDs\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: ketorolac tromethamine\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: dipyridamole\\nInteraction: none\\n\\nSentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug1: amiodarone\\nDrug2: heparin\\nInteraction:,  effect other mechanism none advice )</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>727</th>\n",
       "      <td>1576</td>\n",
       "      <td>DDI-DrugBank.d411.s3.p124</td>\n",
       "      <td>Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.</td>\n",
       "      <td>DDI-false</td>\n",
       "      <td>DDI-DrugBank.d411</td>\n",
       "      <td>dev</td>\n",
       "      <td>glucocorticoids</td>\n",
       "      <td>tamoxifen</td>\n",
       "      <td>Sentence: Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.\\nDrug 1: glucocorticoids\\nDrug 2: tamoxifen\\nInteraction: none</td>\n",
       "      <td>Sentence: Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.\\nDrug1: glucocorticoids\\nDrug2: tamoxifen\\nInteraction:</td>\n",
       "      <td>none</td>\n",
       "      <td>{advice, mechanism, none, effect, other}</td>\n",
       "      <td>Sentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: phenytoin\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: glyburide\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: ranitidine\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: omeprazole\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: estrogens\\nInteraction: none\\n\\nSentence: Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.\\nDrug1: glucocorticoids\\nDrug2: tamoxifen\\nInteraction:</td>\n",
       "      <td>none</td>\n",
       "      <td>({'id': 'cmpl-4IU9ADaMxwnvo7rXTTymAWUE4RPzN', 'object': 'text_completion', 'created': 1640311136, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      2311\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.009043714\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" none\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" none\": -0.009043714\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" none\"\n",
       "}]}, Sentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: phenytoin\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: glyburide\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: ranitidine\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: omeprazole\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: estrogens\\nInteraction: none\\n\\nSentence: Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.\\nDrug1: glucocorticoids\\nDrug2: tamoxifen\\nInteraction:,  effect other mechanism none advice )</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>734</th>\n",
       "      <td>1583</td>\n",
       "      <td>DDI-DrugBank.d411.s3.p131</td>\n",
       "      <td>Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.</td>\n",
       "      <td>DDI-false</td>\n",
       "      <td>DDI-DrugBank.d411</td>\n",
       "      <td>dev</td>\n",
       "      <td>meclofenamic acid</td>\n",
       "      <td>tamoxifen</td>\n",
       "      <td>Sentence: Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.\\nDrug 1: meclofenamic acid\\nDrug 2: tamoxifen\\nInteraction: none</td>\n",
       "      <td>Sentence: Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.\\nDrug1: meclofenamic acid\\nDrug2: tamoxifen\\nInteraction:</td>\n",
       "      <td>none</td>\n",
       "      <td>{advice, mechanism, none, effect, other}</td>\n",
       "      <td>Sentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: phenytoin\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: glyburide\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: ranitidine\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: omeprazole\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: estrogens\\nInteraction: none\\n\\nSentence: Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.\\nDrug1: meclofenamic acid\\nDrug2: tamoxifen\\nInteraction:</td>\n",
       "      <td>none</td>\n",
       "      <td>({'id': 'cmpl-4IU9A6R9U2rtrsdNzYBwHSjD2jD9a', 'object': 'text_completion', 'created': 1640311136, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      2313\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.010498385\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" none\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" none\": -0.010498385\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" none\"\n",
       "}]}, Sentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: phenytoin\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: glyburide\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: ranitidine\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: omeprazole\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: estrogens\\nInteraction: none\\n\\nSentence: Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.\\nDrug1: meclofenamic acid\\nDrug2: tamoxifen\\nInteraction:,  effect other mechanism none advice )</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>607</th>\n",
       "      <td>1298</td>\n",
       "      <td>DDI-DrugBank.d328.s27.p1</td>\n",
       "      <td>Fluconazole and Ketoconazole: Ketoconazole and fluconazole are predominantly CYP 3A4 and 2C9 inhibitors, respectively.</td>\n",
       "      <td>DDI-false</td>\n",
       "      <td>DDI-DrugBank.d328</td>\n",
       "      <td>dev</td>\n",
       "      <td>Fluconazole</td>\n",
       "      <td>Ketoconazole</td>\n",
       "      <td>Sentence: Fluconazole and Ketoconazole: Ketoconazole and fluconazole are predominantly CYP 3A4 and 2C9 inhibitors, respectively.\\nDrug 1: Fluconazole\\nDrug 2: Ketoconazole\\nInteraction: none</td>\n",
       "      <td>Sentence: Fluconazole and Ketoconazole: Ketoconazole and fluconazole are predominantly CYP 3A4 and 2C9 inhibitors, respectively.\\nDrug1: Fluconazole\\nDrug2: Ketoconazole\\nInteraction:</td>\n",
       "      <td>none</td>\n",
       "      <td>{advice, mechanism, none, effect, other}</td>\n",
       "      <td>Sentence: Substances that are potent inhibitors of CYP3A4 activity (eg, ketoconazole and itraconazole) decrease gefitinib metabolism and increase gefitinib plasma concentrations.\\nDrug 1: ketoconazole\\nDrug 2: itraconazole\\nInteraction: none\\n\\nSentence: Substances that are potent inhibitors of CYP3A4 activity (eg, ketoconazole and itraconazole) decrease gefitinib metabolism and increase gefitinib plasma concentrations.\\nDrug 1: ketoconazole\\nDrug 2: gefitinib\\nInteraction: mechanism\\n\\nSentence: Substances that are potent inhibitors of CYP3A4 activity (eg, ketoconazole and itraconazole) decrease gefitinib metabolism and increase gefitinib plasma concentrations.\\nDrug 1: ketoconazole\\nDrug 2: gefitinib\\nInteraction: mechanism\\n\\nSentence: Substances that are potent inhibitors of CYP3A4 activity (eg, ketoconazole and itraconazole) decrease gefitinib metabolism and increase gefitinib plasma concentrations.\\nDrug 1: itraconazole\\nDrug 2: gefitinib\\nInteraction: mechanism\\n\\nSentence: Substances that are potent inhibitors of CYP3A4 activity (eg, ketoconazole and itraconazole) decrease gefitinib metabolism and increase gefitinib plasma concentrations.\\nDrug 1: itraconazole\\nDrug 2: gefitinib\\nInteraction: mechanism\\n\\nSentence: Fluconazole and Ketoconazole: Ketoconazole and fluconazole are predominantly CYP 3A4 and 2C9 inhibitors, respectively.\\nDrug1: Fluconazole\\nDrug2: Ketoconazole\\nInteraction:</td>\n",
       "      <td>none</td>\n",
       "      <td>({'id': 'cmpl-4IU9BGNEyARjAezyBtdi8zBkj7qKl', 'object': 'text_completion', 'created': 1640311137, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      1388\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.5496055\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" none\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" none\": -0.5496055\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" none\"\n",
       "}]}, Sentence: Substances that are potent inhibitors of CYP3A4 activity (eg, ketoconazole and itraconazole) decrease gefitinib metabolism and increase gefitinib plasma concentrations.\\nDrug 1: ketoconazole\\nDrug 2: itraconazole\\nInteraction: none\\n\\nSentence: Substances that are potent inhibitors of CYP3A4 activity (eg, ketoconazole and itraconazole) decrease gefitinib metabolism and increase gefitinib plasma concentrations.\\nDrug 1: ketoconazole\\nDrug 2: gefitinib\\nInteraction: mechanism\\n\\nSentence: Substances that are potent inhibitors of CYP3A4 activity (eg, ketoconazole and itraconazole) decrease gefitinib metabolism and increase gefitinib plasma concentrations.\\nDrug 1: ketoconazole\\nDrug 2: gefitinib\\nInteraction: mechanism\\n\\nSentence: Substances that are potent inhibitors of CYP3A4 activity (eg, ketoconazole and itraconazole) decrease gefitinib metabolism and increase gefitinib plasma concentrations.\\nDrug 1: itraconazole\\nDrug 2: gefitinib\\nInteraction: mechanism\\n\\nSentence: Substances that are potent inhibitors of CYP3A4 activity (eg, ketoconazole and itraconazole) decrease gefitinib metabolism and increase gefitinib plasma concentrations.\\nDrug 1: itraconazole\\nDrug 2: gefitinib\\nInteraction: mechanism\\n\\nSentence: Fluconazole and Ketoconazole: Ketoconazole and fluconazole are predominantly CYP 3A4 and 2C9 inhibitors, respectively.\\nDrug1: Fluconazole\\nDrug2: Ketoconazole\\nInteraction:,  effect other mechanism none advice )</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>763</th>\n",
       "      <td>1612</td>\n",
       "      <td>DDI-DrugBank.d411.s4.p7</td>\n",
       "      <td>Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.</td>\n",
       "      <td>DDI-false</td>\n",
       "      <td>DDI-DrugBank.d411</td>\n",
       "      <td>dev</td>\n",
       "      <td>aminoglutethimide</td>\n",
       "      <td>b-adrenergic blocking agents</td>\n",
       "      <td>Sentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug 1: aminoglutethimide\\nDrug 2: b-adrenergic blocking agents\\nInteraction: none</td>\n",
       "      <td>Sentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug1: aminoglutethimide\\nDrug2: b-adrenergic blocking agents\\nInteraction:</td>\n",
       "      <td>none</td>\n",
       "      <td>{advice, mechanism, none, effect, other}</td>\n",
       "      <td>Sentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: platelet inhibitors\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: acetylsalicylic acid\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: NSAIDs\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: ketorolac tromethamine\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: dipyridamole\\nInteraction: none\\n\\nSentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug1: aminoglutethimide\\nDrug2: b-adrenergic blocking agents\\nInteraction:</td>\n",
       "      <td>none</td>\n",
       "      <td>({'id': 'cmpl-4IU9Bw4Hw5B3lgovBcHGqF82Q5JzJ', 'object': 'text_completion', 'created': 1640311137, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      2316\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.009735515\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" none\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" none\": -0.009735515\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" none\"\n",
       "}]}, Sentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: platelet inhibitors\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: acetylsalicylic acid\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: NSAIDs\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: ketorolac tromethamine\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: dipyridamole\\nInteraction: none\\n\\nSentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug1: aminoglutethimide\\nDrug2: b-adrenergic blocking agents\\nInteraction:,  effect other mechanism none advice )</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>780</th>\n",
       "      <td>1629</td>\n",
       "      <td>DDI-DrugBank.d411.s4.p24</td>\n",
       "      <td>Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.</td>\n",
       "      <td>DDI-false</td>\n",
       "      <td>DDI-DrugBank.d411</td>\n",
       "      <td>dev</td>\n",
       "      <td>aminoglutethimide</td>\n",
       "      <td>nitroprusside</td>\n",
       "      <td>Sentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug 1: aminoglutethimide\\nDrug 2: nitroprusside\\nInteraction: none</td>\n",
       "      <td>Sentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug1: aminoglutethimide\\nDrug2: nitroprusside\\nInteraction:</td>\n",
       "      <td>none</td>\n",
       "      <td>{advice, mechanism, none, effect, other}</td>\n",
       "      <td>Sentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: platelet inhibitors\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: acetylsalicylic acid\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: NSAIDs\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: ketorolac tromethamine\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: dipyridamole\\nInteraction: none\\n\\nSentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug1: aminoglutethimide\\nDrug2: nitroprusside\\nInteraction:</td>\n",
       "      <td>none</td>\n",
       "      <td>({'id': 'cmpl-4IU9BdsGngWSIW1avM7L9u7ExhCkA', 'object': 'text_completion', 'created': 1640311137, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      2301\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.018152107\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" none\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" none\": -0.018152107\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" none\"\n",
       "}]}, Sentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: platelet inhibitors\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: acetylsalicylic acid\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: NSAIDs\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: ketorolac tromethamine\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: dipyridamole\\nInteraction: none\\n\\nSentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug1: aminoglutethimide\\nDrug2: nitroprusside\\nInteraction:,  effect other mechanism none advice )</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>841</th>\n",
       "      <td>1690</td>\n",
       "      <td>DDI-DrugBank.d411.s4.p85</td>\n",
       "      <td>Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.</td>\n",
       "      <td>DDI-false</td>\n",
       "      <td>DDI-DrugBank.d411</td>\n",
       "      <td>dev</td>\n",
       "      <td>amiodarone</td>\n",
       "      <td>metoclopramide</td>\n",
       "      <td>Sentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug 1: amiodarone\\nDrug 2: metoclopramide\\nInteraction: none</td>\n",
       "      <td>Sentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug1: amiodarone\\nDrug2: metoclopramide\\nInteraction:</td>\n",
       "      <td>none</td>\n",
       "      <td>{advice, mechanism, none, effect, other}</td>\n",
       "      <td>Sentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: platelet inhibitors\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: acetylsalicylic acid\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: NSAIDs\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: ketorolac tromethamine\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: dipyridamole\\nInteraction: none\\n\\nSentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug1: amiodarone\\nDrug2: metoclopramide\\nInteraction:</td>\n",
       "      <td>none</td>\n",
       "      <td>({'id': 'cmpl-4IU9CmOdUVa93JE9cOWlhSgRCoJG6', 'object': 'text_completion', 'created': 1640311138, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      2295\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.010840391\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" none\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" none\": -0.010840391\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" none\"\n",
       "}]}, Sentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: platelet inhibitors\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: acetylsalicylic acid\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: NSAIDs\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: ketorolac tromethamine\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: dipyridamole\\nInteraction: none\\n\\nSentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug1: amiodarone\\nDrug2: metoclopramide\\nInteraction:,  effect other mechanism none advice )</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>915</th>\n",
       "      <td>1764</td>\n",
       "      <td>DDI-DrugBank.d411.s4.p159</td>\n",
       "      <td>Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.</td>\n",
       "      <td>DDI-false</td>\n",
       "      <td>DDI-DrugBank.d411</td>\n",
       "      <td>dev</td>\n",
       "      <td>perchlorate</td>\n",
       "      <td>chloral hydrate</td>\n",
       "      <td>Sentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug 1: perchlorate\\nDrug 2: chloral hydrate\\nInteraction: none</td>\n",
       "      <td>Sentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug1: perchlorate\\nDrug2: chloral hydrate\\nInteraction:</td>\n",
       "      <td>none</td>\n",
       "      <td>{advice, mechanism, none, effect, other}</td>\n",
       "      <td>Sentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: platelet inhibitors\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: acetylsalicylic acid\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: NSAIDs\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: ketorolac tromethamine\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: dipyridamole\\nInteraction: none\\n\\nSentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug1: perchlorate\\nDrug2: chloral hydrate\\nInteraction:</td>\n",
       "      <td>none</td>\n",
       "      <td>({'id': 'cmpl-4IU9ChpUnEgo3jCvVPuZHdpuFbErh', 'object': 'text_completion', 'created': 1640311138, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      2297\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.008588092\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" none\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" none\": -0.008588092\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" none\"\n",
       "}]}, Sentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: platelet inhibitors\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: acetylsalicylic acid\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: NSAIDs\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: ketorolac tromethamine\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: dipyridamole\\nInteraction: none\\n\\nSentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug1: perchlorate\\nDrug2: chloral hydrate\\nInteraction:,  effect other mechanism none advice )</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>655</th>\n",
       "      <td>1504</td>\n",
       "      <td>DDI-DrugBank.d411.s3.p52</td>\n",
       "      <td>Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.</td>\n",
       "      <td>DDI-false</td>\n",
       "      <td>DDI-DrugBank.d411</td>\n",
       "      <td>dev</td>\n",
       "      <td>asparaginase</td>\n",
       "      <td>furosemide</td>\n",
       "      <td>Sentence: Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.\\nDrug 1: asparaginase\\nDrug 2: furosemide\\nInteraction: none</td>\n",
       "      <td>Sentence: Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.\\nDrug1: asparaginase\\nDrug2: furosemide\\nInteraction:</td>\n",
       "      <td>none</td>\n",
       "      <td>{advice, mechanism, none, effect, other}</td>\n",
       "      <td>Sentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: phenytoin\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: glyburide\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: ranitidine\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: omeprazole\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: estrogens\\nInteraction: none\\n\\nSentence: Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.\\nDrug1: asparaginase\\nDrug2: furosemide\\nInteraction:</td>\n",
       "      <td>none</td>\n",
       "      <td>({'id': 'cmpl-4IU9DkFX2HXIfVOUUVDit262U5rk8', 'object': 'text_completion', 'created': 1640311139, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      2309\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.0067363116\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" none\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" none\": -0.0067363116\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" none\"\n",
       "}]}, Sentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: phenytoin\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: glyburide\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: ranitidine\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: omeprazole\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: estrogens\\nInteraction: none\\n\\nSentence: Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.\\nDrug1: asparaginase\\nDrug2: furosemide\\nInteraction:,  effect other mechanism none advice )</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>494</th>\n",
       "      <td>611</td>\n",
       "      <td>DDI-DrugBank.d202.s16.p24</td>\n",
       "      <td>Therefore, co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme, including other antidepressants, phenothiazines, carbamazepine, and Type 1C antiarrhythmics (eg, propafenone, flecainide, and encainide), or that inhibit this enzyme (eg, quinidine), should be approached with caution.</td>\n",
       "      <td>DDI-false</td>\n",
       "      <td>DDI-DrugBank.d202</td>\n",
       "      <td>dev</td>\n",
       "      <td>carbamazepine</td>\n",
       "      <td>encainide</td>\n",
       "      <td>Sentence: Therefore, co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme, including other antidepressants, phenothiazines, carbamazepine, and Type 1C antiarrhythmics (eg, propafenone, flecainide, and encainide), or that inhibit this enzyme (eg, quinidine), should be approached with caution.\\nDrug 1: carbamazepine\\nDrug 2: encainide\\nInteraction: none</td>\n",
       "      <td>Sentence: Therefore, co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme, including other antidepressants, phenothiazines, carbamazepine, and Type 1C antiarrhythmics (eg, propafenone, flecainide, and encainide), or that inhibit this enzyme (eg, quinidine), should be approached with caution.\\nDrug1: carbamazepine\\nDrug2: encainide\\nInteraction:</td>\n",
       "      <td>none</td>\n",
       "      <td>{advice, mechanism, none, effect, other}</td>\n",
       "      <td>Sentence: Therefore, co-administration of clozapine with other drugs that are metabolized by this isozyme, including antidepressants, phenothiazines, carbamazepine, and Type 1C antiarrhythmics (e.g., propafenone, flecainide and encainide), or that inhibit this enzyme (e.g., quinidine), should be approached with caution.\\nDrug 1: clozapine\\nDrug 2: antidepressants\\nInteraction: advice\\n\\nSentence: Therefore, co-administration of clozapine with other drugs that are metabolized by this isozyme, including antidepressants, phenothiazines, carbamazepine, and Type 1C antiarrhythmics (e.g., propafenone, flecainide and encainide), or that inhibit this enzyme (e.g., quinidine), should be approached with caution.\\nDrug 1: clozapine\\nDrug 2: phenothiazines\\nInteraction: advice\\n\\nSentence: Therefore, co-administration of clozapine with other drugs that are metabolized by this isozyme, including antidepressants, phenothiazines, carbamazepine, and Type 1C antiarrhythmics (e.g., propafenone, flecainide and encainide), or that inhibit this enzyme (e.g., quinidine), should be approached with caution.\\nDrug 1: clozapine\\nDrug 2: carbamazepine\\nInteraction: advice\\n\\nSentence: Therefore, co-administration of clozapine with other drugs that are metabolized by this isozyme, including antidepressants, phenothiazines, carbamazepine, and Type 1C antiarrhythmics (e.g., propafenone, flecainide and encainide), or that inhibit this enzyme (e.g., quinidine), should be approached with caution.\\nDrug 1: clozapine\\nDrug 2: Type 1C antiarrhythmics\\nInteraction: advice\\n\\nSentence: Therefore, co-administration of clozapine with other drugs that are metabolized by this isozyme, including antidepressants, phenothiazines, carbamazepine, and Type 1C antiarrhythmics (e.g., propafenone, flecainide and encainide), or that inhibit this enzyme (e.g., quinidine), should be approached with caution.\\nDrug 1: clozapine\\nDrug 2: propafenone\\nInteraction: advice\\n\\nSentence: Therefore, co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme, including other antidepressants, phenothiazines, carbamazepine, and Type 1C antiarrhythmics (eg, propafenone, flecainide, and encainide), or that inhibit this enzyme (eg, quinidine), should be approached with caution.\\nDrug1: carbamazepine\\nDrug2: encainide\\nInteraction:</td>\n",
       "      <td>advice</td>\n",
       "      <td>({'id': 'cmpl-4IU9Dl953O2IbXYfvA3hWcI0EnrHq', 'object': 'text_completion', 'created': 1640311139, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      2319\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.04596935\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" advice\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" advice\": -0.04596935\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" advice\"\n",
       "}]}, Sentence: Therefore, co-administration of clozapine with other drugs that are metabolized by this isozyme, including antidepressants, phenothiazines, carbamazepine, and Type 1C antiarrhythmics (e.g., propafenone, flecainide and encainide), or that inhibit this enzyme (e.g., quinidine), should be approached with caution.\\nDrug 1: clozapine\\nDrug 2: antidepressants\\nInteraction: advice\\n\\nSentence: Therefore, co-administration of clozapine with other drugs that are metabolized by this isozyme, including antidepressants, phenothiazines, carbamazepine, and Type 1C antiarrhythmics (e.g., propafenone, flecainide and encainide), or that inhibit this enzyme (e.g., quinidine), should be approached with caution.\\nDrug 1: clozapine\\nDrug 2: phenothiazines\\nInteraction: advice\\n\\nSentence: Therefore, co-administration of clozapine with other drugs that are metabolized by this isozyme, including antidepressants, phenothiazines, carbamazepine, and Type 1C antiarrhythmics (e.g., propafenone, flecainide and encainide), or that inhibit this enzyme (e.g., quinidine), should be approached with caution.\\nDrug 1: clozapine\\nDrug 2: carbamazepine\\nInteraction: advice\\n\\nSentence: Therefore, co-administration of clozapine with other drugs that are metabolized by this isozyme, including antidepressants, phenothiazines, carbamazepine, and Type 1C antiarrhythmics (e.g., propafenone, flecainide and encainide), or that inhibit this enzyme (e.g., quinidine), should be approached with caution.\\nDrug 1: clozapine\\nDrug 2: Type 1C antiarrhythmics\\nInteraction: advice\\n\\nSentence: Therefore, co-administration of clozapine with other drugs that are metabolized by this isozyme, including antidepressants, phenothiazines, carbamazepine, and Type 1C antiarrhythmics (e.g., propafenone, flecainide and encainide), or that inhibit this enzyme (e.g., quinidine), should be approached with caution.\\nDrug 1: clozapine\\nDrug 2: propafenone\\nInteraction: advice\\n\\nSentence: Therefore, co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme, including other antidepressants, phenothiazines, carbamazepine, and Type 1C antiarrhythmics (eg, propafenone, flecainide, and encainide), or that inhibit this enzyme (eg, quinidine), should be approached with caution.\\nDrug1: carbamazepine\\nDrug2: encainide\\nInteraction:,  effect other mechanism none advice )</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>426</th>\n",
       "      <td>283</td>\n",
       "      <td>DDI-DrugBank.d568.s11.p0</td>\n",
       "      <td>Nevertheless, plasma lithium levels should be monitored with appropriate adjustment to the lithium dose in accordance with standard clinical practice.</td>\n",
       "      <td>DDI-false</td>\n",
       "      <td>DDI-DrugBank.d568</td>\n",
       "      <td>dev</td>\n",
       "      <td>lithium</td>\n",
       "      <td>lithium</td>\n",
       "      <td>Sentence: Nevertheless, plasma lithium levels should be monitored with appropriate adjustment to the lithium dose in accordance with standard clinical practice.\\nDrug 1: lithium\\nDrug 2: lithium\\nInteraction: none</td>\n",
       "      <td>Sentence: Nevertheless, plasma lithium levels should be monitored with appropriate adjustment to the lithium dose in accordance with standard clinical practice.\\nDrug1: lithium\\nDrug2: lithium\\nInteraction:</td>\n",
       "      <td>none</td>\n",
       "      <td>{advice, mechanism, none, effect, other}</td>\n",
       "      <td>Sentence: Accordingly, careful patient monitoring and dose adjustment of metformin is recommended in patients concomitantly taking cephalexin and metformin.\\nDrug 1: metformin\\nDrug 2: cephalexin\\nInteraction: none\\n\\nSentence: Accordingly, careful patient monitoring and dose adjustment of metformin is recommended in patients concomitantly taking cephalexin and metformin.\\nDrug 1: metformin\\nDrug 2: metformin\\nInteraction: none\\n\\nSentence: Accordingly, careful patient monitoring and dose adjustment of metformin is recommended in patients concomitantly taking cephalexin and metformin.\\nDrug 1: cephalexin\\nDrug 2: metformin\\nInteraction: advice\\n\\nSentence: In order to avoid lithium intoxication, lithium plasma levels should be monitored closely.\\nDrug 1: lithium\\nDrug 2: lithium\\nInteraction: none\\n\\nSentence: Therefore, cyclosporine serum levels should be monitored and appropriate cyclosporine dosage adjustments made when these drugs are used concomitantly.\\nDrug 1: cyclosporine\\nDrug 2: cyclosporine\\nInteraction: none\\n\\nSentence: Nevertheless, plasma lithium levels should be monitored with appropriate adjustment to the lithium dose in accordance with standard clinical practice.\\nDrug1: lithium\\nDrug2: lithium\\nInteraction:</td>\n",
       "      <td>none</td>\n",
       "      <td>({'id': 'cmpl-4IU9DYBwrOHQAo9fi2YoYYdlgKRbj', 'object': 'text_completion', 'created': 1640311139, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      1217\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.1201114\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" none\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" none\": -0.1201114\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" none\"\n",
       "}]}, Sentence: Accordingly, careful patient monitoring and dose adjustment of metformin is recommended in patients concomitantly taking cephalexin and metformin.\\nDrug 1: metformin\\nDrug 2: cephalexin\\nInteraction: none\\n\\nSentence: Accordingly, careful patient monitoring and dose adjustment of metformin is recommended in patients concomitantly taking cephalexin and metformin.\\nDrug 1: metformin\\nDrug 2: metformin\\nInteraction: none\\n\\nSentence: Accordingly, careful patient monitoring and dose adjustment of metformin is recommended in patients concomitantly taking cephalexin and metformin.\\nDrug 1: cephalexin\\nDrug 2: metformin\\nInteraction: advice\\n\\nSentence: In order to avoid lithium intoxication, lithium plasma levels should be monitored closely.\\nDrug 1: lithium\\nDrug 2: lithium\\nInteraction: none\\n\\nSentence: Therefore, cyclosporine serum levels should be monitored and appropriate cyclosporine dosage adjustments made when these drugs are used concomitantly.\\nDrug 1: cyclosporine\\nDrug 2: cyclosporine\\nInteraction: none\\n\\nSentence: Nevertheless, plasma lithium levels should be monitored with appropriate adjustment to the lithium dose in accordance with standard clinical practice.\\nDrug1: lithium\\nDrug2: lithium\\nInteraction:,  effect other mechanism none advice )</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>977</th>\n",
       "      <td>1826</td>\n",
       "      <td>DDI-DrugBank.d411.s4.p221</td>\n",
       "      <td>Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.</td>\n",
       "      <td>DDI-false</td>\n",
       "      <td>DDI-DrugBank.d411</td>\n",
       "      <td>dev</td>\n",
       "      <td>antithyroid drugs</td>\n",
       "      <td>levodopa</td>\n",
       "      <td>Sentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug 1: antithyroid drugs\\nDrug 2: levodopa\\nInteraction: none</td>\n",
       "      <td>Sentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug1: antithyroid drugs\\nDrug2: levodopa\\nInteraction:</td>\n",
       "      <td>none</td>\n",
       "      <td>{advice, mechanism, none, effect, other}</td>\n",
       "      <td>Sentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: platelet inhibitors\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: acetylsalicylic acid\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: NSAIDs\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: ketorolac tromethamine\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: dipyridamole\\nInteraction: none\\n\\nSentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug1: antithyroid drugs\\nDrug2: levodopa\\nInteraction:</td>\n",
       "      <td>none</td>\n",
       "      <td>({'id': 'cmpl-4IU9EwSY1AiunNfQMutmQtffU1og3', 'object': 'text_completion', 'created': 1640311140, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      2296\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.017196171\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" none\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" none\": -0.017196171\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" none\"\n",
       "}]}, Sentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: platelet inhibitors\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: acetylsalicylic acid\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: NSAIDs\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: ketorolac tromethamine\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: dipyridamole\\nInteraction: none\\n\\nSentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug1: antithyroid drugs\\nDrug2: levodopa\\nInteraction:,  effect other mechanism none advice )</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>896</th>\n",
       "      <td>1745</td>\n",
       "      <td>DDI-DrugBank.d411.s4.p140</td>\n",
       "      <td>Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.</td>\n",
       "      <td>DDI-false</td>\n",
       "      <td>DDI-DrugBank.d411</td>\n",
       "      <td>dev</td>\n",
       "      <td>thiocyanate</td>\n",
       "      <td>levodopa</td>\n",
       "      <td>Sentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug 1: thiocyanate\\nDrug 2: levodopa\\nInteraction: none</td>\n",
       "      <td>Sentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug1: thiocyanate\\nDrug2: levodopa\\nInteraction:</td>\n",
       "      <td>none</td>\n",
       "      <td>{advice, mechanism, none, effect, other}</td>\n",
       "      <td>Sentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: platelet inhibitors\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: acetylsalicylic acid\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: NSAIDs\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: ketorolac tromethamine\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: dipyridamole\\nInteraction: none\\n\\nSentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug1: thiocyanate\\nDrug2: levodopa\\nInteraction:</td>\n",
       "      <td>none</td>\n",
       "      <td>({'id': 'cmpl-4IU9EiF24Ml657eCSWyrgBNwTg54e', 'object': 'text_completion', 'created': 1640311140, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      2290\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.012775228\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" none\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" none\": -0.012775228\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" none\"\n",
       "}]}, Sentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: platelet inhibitors\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: acetylsalicylic acid\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: NSAIDs\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: ketorolac tromethamine\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: dipyridamole\\nInteraction: none\\n\\nSentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug1: thiocyanate\\nDrug2: levodopa\\nInteraction:,  effect other mechanism none advice )</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1591</th>\n",
       "      <td>6697</td>\n",
       "      <td>DDI-DrugBank.d205.s0.p1</td>\n",
       "      <td>Since Zarontin (ethosuximide) may interact with concurrently administered antiepileptic drugs, periodic serum level determinations of these drugs may be necessary (eg, ethosuximide may elevate phenytoin serum levels and valproic acid has been reported to both increase and decrease ethosuximide levels).</td>\n",
       "      <td>DDI-int</td>\n",
       "      <td>DDI-DrugBank.d205</td>\n",
       "      <td>dev</td>\n",
       "      <td>Zarontin</td>\n",
       "      <td>antiepileptic drugs</td>\n",
       "      <td>Sentence: Since Zarontin (ethosuximide) may interact with concurrently administered antiepileptic drugs, periodic serum level determinations of these drugs may be necessary (eg, ethosuximide may elevate phenytoin serum levels and valproic acid has been reported to both increase and decrease ethosuximide levels).\\nDrug 1: Zarontin\\nDrug 2: antiepileptic drugs\\nInteraction: other</td>\n",
       "      <td>Sentence: Since Zarontin (ethosuximide) may interact with concurrently administered antiepileptic drugs, periodic serum level determinations of these drugs may be necessary (eg, ethosuximide may elevate phenytoin serum levels and valproic acid has been reported to both increase and decrease ethosuximide levels).\\nDrug1: Zarontin\\nDrug2: antiepileptic drugs\\nInteraction:</td>\n",
       "      <td>other</td>\n",
       "      <td>{advice, mechanism, none, effect, other}</td>\n",
       "      <td>Sentence: If desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/hypnotics, careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines (e.g., chlordiazepoxide or diazepam) are additive.\\nDrug 1: desipramine hydrochloride\\nDrug 2: psychotropic agents\\nInteraction: effect\\n\\nSentence: If desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/hypnotics, careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines (e.g., chlordiazepoxide or diazepam) are additive.\\nDrug 1: desipramine hydrochloride\\nDrug 2: tranquilizers\\nInteraction: effect\\n\\nSentence: If desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/hypnotics, careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines (e.g., chlordiazepoxide or diazepam) are additive.\\nDrug 1: desipramine hydrochloride\\nDrug 2: sedative\\nInteraction: effect\\n\\nSentence: If desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/hypnotics, careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines (e.g., chlordiazepoxide or diazepam) are additive.\\nDrug 1: desipramine hydrochloride\\nDrug 2: hypnotics\\nInteraction: effect\\n\\nSentence: If desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/hypnotics, careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines (e.g., chlordiazepoxide or diazepam) are additive.\\nDrug 1: desipramine hydrochloride\\nDrug 2: desipramine\\nInteraction: none\\n\\nSentence: Since Zarontin (ethosuximide) may interact with concurrently administered antiepileptic drugs, periodic serum level determinations of these drugs may be necessary (eg, ethosuximide may elevate phenytoin serum levels and valproic acid has been reported to both increase and decrease ethosuximide levels).\\nDrug1: Zarontin\\nDrug2: antiepileptic drugs\\nInteraction:</td>\n",
       "      <td>none</td>\n",
       "      <td>({'id': 'cmpl-4IU9Ece9q4A4f37TAnysWAPGtwMxm', 'object': 'text_completion', 'created': 1640311140, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      2382\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.4127358\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" none\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" none\": -0.4127358\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" none\"\n",
       "}]}, Sentence: If desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/hypnotics, careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines (e.g., chlordiazepoxide or diazepam) are additive.\\nDrug 1: desipramine hydrochloride\\nDrug 2: psychotropic agents\\nInteraction: effect\\n\\nSentence: If desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/hypnotics, careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines (e.g., chlordiazepoxide or diazepam) are additive.\\nDrug 1: desipramine hydrochloride\\nDrug 2: tranquilizers\\nInteraction: effect\\n\\nSentence: If desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/hypnotics, careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines (e.g., chlordiazepoxide or diazepam) are additive.\\nDrug 1: desipramine hydrochloride\\nDrug 2: sedative\\nInteraction: effect\\n\\nSentence: If desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/hypnotics, careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines (e.g., chlordiazepoxide or diazepam) are additive.\\nDrug 1: desipramine hydrochloride\\nDrug 2: hypnotics\\nInteraction: effect\\n\\nSentence: If desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/hypnotics, careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines (e.g., chlordiazepoxide or diazepam) are additive.\\nDrug 1: desipramine hydrochloride\\nDrug 2: desipramine\\nInteraction: none\\n\\nSentence: Since Zarontin (ethosuximide) may interact with concurrently administered antiepileptic drugs, periodic serum level determinations of these drugs may be necessary (eg, ethosuximide may elevate phenytoin serum levels and valproic acid has been reported to both increase and decrease ethosuximide levels).\\nDrug1: Zarontin\\nDrug2: antiepileptic drugs\\nInteraction:,  effect other mechanism none advice )</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "      Unnamed: 0                      index  \\\n",
       "1065        4386    DDI-DrugBank.d48.s12.p2   \n",
       "1157       17780     DDI-DrugBank.d31.s0.p0   \n",
       "1096        9530   DDI-DrugBank.d165.s16.p2   \n",
       "1164       19325    DDI-DrugBank.d297.s5.p0   \n",
       "1133       14414   DDI-DrugBank.d364.s10.p1   \n",
       "30           930    DDI-DrugBank.d246.s0.p4   \n",
       "299        19162    DDI-DrugBank.d222.s0.p0   \n",
       "177        10039    DDI-DrugBank.d176.s6.p9   \n",
       "204        12858    DDI-DrugBank.d335.s3.p4   \n",
       "354        21838    DDI-DrugBank.d558.s8.p0   \n",
       "265        17981   DDI-DrugBank.d396.s0.p18   \n",
       "41          2563   DDI-DrugBank.d132.s14.p0   \n",
       "13           643    DDI-DrugBank.d238.s4.p0   \n",
       "55          3227    DDI-DrugBank.d564.s0.p7   \n",
       "196        12582   DDI-DrugBank.d485.s10.p2   \n",
       "137         8035   DDI-DrugBank.d522.s23.p3   \n",
       "29           929    DDI-DrugBank.d246.s0.p3   \n",
       "1560       21139   DDI-DrugBank.d413.s20.p9   \n",
       "1283        4216    DDI-DrugBank.d487.s1.p7   \n",
       "1458       14400    DDI-DrugBank.d157.s1.p0   \n",
       "1462       14502   DDI-DrugBank.d198.s22.p3   \n",
       "1501       15384   DDI-DrugBank.d94.s11.p27   \n",
       "1558       21031    DDI-DrugBank.d195.s8.p0   \n",
       "1490       15373   DDI-DrugBank.d94.s11.p16   \n",
       "1493       15376   DDI-DrugBank.d94.s11.p19   \n",
       "1319        6252   DDI-DrugBank.d236.s23.p2   \n",
       "1312        5648    DDI-DrugBank.d506.s5.p0   \n",
       "1337        7549   DDI-DrugBank.d382.s18.p9   \n",
       "923         1772  DDI-DrugBank.d411.s4.p167   \n",
       "667         1516   DDI-DrugBank.d411.s3.p64   \n",
       "625         1474   DDI-DrugBank.d411.s3.p22   \n",
       "907         1756  DDI-DrugBank.d411.s4.p151   \n",
       "455          438    DDI-DrugBank.d561.s4.p5   \n",
       "416          195     DDI-DrugBank.d5.s19.p1   \n",
       "834         1683   DDI-DrugBank.d411.s4.p78   \n",
       "727         1576  DDI-DrugBank.d411.s3.p124   \n",
       "734         1583  DDI-DrugBank.d411.s3.p131   \n",
       "607         1298   DDI-DrugBank.d328.s27.p1   \n",
       "763         1612    DDI-DrugBank.d411.s4.p7   \n",
       "780         1629   DDI-DrugBank.d411.s4.p24   \n",
       "841         1690   DDI-DrugBank.d411.s4.p85   \n",
       "915         1764  DDI-DrugBank.d411.s4.p159   \n",
       "655         1504   DDI-DrugBank.d411.s3.p52   \n",
       "494          611  DDI-DrugBank.d202.s16.p24   \n",
       "426          283   DDI-DrugBank.d568.s11.p0   \n",
       "977         1826  DDI-DrugBank.d411.s4.p221   \n",
       "896         1745  DDI-DrugBank.d411.s4.p140   \n",
       "1591        6697    DDI-DrugBank.d205.s0.p1   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              sentence  \\\n",
       "1065                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     The concomitant use of H2 blockers or proton pump inhibitors with SPRYCEL is not recommended.   \n",
       "1157                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     MAO inhibitors should be used with caution in patients receiving hydralazine.   \n",
       "1096                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Cyclosporine, tacrolimus and digoxin concentrations should be monitored at the initiation of Itraconazole therapy and frequently thereafter, and the dose of these three drug products adjusted appropriately.   \n",
       "1164                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 There is insufficient experience to assess the safety and efficacy of ORENCIA administered concurrently with anakinra, and therefore such use is not recommended.   \n",
       "1133                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Coadministration of alosetron and strong CYP3A4 inhibitors, such as clarithromycin, telithromycin, protease inhibitors, voriconazole, and itraconazole has not been evaluated but should be undertaken with caution because of similar potential drug interactions.   \n",
       "30                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Concurrent use of butorphanol with central nervous system depressants (e.g., alcohol, barbiturates, tranquilizers, and antihistamines) may result in increased central nervous system depressant effects.   \n",
       "299                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                When atropine and pralidoxime are used together, the signs of atropinization (flushing, mydriasis, tachycardia, dryness of the mouth and nose) may occur earlier than might be expected than when atropine is used alone because pralidoxime may potentiate the effect of atropine.   \n",
       "177                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Lithium: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ACE inhibitors during therapy with lithium.   \n",
       "204                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           The actions of the benzodiazepines may be potentiated by barbiturates, narcotics, phenothiazines, monoamine oxidase inhibitors or other antidepressants.   \n",
       "354                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      In an analysis of the supraventricular arrhythmia and DIAMOND patient populations, the concomitant administration of verapamil with dofetilide was associated with a higher occurrence of torsade de pointes.   \n",
       "265                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Patients receiving other narcotic analgesics, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with hydrocodone and acetaminophen tablets may exhibit an additive CNS depression.   \n",
       "41                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Concomitant administration of diflunisal and acetaminophen in dogs, but not in rats, at approximately 2 times the recommended maximum human therapeutic dose of each (40 to 52 mg/kg/day of diflunisal/acetaminophen) resulted in greater gastrointestinal toxicity than when either drug was administered alone.   \n",
       "13                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Several tricyclic antidepressants have been reported to block the pharmacologic effects of guanethidine, clonidine, or similar agents, and such an effect may be anticipated with CMI because of its structural similarity to other tricyclic antidepressants.   \n",
       "55                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension.   \n",
       "196                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Anticoagulants: Combination hormonal contraceptives may increase or decrease the effects of coumarin derivatives.   \n",
       "137                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Ergotamine: Concurrent use of erythromycin and ergotamine or dihydroergotamine has been associated in some patients with acute ergot toxicity characterized by severe peripheral vasospasm and dysesthesia.   \n",
       "29                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Concurrent use of butorphanol with central nervous system depressants (e.g., alcohol, barbiturates, tranquilizers, and antihistamines) may result in increased central nervous system depressant effects.   \n",
       "1560                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Chlorpropamide: Chlorpropamides plasma half-life may be prolonged by allopurinol, since allopurinol and chlorpropamide may compete for excretion in the renal tubule.   \n",
       "1283                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Drugs that induce hepatic enzymes such as phenobarbital, phenytoin and rifampin may increase the clearance of corticosteroids and may require increases in corticosteroid dose to achieve the desired response.   \n",
       "1458                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            (See CLINICAL PHARMACOLOGY) Coadministration of Femara and tamoxifen 20 mg daily resulted in a reduction of letrozole plasma levels by 38% on average.   \n",
       "1462                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    In vivo studies: Nitrates: The blood pressure lowering effects of sublingual nitrates (0.4 mg) taken 1 and 4 hours after vardenafil and increases in heart rate when taken at 1, 4 and 8 hours were potentiated by a 20 mg dose of Vardenafil in healthy middle-aged subjects.   \n",
       "1501                                                                                                         Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.   \n",
       "1558                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Co-administration of anastrozole and tamoxifen resulted in a reduction of anastrozole plasma levels by 27% compared with those achieved with anastrozole alone.   \n",
       "1490                                                                                                         Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.   \n",
       "1493                                                                                                         Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.   \n",
       "1319                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Phenobarbital: Amphetamines may delay intestinal absorption of phenobarbital;   \n",
       "1312                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Concomitant administration of Norpace and quinidine resulted in slight increases in plasma disopyramide levels and slight decreases in plasma quinidine levels.   \n",
       "1337                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Tolbutamide: Aprepitant, when given as 125 mg on Day 1 and 80 mg/day on Days 2 and 3, decreased the AUC of tolbutamide (a CYP2C9 substrate) by 23% on Day 4, 28% on Day 8, and 15% on Day 15, when a single dose of tolbutamide 500 mg was admini,stered orally prior to the administration of the 3-day regimen of Aprepitant and on Days 4,8, and 15.   \n",
       "923   Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.   \n",
       "667                                                                                                                                                                                                                                                                                                                                                                                                                               Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.   \n",
       "625                                                                                                                                                                                                                                                                                                                                                                                                                               Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.   \n",
       "907   Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.   \n",
       "455                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Potassium-sparing diuretics (spironolactone, amiloride, triamterene, and others) or potassium supplements can increase the risk of hyperkalemia.   \n",
       "416                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  MAO Inhibitors: Studies in animals demonstrate that the acute toxicity of bupropion is enhanced by the MAO inhibitor phenelzine .   \n",
       "834   Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.   \n",
       "727                                                                                                                                                                                                                                                                                                                                                                                                                               Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.   \n",
       "734                                                                                                                                                                                                                                                                                                                                                                                                                               Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.   \n",
       "607                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Fluconazole and Ketoconazole: Ketoconazole and fluconazole are predominantly CYP 3A4 and 2C9 inhibitors, respectively.   \n",
       "763   Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.   \n",
       "780   Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.   \n",
       "841   Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.   \n",
       "915   Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.   \n",
       "655                                                                                                                                                                                                                                                                                                                                                                                                                               Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.   \n",
       "494                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Therefore, co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme, including other antidepressants, phenothiazines, carbamazepine, and Type 1C antiarrhythmics (eg, propafenone, flecainide, and encainide), or that inhibit this enzyme (eg, quinidine), should be approached with caution.   \n",
       "426                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Nevertheless, plasma lithium levels should be monitored with appropriate adjustment to the lithium dose in accordance with standard clinical practice.   \n",
       "977   Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.   \n",
       "896   Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.   \n",
       "1591                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Since Zarontin (ethosuximide) may interact with concurrently administered antiepileptic drugs, periodic serum level determinations of these drugs may be necessary (eg, ethosuximide may elevate phenytoin serum levels and valproic acid has been reported to both increase and decrease ethosuximide levels).   \n",
       "\n",
       "              label                doc split                    entity1  \\\n",
       "1065     DDI-advise   DDI-DrugBank.d48   dev     proton pump inhibitors   \n",
       "1157     DDI-advise   DDI-DrugBank.d31   dev             MAO inhibitors   \n",
       "1096     DDI-advise  DDI-DrugBank.d165   dev               Cyclosporine   \n",
       "1164     DDI-advise  DDI-DrugBank.d297   dev                    ORENCIA   \n",
       "1133     DDI-advise  DDI-DrugBank.d364   dev                  alosetron   \n",
       "30       DDI-effect  DDI-DrugBank.d246   dev                butorphanol   \n",
       "299      DDI-effect  DDI-DrugBank.d222   dev                   atropine   \n",
       "177      DDI-effect  DDI-DrugBank.d176   dev             ACE inhibitors   \n",
       "204      DDI-effect  DDI-DrugBank.d335   dev            benzodiazepines   \n",
       "354      DDI-effect  DDI-DrugBank.d558   dev                  verapamil   \n",
       "265      DDI-effect  DDI-DrugBank.d396   dev                    alcohol   \n",
       "41       DDI-effect  DDI-DrugBank.d132   dev                 diflunisal   \n",
       "13       DDI-effect  DDI-DrugBank.d238   dev  tricyclic antidepressants   \n",
       "55       DDI-effect  DDI-DrugBank.d564   dev             norepinephrine   \n",
       "196      DDI-effect  DDI-DrugBank.d485   dev    hormonal contraceptives   \n",
       "137      DDI-effect  DDI-DrugBank.d522   dev               erythromycin   \n",
       "29       DDI-effect  DDI-DrugBank.d246   dev                butorphanol   \n",
       "1560  DDI-mechanism  DDI-DrugBank.d413   dev                allopurinol   \n",
       "1283  DDI-mechanism  DDI-DrugBank.d487   dev                   rifampin   \n",
       "1458  DDI-mechanism  DDI-DrugBank.d157   dev                     Femara   \n",
       "1462  DDI-mechanism  DDI-DrugBank.d198   dev                   nitrates   \n",
       "1501  DDI-mechanism   DDI-DrugBank.d94   dev                  EQUETROTM   \n",
       "1558  DDI-mechanism  DDI-DrugBank.d195   dev                anastrozole   \n",
       "1490  DDI-mechanism   DDI-DrugBank.d94   dev                  EQUETROTM   \n",
       "1493  DDI-mechanism   DDI-DrugBank.d94   dev                  EQUETROTM   \n",
       "1319  DDI-mechanism  DDI-DrugBank.d236   dev               Amphetamines   \n",
       "1312  DDI-mechanism  DDI-DrugBank.d506   dev                    Norpace   \n",
       "1337  DDI-mechanism  DDI-DrugBank.d382   dev                tolbutamide   \n",
       "923       DDI-false  DDI-DrugBank.d411   dev                perchlorate   \n",
       "667       DDI-false  DDI-DrugBank.d411   dev                 clofibrate   \n",
       "625       DDI-false  DDI-DrugBank.d411   dev                  androgens   \n",
       "907       DDI-false  DDI-DrugBank.d411   dev                thiocyanate   \n",
       "455       DDI-false  DDI-DrugBank.d561   dev             spironolactone   \n",
       "416       DDI-false    DDI-DrugBank.d5   dev             MAO Inhibitors   \n",
       "834       DDI-false  DDI-DrugBank.d411   dev                 amiodarone   \n",
       "727       DDI-false  DDI-DrugBank.d411   dev            glucocorticoids   \n",
       "734       DDI-false  DDI-DrugBank.d411   dev          meclofenamic acid   \n",
       "607       DDI-false  DDI-DrugBank.d328   dev                Fluconazole   \n",
       "763       DDI-false  DDI-DrugBank.d411   dev          aminoglutethimide   \n",
       "780       DDI-false  DDI-DrugBank.d411   dev          aminoglutethimide   \n",
       "841       DDI-false  DDI-DrugBank.d411   dev                 amiodarone   \n",
       "915       DDI-false  DDI-DrugBank.d411   dev                perchlorate   \n",
       "655       DDI-false  DDI-DrugBank.d411   dev               asparaginase   \n",
       "494       DDI-false  DDI-DrugBank.d202   dev              carbamazepine   \n",
       "426       DDI-false  DDI-DrugBank.d568   dev                    lithium   \n",
       "977       DDI-false  DDI-DrugBank.d411   dev          antithyroid drugs   \n",
       "896       DDI-false  DDI-DrugBank.d411   dev                thiocyanate   \n",
       "1591        DDI-int  DDI-DrugBank.d205   dev                   Zarontin   \n",
       "\n",
       "                           entity2  \\\n",
       "1065                       SPRYCEL   \n",
       "1157                   hydralazine   \n",
       "1096                  Itraconazole   \n",
       "1164                      anakinra   \n",
       "1133                 telithromycin   \n",
       "30                  antihistamines   \n",
       "299                    pralidoxime   \n",
       "177                        lithium   \n",
       "204                antidepressants   \n",
       "354                     dofetilide   \n",
       "265                    hydrocodone   \n",
       "41                   acetaminophen   \n",
       "13                    guanethidine   \n",
       "55    monoamine oxidase inhibitors   \n",
       "196           coumarin derivatives   \n",
       "137                     ergotamine   \n",
       "29                   tranquilizers   \n",
       "1560                chlorpropamide   \n",
       "1283               corticosteroids   \n",
       "1458                     tamoxifen   \n",
       "1462                    vardenafil   \n",
       "1501                 nortriptyline   \n",
       "1558                     tamoxifen   \n",
       "1490                     felbamate   \n",
       "1493                   haloperidol   \n",
       "1319                 phenobarbital   \n",
       "1312                     quinidine   \n",
       "1337                    Aprepitant   \n",
       "923    iodine-containing compounds   \n",
       "667                 5-fluorouracil   \n",
       "625                 5-fluorouracil   \n",
       "907           somatostatin analogs   \n",
       "455                    triamterene   \n",
       "416                  MAO inhibitor   \n",
       "834                        heparin   \n",
       "727                      tamoxifen   \n",
       "734                      tamoxifen   \n",
       "607                   Ketoconazole   \n",
       "763   b-adrenergic blocking agents   \n",
       "780                  nitroprusside   \n",
       "841                 metoclopramide   \n",
       "915                chloral hydrate   \n",
       "655                     furosemide   \n",
       "494                      encainide   \n",
       "426                        lithium   \n",
       "977                       levodopa   \n",
       "896                       levodopa   \n",
       "1591           antiepileptic drugs   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             prompts  \\\n",
       "1065                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Sentence: The concomitant use of H2 blockers or proton pump inhibitors with SPRYCEL is not recommended.\\nDrug 1: proton pump inhibitors\\nDrug 2: SPRYCEL\\nInteraction: advice   \n",
       "1157                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Sentence: MAO inhibitors should be used with caution in patients receiving hydralazine.\\nDrug 1: MAO inhibitors\\nDrug 2: hydralazine\\nInteraction: advice   \n",
       "1096                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Sentence: Cyclosporine, tacrolimus and digoxin concentrations should be monitored at the initiation of Itraconazole therapy and frequently thereafter, and the dose of these three drug products adjusted appropriately.\\nDrug 1: Cyclosporine\\nDrug 2: Itraconazole\\nInteraction: advice   \n",
       "1164                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Sentence: There is insufficient experience to assess the safety and efficacy of ORENCIA administered concurrently with anakinra, and therefore such use is not recommended.\\nDrug 1: ORENCIA\\nDrug 2: anakinra\\nInteraction: advice   \n",
       "1133                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Sentence: Coadministration of alosetron and strong CYP3A4 inhibitors, such as clarithromycin, telithromycin, protease inhibitors, voriconazole, and itraconazole has not been evaluated but should be undertaken with caution because of similar potential drug interactions.\\nDrug 1: alosetron\\nDrug 2: telithromycin\\nInteraction: advice   \n",
       "30                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Sentence: Concurrent use of butorphanol with central nervous system depressants (e.g., alcohol, barbiturates, tranquilizers, and antihistamines) may result in increased central nervous system depressant effects.\\nDrug 1: butorphanol\\nDrug 2: antihistamines\\nInteraction: effect   \n",
       "299                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Sentence: When atropine and pralidoxime are used together, the signs of atropinization (flushing, mydriasis, tachycardia, dryness of the mouth and nose) may occur earlier than might be expected than when atropine is used alone because pralidoxime may potentiate the effect of atropine.\\nDrug 1: atropine\\nDrug 2: pralidoxime\\nInteraction: effect   \n",
       "177                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Sentence: Lithium: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ACE inhibitors during therapy with lithium.\\nDrug 1: ACE inhibitors\\nDrug 2: lithium\\nInteraction: effect   \n",
       "204                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Sentence: The actions of the benzodiazepines may be potentiated by barbiturates, narcotics, phenothiazines, monoamine oxidase inhibitors or other antidepressants.\\nDrug 1: benzodiazepines\\nDrug 2: antidepressants\\nInteraction: effect   \n",
       "354                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Sentence: In an analysis of the supraventricular arrhythmia and DIAMOND patient populations, the concomitant administration of verapamil with dofetilide was associated with a higher occurrence of torsade de pointes.\\nDrug 1: verapamil\\nDrug 2: dofetilide\\nInteraction: effect   \n",
       "265                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Sentence: Patients receiving other narcotic analgesics, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with hydrocodone and acetaminophen tablets may exhibit an additive CNS depression.\\nDrug 1: alcohol\\nDrug 2: hydrocodone\\nInteraction: effect   \n",
       "41                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Sentence: Concomitant administration of diflunisal and acetaminophen in dogs, but not in rats, at approximately 2 times the recommended maximum human therapeutic dose of each (40 to 52 mg/kg/day of diflunisal/acetaminophen) resulted in greater gastrointestinal toxicity than when either drug was administered alone.\\nDrug 1: diflunisal\\nDrug 2: acetaminophen\\nInteraction: effect   \n",
       "13                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Sentence: Several tricyclic antidepressants have been reported to block the pharmacologic effects of guanethidine, clonidine, or similar agents, and such an effect may be anticipated with CMI because of its structural similarity to other tricyclic antidepressants.\\nDrug 1: tricyclic antidepressants\\nDrug 2: guanethidine\\nInteraction: effect   \n",
       "55                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Sentence: The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension.\\nDrug 1: norepinephrine\\nDrug 2: monoamine oxidase inhibitors\\nInteraction: effect   \n",
       "196                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Sentence: Anticoagulants: Combination hormonal contraceptives may increase or decrease the effects of coumarin derivatives.\\nDrug 1: hormonal contraceptives\\nDrug 2: coumarin derivatives\\nInteraction: effect   \n",
       "137                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Sentence: Ergotamine: Concurrent use of erythromycin and ergotamine or dihydroergotamine has been associated in some patients with acute ergot toxicity characterized by severe peripheral vasospasm and dysesthesia.\\nDrug 1: erythromycin\\nDrug 2: ergotamine\\nInteraction: effect   \n",
       "29                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Sentence: Concurrent use of butorphanol with central nervous system depressants (e.g., alcohol, barbiturates, tranquilizers, and antihistamines) may result in increased central nervous system depressant effects.\\nDrug 1: butorphanol\\nDrug 2: tranquilizers\\nInteraction: effect   \n",
       "1560                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Sentence: Chlorpropamide: Chlorpropamides plasma half-life may be prolonged by allopurinol, since allopurinol and chlorpropamide may compete for excretion in the renal tubule.\\nDrug 1: allopurinol\\nDrug 2: chlorpropamide\\nInteraction: mechanism   \n",
       "1283                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Sentence: Drugs that induce hepatic enzymes such as phenobarbital, phenytoin and rifampin may increase the clearance of corticosteroids and may require increases in corticosteroid dose to achieve the desired response.\\nDrug 1: rifampin\\nDrug 2: corticosteroids\\nInteraction: mechanism   \n",
       "1458                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Sentence: (See CLINICAL PHARMACOLOGY) Coadministration of Femara and tamoxifen 20 mg daily resulted in a reduction of letrozole plasma levels by 38% on average.\\nDrug 1: Femara\\nDrug 2: tamoxifen\\nInteraction: mechanism   \n",
       "1462                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Sentence: In vivo studies: Nitrates: The blood pressure lowering effects of sublingual nitrates (0.4 mg) taken 1 and 4 hours after vardenafil and increases in heart rate when taken at 1, 4 and 8 hours were potentiated by a 20 mg dose of Vardenafil in healthy middle-aged subjects.\\nDrug 1: nitrates\\nDrug 2: vardenafil\\nInteraction: mechanism   \n",
       "1501                                                                                                                           Sentence: Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.\\nDrug 1: EQUETROTM\\nDrug 2: nortriptyline\\nInteraction: mechanism   \n",
       "1558                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Sentence: Co-administration of anastrozole and tamoxifen resulted in a reduction of anastrozole plasma levels by 27% compared with those achieved with anastrozole alone.\\nDrug 1: anastrozole\\nDrug 2: tamoxifen\\nInteraction: mechanism   \n",
       "1490                                                                                                                               Sentence: Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.\\nDrug 1: EQUETROTM\\nDrug 2: felbamate\\nInteraction: mechanism   \n",
       "1493                                                                                                                             Sentence: Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.\\nDrug 1: EQUETROTM\\nDrug 2: haloperidol\\nInteraction: mechanism   \n",
       "1319                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Sentence: Phenobarbital: Amphetamines may delay intestinal absorption of phenobarbital;\\nDrug 1: Amphetamines\\nDrug 2: phenobarbital\\nInteraction: mechanism   \n",
       "1312                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Sentence: Concomitant administration of Norpace and quinidine resulted in slight increases in plasma disopyramide levels and slight decreases in plasma quinidine levels.\\nDrug 1: Norpace\\nDrug 2: quinidine\\nInteraction: mechanism   \n",
       "1337                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Sentence: Tolbutamide: Aprepitant, when given as 125 mg on Day 1 and 80 mg/day on Days 2 and 3, decreased the AUC of tolbutamide (a CYP2C9 substrate) by 23% on Day 4, 28% on Day 8, and 15% on Day 15, when a single dose of tolbutamide 500 mg was admini,stered orally prior to the administration of the 3-day regimen of Aprepitant and on Days 4,8, and 15.\\nDrug 1: tolbutamide\\nDrug 2: Aprepitant\\nInteraction: mechanism   \n",
       "923          Sentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug 1: perchlorate\\nDrug 2: iodine-containing compounds\\nInteraction: none   \n",
       "667                                                                                                                                                                                                                                                                                                                                                                                                                                                    Sentence: Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.\\nDrug 1: clofibrate\\nDrug 2: 5-fluorouracil\\nInteraction: none   \n",
       "625                                                                                                                                                                                                                                                                                                                                                                                                                                                     Sentence: Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.\\nDrug 1: androgens\\nDrug 2: 5-fluorouracil\\nInteraction: none   \n",
       "907                 Sentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug 1: thiocyanate\\nDrug 2: somatostatin analogs\\nInteraction: none   \n",
       "455                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Sentence: Potassium-sparing diuretics (spironolactone, amiloride, triamterene, and others) or potassium supplements can increase the risk of hyperkalemia.\\nDrug 1: spironolactone\\nDrug 2: triamterene\\nInteraction: none   \n",
       "416                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Sentence: MAO Inhibitors: Studies in animals demonstrate that the acute toxicity of bupropion is enhanced by the MAO inhibitor phenelzine .\\nDrug 1: MAO Inhibitors\\nDrug 2: MAO inhibitor\\nInteraction: none   \n",
       "834                               Sentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug 1: amiodarone\\nDrug 2: heparin\\nInteraction: none   \n",
       "727                                                                                                                                                                                                                                                                                                                                                                                                                                                    Sentence: Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.\\nDrug 1: glucocorticoids\\nDrug 2: tamoxifen\\nInteraction: none   \n",
       "734                                                                                                                                                                                                                                                                                                                                                                                                                                                  Sentence: Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.\\nDrug 1: meclofenamic acid\\nDrug 2: tamoxifen\\nInteraction: none   \n",
       "607                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Sentence: Fluconazole and Ketoconazole: Ketoconazole and fluconazole are predominantly CYP 3A4 and 2C9 inhibitors, respectively.\\nDrug 1: Fluconazole\\nDrug 2: Ketoconazole\\nInteraction: none   \n",
       "763   Sentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug 1: aminoglutethimide\\nDrug 2: b-adrenergic blocking agents\\nInteraction: none   \n",
       "780                  Sentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug 1: aminoglutethimide\\nDrug 2: nitroprusside\\nInteraction: none   \n",
       "841                        Sentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug 1: amiodarone\\nDrug 2: metoclopramide\\nInteraction: none   \n",
       "915                      Sentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug 1: perchlorate\\nDrug 2: chloral hydrate\\nInteraction: none   \n",
       "655                                                                                                                                                                                                                                                                                                                                                                                                                                                      Sentence: Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.\\nDrug 1: asparaginase\\nDrug 2: furosemide\\nInteraction: none   \n",
       "494                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Sentence: Therefore, co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme, including other antidepressants, phenothiazines, carbamazepine, and Type 1C antiarrhythmics (eg, propafenone, flecainide, and encainide), or that inhibit this enzyme (eg, quinidine), should be approached with caution.\\nDrug 1: carbamazepine\\nDrug 2: encainide\\nInteraction: none   \n",
       "426                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Sentence: Nevertheless, plasma lithium levels should be monitored with appropriate adjustment to the lithium dose in accordance with standard clinical practice.\\nDrug 1: lithium\\nDrug 2: lithium\\nInteraction: none   \n",
       "977                       Sentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug 1: antithyroid drugs\\nDrug 2: levodopa\\nInteraction: none   \n",
       "896                             Sentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug 1: thiocyanate\\nDrug 2: levodopa\\nInteraction: none   \n",
       "1591                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Sentence: Since Zarontin (ethosuximide) may interact with concurrently administered antiepileptic drugs, periodic serum level determinations of these drugs may be necessary (eg, ethosuximide may elevate phenytoin serum levels and valproic acid has been reported to both increase and decrease ethosuximide levels).\\nDrug 1: Zarontin\\nDrug 2: antiepileptic drugs\\nInteraction: other   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                empty_prompts  \\\n",
       "1065                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Sentence: The concomitant use of H2 blockers or proton pump inhibitors with SPRYCEL is not recommended.\\nDrug1: proton pump inhibitors\\nDrug2: SPRYCEL\\nInteraction:   \n",
       "1157                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Sentence: MAO inhibitors should be used with caution in patients receiving hydralazine.\\nDrug1: MAO inhibitors\\nDrug2: hydralazine\\nInteraction:   \n",
       "1096                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Sentence: Cyclosporine, tacrolimus and digoxin concentrations should be monitored at the initiation of Itraconazole therapy and frequently thereafter, and the dose of these three drug products adjusted appropriately.\\nDrug1: Cyclosporine\\nDrug2: Itraconazole\\nInteraction:   \n",
       "1164                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Sentence: There is insufficient experience to assess the safety and efficacy of ORENCIA administered concurrently with anakinra, and therefore such use is not recommended.\\nDrug1: ORENCIA\\nDrug2: anakinra\\nInteraction:   \n",
       "1133                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Sentence: Coadministration of alosetron and strong CYP3A4 inhibitors, such as clarithromycin, telithromycin, protease inhibitors, voriconazole, and itraconazole has not been evaluated but should be undertaken with caution because of similar potential drug interactions.\\nDrug1: alosetron\\nDrug2: telithromycin\\nInteraction:   \n",
       "30                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Sentence: Concurrent use of butorphanol with central nervous system depressants (e.g., alcohol, barbiturates, tranquilizers, and antihistamines) may result in increased central nervous system depressant effects.\\nDrug1: butorphanol\\nDrug2: antihistamines\\nInteraction:   \n",
       "299                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Sentence: When atropine and pralidoxime are used together, the signs of atropinization (flushing, mydriasis, tachycardia, dryness of the mouth and nose) may occur earlier than might be expected than when atropine is used alone because pralidoxime may potentiate the effect of atropine.\\nDrug1: atropine\\nDrug2: pralidoxime\\nInteraction:   \n",
       "177                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Sentence: Lithium: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ACE inhibitors during therapy with lithium.\\nDrug1: ACE inhibitors\\nDrug2: lithium\\nInteraction:   \n",
       "204                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Sentence: The actions of the benzodiazepines may be potentiated by barbiturates, narcotics, phenothiazines, monoamine oxidase inhibitors or other antidepressants.\\nDrug1: benzodiazepines\\nDrug2: antidepressants\\nInteraction:   \n",
       "354                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Sentence: In an analysis of the supraventricular arrhythmia and DIAMOND patient populations, the concomitant administration of verapamil with dofetilide was associated with a higher occurrence of torsade de pointes.\\nDrug1: verapamil\\nDrug2: dofetilide\\nInteraction:   \n",
       "265                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Sentence: Patients receiving other narcotic analgesics, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with hydrocodone and acetaminophen tablets may exhibit an additive CNS depression.\\nDrug1: alcohol\\nDrug2: hydrocodone\\nInteraction:   \n",
       "41                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Sentence: Concomitant administration of diflunisal and acetaminophen in dogs, but not in rats, at approximately 2 times the recommended maximum human therapeutic dose of each (40 to 52 mg/kg/day of diflunisal/acetaminophen) resulted in greater gastrointestinal toxicity than when either drug was administered alone.\\nDrug1: diflunisal\\nDrug2: acetaminophen\\nInteraction:   \n",
       "13                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Sentence: Several tricyclic antidepressants have been reported to block the pharmacologic effects of guanethidine, clonidine, or similar agents, and such an effect may be anticipated with CMI because of its structural similarity to other tricyclic antidepressants.\\nDrug1: tricyclic antidepressants\\nDrug2: guanethidine\\nInteraction:   \n",
       "55                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Sentence: The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension.\\nDrug1: norepinephrine\\nDrug2: monoamine oxidase inhibitors\\nInteraction:   \n",
       "196                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Sentence: Anticoagulants: Combination hormonal contraceptives may increase or decrease the effects of coumarin derivatives.\\nDrug1: hormonal contraceptives\\nDrug2: coumarin derivatives\\nInteraction:   \n",
       "137                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Sentence: Ergotamine: Concurrent use of erythromycin and ergotamine or dihydroergotamine has been associated in some patients with acute ergot toxicity characterized by severe peripheral vasospasm and dysesthesia.\\nDrug1: erythromycin\\nDrug2: ergotamine\\nInteraction:   \n",
       "29                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Sentence: Concurrent use of butorphanol with central nervous system depressants (e.g., alcohol, barbiturates, tranquilizers, and antihistamines) may result in increased central nervous system depressant effects.\\nDrug1: butorphanol\\nDrug2: tranquilizers\\nInteraction:   \n",
       "1560                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Sentence: Chlorpropamide: Chlorpropamides plasma half-life may be prolonged by allopurinol, since allopurinol and chlorpropamide may compete for excretion in the renal tubule.\\nDrug1: allopurinol\\nDrug2: chlorpropamide\\nInteraction:   \n",
       "1283                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Sentence: Drugs that induce hepatic enzymes such as phenobarbital, phenytoin and rifampin may increase the clearance of corticosteroids and may require increases in corticosteroid dose to achieve the desired response.\\nDrug1: rifampin\\nDrug2: corticosteroids\\nInteraction:   \n",
       "1458                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Sentence: (See CLINICAL PHARMACOLOGY) Coadministration of Femara and tamoxifen 20 mg daily resulted in a reduction of letrozole plasma levels by 38% on average.\\nDrug1: Femara\\nDrug2: tamoxifen\\nInteraction:   \n",
       "1462                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Sentence: In vivo studies: Nitrates: The blood pressure lowering effects of sublingual nitrates (0.4 mg) taken 1 and 4 hours after vardenafil and increases in heart rate when taken at 1, 4 and 8 hours were potentiated by a 20 mg dose of Vardenafil in healthy middle-aged subjects.\\nDrug1: nitrates\\nDrug2: vardenafil\\nInteraction:   \n",
       "1501                                                                                                                                Sentence: Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.\\nDrug1: EQUETROTM\\nDrug2: nortriptyline\\nInteraction:   \n",
       "1558                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Sentence: Co-administration of anastrozole and tamoxifen resulted in a reduction of anastrozole plasma levels by 27% compared with those achieved with anastrozole alone.\\nDrug1: anastrozole\\nDrug2: tamoxifen\\nInteraction:   \n",
       "1490                                                                                                                                    Sentence: Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.\\nDrug1: EQUETROTM\\nDrug2: felbamate\\nInteraction:   \n",
       "1493                                                                                                                                  Sentence: Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.\\nDrug1: EQUETROTM\\nDrug2: haloperidol\\nInteraction:   \n",
       "1319                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Sentence: Phenobarbital: Amphetamines may delay intestinal absorption of phenobarbital;\\nDrug1: Amphetamines\\nDrug2: phenobarbital\\nInteraction:   \n",
       "1312                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Sentence: Concomitant administration of Norpace and quinidine resulted in slight increases in plasma disopyramide levels and slight decreases in plasma quinidine levels.\\nDrug1: Norpace\\nDrug2: quinidine\\nInteraction:   \n",
       "1337                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Sentence: Tolbutamide: Aprepitant, when given as 125 mg on Day 1 and 80 mg/day on Days 2 and 3, decreased the AUC of tolbutamide (a CYP2C9 substrate) by 23% on Day 4, 28% on Day 8, and 15% on Day 15, when a single dose of tolbutamide 500 mg was admini,stered orally prior to the administration of the 3-day regimen of Aprepitant and on Days 4,8, and 15.\\nDrug1: tolbutamide\\nDrug2: Aprepitant\\nInteraction:   \n",
       "923          Sentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug1: perchlorate\\nDrug2: iodine-containing compounds\\nInteraction:   \n",
       "667                                                                                                                                                                                                                                                                                                                                                                                                                                                    Sentence: Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.\\nDrug1: clofibrate\\nDrug2: 5-fluorouracil\\nInteraction:   \n",
       "625                                                                                                                                                                                                                                                                                                                                                                                                                                                     Sentence: Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.\\nDrug1: androgens\\nDrug2: 5-fluorouracil\\nInteraction:   \n",
       "907                 Sentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug1: thiocyanate\\nDrug2: somatostatin analogs\\nInteraction:   \n",
       "455                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Sentence: Potassium-sparing diuretics (spironolactone, amiloride, triamterene, and others) or potassium supplements can increase the risk of hyperkalemia.\\nDrug1: spironolactone\\nDrug2: triamterene\\nInteraction:   \n",
       "416                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Sentence: MAO Inhibitors: Studies in animals demonstrate that the acute toxicity of bupropion is enhanced by the MAO inhibitor phenelzine .\\nDrug1: MAO Inhibitors\\nDrug2: MAO inhibitor\\nInteraction:   \n",
       "834                               Sentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug1: amiodarone\\nDrug2: heparin\\nInteraction:   \n",
       "727                                                                                                                                                                                                                                                                                                                                                                                                                                                    Sentence: Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.\\nDrug1: glucocorticoids\\nDrug2: tamoxifen\\nInteraction:   \n",
       "734                                                                                                                                                                                                                                                                                                                                                                                                                                                  Sentence: Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.\\nDrug1: meclofenamic acid\\nDrug2: tamoxifen\\nInteraction:   \n",
       "607                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Sentence: Fluconazole and Ketoconazole: Ketoconazole and fluconazole are predominantly CYP 3A4 and 2C9 inhibitors, respectively.\\nDrug1: Fluconazole\\nDrug2: Ketoconazole\\nInteraction:   \n",
       "763   Sentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug1: aminoglutethimide\\nDrug2: b-adrenergic blocking agents\\nInteraction:   \n",
       "780                  Sentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug1: aminoglutethimide\\nDrug2: nitroprusside\\nInteraction:   \n",
       "841                        Sentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug1: amiodarone\\nDrug2: metoclopramide\\nInteraction:   \n",
       "915                      Sentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug1: perchlorate\\nDrug2: chloral hydrate\\nInteraction:   \n",
       "655                                                                                                                                                                                                                                                                                                                                                                                                                                                      Sentence: Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.\\nDrug1: asparaginase\\nDrug2: furosemide\\nInteraction:   \n",
       "494                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Sentence: Therefore, co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme, including other antidepressants, phenothiazines, carbamazepine, and Type 1C antiarrhythmics (eg, propafenone, flecainide, and encainide), or that inhibit this enzyme (eg, quinidine), should be approached with caution.\\nDrug1: carbamazepine\\nDrug2: encainide\\nInteraction:   \n",
       "426                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Sentence: Nevertheless, plasma lithium levels should be monitored with appropriate adjustment to the lithium dose in accordance with standard clinical practice.\\nDrug1: lithium\\nDrug2: lithium\\nInteraction:   \n",
       "977                       Sentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug1: antithyroid drugs\\nDrug2: levodopa\\nInteraction:   \n",
       "896                             Sentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug1: thiocyanate\\nDrug2: levodopa\\nInteraction:   \n",
       "1591                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Sentence: Since Zarontin (ethosuximide) may interact with concurrently administered antiepileptic drugs, periodic serum level determinations of these drugs may be necessary (eg, ethosuximide may elevate phenytoin serum levels and valproic acid has been reported to both increase and decrease ethosuximide levels).\\nDrug1: Zarontin\\nDrug2: antiepileptic drugs\\nInteraction:   \n",
       "\n",
       "         labels                             unique_labels  \\\n",
       "1065     advice  {advice, mechanism, none, effect, other}   \n",
       "1157     advice  {advice, mechanism, none, effect, other}   \n",
       "1096     advice  {advice, mechanism, none, effect, other}   \n",
       "1164     advice  {advice, mechanism, none, effect, other}   \n",
       "1133     advice  {advice, mechanism, none, effect, other}   \n",
       "30       effect  {advice, mechanism, none, effect, other}   \n",
       "299      effect  {advice, mechanism, none, effect, other}   \n",
       "177      effect  {advice, mechanism, none, effect, other}   \n",
       "204      effect  {advice, mechanism, none, effect, other}   \n",
       "354      effect  {advice, mechanism, none, effect, other}   \n",
       "265      effect  {advice, mechanism, none, effect, other}   \n",
       "41       effect  {advice, mechanism, none, effect, other}   \n",
       "13       effect  {advice, mechanism, none, effect, other}   \n",
       "55       effect  {advice, mechanism, none, effect, other}   \n",
       "196      effect  {advice, mechanism, none, effect, other}   \n",
       "137      effect  {advice, mechanism, none, effect, other}   \n",
       "29       effect  {advice, mechanism, none, effect, other}   \n",
       "1560  mechanism  {advice, mechanism, none, effect, other}   \n",
       "1283  mechanism  {advice, mechanism, none, effect, other}   \n",
       "1458  mechanism  {advice, mechanism, none, effect, other}   \n",
       "1462  mechanism  {advice, mechanism, none, effect, other}   \n",
       "1501  mechanism  {advice, mechanism, none, effect, other}   \n",
       "1558  mechanism  {advice, mechanism, none, effect, other}   \n",
       "1490  mechanism  {advice, mechanism, none, effect, other}   \n",
       "1493  mechanism  {advice, mechanism, none, effect, other}   \n",
       "1319  mechanism  {advice, mechanism, none, effect, other}   \n",
       "1312  mechanism  {advice, mechanism, none, effect, other}   \n",
       "1337  mechanism  {advice, mechanism, none, effect, other}   \n",
       "923        none  {advice, mechanism, none, effect, other}   \n",
       "667        none  {advice, mechanism, none, effect, other}   \n",
       "625        none  {advice, mechanism, none, effect, other}   \n",
       "907        none  {advice, mechanism, none, effect, other}   \n",
       "455        none  {advice, mechanism, none, effect, other}   \n",
       "416        none  {advice, mechanism, none, effect, other}   \n",
       "834        none  {advice, mechanism, none, effect, other}   \n",
       "727        none  {advice, mechanism, none, effect, other}   \n",
       "734        none  {advice, mechanism, none, effect, other}   \n",
       "607        none  {advice, mechanism, none, effect, other}   \n",
       "763        none  {advice, mechanism, none, effect, other}   \n",
       "780        none  {advice, mechanism, none, effect, other}   \n",
       "841        none  {advice, mechanism, none, effect, other}   \n",
       "915        none  {advice, mechanism, none, effect, other}   \n",
       "655        none  {advice, mechanism, none, effect, other}   \n",
       "494        none  {advice, mechanism, none, effect, other}   \n",
       "426        none  {advice, mechanism, none, effect, other}   \n",
       "977        none  {advice, mechanism, none, effect, other}   \n",
       "896        none  {advice, mechanism, none, effect, other}   \n",
       "1591      other  {advice, mechanism, none, effect, other}   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        test_ready_prompt  \\\n",
       "1065                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Sentence: The use of antacids should be considered in place of H2 blockers or proton pump inhibitors in patients receiving SPRYCEL therapy.\\nDrug 1: antacids\\nDrug 2: H2 blockers\\nInteraction: none\\n\\nSentence: The use of antacids should be considered in place of H2 blockers or proton pump inhibitors in patients receiving SPRYCEL therapy.\\nDrug 1: antacids\\nDrug 2: proton pump inhibitors\\nInteraction: none\\n\\nSentence: The use of antacids should be considered in place of H2 blockers or proton pump inhibitors in patients receiving SPRYCEL therapy.\\nDrug 1: antacids\\nDrug 2: SPRYCEL\\nInteraction: none\\n\\nSentence: The use of antacids should be considered in place of H2 blockers or proton pump inhibitors in patients receiving SPRYCEL therapy.\\nDrug 1: H2 blockers\\nDrug 2: proton pump inhibitors\\nInteraction: none\\n\\nSentence: The use of antacids should be considered in place of H2 blockers or proton pump inhibitors in patients receiving SPRYCEL therapy.\\nDrug 1: H2 blockers\\nDrug 2: SPRYCEL\\nInteraction: advice\\n\\nSentence: The concomitant use of H2 blockers or proton pump inhibitors with SPRYCEL is not recommended.\\nDrug1: proton pump inhibitors\\nDrug2: SPRYCEL\\nInteraction:   \n",
       "1157                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Sentence: Cevimeline should be administered with caution to patients taking beta adrenergic antagonists, because of the possibility of conduction disturbances.\\nDrug 1: Cevimeline\\nDrug 2: beta adrenergic antagonists\\nInteraction: advice\\n\\nSentence: All vasopressors should be used cautiously in patients taking monoamine oxidase (MAO) inhibitors.\\nDrug 1: vasopressors\\nDrug 2: monoamine oxidase (MAO) inhibitors\\nInteraction: advice\\n\\nSentence: DISULFIRAM SHOULD BE USED WITH CAUTION IN THOSE PATIENTS REVEIVING PHENYTOIN AND ITS CONGENERS.\\nDrug 1: DISULFIRAM\\nDrug 2: PHENYTOIN\\nInteraction: advice\\n\\nSentence: NSAIDs should be used with caution in patients taking cyclosporine, and renal function should be carefully monitored.\\nDrug 1: NSAIDs\\nDrug 2: cyclosporine\\nInteraction: advice\\n\\nSentence: NSAIDs should be used with caution in patients taking cyclosporine, and renal function should be carefully monitored.\\nDrug 1: NSAIDs\\nDrug 2: cyclosporine\\nInteraction: advice\\n\\nSentence: MAO inhibitors should be used with caution in patients receiving hydralazine.\\nDrug1: MAO inhibitors\\nDrug2: hydralazine\\nInteraction:   \n",
       "1096                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Sentence: For patients receiving both therapies, standard monitoring of tacrolimus blood concentrations and appropriate tacrolimus dosage adjustments are recommended.\\nDrug 1: tacrolimus\\nDrug 2: tacrolimus\\nInteraction: none\\n\\nSentence: The physician is advised to monitor the plasma concentrations of itraconazole when any of these drugs is taken concurrently, and to increase the dose of Itraconazole if necessary.\\nDrug 1: itraconazole\\nDrug 2: Itraconazole\\nInteraction: none\\n\\nSentence: Therefore, cyclosporine serum levels should be monitored and appropriate cyclosporine dosage adjustments made when these drugs are used concomitantly.\\nDrug 1: cyclosporine\\nDrug 2: cyclosporine\\nInteraction: none\\n\\nSentence: Therefore, cyclosporine serum levels should be monitored and appropriate cyclosporine dosage adjustments made when these drugs are used concomitantly.\\nDrug 1: cyclosporine\\nDrug 2: cyclosporine\\nInteraction: none\\n\\nSentence: Coadministration of Itraconazole and cyclosporine, tacrolimus or digoxin has led to increased plasma concentrations of the latter three drugs.\\nDrug 1: Itraconazole\\nDrug 2: cyclosporine\\nInteraction: mechanism\\n\\nSentence: Cyclosporine, tacrolimus and digoxin concentrations should be monitored at the initiation of Itraconazole therapy and frequently thereafter, and the dose of these three drug products adjusted appropriately.\\nDrug1: Cyclosporine\\nDrug2: Itraconazole\\nInteraction:   \n",
       "1164                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Sentence: Although there is little published information on concomitant administration of lidocaine and Bretylium Tosylate, these drugs are often administered concurrently without any evidence of interactions resulting in adverse effects or diminished efficacy.\\nDrug 1: lidocaine\\nDrug 2: Bretylium Tosylate\\nInteraction: none\\n\\nSentence: The safety and efficacy of anakinra used in combination with HUMIRA has not been studied.\\nDrug 1: anakinra\\nDrug 2: HUMIRA\\nInteraction: none\\n\\nSentence: Aspirin: As with other NSAIDs, concomitant administration of Ponstel and aspirin is not generally recommended because of the potential of increased adverse effects.\\nDrug 1: Aspirin\\nDrug 2: NSAIDs\\nInteraction: none\\n\\nSentence: Aspirin: As with other NSAIDs, concomitant administration of Ponstel and aspirin is not generally recommended because of the potential of increased adverse effects.\\nDrug 1: Aspirin\\nDrug 2: Ponstel\\nInteraction: none\\n\\nSentence: Aspirin: As with other NSAIDs, concomitant administration of Ponstel and aspirin is not generally recommended because of the potential of increased adverse effects.\\nDrug 1: Aspirin\\nDrug 2: aspirin\\nInteraction: none\\n\\nSentence: There is insufficient experience to assess the safety and efficacy of ORENCIA administered concurrently with anakinra, and therefore such use is not recommended.\\nDrug1: ORENCIA\\nDrug2: anakinra\\nInteraction:   \n",
       "1133                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Sentence: Concomitant administration of alosetron and moderate CYP1A2 inhibitors, including quinolone antibiotics and cimetidine, has not been evaluated, but should be avoided unless clinically necessary because of similar potential drug interactions.\\nDrug 1: alosetron\\nDrug 2: quinolone antibiotics\\nInteraction: advice\\n\\nSentence: Concomitant administration of alosetron and moderate CYP1A2 inhibitors, including quinolone antibiotics and cimetidine, has not been evaluated, but should be avoided unless clinically necessary because of similar potential drug interactions.\\nDrug 1: alosetron\\nDrug 2: cimetidine\\nInteraction: advice\\n\\nSentence: Concomitant administration of alosetron and moderate CYP1A2 inhibitors, including quinolone antibiotics and cimetidine, has not been evaluated, but should be avoided unless clinically necessary because of similar potential drug interactions.\\nDrug 1: quinolone antibiotics\\nDrug 2: cimetidine\\nInteraction: none\\n\\nSentence: Consequently, concomitant administration of Aprepitant with strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, nefazodone, troleandomycin, clarithromycin, ritonavir, nelfinavir) should be approached with caution.\\nDrug 1: Aprepitant\\nDrug 2: ketoconazole\\nInteraction: advice\\n\\nSentence: Consequently, concomitant administration of Aprepitant with strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, nefazodone, troleandomycin, clarithromycin, ritonavir, nelfinavir) should be approached with caution.\\nDrug 1: Aprepitant\\nDrug 2: itraconazole\\nInteraction: advice\\n\\nSentence: Coadministration of alosetron and strong CYP3A4 inhibitors, such as clarithromycin, telithromycin, protease inhibitors, voriconazole, and itraconazole has not been evaluated but should be undertaken with caution because of similar potential drug interactions.\\nDrug1: alosetron\\nDrug2: telithromycin\\nInteraction:   \n",
       "30                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Sentence: Antihistamines may have additive effects with alcohol and other CNS depressants, e.g., hypnotics, sedatives, tranquilizers, antianxiety agents.\\nDrug 1: Antihistamines\\nDrug 2: alcohol\\nInteraction: effect\\n\\nSentence: Antihistamines may have additive effects with alcohol and other CNS depressants, e.g., hypnotics, sedatives, tranquilizers, antianxiety agents.\\nDrug 1: Antihistamines\\nDrug 2: CNS depressants\\nInteraction: effect\\n\\nSentence: Antihistamines may have additive effects with alcohol and other CNS depressants, e.g., hypnotics, sedatives, tranquilizers, antianxiety agents.\\nDrug 1: Antihistamines\\nDrug 2: hypnotics\\nInteraction: effect\\n\\nSentence: Antihistamines may have additive effects with alcohol and other CNS depressants, e.g., hypnotics, sedatives, tranquilizers, antianxiety agents.\\nDrug 1: Antihistamines\\nDrug 2: sedatives\\nInteraction: effect\\n\\nSentence: Antihistamines may have additive effects with alcohol and other CNS depressants, e.g., hypnotics, sedatives, tranquilizers, antianxiety agents.\\nDrug 1: Antihistamines\\nDrug 2: tranquilizers\\nInteraction: effect\\n\\nSentence: Concurrent use of butorphanol with central nervous system depressants (e.g., alcohol, barbiturates, tranquilizers, and antihistamines) may result in increased central nervous system depressant effects.\\nDrug1: butorphanol\\nDrug2: antihistamines\\nInteraction:   \n",
       "299                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Sentence: Particular caution is necessary when using ROMAZICON in cases of mixed drug overdosage since the toxic effects (such as convulsions and cardiac dysrhythmias) of other drugs taken in overdose (especially cyclic antidepressants) may emerge with the reversal of the benzodiazepine effect by flumazenil.\\nDrug 1: ROMAZICON\\nDrug 2: cyclic antidepressants\\nInteraction: effect\\n\\nSentence: Particular caution is necessary when using ROMAZICON in cases of mixed drug overdosage since the toxic effects (such as convulsions and cardiac dysrhythmias) of other drugs taken in overdose (especially cyclic antidepressants) may emerge with the reversal of the benzodiazepine effect by flumazenil.\\nDrug 1: ROMAZICON\\nDrug 2: benzodiazepine\\nInteraction: none\\n\\nSentence: Particular caution is necessary when using ROMAZICON in cases of mixed drug overdosage since the toxic effects (such as convulsions and cardiac dysrhythmias) of other drugs taken in overdose (especially cyclic antidepressants) may emerge with the reversal of the benzodiazepine effect by flumazenil.\\nDrug 1: ROMAZICON\\nDrug 2: flumazenil\\nInteraction: none\\n\\nSentence: Particular caution is necessary when using ROMAZICON in cases of mixed drug overdosage since the toxic effects (such as convulsions and cardiac dysrhythmias) of other drugs taken in overdose (especially cyclic antidepressants) may emerge with the reversal of the benzodiazepine effect by flumazenil.\\nDrug 1: cyclic antidepressants\\nDrug 2: benzodiazepine\\nInteraction: none\\n\\nSentence: Particular caution is necessary when using ROMAZICON in cases of mixed drug overdosage since the toxic effects (such as convulsions and cardiac dysrhythmias) of other drugs taken in overdose (especially cyclic antidepressants) may emerge with the reversal of the benzodiazepine effect by flumazenil.\\nDrug 1: cyclic antidepressants\\nDrug 2: flumazenil\\nInteraction: none\\n\\nSentence: When atropine and pralidoxime are used together, the signs of atropinization (flushing, mydriasis, tachycardia, dryness of the mouth and nose) may occur earlier than might be expected than when atropine is used alone because pralidoxime may potentiate the effect of atropine.\\nDrug1: atropine\\nDrug2: pralidoxime\\nInteraction:   \n",
       "177                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Sentence: Lithium: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ACE inhibitors during therapy with lithium.\\nDrug 1: Lithium\\nDrug 2: lithium\\nInteraction: none\\n\\nSentence: Lithium: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ACE inhibitors during therapy with lithium.\\nDrug 1: Lithium\\nDrug 2: lithium\\nInteraction: none\\n\\nSentence: Lithium: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ACE inhibitors during therapy with lithium.\\nDrug 1: Lithium\\nDrug 2: ACE inhibitors\\nInteraction: none\\n\\nSentence: Lithium: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ACE inhibitors during therapy with lithium.\\nDrug 1: Lithium\\nDrug 2: lithium\\nInteraction: none\\n\\nSentence: Lithium: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ACE inhibitors during therapy with lithium.\\nDrug 1: lithium\\nDrug 2: lithium\\nInteraction: none\\n\\nSentence: Lithium: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ACE inhibitors during therapy with lithium.\\nDrug1: ACE inhibitors\\nDrug2: lithium\\nInteraction:   \n",
       "204                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Sentence: The action of the benzodiazepines may be potentiated by anticonvulsants, antihistamines, alcohol, barbiturates, monoamine oxidase inhibitors, narcotics, phenothiazines, psychotropic medications, or other drugs that produce CNS depression.\\nDrug 1: benzodiazepines\\nDrug 2: anticonvulsants\\nInteraction: effect\\n\\nSentence: The action of the benzodiazepines may be potentiated by anticonvulsants, antihistamines, alcohol, barbiturates, monoamine oxidase inhibitors, narcotics, phenothiazines, psychotropic medications, or other drugs that produce CNS depression.\\nDrug 1: benzodiazepines\\nDrug 2: antihistamines\\nInteraction: effect\\n\\nSentence: The action of the benzodiazepines may be potentiated by anticonvulsants, antihistamines, alcohol, barbiturates, monoamine oxidase inhibitors, narcotics, phenothiazines, psychotropic medications, or other drugs that produce CNS depression.\\nDrug 1: benzodiazepines\\nDrug 2: alcohol\\nInteraction: effect\\n\\nSentence: The action of the benzodiazepines may be potentiated by anticonvulsants, antihistamines, alcohol, barbiturates, monoamine oxidase inhibitors, narcotics, phenothiazines, psychotropic medications, or other drugs that produce CNS depression.\\nDrug 1: benzodiazepines\\nDrug 2: barbiturates\\nInteraction: effect\\n\\nSentence: The action of the benzodiazepines may be potentiated by anticonvulsants, antihistamines, alcohol, barbiturates, monoamine oxidase inhibitors, narcotics, phenothiazines, psychotropic medications, or other drugs that produce CNS depression.\\nDrug 1: benzodiazepines\\nDrug 2: monoamine oxidase inhibitors\\nInteraction: effect\\n\\nSentence: The actions of the benzodiazepines may be potentiated by barbiturates, narcotics, phenothiazines, monoamine oxidase inhibitors or other antidepressants.\\nDrug1: benzodiazepines\\nDrug2: antidepressants\\nInteraction:   \n",
       "354                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Sentence: In patients, the concomitant administration of digoxin with dofetilide was associated with a higher occurrence of torsade de pointes.\\nDrug 1: digoxin\\nDrug 2: dofetilide\\nInteraction: effect\\n\\nSentence: In clinical trials in patients undergoing PTCA/PCI, co-administration of Angiomax with heparin, warfarin, thrombolytics or glycoprotein IIb/IIIa inhibitors was associated with increased risks of major bleeding events compared to patients not receiving these concomitant medications.\\nDrug 1: Angiomax\\nDrug 2: heparin\\nInteraction: effect\\n\\nSentence: In clinical trials in patients undergoing PTCA/PCI, co-administration of Angiomax with heparin, warfarin, thrombolytics or glycoprotein IIb/IIIa inhibitors was associated with increased risks of major bleeding events compared to patients not receiving these concomitant medications.\\nDrug 1: Angiomax\\nDrug 2: warfarin\\nInteraction: effect\\n\\nSentence: In clinical trials in patients undergoing PTCA/PCI, co-administration of Angiomax with heparin, warfarin, thrombolytics or glycoprotein IIb/IIIa inhibitors was associated with increased risks of major bleeding events compared to patients not receiving these concomitant medications.\\nDrug 1: Angiomax\\nDrug 2: thrombolytics\\nInteraction: effect\\n\\nSentence: In clinical trials in patients undergoing PTCA/PCI, co-administration of Angiomax with heparin, warfarin, thrombolytics or glycoprotein IIb/IIIa inhibitors was associated with increased risks of major bleeding events compared to patients not receiving these concomitant medications.\\nDrug 1: heparin\\nDrug 2: warfarin\\nInteraction: none\\n\\nSentence: In an analysis of the supraventricular arrhythmia and DIAMOND patient populations, the concomitant administration of verapamil with dofetilide was associated with a higher occurrence of torsade de pointes.\\nDrug1: verapamil\\nDrug2: dofetilide\\nInteraction:   \n",
       "265                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Sentence: Patients receiving other narcotic analgesics, general anesthetics, phenothiazines, tranquilizers, sedative-hypnotics, tricyclic antidepressants or other CNS depressants (including alcohol) concomitantly with DILAUDID may exhibit an additive CNS depression.\\nDrug 1: narcotic analgesic\\nDrug 2: anesthetics\\nInteraction: none\\n\\nSentence: Patients receiving other narcotic analgesics, general anesthetics, phenothiazines, tranquilizers, sedative-hypnotics, tricyclic antidepressants or other CNS depressants (including alcohol) concomitantly with DILAUDID may exhibit an additive CNS depression.\\nDrug 1: narcotic analgesic\\nDrug 2: phenothiazines\\nInteraction: none\\n\\nSentence: Patients receiving other narcotic analgesics, general anesthetics, phenothiazines, tranquilizers, sedative-hypnotics, tricyclic antidepressants or other CNS depressants (including alcohol) concomitantly with DILAUDID may exhibit an additive CNS depression.\\nDrug 1: narcotic analgesic\\nDrug 2: tranquilizers\\nInteraction: none\\n\\nSentence: Patients receiving other narcotic analgesics, general anesthetics, phenothiazines, tranquilizers, sedative-hypnotics, tricyclic antidepressants or other CNS depressants (including alcohol) concomitantly with DILAUDID may exhibit an additive CNS depression.\\nDrug 1: narcotic analgesic\\nDrug 2: sedative-hypnotics\\nInteraction: none\\n\\nSentence: Patients receiving other narcotic analgesics, general anesthetics, phenothiazines, tranquilizers, sedative-hypnotics, tricyclic antidepressants or other CNS depressants (including alcohol) concomitantly with DILAUDID may exhibit an additive CNS depression.\\nDrug 1: narcotic analgesic\\nDrug 2: tricyclic antidepressants\\nInteraction: none\\n\\nSentence: Patients receiving other narcotic analgesics, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with hydrocodone and acetaminophen tablets may exhibit an additive CNS depression.\\nDrug1: alcohol\\nDrug2: hydrocodone\\nInteraction:   \n",
       "41                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Sentence: Diclofenac: Administration of morning and lunch doses of Starlix 120 mg in combination with a single 75-mg dose of diclofenac in healthy volunteers resulted in no significant changes to the pharmacokinetics of either agent.\\nDrug 1: Diclofenac\\nDrug 2: Starlix\\nInteraction: none\\n\\nSentence: Diclofenac: Administration of morning and lunch doses of Starlix 120 mg in combination with a single 75-mg dose of diclofenac in healthy volunteers resulted in no significant changes to the pharmacokinetics of either agent.\\nDrug 1: Diclofenac\\nDrug 2: diclofenac\\nInteraction: none\\n\\nSentence: Diclofenac: Administration of morning and lunch doses of Starlix 120 mg in combination with a single 75-mg dose of diclofenac in healthy volunteers resulted in no significant changes to the pharmacokinetics of either agent.\\nDrug 1: Starlix\\nDrug 2: diclofenac\\nInteraction: none\\n\\nSentence: Warfarin: In a study in healthy volunteers, no clinically relevant pharmacokinetic or pharmacodynamic interaction between isradipine and racemic warfarin was seen when two single oral doses of warfarin (0.7 mg/kg body weight) were administered during 11 days of multipledose treatment with 5 mg b.i.d. isradipine.\\nDrug 1: Warfarin\\nDrug 2: isradipine\\nInteraction: none\\n\\nSentence: Warfarin: In a study in healthy volunteers, no clinically relevant pharmacokinetic or pharmacodynamic interaction between isradipine and racemic warfarin was seen when two single oral doses of warfarin (0.7 mg/kg body weight) were administered during 11 days of multipledose treatment with 5 mg b.i.d. isradipine.\\nDrug 1: Warfarin\\nDrug 2: warfarin\\nInteraction: none\\n\\nSentence: Concomitant administration of diflunisal and acetaminophen in dogs, but not in rats, at approximately 2 times the recommended maximum human therapeutic dose of each (40 to 52 mg/kg/day of diflunisal/acetaminophen) resulted in greater gastrointestinal toxicity than when either drug was administered alone.\\nDrug1: diflunisal\\nDrug2: acetaminophen\\nInteraction:   \n",
       "13                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Sentence: Tricyclic antidepressants have been reported to blunt the hypotensive effect of systemic clonidine.It is not known whether the concurrent use of these agents with ALPHAGAN P in humans can lead to resulting interference with the IOP lowering effect.\\nDrug 1: Tricyclic antidepressants\\nDrug 2: clonidine\\nInteraction: effect\\n\\nSentence: Tricyclic antidepressants have been reported to blunt the hypotensive effect of systemic clonidine.It is not known whether the concurrent use of these agents with ALPHAGAN P in humans can lead to resulting interference with the IOP lowering effect.\\nDrug 1: Tricyclic antidepressants\\nDrug 2: ALPHAGAN P\\nInteraction: none\\n\\nSentence: Tricyclic antidepressants have been reported to blunt the hypotensive effect of systemic clonidine.It is not known whether the concurrent use of these agents with ALPHAGAN P in humans can lead to resulting interference with the IOP lowering effect.\\nDrug 1: clonidine\\nDrug 2: ALPHAGAN P\\nInteraction: none\\n\\nSentence: Due to their similar mechanism of action, it is expected that the neuromuscular blockade produced by any of the non-depolarizing muscle relaxants could be prolonged in the presence of piperacillin.\\nDrug 1: non-depolarizing muscle relaxants\\nDrug 2: piperacillin\\nInteraction: effect\\n\\nSentence: Avoid the use of preparations such as decongestants and local anesthetics which contain any sympathomimetic amine (e.g., epinephrine, norepinephrine), since it has been reported that tricyclic antidepressants can potentiate the effects of catecholamines.\\nDrug 1: decongestants\\nDrug 2: anesthetics\\nInteraction: none\\n\\nSentence: Several tricyclic antidepressants have been reported to block the pharmacologic effects of guanethidine, clonidine, or similar agents, and such an effect may be anticipated with CMI because of its structural similarity to other tricyclic antidepressants.\\nDrug1: tricyclic antidepressants\\nDrug2: guanethidine\\nInteraction:   \n",
       "55                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Sentence: The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension.\\nDrug 1: anesthetic solutions\\nDrug 2: epinephrine\\nInteraction: none\\n\\nSentence: The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension.\\nDrug 1: anesthetic solutions\\nDrug 2: norepinephrine\\nInteraction: none\\n\\nSentence: The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension.\\nDrug 1: anesthetic solutions\\nDrug 2: monoamine oxidase inhibitors\\nInteraction: none\\n\\nSentence: The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension.\\nDrug 1: anesthetic solutions\\nDrug 2: tricyclic antidepressants\\nInteraction: none\\n\\nSentence: The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension.\\nDrug 1: epinephrine\\nDrug 2: norepinephrine\\nInteraction: none\\n\\nSentence: The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension.\\nDrug1: norepinephrine\\nDrug2: monoamine oxidase inhibitors\\nInteraction:   \n",
       "196                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Sentence: Warfarin: Quinolones have been reported to enhance the effects of the oral anticoagulant warfarin or its derivatives.\\nDrug 1: Warfarin\\nDrug 2: Quinolones\\nInteraction: none\\n\\nSentence: Warfarin: Quinolones have been reported to enhance the effects of the oral anticoagulant warfarin or its derivatives.\\nDrug 1: Warfarin\\nDrug 2: anticoagulant\\nInteraction: none\\n\\nSentence: Warfarin: Quinolones have been reported to enhance the effects of the oral anticoagulant warfarin or its derivatives.\\nDrug 1: Warfarin\\nDrug 2: warfarin\\nInteraction: none\\n\\nSentence: Warfarin: Quinolones have been reported to enhance the effects of the oral anticoagulant warfarin or its derivatives.\\nDrug 1: Quinolones\\nDrug 2: anticoagulant\\nInteraction: none\\n\\nSentence: Warfarin: Quinolones have been reported to enhance the effects of the oral anticoagulant warfarin or its derivatives.\\nDrug 1: Quinolones\\nDrug 2: warfarin\\nInteraction: effect\\n\\nSentence: Anticoagulants: Combination hormonal contraceptives may increase or decrease the effects of coumarin derivatives.\\nDrug1: hormonal contraceptives\\nDrug2: coumarin derivatives\\nInteraction:   \n",
       "137                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Sentence: Concurrent use of erythromycin and ergotamine or dihydroergotamine has been associated in some patients with acute ergot toxicity characterized by severe peripheral vasospasm and dysesthesia.\\nDrug 1: erythromycin\\nDrug 2: ergotamine\\nInteraction: effect\\n\\nSentence: Concurrent use of erythromycin and ergotamine or dihydroergotamine has been associated in some patients with acute ergot toxicity characterized by severe peripheral vasospasm and dysesthesia.\\nDrug 1: erythromycin\\nDrug 2: dihydroergotamine\\nInteraction: effect\\n\\nSentence: Concurrent use of erythromycin and ergotamine or dihydroergotamine has been associated in some patients with acute ergot toxicity characterized by severe peripheral vasospasm and dysesthesia.\\nDrug 1: ergotamine\\nDrug 2: dihydroergotamine\\nInteraction: none\\n\\nSentence: Sumatriptan - There have been rare postmarketing reports describing patients with weakness, hyperreflexia, and incoordination following the use of a selective serotonin reuptake inhibitor (SSRI) and sumatriptan.\\nDrug 1: Sumatriptan\\nDrug 2: selective serotonin reuptake inhibitor\\nInteraction: none\\n\\nSentence: Sumatriptan - There have been rare postmarketing reports describing patients with weakness, hyperreflexia, and incoordination following the use of a selective serotonin reuptake inhibitor (SSRI) and sumatriptan.\\nDrug 1: Sumatriptan\\nDrug 2: SSRI\\nInteraction: none\\n\\nSentence: Ergotamine: Concurrent use of erythromycin and ergotamine or dihydroergotamine has been associated in some patients with acute ergot toxicity characterized by severe peripheral vasospasm and dysesthesia.\\nDrug1: erythromycin\\nDrug2: ergotamine\\nInteraction:   \n",
       "29                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Sentence: Antihistamines may have additive effects with alcohol and other CNS depressants, e.g., hypnotics, sedatives, tranquilizers, antianxiety agents.\\nDrug 1: Antihistamines\\nDrug 2: alcohol\\nInteraction: effect\\n\\nSentence: Antihistamines may have additive effects with alcohol and other CNS depressants, e.g., hypnotics, sedatives, tranquilizers, antianxiety agents.\\nDrug 1: Antihistamines\\nDrug 2: CNS depressants\\nInteraction: effect\\n\\nSentence: Antihistamines may have additive effects with alcohol and other CNS depressants, e.g., hypnotics, sedatives, tranquilizers, antianxiety agents.\\nDrug 1: Antihistamines\\nDrug 2: hypnotics\\nInteraction: effect\\n\\nSentence: Antihistamines may have additive effects with alcohol and other CNS depressants, e.g., hypnotics, sedatives, tranquilizers, antianxiety agents.\\nDrug 1: Antihistamines\\nDrug 2: sedatives\\nInteraction: effect\\n\\nSentence: Antihistamines may have additive effects with alcohol and other CNS depressants, e.g., hypnotics, sedatives, tranquilizers, antianxiety agents.\\nDrug 1: Antihistamines\\nDrug 2: tranquilizers\\nInteraction: effect\\n\\nSentence: Concurrent use of butorphanol with central nervous system depressants (e.g., alcohol, barbiturates, tranquilizers, and antihistamines) may result in increased central nervous system depressant effects.\\nDrug1: butorphanol\\nDrug2: tranquilizers\\nInteraction:   \n",
       "1560                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Sentence: Aspirin: Concomitant administration of diclofenac and aspirin is not recommended because diclofenac is displaced from its binding sites during the concomitant administration of aspirin, resulting in lower plasma concentrations, peak plasma levels, and AUC values.\\nDrug 1: Aspirin\\nDrug 2: diclofenac\\nInteraction: none\\n\\nSentence: Aspirin: Concomitant administration of diclofenac and aspirin is not recommended because diclofenac is displaced from its binding sites during the concomitant administration of aspirin, resulting in lower plasma concentrations, peak plasma levels, and AUC values.\\nDrug 1: Aspirin\\nDrug 2: aspirin\\nInteraction: none\\n\\nSentence: Aspirin: Concomitant administration of diclofenac and aspirin is not recommended because diclofenac is displaced from its binding sites during the concomitant administration of aspirin, resulting in lower plasma concentrations, peak plasma levels, and AUC values.\\nDrug 1: Aspirin\\nDrug 2: diclofenac\\nInteraction: none\\n\\nSentence: Aspirin: Concomitant administration of diclofenac and aspirin is not recommended because diclofenac is displaced from its binding sites during the concomitant administration of aspirin, resulting in lower plasma concentrations, peak plasma levels, and AUC values.\\nDrug 1: Aspirin\\nDrug 2: aspirin\\nInteraction: none\\n\\nSentence: Aspirin: Concomitant administration of diclofenac and aspirin is not recommended because diclofenac is displaced from its binding sites during the concomitant administration of aspirin, resulting in lower plasma concentrations, peak plasma levels, and AUC values.\\nDrug 1: diclofenac\\nDrug 2: aspirin\\nInteraction: advice\\n\\nSentence: Chlorpropamide: Chlorpropamides plasma half-life may be prolonged by allopurinol, since allopurinol and chlorpropamide may compete for excretion in the renal tubule.\\nDrug1: allopurinol\\nDrug2: chlorpropamide\\nInteraction:   \n",
       "1283                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Sentence: Drugs which inhibit CYP 3A4 (e.g., ketoconazole, macrolide antibiotics such as erythromycin) have the potential to result in increased plasma concentrations of corticosteroids.\\nDrug 1: ketoconazole\\nDrug 2: macrolide antibiotics\\nInteraction: none\\n\\nSentence: Drugs which inhibit CYP 3A4 (e.g., ketoconazole, macrolide antibiotics such as erythromycin) have the potential to result in increased plasma concentrations of corticosteroids.\\nDrug 1: ketoconazole\\nDrug 2: erythromycin\\nInteraction: none\\n\\nSentence: Drugs which inhibit CYP 3A4 (e.g., ketoconazole, macrolide antibiotics such as erythromycin) have the potential to result in increased plasma concentrations of corticosteroids.\\nDrug 1: ketoconazole\\nDrug 2: corticosteroids\\nInteraction: mechanism\\n\\nSentence: Drugs which inhibit CYP 3A4 (e.g., ketoconazole, macrolide antibiotics such as erythromycin) have the potential to result in increased plasma concentrations of corticosteroids.\\nDrug 1: macrolide antibiotics\\nDrug 2: erythromycin\\nInteraction: none\\n\\nSentence: Drugs which inhibit CYP 3A4 (e.g., ketoconazole, macrolide antibiotics such as erythromycin) have the potential to result in increased plasma concentrations of corticosteroids.\\nDrug 1: macrolide antibiotics\\nDrug 2: corticosteroids\\nInteraction: mechanism\\n\\nSentence: Drugs that induce hepatic enzymes such as phenobarbital, phenytoin and rifampin may increase the clearance of corticosteroids and may require increases in corticosteroid dose to achieve the desired response.\\nDrug1: rifampin\\nDrug2: corticosteroids\\nInteraction:   \n",
       "1458                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Sentence: Rifampin: Co-administration of VIOXX with rifampin 600 mg daily, a potent inducer of hepatic metabolism, produced an approximate 50% decrease in rofecoxib plasma concentrations.\\nDrug 1: Rifampin\\nDrug 2: VIOXX\\nInteraction: none\\n\\nSentence: Rifampin: Co-administration of VIOXX with rifampin 600 mg daily, a potent inducer of hepatic metabolism, produced an approximate 50% decrease in rofecoxib plasma concentrations.\\nDrug 1: Rifampin\\nDrug 2: rifampin\\nInteraction: none\\n\\nSentence: Rifampin: Co-administration of VIOXX with rifampin 600 mg daily, a potent inducer of hepatic metabolism, produced an approximate 50% decrease in rofecoxib plasma concentrations.\\nDrug 1: Rifampin\\nDrug 2: rofecoxib\\nInteraction: none\\n\\nSentence: Rifampin: Co-administration of VIOXX with rifampin 600 mg daily, a potent inducer of hepatic metabolism, produced an approximate 50% decrease in rofecoxib plasma concentrations.\\nDrug 1: VIOXX\\nDrug 2: rifampin\\nInteraction: mechanism\\n\\nSentence: Rifampin: Co-administration of VIOXX with rifampin 600 mg daily, a potent inducer of hepatic metabolism, produced an approximate 50% decrease in rofecoxib plasma concentrations.\\nDrug 1: VIOXX\\nDrug 2: rofecoxib\\nInteraction: none\\n\\nSentence: (See CLINICAL PHARMACOLOGY) Coadministration of Femara and tamoxifen 20 mg daily resulted in a reduction of letrozole plasma levels by 38% on average.\\nDrug1: Femara\\nDrug2: tamoxifen\\nInteraction:   \n",
       "1462                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Sentence: Alpha-blockers: When Vardenafil 10 or 20 mg was given to healthy volunteers either simultaneously or 6 hours after a 10 mg dose of terazosin, significant hypotension developed in a substantial number of subjects.\\nDrug 1: Alpha-blockers\\nDrug 2: Vardenafil\\nInteraction: none\\n\\nSentence: Alpha-blockers: When Vardenafil 10 or 20 mg was given to healthy volunteers either simultaneously or 6 hours after a 10 mg dose of terazosin, significant hypotension developed in a substantial number of subjects.\\nDrug 1: Alpha-blockers\\nDrug 2: terazosin\\nInteraction: none\\n\\nSentence: Alpha-blockers: When Vardenafil 10 or 20 mg was given to healthy volunteers either simultaneously or 6 hours after a 10 mg dose of terazosin, significant hypotension developed in a substantial number of subjects.\\nDrug 1: Vardenafil\\nDrug 2: terazosin\\nInteraction: effect\\n\\nSentence: Cimetidine: In a study in healthy volunteers, a one-week course of cimetidine at 400 mg b.i.d. with a single 5 mg dose of isradipine on the sixth day showed an increase in isradipine mean peak plasma concentrations (36%) and significant increase in area under the curve (50%).\\nDrug 1: Cimetidine\\nDrug 2: cimetidine\\nInteraction: none\\n\\nSentence: Cimetidine: In a study in healthy volunteers, a one-week course of cimetidine at 400 mg b.i.d. with a single 5 mg dose of isradipine on the sixth day showed an increase in isradipine mean peak plasma concentrations (36%) and significant increase in area under the curve (50%).\\nDrug 1: Cimetidine\\nDrug 2: isradipine\\nInteraction: none\\n\\nSentence: In vivo studies: Nitrates: The blood pressure lowering effects of sublingual nitrates (0.4 mg) taken 1 and 4 hours after vardenafil and increases in heart rate when taken at 1, 4 and 8 hours were potentiated by a 20 mg dose of Vardenafil in healthy middle-aged subjects.\\nDrug1: nitrates\\nDrug2: vardenafil\\nInteraction:   \n",
       "1501  Sentence: Agents that are CYP3A4 inhibitors that have been found, or are expected, to increase plasma levels of EQUETROTM are the following: Acetazolamide, azole antifungals, cimetidine, clarithromycin(1), dalfopristin, danazol, delavirdine, diltiazem, erythromycin(1), fluoxetine, fluvoxamine, grapefruit juice, isoniazid, itraconazole, ketoconazole, loratadine, nefazodone, niacinamide, nicotinamide, protease inhibitors, propoxyphene, quinine, quinupristin, troleandomycin, valproate(1), verapamil, zileuton.\\nDrug 1: EQUETROTM\\nDrug 2: Acetazolamide\\nInteraction: mechanism\\n\\nSentence: Agents that are CYP3A4 inhibitors that have been found, or are expected, to increase plasma levels of EQUETROTM are the following: Acetazolamide, azole antifungals, cimetidine, clarithromycin(1), dalfopristin, danazol, delavirdine, diltiazem, erythromycin(1), fluoxetine, fluvoxamine, grapefruit juice, isoniazid, itraconazole, ketoconazole, loratadine, nefazodone, niacinamide, nicotinamide, protease inhibitors, propoxyphene, quinine, quinupristin, troleandomycin, valproate(1), verapamil, zileuton.\\nDrug 1: EQUETROTM\\nDrug 2: azole antifungals\\nInteraction: mechanism\\n\\nSentence: Agents that are CYP3A4 inhibitors that have been found, or are expected, to increase plasma levels of EQUETROTM are the following: Acetazolamide, azole antifungals, cimetidine, clarithromycin(1), dalfopristin, danazol, delavirdine, diltiazem, erythromycin(1), fluoxetine, fluvoxamine, grapefruit juice, isoniazid, itraconazole, ketoconazole, loratadine, nefazodone, niacinamide, nicotinamide, protease inhibitors, propoxyphene, quinine, quinupristin, troleandomycin, valproate(1), verapamil, zileuton.\\nDrug 1: EQUETROTM\\nDrug 2: cimetidine\\nInteraction: mechanism\\n\\nSentence: Agents that are CYP3A4 inhibitors that have been found, or are expected, to increase plasma levels of EQUETROTM are the following: Acetazolamide, azole antifungals, cimetidine, clarithromycin(1), dalfopristin, danazol, delavirdine, diltiazem, erythromycin(1), fluoxetine, fluvoxamine, grapefruit juice, isoniazid, itraconazole, ketoconazole, loratadine, nefazodone, niacinamide, nicotinamide, protease inhibitors, propoxyphene, quinine, quinupristin, troleandomycin, valproate(1), verapamil, zileuton.\\nDrug 1: EQUETROTM\\nDrug 2: clarithromycin\\nInteraction: mechanism\\n\\nSentence: Agents that are CYP3A4 inhibitors that have been found, or are expected, to increase plasma levels of EQUETROTM are the following: Acetazolamide, azole antifungals, cimetidine, clarithromycin(1), dalfopristin, danazol, delavirdine, diltiazem, erythromycin(1), fluoxetine, fluvoxamine, grapefruit juice, isoniazid, itraconazole, ketoconazole, loratadine, nefazodone, niacinamide, nicotinamide, protease inhibitors, propoxyphene, quinine, quinupristin, troleandomycin, valproate(1), verapamil, zileuton.\\nDrug 1: EQUETROTM\\nDrug 2: dalfopristin\\nInteraction: mechanism\\n\\nSentence: Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.\\nDrug1: EQUETROTM\\nDrug2: nortriptyline\\nInteraction:   \n",
       "1558                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Sentence: Co-administration of TIKOSYN with verapamil resulted in increases in dofetilide peak plasma levels of 42%, although overall exposure to dofetilide was not significantly increased.\\nDrug 1: TIKOSYN\\nDrug 2: verapamil\\nInteraction: mechanism\\n\\nSentence: Co-administration of TIKOSYN with verapamil resulted in increases in dofetilide peak plasma levels of 42%, although overall exposure to dofetilide was not significantly increased.\\nDrug 1: TIKOSYN\\nDrug 2: dofetilide\\nInteraction: none\\n\\nSentence: Co-administration of TIKOSYN with verapamil resulted in increases in dofetilide peak plasma levels of 42%, although overall exposure to dofetilide was not significantly increased.\\nDrug 1: TIKOSYN\\nDrug 2: dofetilide\\nInteraction: none\\n\\nSentence: Co-administration of TIKOSYN with verapamil resulted in increases in dofetilide peak plasma levels of 42%, although overall exposure to dofetilide was not significantly increased.\\nDrug 1: verapamil\\nDrug 2: dofetilide\\nInteraction: none\\n\\nSentence: Co-administration of TIKOSYN with verapamil resulted in increases in dofetilide peak plasma levels of 42%, although overall exposure to dofetilide was not significantly increased.\\nDrug 1: verapamil\\nDrug 2: dofetilide\\nInteraction: none\\n\\nSentence: Co-administration of anastrozole and tamoxifen resulted in a reduction of anastrozole plasma levels by 27% compared with those achieved with anastrozole alone.\\nDrug1: anastrozole\\nDrug2: tamoxifen\\nInteraction:   \n",
       "1490      Sentence: Agents that are CYP3A4 inhibitors that have been found, or are expected, to increase plasma levels of EQUETROTM are the following: Acetazolamide, azole antifungals, cimetidine, clarithromycin(1), dalfopristin, danazol, delavirdine, diltiazem, erythromycin(1), fluoxetine, fluvoxamine, grapefruit juice, isoniazid, itraconazole, ketoconazole, loratadine, nefazodone, niacinamide, nicotinamide, protease inhibitors, propoxyphene, quinine, quinupristin, troleandomycin, valproate(1), verapamil, zileuton.\\nDrug 1: EQUETROTM\\nDrug 2: Acetazolamide\\nInteraction: mechanism\\n\\nSentence: Agents that are CYP3A4 inhibitors that have been found, or are expected, to increase plasma levels of EQUETROTM are the following: Acetazolamide, azole antifungals, cimetidine, clarithromycin(1), dalfopristin, danazol, delavirdine, diltiazem, erythromycin(1), fluoxetine, fluvoxamine, grapefruit juice, isoniazid, itraconazole, ketoconazole, loratadine, nefazodone, niacinamide, nicotinamide, protease inhibitors, propoxyphene, quinine, quinupristin, troleandomycin, valproate(1), verapamil, zileuton.\\nDrug 1: EQUETROTM\\nDrug 2: azole antifungals\\nInteraction: mechanism\\n\\nSentence: Agents that are CYP3A4 inhibitors that have been found, or are expected, to increase plasma levels of EQUETROTM are the following: Acetazolamide, azole antifungals, cimetidine, clarithromycin(1), dalfopristin, danazol, delavirdine, diltiazem, erythromycin(1), fluoxetine, fluvoxamine, grapefruit juice, isoniazid, itraconazole, ketoconazole, loratadine, nefazodone, niacinamide, nicotinamide, protease inhibitors, propoxyphene, quinine, quinupristin, troleandomycin, valproate(1), verapamil, zileuton.\\nDrug 1: EQUETROTM\\nDrug 2: cimetidine\\nInteraction: mechanism\\n\\nSentence: Agents that are CYP3A4 inhibitors that have been found, or are expected, to increase plasma levels of EQUETROTM are the following: Acetazolamide, azole antifungals, cimetidine, clarithromycin(1), dalfopristin, danazol, delavirdine, diltiazem, erythromycin(1), fluoxetine, fluvoxamine, grapefruit juice, isoniazid, itraconazole, ketoconazole, loratadine, nefazodone, niacinamide, nicotinamide, protease inhibitors, propoxyphene, quinine, quinupristin, troleandomycin, valproate(1), verapamil, zileuton.\\nDrug 1: EQUETROTM\\nDrug 2: clarithromycin\\nInteraction: mechanism\\n\\nSentence: Agents that are CYP3A4 inhibitors that have been found, or are expected, to increase plasma levels of EQUETROTM are the following: Acetazolamide, azole antifungals, cimetidine, clarithromycin(1), dalfopristin, danazol, delavirdine, diltiazem, erythromycin(1), fluoxetine, fluvoxamine, grapefruit juice, isoniazid, itraconazole, ketoconazole, loratadine, nefazodone, niacinamide, nicotinamide, protease inhibitors, propoxyphene, quinine, quinupristin, troleandomycin, valproate(1), verapamil, zileuton.\\nDrug 1: EQUETROTM\\nDrug 2: dalfopristin\\nInteraction: mechanism\\n\\nSentence: Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.\\nDrug1: EQUETROTM\\nDrug2: felbamate\\nInteraction:   \n",
       "1493    Sentence: Agents that are CYP3A4 inhibitors that have been found, or are expected, to increase plasma levels of EQUETROTM are the following: Acetazolamide, azole antifungals, cimetidine, clarithromycin(1), dalfopristin, danazol, delavirdine, diltiazem, erythromycin(1), fluoxetine, fluvoxamine, grapefruit juice, isoniazid, itraconazole, ketoconazole, loratadine, nefazodone, niacinamide, nicotinamide, protease inhibitors, propoxyphene, quinine, quinupristin, troleandomycin, valproate(1), verapamil, zileuton.\\nDrug 1: EQUETROTM\\nDrug 2: Acetazolamide\\nInteraction: mechanism\\n\\nSentence: Agents that are CYP3A4 inhibitors that have been found, or are expected, to increase plasma levels of EQUETROTM are the following: Acetazolamide, azole antifungals, cimetidine, clarithromycin(1), dalfopristin, danazol, delavirdine, diltiazem, erythromycin(1), fluoxetine, fluvoxamine, grapefruit juice, isoniazid, itraconazole, ketoconazole, loratadine, nefazodone, niacinamide, nicotinamide, protease inhibitors, propoxyphene, quinine, quinupristin, troleandomycin, valproate(1), verapamil, zileuton.\\nDrug 1: EQUETROTM\\nDrug 2: azole antifungals\\nInteraction: mechanism\\n\\nSentence: Agents that are CYP3A4 inhibitors that have been found, or are expected, to increase plasma levels of EQUETROTM are the following: Acetazolamide, azole antifungals, cimetidine, clarithromycin(1), dalfopristin, danazol, delavirdine, diltiazem, erythromycin(1), fluoxetine, fluvoxamine, grapefruit juice, isoniazid, itraconazole, ketoconazole, loratadine, nefazodone, niacinamide, nicotinamide, protease inhibitors, propoxyphene, quinine, quinupristin, troleandomycin, valproate(1), verapamil, zileuton.\\nDrug 1: EQUETROTM\\nDrug 2: cimetidine\\nInteraction: mechanism\\n\\nSentence: Agents that are CYP3A4 inhibitors that have been found, or are expected, to increase plasma levels of EQUETROTM are the following: Acetazolamide, azole antifungals, cimetidine, clarithromycin(1), dalfopristin, danazol, delavirdine, diltiazem, erythromycin(1), fluoxetine, fluvoxamine, grapefruit juice, isoniazid, itraconazole, ketoconazole, loratadine, nefazodone, niacinamide, nicotinamide, protease inhibitors, propoxyphene, quinine, quinupristin, troleandomycin, valproate(1), verapamil, zileuton.\\nDrug 1: EQUETROTM\\nDrug 2: clarithromycin\\nInteraction: mechanism\\n\\nSentence: Agents that are CYP3A4 inhibitors that have been found, or are expected, to increase plasma levels of EQUETROTM are the following: Acetazolamide, azole antifungals, cimetidine, clarithromycin(1), dalfopristin, danazol, delavirdine, diltiazem, erythromycin(1), fluoxetine, fluvoxamine, grapefruit juice, isoniazid, itraconazole, ketoconazole, loratadine, nefazodone, niacinamide, nicotinamide, protease inhibitors, propoxyphene, quinine, quinupristin, troleandomycin, valproate(1), verapamil, zileuton.\\nDrug 1: EQUETROTM\\nDrug 2: dalfopristin\\nInteraction: mechanism\\n\\nSentence: Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.\\nDrug1: EQUETROTM\\nDrug2: haloperidol\\nInteraction:   \n",
       "1319                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Sentence: Phenytoin: Amphetamines may delay intestinal absorption of phenytoin;\\nDrug 1: Phenytoin\\nDrug 2: Amphetamines\\nInteraction: none\\n\\nSentence: Phenytoin: Amphetamines may delay intestinal absorption of phenytoin;\\nDrug 1: Phenytoin\\nDrug 2: phenytoin\\nInteraction: none\\n\\nSentence: Phenytoin: Amphetamines may delay intestinal absorption of phenytoin;\\nDrug 1: Amphetamines\\nDrug 2: phenytoin\\nInteraction: mechanism\\n\\nSentence: Phenytoin: Amphetamines may delay intestinal absorption of phenytoin;\\nDrug 1: Phenytoin\\nDrug 2: Amphetamines\\nInteraction: none\\n\\nSentence: Phenytoin: Amphetamines may delay intestinal absorption of phenytoin;\\nDrug 1: Phenytoin\\nDrug 2: phenytoin\\nInteraction: none\\n\\nSentence: Phenobarbital: Amphetamines may delay intestinal absorption of phenobarbital;\\nDrug1: Amphetamines\\nDrug2: phenobarbital\\nInteraction:   \n",
       "1312                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Sentence: Concurrent administration of cimetidine and tricyclic antidepressants can produce clinically significant increases in the plasma levels of the tricyclic antidepressants.\\nDrug 1: cimetidine\\nDrug 2: tricyclic antidepressants\\nInteraction: mechanism\\n\\nSentence: Concurrent administration of cimetidine and tricyclic antidepressants can produce clinically significant increases in the plasma levels of the tricyclic antidepressants.\\nDrug 1: cimetidine\\nDrug 2: tricyclic antidepressants\\nInteraction: none\\n\\nSentence: Concurrent administration of cimetidine and tricyclic antidepressants can produce clinically significant increases in the plasma levels of the tricyclic antidepressants.\\nDrug 1: tricyclic antidepressants\\nDrug 2: tricyclic antidepressants\\nInteraction: none\\n\\nSentence: Aspirin: In normal volunteers, a small decrease in diflunisal levels was observed when multiple doses of diflunisal and aspirin were administered concomitantly.\\nDrug 1: Aspirin\\nDrug 2: diflunisal\\nInteraction: none\\n\\nSentence: Aspirin: In normal volunteers, a small decrease in diflunisal levels was observed when multiple doses of diflunisal and aspirin were administered concomitantly.\\nDrug 1: Aspirin\\nDrug 2: diflunisal\\nInteraction: none\\n\\nSentence: Concomitant administration of Norpace and quinidine resulted in slight increases in plasma disopyramide levels and slight decreases in plasma quinidine levels.\\nDrug1: Norpace\\nDrug2: quinidine\\nInteraction:   \n",
       "1337                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Sentence: Midazolam: Aprepitant increased the AUC of midazolam, a sensitive CYP3A4 substrate, by 2.3-fold on Day 1 and 3.3-fold on Day 5, when a single oral dose of midazolam 2 mg was coadministered on Day 1 and Day 5 of a regimen of Aprepitant 125 mg on Day 1 and 80 mg/day on Days 2 through 5.\\nDrug 1: Midazolam\\nDrug 2: Aprepitant\\nInteraction: none\\n\\nSentence: Midazolam: Aprepitant increased the AUC of midazolam, a sensitive CYP3A4 substrate, by 2.3-fold on Day 1 and 3.3-fold on Day 5, when a single oral dose of midazolam 2 mg was coadministered on Day 1 and Day 5 of a regimen of Aprepitant 125 mg on Day 1 and 80 mg/day on Days 2 through 5.\\nDrug 1: Midazolam\\nDrug 2: midazolam\\nInteraction: none\\n\\nSentence: Midazolam: Aprepitant increased the AUC of midazolam, a sensitive CYP3A4 substrate, by 2.3-fold on Day 1 and 3.3-fold on Day 5, when a single oral dose of midazolam 2 mg was coadministered on Day 1 and Day 5 of a regimen of Aprepitant 125 mg on Day 1 and 80 mg/day on Days 2 through 5.\\nDrug 1: Midazolam\\nDrug 2: midazolam\\nInteraction: none\\n\\nSentence: Midazolam: Aprepitant increased the AUC of midazolam, a sensitive CYP3A4 substrate, by 2.3-fold on Day 1 and 3.3-fold on Day 5, when a single oral dose of midazolam 2 mg was coadministered on Day 1 and Day 5 of a regimen of Aprepitant 125 mg on Day 1 and 80 mg/day on Days 2 through 5.\\nDrug 1: Midazolam\\nDrug 2: Aprepitant\\nInteraction: none\\n\\nSentence: Midazolam: Aprepitant increased the AUC of midazolam, a sensitive CYP3A4 substrate, by 2.3-fold on Day 1 and 3.3-fold on Day 5, when a single oral dose of midazolam 2 mg was coadministered on Day 1 and Day 5 of a regimen of Aprepitant 125 mg on Day 1 and 80 mg/day on Days 2 through 5.\\nDrug 1: Aprepitant\\nDrug 2: midazolam\\nInteraction: mechanism\\n\\nSentence: Tolbutamide: Aprepitant, when given as 125 mg on Day 1 and 80 mg/day on Days 2 and 3, decreased the AUC of tolbutamide (a CYP2C9 substrate) by 23% on Day 4, 28% on Day 8, and 15% on Day 15, when a single dose of tolbutamide 500 mg was admini,stered orally prior to the administration of the 3-day regimen of Aprepitant and on Days 4,8, and 15.\\nDrug1: tolbutamide\\nDrug2: Aprepitant\\nInteraction:   \n",
       "923                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Sentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: platelet inhibitors\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: acetylsalicylic acid\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: NSAIDs\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: ketorolac tromethamine\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: dipyridamole\\nInteraction: none\\n\\nSentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug1: perchlorate\\nDrug2: iodine-containing compounds\\nInteraction:   \n",
       "667                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Sentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: phenytoin\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: glyburide\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: ranitidine\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: omeprazole\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: estrogens\\nInteraction: none\\n\\nSentence: Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.\\nDrug1: clofibrate\\nDrug2: 5-fluorouracil\\nInteraction:   \n",
       "625                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Sentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: phenytoin\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: glyburide\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: ranitidine\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: omeprazole\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: estrogens\\nInteraction: none\\n\\nSentence: Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.\\nDrug1: androgens\\nDrug2: 5-fluorouracil\\nInteraction:   \n",
       "907                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Sentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: platelet inhibitors\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: acetylsalicylic acid\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: NSAIDs\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: ketorolac tromethamine\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: dipyridamole\\nInteraction: none\\n\\nSentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug1: thiocyanate\\nDrug2: somatostatin analogs\\nInteraction:   \n",
       "455                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Sentence: Potassium-sparing diuretics (e.g., spironolactone, triamterene, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.\\nDrug 1: Potassium-sparing diuretics\\nDrug 2: spironolactone\\nInteraction: none\\n\\nSentence: Potassium-sparing diuretics (e.g., spironolactone, triamterene, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.\\nDrug 1: Potassium-sparing diuretics\\nDrug 2: triamterene\\nInteraction: none\\n\\nSentence: Potassium-sparing diuretics (e.g., spironolactone, triamterene, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.\\nDrug 1: Potassium-sparing diuretics\\nDrug 2: amiloride\\nInteraction: none\\n\\nSentence: Potassium-sparing diuretics (e.g., spironolactone, triamterene, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.\\nDrug 1: Potassium-sparing diuretics\\nDrug 2: potassium\\nInteraction: none\\n\\nSentence: Potassium-sparing diuretics (e.g., spironolactone, triamterene, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.\\nDrug 1: Potassium-sparing diuretics\\nDrug 2: potassium\\nInteraction: none\\n\\nSentence: Potassium-sparing diuretics (spironolactone, amiloride, triamterene, and others) or potassium supplements can increase the risk of hyperkalemia.\\nDrug1: spironolactone\\nDrug2: triamterene\\nInteraction:   \n",
       "416                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Sentence: Effect of Other Drugs on the Pharmacokinetics of Clonazepam: Literature reports suggest that ranitidine, an agent that decreases stomach acidity, does not greatly alter clonazepam pharmacokinetics.\\nDrug 1: Clonazepam\\nDrug 2: ranitidine\\nInteraction: none\\n\\nSentence: Effect of Other Drugs on the Pharmacokinetics of Clonazepam: Literature reports suggest that ranitidine, an agent that decreases stomach acidity, does not greatly alter clonazepam pharmacokinetics.\\nDrug 1: Clonazepam\\nDrug 2: clonazepam\\nInteraction: none\\n\\nSentence: Effect of Other Drugs on the Pharmacokinetics of Clonazepam: Literature reports suggest that ranitidine, an agent that decreases stomach acidity, does not greatly alter clonazepam pharmacokinetics.\\nDrug 1: ranitidine\\nDrug 2: clonazepam\\nInteraction: none\\n\\nSentence: It has been reported that results of studies in animals indicate that dopamine-induced ventricular arrhythmias during anesthesia can be reversed by propranolol.\\nDrug 1: dopamine\\nDrug 2: propranolol\\nInteraction: effect\\n\\nSentence: Inhibitors Of Endogenous Prostaglandin Synthesis It has been reported that indomethacin may reduce the antihypertensive effect of captopril, especially in cases of low renin hypertension.\\nDrug 1: indomethacin\\nDrug 2: captopril\\nInteraction: effect\\n\\nSentence: MAO Inhibitors: Studies in animals demonstrate that the acute toxicity of bupropion is enhanced by the MAO inhibitor phenelzine .\\nDrug1: MAO Inhibitors\\nDrug2: MAO inhibitor\\nInteraction:   \n",
       "834                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Sentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: platelet inhibitors\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: acetylsalicylic acid\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: NSAIDs\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: ketorolac tromethamine\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: dipyridamole\\nInteraction: none\\n\\nSentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug1: amiodarone\\nDrug2: heparin\\nInteraction:   \n",
       "727                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Sentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: phenytoin\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: glyburide\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: ranitidine\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: omeprazole\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: estrogens\\nInteraction: none\\n\\nSentence: Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.\\nDrug1: glucocorticoids\\nDrug2: tamoxifen\\nInteraction:   \n",
       "734                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Sentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: phenytoin\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: glyburide\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: ranitidine\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: omeprazole\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: estrogens\\nInteraction: none\\n\\nSentence: Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.\\nDrug1: meclofenamic acid\\nDrug2: tamoxifen\\nInteraction:   \n",
       "607                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Sentence: Substances that are potent inhibitors of CYP3A4 activity (eg, ketoconazole and itraconazole) decrease gefitinib metabolism and increase gefitinib plasma concentrations.\\nDrug 1: ketoconazole\\nDrug 2: itraconazole\\nInteraction: none\\n\\nSentence: Substances that are potent inhibitors of CYP3A4 activity (eg, ketoconazole and itraconazole) decrease gefitinib metabolism and increase gefitinib plasma concentrations.\\nDrug 1: ketoconazole\\nDrug 2: gefitinib\\nInteraction: mechanism\\n\\nSentence: Substances that are potent inhibitors of CYP3A4 activity (eg, ketoconazole and itraconazole) decrease gefitinib metabolism and increase gefitinib plasma concentrations.\\nDrug 1: ketoconazole\\nDrug 2: gefitinib\\nInteraction: mechanism\\n\\nSentence: Substances that are potent inhibitors of CYP3A4 activity (eg, ketoconazole and itraconazole) decrease gefitinib metabolism and increase gefitinib plasma concentrations.\\nDrug 1: itraconazole\\nDrug 2: gefitinib\\nInteraction: mechanism\\n\\nSentence: Substances that are potent inhibitors of CYP3A4 activity (eg, ketoconazole and itraconazole) decrease gefitinib metabolism and increase gefitinib plasma concentrations.\\nDrug 1: itraconazole\\nDrug 2: gefitinib\\nInteraction: mechanism\\n\\nSentence: Fluconazole and Ketoconazole: Ketoconazole and fluconazole are predominantly CYP 3A4 and 2C9 inhibitors, respectively.\\nDrug1: Fluconazole\\nDrug2: Ketoconazole\\nInteraction:   \n",
       "763                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Sentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: platelet inhibitors\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: acetylsalicylic acid\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: NSAIDs\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: ketorolac tromethamine\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: dipyridamole\\nInteraction: none\\n\\nSentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug1: aminoglutethimide\\nDrug2: b-adrenergic blocking agents\\nInteraction:   \n",
       "780                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Sentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: platelet inhibitors\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: acetylsalicylic acid\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: NSAIDs\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: ketorolac tromethamine\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: dipyridamole\\nInteraction: none\\n\\nSentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug1: aminoglutethimide\\nDrug2: nitroprusside\\nInteraction:   \n",
       "841                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Sentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: platelet inhibitors\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: acetylsalicylic acid\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: NSAIDs\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: ketorolac tromethamine\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: dipyridamole\\nInteraction: none\\n\\nSentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug1: amiodarone\\nDrug2: metoclopramide\\nInteraction:   \n",
       "915                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Sentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: platelet inhibitors\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: acetylsalicylic acid\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: NSAIDs\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: ketorolac tromethamine\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: dipyridamole\\nInteraction: none\\n\\nSentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug1: perchlorate\\nDrug2: chloral hydrate\\nInteraction:   \n",
       "655                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Sentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: phenytoin\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: glyburide\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: ranitidine\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: omeprazole\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: estrogens\\nInteraction: none\\n\\nSentence: Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.\\nDrug1: asparaginase\\nDrug2: furosemide\\nInteraction:   \n",
       "494                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Sentence: Therefore, co-administration of clozapine with other drugs that are metabolized by this isozyme, including antidepressants, phenothiazines, carbamazepine, and Type 1C antiarrhythmics (e.g., propafenone, flecainide and encainide), or that inhibit this enzyme (e.g., quinidine), should be approached with caution.\\nDrug 1: clozapine\\nDrug 2: antidepressants\\nInteraction: advice\\n\\nSentence: Therefore, co-administration of clozapine with other drugs that are metabolized by this isozyme, including antidepressants, phenothiazines, carbamazepine, and Type 1C antiarrhythmics (e.g., propafenone, flecainide and encainide), or that inhibit this enzyme (e.g., quinidine), should be approached with caution.\\nDrug 1: clozapine\\nDrug 2: phenothiazines\\nInteraction: advice\\n\\nSentence: Therefore, co-administration of clozapine with other drugs that are metabolized by this isozyme, including antidepressants, phenothiazines, carbamazepine, and Type 1C antiarrhythmics (e.g., propafenone, flecainide and encainide), or that inhibit this enzyme (e.g., quinidine), should be approached with caution.\\nDrug 1: clozapine\\nDrug 2: carbamazepine\\nInteraction: advice\\n\\nSentence: Therefore, co-administration of clozapine with other drugs that are metabolized by this isozyme, including antidepressants, phenothiazines, carbamazepine, and Type 1C antiarrhythmics (e.g., propafenone, flecainide and encainide), or that inhibit this enzyme (e.g., quinidine), should be approached with caution.\\nDrug 1: clozapine\\nDrug 2: Type 1C antiarrhythmics\\nInteraction: advice\\n\\nSentence: Therefore, co-administration of clozapine with other drugs that are metabolized by this isozyme, including antidepressants, phenothiazines, carbamazepine, and Type 1C antiarrhythmics (e.g., propafenone, flecainide and encainide), or that inhibit this enzyme (e.g., quinidine), should be approached with caution.\\nDrug 1: clozapine\\nDrug 2: propafenone\\nInteraction: advice\\n\\nSentence: Therefore, co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme, including other antidepressants, phenothiazines, carbamazepine, and Type 1C antiarrhythmics (eg, propafenone, flecainide, and encainide), or that inhibit this enzyme (eg, quinidine), should be approached with caution.\\nDrug1: carbamazepine\\nDrug2: encainide\\nInteraction:   \n",
       "426                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Sentence: Accordingly, careful patient monitoring and dose adjustment of metformin is recommended in patients concomitantly taking cephalexin and metformin.\\nDrug 1: metformin\\nDrug 2: cephalexin\\nInteraction: none\\n\\nSentence: Accordingly, careful patient monitoring and dose adjustment of metformin is recommended in patients concomitantly taking cephalexin and metformin.\\nDrug 1: metformin\\nDrug 2: metformin\\nInteraction: none\\n\\nSentence: Accordingly, careful patient monitoring and dose adjustment of metformin is recommended in patients concomitantly taking cephalexin and metformin.\\nDrug 1: cephalexin\\nDrug 2: metformin\\nInteraction: advice\\n\\nSentence: In order to avoid lithium intoxication, lithium plasma levels should be monitored closely.\\nDrug 1: lithium\\nDrug 2: lithium\\nInteraction: none\\n\\nSentence: Therefore, cyclosporine serum levels should be monitored and appropriate cyclosporine dosage adjustments made when these drugs are used concomitantly.\\nDrug 1: cyclosporine\\nDrug 2: cyclosporine\\nInteraction: none\\n\\nSentence: Nevertheless, plasma lithium levels should be monitored with appropriate adjustment to the lithium dose in accordance with standard clinical practice.\\nDrug1: lithium\\nDrug2: lithium\\nInteraction:   \n",
       "977                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Sentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: platelet inhibitors\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: acetylsalicylic acid\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: NSAIDs\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: ketorolac tromethamine\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: dipyridamole\\nInteraction: none\\n\\nSentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug1: antithyroid drugs\\nDrug2: levodopa\\nInteraction:   \n",
       "896                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Sentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: platelet inhibitors\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: acetylsalicylic acid\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: NSAIDs\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: ketorolac tromethamine\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: dipyridamole\\nInteraction: none\\n\\nSentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug1: thiocyanate\\nDrug2: levodopa\\nInteraction:   \n",
       "1591                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Sentence: If desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/hypnotics, careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines (e.g., chlordiazepoxide or diazepam) are additive.\\nDrug 1: desipramine hydrochloride\\nDrug 2: psychotropic agents\\nInteraction: effect\\n\\nSentence: If desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/hypnotics, careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines (e.g., chlordiazepoxide or diazepam) are additive.\\nDrug 1: desipramine hydrochloride\\nDrug 2: tranquilizers\\nInteraction: effect\\n\\nSentence: If desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/hypnotics, careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines (e.g., chlordiazepoxide or diazepam) are additive.\\nDrug 1: desipramine hydrochloride\\nDrug 2: sedative\\nInteraction: effect\\n\\nSentence: If desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/hypnotics, careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines (e.g., chlordiazepoxide or diazepam) are additive.\\nDrug 1: desipramine hydrochloride\\nDrug 2: hypnotics\\nInteraction: effect\\n\\nSentence: If desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/hypnotics, careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines (e.g., chlordiazepoxide or diazepam) are additive.\\nDrug 1: desipramine hydrochloride\\nDrug 2: desipramine\\nInteraction: none\\n\\nSentence: Since Zarontin (ethosuximide) may interact with concurrently administered antiepileptic drugs, periodic serum level determinations of these drugs may be necessary (eg, ethosuximide may elevate phenytoin serum levels and valproic acid has been reported to both increase and decrease ethosuximide levels).\\nDrug1: Zarontin\\nDrug2: antiepileptic drugs\\nInteraction:   \n",
       "\n",
       "     ddi_test_prompts_random_42.5.50.perm_0.  \\\n",
       "1065                                    none   \n",
       "1157                                  advice   \n",
       "1096                                    none   \n",
       "1164                                    none   \n",
       "1133                                    none   \n",
       "30                                    effect   \n",
       "299                                     none   \n",
       "177                                     none   \n",
       "204                                   effect   \n",
       "354                                   effect   \n",
       "265                                     none   \n",
       "41                                      none   \n",
       "13                                      none   \n",
       "55                                      none   \n",
       "196                                   effect   \n",
       "137                                   effect   \n",
       "29                                    effect   \n",
       "1560                                    none   \n",
       "1283                               mechanism   \n",
       "1458                               mechanism   \n",
       "1462                                    none   \n",
       "1501                               mechanism   \n",
       "1558                               mechanism   \n",
       "1490                               mechanism   \n",
       "1493                               mechanism   \n",
       "1319                                    none   \n",
       "1312                                    none   \n",
       "1337                               mechanism   \n",
       "923                                     none   \n",
       "667                                     none   \n",
       "625                                     none   \n",
       "907                                     none   \n",
       "455                                     none   \n",
       "416                                   effect   \n",
       "834                                     none   \n",
       "727                                     none   \n",
       "734                                     none   \n",
       "607                                     none   \n",
       "763                                     none   \n",
       "780                                     none   \n",
       "841                                     none   \n",
       "915                                     none   \n",
       "655                                     none   \n",
       "494                                   advice   \n",
       "426                                     none   \n",
       "977                                     none   \n",
       "896                                     none   \n",
       "1591                                    none   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          gpt3_output_ddi_test_prompts_random_42.5.50.perm_0.  \n",
       "1065                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               ({'id': 'cmpl-4IU8yuPU9WAmvuVcrvDxgoAnQtZKU', 'object': 'text_completion', 'created': 1640311124, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      1163\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.23378392\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" none\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" none\": -0.23378392\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" none\"\n",
       "}]}, Sentence: The use of antacids should be considered in place of H2 blockers or proton pump inhibitors in patients receiving SPRYCEL therapy.\\nDrug 1: antacids\\nDrug 2: H2 blockers\\nInteraction: none\\n\\nSentence: The use of antacids should be considered in place of H2 blockers or proton pump inhibitors in patients receiving SPRYCEL therapy.\\nDrug 1: antacids\\nDrug 2: proton pump inhibitors\\nInteraction: none\\n\\nSentence: The use of antacids should be considered in place of H2 blockers or proton pump inhibitors in patients receiving SPRYCEL therapy.\\nDrug 1: antacids\\nDrug 2: SPRYCEL\\nInteraction: none\\n\\nSentence: The use of antacids should be considered in place of H2 blockers or proton pump inhibitors in patients receiving SPRYCEL therapy.\\nDrug 1: H2 blockers\\nDrug 2: proton pump inhibitors\\nInteraction: none\\n\\nSentence: The use of antacids should be considered in place of H2 blockers or proton pump inhibitors in patients receiving SPRYCEL therapy.\\nDrug 1: H2 blockers\\nDrug 2: SPRYCEL\\nInteraction: advice\\n\\nSentence: The concomitant use of H2 blockers or proton pump inhibitors with SPRYCEL is not recommended.\\nDrug1: proton pump inhibitors\\nDrug2: SPRYCEL\\nInteraction:,  effect other mechanism none advice )  \n",
       "1157                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  ({'id': 'cmpl-4IU8ym4u4Kyep29mBPWYn6dKI0xjE', 'object': 'text_completion', 'created': 1640311124, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      1104\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.004028529\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" advice\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" advice\": -0.004028529\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" advice\"\n",
       "}]}, Sentence: Cevimeline should be administered with caution to patients taking beta adrenergic antagonists, because of the possibility of conduction disturbances.\\nDrug 1: Cevimeline\\nDrug 2: beta adrenergic antagonists\\nInteraction: advice\\n\\nSentence: All vasopressors should be used cautiously in patients taking monoamine oxidase (MAO) inhibitors.\\nDrug 1: vasopressors\\nDrug 2: monoamine oxidase (MAO) inhibitors\\nInteraction: advice\\n\\nSentence: DISULFIRAM SHOULD BE USED WITH CAUTION IN THOSE PATIENTS REVEIVING PHENYTOIN AND ITS CONGENERS.\\nDrug 1: DISULFIRAM\\nDrug 2: PHENYTOIN\\nInteraction: advice\\n\\nSentence: NSAIDs should be used with caution in patients taking cyclosporine, and renal function should be carefully monitored.\\nDrug 1: NSAIDs\\nDrug 2: cyclosporine\\nInteraction: advice\\n\\nSentence: NSAIDs should be used with caution in patients taking cyclosporine, and renal function should be carefully monitored.\\nDrug 1: NSAIDs\\nDrug 2: cyclosporine\\nInteraction: advice\\n\\nSentence: MAO inhibitors should be used with caution in patients receiving hydralazine.\\nDrug1: MAO inhibitors\\nDrug2: hydralazine\\nInteraction:,  effect other mechanism none advice )  \n",
       "1096                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             ({'id': 'cmpl-4IU8zW6xaSCy1WxGEXwYUqbQNKIwO', 'object': 'text_completion', 'created': 1640311125, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      1407\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.3778825\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" none\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" none\": -0.3778825\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" none\"\n",
       "}]}, Sentence: For patients receiving both therapies, standard monitoring of tacrolimus blood concentrations and appropriate tacrolimus dosage adjustments are recommended.\\nDrug 1: tacrolimus\\nDrug 2: tacrolimus\\nInteraction: none\\n\\nSentence: The physician is advised to monitor the plasma concentrations of itraconazole when any of these drugs is taken concurrently, and to increase the dose of Itraconazole if necessary.\\nDrug 1: itraconazole\\nDrug 2: Itraconazole\\nInteraction: none\\n\\nSentence: Therefore, cyclosporine serum levels should be monitored and appropriate cyclosporine dosage adjustments made when these drugs are used concomitantly.\\nDrug 1: cyclosporine\\nDrug 2: cyclosporine\\nInteraction: none\\n\\nSentence: Therefore, cyclosporine serum levels should be monitored and appropriate cyclosporine dosage adjustments made when these drugs are used concomitantly.\\nDrug 1: cyclosporine\\nDrug 2: cyclosporine\\nInteraction: none\\n\\nSentence: Coadministration of Itraconazole and cyclosporine, tacrolimus or digoxin has led to increased plasma concentrations of the latter three drugs.\\nDrug 1: Itraconazole\\nDrug 2: cyclosporine\\nInteraction: mechanism\\n\\nSentence: Cyclosporine, tacrolimus and digoxin concentrations should be monitored at the initiation of Itraconazole therapy and frequently thereafter, and the dose of these three drug products adjusted appropriately.\\nDrug1: Cyclosporine\\nDrug2: Itraconazole\\nInteraction:,  effect other mechanism none advice )  \n",
       "1164                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           ({'id': 'cmpl-4IU8zd0FzOR9XmIoT2I4tqglCkWdy', 'object': 'text_completion', 'created': 1640311125, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      1369\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.00047064314\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" none\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" none\": -0.00047064314\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" none\"\n",
       "}]}, Sentence: Although there is little published information on concomitant administration of lidocaine and Bretylium Tosylate, these drugs are often administered concurrently without any evidence of interactions resulting in adverse effects or diminished efficacy.\\nDrug 1: lidocaine\\nDrug 2: Bretylium Tosylate\\nInteraction: none\\n\\nSentence: The safety and efficacy of anakinra used in combination with HUMIRA has not been studied.\\nDrug 1: anakinra\\nDrug 2: HUMIRA\\nInteraction: none\\n\\nSentence: Aspirin: As with other NSAIDs, concomitant administration of Ponstel and aspirin is not generally recommended because of the potential of increased adverse effects.\\nDrug 1: Aspirin\\nDrug 2: NSAIDs\\nInteraction: none\\n\\nSentence: Aspirin: As with other NSAIDs, concomitant administration of Ponstel and aspirin is not generally recommended because of the potential of increased adverse effects.\\nDrug 1: Aspirin\\nDrug 2: Ponstel\\nInteraction: none\\n\\nSentence: Aspirin: As with other NSAIDs, concomitant administration of Ponstel and aspirin is not generally recommended because of the potential of increased adverse effects.\\nDrug 1: Aspirin\\nDrug 2: aspirin\\nInteraction: none\\n\\nSentence: There is insufficient experience to assess the safety and efficacy of ORENCIA administered concurrently with anakinra, and therefore such use is not recommended.\\nDrug1: ORENCIA\\nDrug2: anakinra\\nInteraction:,  effect other mechanism none advice )  \n",
       "1133                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           ({'id': 'cmpl-4IU8zi6Lp7opAJ8VVBb868IfkA8Ao', 'object': 'text_completion', 'created': 1640311125, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      1857\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.6837042\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" none\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" none\": -0.6837042\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" none\"\n",
       "}]}, Sentence: Concomitant administration of alosetron and moderate CYP1A2 inhibitors, including quinolone antibiotics and cimetidine, has not been evaluated, but should be avoided unless clinically necessary because of similar potential drug interactions.\\nDrug 1: alosetron\\nDrug 2: quinolone antibiotics\\nInteraction: advice\\n\\nSentence: Concomitant administration of alosetron and moderate CYP1A2 inhibitors, including quinolone antibiotics and cimetidine, has not been evaluated, but should be avoided unless clinically necessary because of similar potential drug interactions.\\nDrug 1: alosetron\\nDrug 2: cimetidine\\nInteraction: advice\\n\\nSentence: Concomitant administration of alosetron and moderate CYP1A2 inhibitors, including quinolone antibiotics and cimetidine, has not been evaluated, but should be avoided unless clinically necessary because of similar potential drug interactions.\\nDrug 1: quinolone antibiotics\\nDrug 2: cimetidine\\nInteraction: none\\n\\nSentence: Consequently, concomitant administration of Aprepitant with strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, nefazodone, troleandomycin, clarithromycin, ritonavir, nelfinavir) should be approached with caution.\\nDrug 1: Aprepitant\\nDrug 2: ketoconazole\\nInteraction: advice\\n\\nSentence: Consequently, concomitant administration of Aprepitant with strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, nefazodone, troleandomycin, clarithromycin, ritonavir, nelfinavir) should be approached with caution.\\nDrug 1: Aprepitant\\nDrug 2: itraconazole\\nInteraction: advice\\n\\nSentence: Coadministration of alosetron and strong CYP3A4 inhibitors, such as clarithromycin, telithromycin, protease inhibitors, voriconazole, and itraconazole has not been evaluated but should be undertaken with caution because of similar potential drug interactions.\\nDrug1: alosetron\\nDrug2: telithromycin\\nInteraction:,  effect other mechanism none advice )  \n",
       "30                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           ({'id': 'cmpl-4IU8zfDqpsak0mEPlNNqQ6P7sD9kO', 'object': 'text_completion', 'created': 1640311125, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      1353\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.027719622\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" effect\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" effect\": -0.027719622\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" effect\"\n",
       "}]}, Sentence: Antihistamines may have additive effects with alcohol and other CNS depressants, e.g., hypnotics, sedatives, tranquilizers, antianxiety agents.\\nDrug 1: Antihistamines\\nDrug 2: alcohol\\nInteraction: effect\\n\\nSentence: Antihistamines may have additive effects with alcohol and other CNS depressants, e.g., hypnotics, sedatives, tranquilizers, antianxiety agents.\\nDrug 1: Antihistamines\\nDrug 2: CNS depressants\\nInteraction: effect\\n\\nSentence: Antihistamines may have additive effects with alcohol and other CNS depressants, e.g., hypnotics, sedatives, tranquilizers, antianxiety agents.\\nDrug 1: Antihistamines\\nDrug 2: hypnotics\\nInteraction: effect\\n\\nSentence: Antihistamines may have additive effects with alcohol and other CNS depressants, e.g., hypnotics, sedatives, tranquilizers, antianxiety agents.\\nDrug 1: Antihistamines\\nDrug 2: sedatives\\nInteraction: effect\\n\\nSentence: Antihistamines may have additive effects with alcohol and other CNS depressants, e.g., hypnotics, sedatives, tranquilizers, antianxiety agents.\\nDrug 1: Antihistamines\\nDrug 2: tranquilizers\\nInteraction: effect\\n\\nSentence: Concurrent use of butorphanol with central nervous system depressants (e.g., alcohol, barbiturates, tranquilizers, and antihistamines) may result in increased central nervous system depressant effects.\\nDrug1: butorphanol\\nDrug2: antihistamines\\nInteraction:,  effect other mechanism none advice )  \n",
       "299                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          ({'id': 'cmpl-4IU90xeGU5nqC6ovMrbi47RslkRo8', 'object': 'text_completion', 'created': 1640311126, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      2211\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.4597337\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" none\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" none\": -0.4597337\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" none\"\n",
       "}]}, Sentence: Particular caution is necessary when using ROMAZICON in cases of mixed drug overdosage since the toxic effects (such as convulsions and cardiac dysrhythmias) of other drugs taken in overdose (especially cyclic antidepressants) may emerge with the reversal of the benzodiazepine effect by flumazenil.\\nDrug 1: ROMAZICON\\nDrug 2: cyclic antidepressants\\nInteraction: effect\\n\\nSentence: Particular caution is necessary when using ROMAZICON in cases of mixed drug overdosage since the toxic effects (such as convulsions and cardiac dysrhythmias) of other drugs taken in overdose (especially cyclic antidepressants) may emerge with the reversal of the benzodiazepine effect by flumazenil.\\nDrug 1: ROMAZICON\\nDrug 2: benzodiazepine\\nInteraction: none\\n\\nSentence: Particular caution is necessary when using ROMAZICON in cases of mixed drug overdosage since the toxic effects (such as convulsions and cardiac dysrhythmias) of other drugs taken in overdose (especially cyclic antidepressants) may emerge with the reversal of the benzodiazepine effect by flumazenil.\\nDrug 1: ROMAZICON\\nDrug 2: flumazenil\\nInteraction: none\\n\\nSentence: Particular caution is necessary when using ROMAZICON in cases of mixed drug overdosage since the toxic effects (such as convulsions and cardiac dysrhythmias) of other drugs taken in overdose (especially cyclic antidepressants) may emerge with the reversal of the benzodiazepine effect by flumazenil.\\nDrug 1: cyclic antidepressants\\nDrug 2: benzodiazepine\\nInteraction: none\\n\\nSentence: Particular caution is necessary when using ROMAZICON in cases of mixed drug overdosage since the toxic effects (such as convulsions and cardiac dysrhythmias) of other drugs taken in overdose (especially cyclic antidepressants) may emerge with the reversal of the benzodiazepine effect by flumazenil.\\nDrug 1: cyclic antidepressants\\nDrug 2: flumazenil\\nInteraction: none\\n\\nSentence: When atropine and pralidoxime are used together, the signs of atropinization (flushing, mydriasis, tachycardia, dryness of the mouth and nose) may occur earlier than might be expected than when atropine is used alone because pralidoxime may potentiate the effect of atropine.\\nDrug1: atropine\\nDrug2: pralidoxime\\nInteraction:,  effect other mechanism none advice )  \n",
       "177                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                ({'id': 'cmpl-4IU90jfZkOKzbVibrfvxlp5JNx3yY', 'object': 'text_completion', 'created': 1640311126, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      1319\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.0018755054\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" none\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" none\": -0.0018755054\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" none\"\n",
       "}]}, Sentence: Lithium: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ACE inhibitors during therapy with lithium.\\nDrug 1: Lithium\\nDrug 2: lithium\\nInteraction: none\\n\\nSentence: Lithium: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ACE inhibitors during therapy with lithium.\\nDrug 1: Lithium\\nDrug 2: lithium\\nInteraction: none\\n\\nSentence: Lithium: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ACE inhibitors during therapy with lithium.\\nDrug 1: Lithium\\nDrug 2: ACE inhibitors\\nInteraction: none\\n\\nSentence: Lithium: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ACE inhibitors during therapy with lithium.\\nDrug 1: Lithium\\nDrug 2: lithium\\nInteraction: none\\n\\nSentence: Lithium: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ACE inhibitors during therapy with lithium.\\nDrug 1: lithium\\nDrug 2: lithium\\nInteraction: none\\n\\nSentence: Lithium: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ACE inhibitors during therapy with lithium.\\nDrug1: ACE inhibitors\\nDrug2: lithium\\nInteraction:,  effect other mechanism none advice )  \n",
       "204                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               ({'id': 'cmpl-4IU903C7EzxX7sFulCKkf9Beo4mzL', 'object': 'text_completion', 'created': 1640311126, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      1812\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.008146561\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" effect\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" effect\": -0.008146561\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" effect\"\n",
       "}]}, Sentence: The action of the benzodiazepines may be potentiated by anticonvulsants, antihistamines, alcohol, barbiturates, monoamine oxidase inhibitors, narcotics, phenothiazines, psychotropic medications, or other drugs that produce CNS depression.\\nDrug 1: benzodiazepines\\nDrug 2: anticonvulsants\\nInteraction: effect\\n\\nSentence: The action of the benzodiazepines may be potentiated by anticonvulsants, antihistamines, alcohol, barbiturates, monoamine oxidase inhibitors, narcotics, phenothiazines, psychotropic medications, or other drugs that produce CNS depression.\\nDrug 1: benzodiazepines\\nDrug 2: antihistamines\\nInteraction: effect\\n\\nSentence: The action of the benzodiazepines may be potentiated by anticonvulsants, antihistamines, alcohol, barbiturates, monoamine oxidase inhibitors, narcotics, phenothiazines, psychotropic medications, or other drugs that produce CNS depression.\\nDrug 1: benzodiazepines\\nDrug 2: alcohol\\nInteraction: effect\\n\\nSentence: The action of the benzodiazepines may be potentiated by anticonvulsants, antihistamines, alcohol, barbiturates, monoamine oxidase inhibitors, narcotics, phenothiazines, psychotropic medications, or other drugs that produce CNS depression.\\nDrug 1: benzodiazepines\\nDrug 2: barbiturates\\nInteraction: effect\\n\\nSentence: The action of the benzodiazepines may be potentiated by anticonvulsants, antihistamines, alcohol, barbiturates, monoamine oxidase inhibitors, narcotics, phenothiazines, psychotropic medications, or other drugs that produce CNS depression.\\nDrug 1: benzodiazepines\\nDrug 2: monoamine oxidase inhibitors\\nInteraction: effect\\n\\nSentence: The actions of the benzodiazepines may be potentiated by barbiturates, narcotics, phenothiazines, monoamine oxidase inhibitors or other antidepressants.\\nDrug1: benzodiazepines\\nDrug2: antidepressants\\nInteraction:,  effect other mechanism none advice )  \n",
       "354                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   ({'id': 'cmpl-4IU91N7Sk5Bs398xpFdRwwDvzGRjS', 'object': 'text_completion', 'created': 1640311127, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      1856\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.020413725\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" effect\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" effect\": -0.020413725\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" effect\"\n",
       "}]}, Sentence: In patients, the concomitant administration of digoxin with dofetilide was associated with a higher occurrence of torsade de pointes.\\nDrug 1: digoxin\\nDrug 2: dofetilide\\nInteraction: effect\\n\\nSentence: In clinical trials in patients undergoing PTCA/PCI, co-administration of Angiomax with heparin, warfarin, thrombolytics or glycoprotein IIb/IIIa inhibitors was associated with increased risks of major bleeding events compared to patients not receiving these concomitant medications.\\nDrug 1: Angiomax\\nDrug 2: heparin\\nInteraction: effect\\n\\nSentence: In clinical trials in patients undergoing PTCA/PCI, co-administration of Angiomax with heparin, warfarin, thrombolytics or glycoprotein IIb/IIIa inhibitors was associated with increased risks of major bleeding events compared to patients not receiving these concomitant medications.\\nDrug 1: Angiomax\\nDrug 2: warfarin\\nInteraction: effect\\n\\nSentence: In clinical trials in patients undergoing PTCA/PCI, co-administration of Angiomax with heparin, warfarin, thrombolytics or glycoprotein IIb/IIIa inhibitors was associated with increased risks of major bleeding events compared to patients not receiving these concomitant medications.\\nDrug 1: Angiomax\\nDrug 2: thrombolytics\\nInteraction: effect\\n\\nSentence: In clinical trials in patients undergoing PTCA/PCI, co-administration of Angiomax with heparin, warfarin, thrombolytics or glycoprotein IIb/IIIa inhibitors was associated with increased risks of major bleeding events compared to patients not receiving these concomitant medications.\\nDrug 1: heparin\\nDrug 2: warfarin\\nInteraction: none\\n\\nSentence: In an analysis of the supraventricular arrhythmia and DIAMOND patient populations, the concomitant administration of verapamil with dofetilide was associated with a higher occurrence of torsade de pointes.\\nDrug1: verapamil\\nDrug2: dofetilide\\nInteraction:,  effect other mechanism none advice )  \n",
       "265                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      ({'id': 'cmpl-4IU91IOnl7d0F6Hoh6giSD0zUZ0x8', 'object': 'text_completion', 'created': 1640311127, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      1971\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.007345331\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" none\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" none\": -0.007345331\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" none\"\n",
       "}]}, Sentence: Patients receiving other narcotic analgesics, general anesthetics, phenothiazines, tranquilizers, sedative-hypnotics, tricyclic antidepressants or other CNS depressants (including alcohol) concomitantly with DILAUDID may exhibit an additive CNS depression.\\nDrug 1: narcotic analgesic\\nDrug 2: anesthetics\\nInteraction: none\\n\\nSentence: Patients receiving other narcotic analgesics, general anesthetics, phenothiazines, tranquilizers, sedative-hypnotics, tricyclic antidepressants or other CNS depressants (including alcohol) concomitantly with DILAUDID may exhibit an additive CNS depression.\\nDrug 1: narcotic analgesic\\nDrug 2: phenothiazines\\nInteraction: none\\n\\nSentence: Patients receiving other narcotic analgesics, general anesthetics, phenothiazines, tranquilizers, sedative-hypnotics, tricyclic antidepressants or other CNS depressants (including alcohol) concomitantly with DILAUDID may exhibit an additive CNS depression.\\nDrug 1: narcotic analgesic\\nDrug 2: tranquilizers\\nInteraction: none\\n\\nSentence: Patients receiving other narcotic analgesics, general anesthetics, phenothiazines, tranquilizers, sedative-hypnotics, tricyclic antidepressants or other CNS depressants (including alcohol) concomitantly with DILAUDID may exhibit an additive CNS depression.\\nDrug 1: narcotic analgesic\\nDrug 2: sedative-hypnotics\\nInteraction: none\\n\\nSentence: Patients receiving other narcotic analgesics, general anesthetics, phenothiazines, tranquilizers, sedative-hypnotics, tricyclic antidepressants or other CNS depressants (including alcohol) concomitantly with DILAUDID may exhibit an additive CNS depression.\\nDrug 1: narcotic analgesic\\nDrug 2: tricyclic antidepressants\\nInteraction: none\\n\\nSentence: Patients receiving other narcotic analgesics, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with hydrocodone and acetaminophen tablets may exhibit an additive CNS depression.\\nDrug1: alcohol\\nDrug2: hydrocodone\\nInteraction:,  effect other mechanism none advice )  \n",
       "41                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    ({'id': 'cmpl-4IU91cqSSKVbT2QXgi7Ue30Unb1vt', 'object': 'text_completion', 'created': 1640311127, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      1990\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.008622842\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" none\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" none\": -0.008622842\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" none\"\n",
       "}]}, Sentence: Diclofenac: Administration of morning and lunch doses of Starlix 120 mg in combination with a single 75-mg dose of diclofenac in healthy volunteers resulted in no significant changes to the pharmacokinetics of either agent.\\nDrug 1: Diclofenac\\nDrug 2: Starlix\\nInteraction: none\\n\\nSentence: Diclofenac: Administration of morning and lunch doses of Starlix 120 mg in combination with a single 75-mg dose of diclofenac in healthy volunteers resulted in no significant changes to the pharmacokinetics of either agent.\\nDrug 1: Diclofenac\\nDrug 2: diclofenac\\nInteraction: none\\n\\nSentence: Diclofenac: Administration of morning and lunch doses of Starlix 120 mg in combination with a single 75-mg dose of diclofenac in healthy volunteers resulted in no significant changes to the pharmacokinetics of either agent.\\nDrug 1: Starlix\\nDrug 2: diclofenac\\nInteraction: none\\n\\nSentence: Warfarin: In a study in healthy volunteers, no clinically relevant pharmacokinetic or pharmacodynamic interaction between isradipine and racemic warfarin was seen when two single oral doses of warfarin (0.7 mg/kg body weight) were administered during 11 days of multipledose treatment with 5 mg b.i.d. isradipine.\\nDrug 1: Warfarin\\nDrug 2: isradipine\\nInteraction: none\\n\\nSentence: Warfarin: In a study in healthy volunteers, no clinically relevant pharmacokinetic or pharmacodynamic interaction between isradipine and racemic warfarin was seen when two single oral doses of warfarin (0.7 mg/kg body weight) were administered during 11 days of multipledose treatment with 5 mg b.i.d. isradipine.\\nDrug 1: Warfarin\\nDrug 2: warfarin\\nInteraction: none\\n\\nSentence: Concomitant administration of diflunisal and acetaminophen in dogs, but not in rats, at approximately 2 times the recommended maximum human therapeutic dose of each (40 to 52 mg/kg/day of diflunisal/acetaminophen) resulted in greater gastrointestinal toxicity than when either drug was administered alone.\\nDrug1: diflunisal\\nDrug2: acetaminophen\\nInteraction:,  effect other mechanism none advice )  \n",
       "13                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      ({'id': 'cmpl-4IU927UqzTrtLVSqJBXOINZ8XaxE0', 'object': 'text_completion', 'created': 1640311128, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      1926\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.58492255\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" none\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" none\": -0.58492255\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" none\"\n",
       "}]}, Sentence: Tricyclic antidepressants have been reported to blunt the hypotensive effect of systemic clonidine.It is not known whether the concurrent use of these agents with ALPHAGAN P in humans can lead to resulting interference with the IOP lowering effect.\\nDrug 1: Tricyclic antidepressants\\nDrug 2: clonidine\\nInteraction: effect\\n\\nSentence: Tricyclic antidepressants have been reported to blunt the hypotensive effect of systemic clonidine.It is not known whether the concurrent use of these agents with ALPHAGAN P in humans can lead to resulting interference with the IOP lowering effect.\\nDrug 1: Tricyclic antidepressants\\nDrug 2: ALPHAGAN P\\nInteraction: none\\n\\nSentence: Tricyclic antidepressants have been reported to blunt the hypotensive effect of systemic clonidine.It is not known whether the concurrent use of these agents with ALPHAGAN P in humans can lead to resulting interference with the IOP lowering effect.\\nDrug 1: clonidine\\nDrug 2: ALPHAGAN P\\nInteraction: none\\n\\nSentence: Due to their similar mechanism of action, it is expected that the neuromuscular blockade produced by any of the non-depolarizing muscle relaxants could be prolonged in the presence of piperacillin.\\nDrug 1: non-depolarizing muscle relaxants\\nDrug 2: piperacillin\\nInteraction: effect\\n\\nSentence: Avoid the use of preparations such as decongestants and local anesthetics which contain any sympathomimetic amine (e.g., epinephrine, norepinephrine), since it has been reported that tricyclic antidepressants can potentiate the effects of catecholamines.\\nDrug 1: decongestants\\nDrug 2: anesthetics\\nInteraction: none\\n\\nSentence: Several tricyclic antidepressants have been reported to block the pharmacologic effects of guanethidine, clonidine, or similar agents, and such an effect may be anticipated with CMI because of its structural similarity to other tricyclic antidepressants.\\nDrug1: tricyclic antidepressants\\nDrug2: guanethidine\\nInteraction:,  effect other mechanism none advice )  \n",
       "55                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  ({'id': 'cmpl-4IU923UYZaYlfV7EwXb8LRjgKs3qa', 'object': 'text_completion', 'created': 1640311128, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      1782\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.0006991211\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" none\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" none\": -0.0006991211\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" none\"\n",
       "}]}, Sentence: The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension.\\nDrug 1: anesthetic solutions\\nDrug 2: epinephrine\\nInteraction: none\\n\\nSentence: The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension.\\nDrug 1: anesthetic solutions\\nDrug 2: norepinephrine\\nInteraction: none\\n\\nSentence: The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension.\\nDrug 1: anesthetic solutions\\nDrug 2: monoamine oxidase inhibitors\\nInteraction: none\\n\\nSentence: The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension.\\nDrug 1: anesthetic solutions\\nDrug 2: tricyclic antidepressants\\nInteraction: none\\n\\nSentence: The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension.\\nDrug 1: epinephrine\\nDrug 2: norepinephrine\\nInteraction: none\\n\\nSentence: The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension.\\nDrug1: norepinephrine\\nDrug2: monoamine oxidase inhibitors\\nInteraction:,  effect other mechanism none advice )  \n",
       "196                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         ({'id': 'cmpl-4IU920kULeqcOLjZDnZnmRLy0d7Mu', 'object': 'text_completion', 'created': 1640311128, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      1118\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.6050804\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" effect\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" effect\": -0.6050804\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" effect\"\n",
       "}]}, Sentence: Warfarin: Quinolones have been reported to enhance the effects of the oral anticoagulant warfarin or its derivatives.\\nDrug 1: Warfarin\\nDrug 2: Quinolones\\nInteraction: none\\n\\nSentence: Warfarin: Quinolones have been reported to enhance the effects of the oral anticoagulant warfarin or its derivatives.\\nDrug 1: Warfarin\\nDrug 2: anticoagulant\\nInteraction: none\\n\\nSentence: Warfarin: Quinolones have been reported to enhance the effects of the oral anticoagulant warfarin or its derivatives.\\nDrug 1: Warfarin\\nDrug 2: warfarin\\nInteraction: none\\n\\nSentence: Warfarin: Quinolones have been reported to enhance the effects of the oral anticoagulant warfarin or its derivatives.\\nDrug 1: Quinolones\\nDrug 2: anticoagulant\\nInteraction: none\\n\\nSentence: Warfarin: Quinolones have been reported to enhance the effects of the oral anticoagulant warfarin or its derivatives.\\nDrug 1: Quinolones\\nDrug 2: warfarin\\nInteraction: effect\\n\\nSentence: Anticoagulants: Combination hormonal contraceptives may increase or decrease the effects of coumarin derivatives.\\nDrug1: hormonal contraceptives\\nDrug2: coumarin derivatives\\nInteraction:,  effect other mechanism none advice )  \n",
       "137                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        ({'id': 'cmpl-4IU93tGLDIRJPofMzuI3g0kQTtD7P', 'object': 'text_completion', 'created': 1640311129, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      1645\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.23617452\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" effect\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" effect\": -0.23617452\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" effect\"\n",
       "}]}, Sentence: Concurrent use of erythromycin and ergotamine or dihydroergotamine has been associated in some patients with acute ergot toxicity characterized by severe peripheral vasospasm and dysesthesia.\\nDrug 1: erythromycin\\nDrug 2: ergotamine\\nInteraction: effect\\n\\nSentence: Concurrent use of erythromycin and ergotamine or dihydroergotamine has been associated in some patients with acute ergot toxicity characterized by severe peripheral vasospasm and dysesthesia.\\nDrug 1: erythromycin\\nDrug 2: dihydroergotamine\\nInteraction: effect\\n\\nSentence: Concurrent use of erythromycin and ergotamine or dihydroergotamine has been associated in some patients with acute ergot toxicity characterized by severe peripheral vasospasm and dysesthesia.\\nDrug 1: ergotamine\\nDrug 2: dihydroergotamine\\nInteraction: none\\n\\nSentence: Sumatriptan - There have been rare postmarketing reports describing patients with weakness, hyperreflexia, and incoordination following the use of a selective serotonin reuptake inhibitor (SSRI) and sumatriptan.\\nDrug 1: Sumatriptan\\nDrug 2: selective serotonin reuptake inhibitor\\nInteraction: none\\n\\nSentence: Sumatriptan - There have been rare postmarketing reports describing patients with weakness, hyperreflexia, and incoordination following the use of a selective serotonin reuptake inhibitor (SSRI) and sumatriptan.\\nDrug 1: Sumatriptan\\nDrug 2: SSRI\\nInteraction: none\\n\\nSentence: Ergotamine: Concurrent use of erythromycin and ergotamine or dihydroergotamine has been associated in some patients with acute ergot toxicity characterized by severe peripheral vasospasm and dysesthesia.\\nDrug1: erythromycin\\nDrug2: ergotamine\\nInteraction:,  effect other mechanism none advice )  \n",
       "29                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            ({'id': 'cmpl-4IU93mG6UxSJgsqJqiedRrFrIbLiG', 'object': 'text_completion', 'created': 1640311129, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      1352\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.026047714\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" effect\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" effect\": -0.026047714\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" effect\"\n",
       "}]}, Sentence: Antihistamines may have additive effects with alcohol and other CNS depressants, e.g., hypnotics, sedatives, tranquilizers, antianxiety agents.\\nDrug 1: Antihistamines\\nDrug 2: alcohol\\nInteraction: effect\\n\\nSentence: Antihistamines may have additive effects with alcohol and other CNS depressants, e.g., hypnotics, sedatives, tranquilizers, antianxiety agents.\\nDrug 1: Antihistamines\\nDrug 2: CNS depressants\\nInteraction: effect\\n\\nSentence: Antihistamines may have additive effects with alcohol and other CNS depressants, e.g., hypnotics, sedatives, tranquilizers, antianxiety agents.\\nDrug 1: Antihistamines\\nDrug 2: hypnotics\\nInteraction: effect\\n\\nSentence: Antihistamines may have additive effects with alcohol and other CNS depressants, e.g., hypnotics, sedatives, tranquilizers, antianxiety agents.\\nDrug 1: Antihistamines\\nDrug 2: sedatives\\nInteraction: effect\\n\\nSentence: Antihistamines may have additive effects with alcohol and other CNS depressants, e.g., hypnotics, sedatives, tranquilizers, antianxiety agents.\\nDrug 1: Antihistamines\\nDrug 2: tranquilizers\\nInteraction: effect\\n\\nSentence: Concurrent use of butorphanol with central nervous system depressants (e.g., alcohol, barbiturates, tranquilizers, and antihistamines) may result in increased central nervous system depressant effects.\\nDrug1: butorphanol\\nDrug2: tranquilizers\\nInteraction:,  effect other mechanism none advice )  \n",
       "1560                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     ({'id': 'cmpl-4IU93kBZdiYjlFcIdAfisMwAE6Wff', 'object': 'text_completion', 'created': 1640311129, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      1865\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.678508\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" none\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" none\": -0.678508\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" none\"\n",
       "}]}, Sentence: Aspirin: Concomitant administration of diclofenac and aspirin is not recommended because diclofenac is displaced from its binding sites during the concomitant administration of aspirin, resulting in lower plasma concentrations, peak plasma levels, and AUC values.\\nDrug 1: Aspirin\\nDrug 2: diclofenac\\nInteraction: none\\n\\nSentence: Aspirin: Concomitant administration of diclofenac and aspirin is not recommended because diclofenac is displaced from its binding sites during the concomitant administration of aspirin, resulting in lower plasma concentrations, peak plasma levels, and AUC values.\\nDrug 1: Aspirin\\nDrug 2: aspirin\\nInteraction: none\\n\\nSentence: Aspirin: Concomitant administration of diclofenac and aspirin is not recommended because diclofenac is displaced from its binding sites during the concomitant administration of aspirin, resulting in lower plasma concentrations, peak plasma levels, and AUC values.\\nDrug 1: Aspirin\\nDrug 2: diclofenac\\nInteraction: none\\n\\nSentence: Aspirin: Concomitant administration of diclofenac and aspirin is not recommended because diclofenac is displaced from its binding sites during the concomitant administration of aspirin, resulting in lower plasma concentrations, peak plasma levels, and AUC values.\\nDrug 1: Aspirin\\nDrug 2: aspirin\\nInteraction: none\\n\\nSentence: Aspirin: Concomitant administration of diclofenac and aspirin is not recommended because diclofenac is displaced from its binding sites during the concomitant administration of aspirin, resulting in lower plasma concentrations, peak plasma levels, and AUC values.\\nDrug 1: diclofenac\\nDrug 2: aspirin\\nInteraction: advice\\n\\nSentence: Chlorpropamide: Chlorpropamides plasma half-life may be prolonged by allopurinol, since allopurinol and chlorpropamide may compete for excretion in the renal tubule.\\nDrug1: allopurinol\\nDrug2: chlorpropamide\\nInteraction:,  effect other mechanism none advice )  \n",
       "1283                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           ({'id': 'cmpl-4IU93OJiZV0Pcty6bu1Kcd7rhAfK1', 'object': 'text_completion', 'created': 1640311129, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      1552\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.24739274\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" mechanism\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" mechanism\": -0.24739274\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" mechanism\"\n",
       "}]}, Sentence: Drugs which inhibit CYP 3A4 (e.g., ketoconazole, macrolide antibiotics such as erythromycin) have the potential to result in increased plasma concentrations of corticosteroids.\\nDrug 1: ketoconazole\\nDrug 2: macrolide antibiotics\\nInteraction: none\\n\\nSentence: Drugs which inhibit CYP 3A4 (e.g., ketoconazole, macrolide antibiotics such as erythromycin) have the potential to result in increased plasma concentrations of corticosteroids.\\nDrug 1: ketoconazole\\nDrug 2: erythromycin\\nInteraction: none\\n\\nSentence: Drugs which inhibit CYP 3A4 (e.g., ketoconazole, macrolide antibiotics such as erythromycin) have the potential to result in increased plasma concentrations of corticosteroids.\\nDrug 1: ketoconazole\\nDrug 2: corticosteroids\\nInteraction: mechanism\\n\\nSentence: Drugs which inhibit CYP 3A4 (e.g., ketoconazole, macrolide antibiotics such as erythromycin) have the potential to result in increased plasma concentrations of corticosteroids.\\nDrug 1: macrolide antibiotics\\nDrug 2: erythromycin\\nInteraction: none\\n\\nSentence: Drugs which inhibit CYP 3A4 (e.g., ketoconazole, macrolide antibiotics such as erythromycin) have the potential to result in increased plasma concentrations of corticosteroids.\\nDrug 1: macrolide antibiotics\\nDrug 2: corticosteroids\\nInteraction: mechanism\\n\\nSentence: Drugs that induce hepatic enzymes such as phenobarbital, phenytoin and rifampin may increase the clearance of corticosteroids and may require increases in corticosteroid dose to achieve the desired response.\\nDrug1: rifampin\\nDrug2: corticosteroids\\nInteraction:,  effect other mechanism none advice )  \n",
       "1458                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            ({'id': 'cmpl-4IU940JPgGvVuIy87rHlTgE157C88', 'object': 'text_completion', 'created': 1640311130, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      1407\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.17020744\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" mechanism\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" mechanism\": -0.17020744\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" mechanism\"\n",
       "}]}, Sentence: Rifampin: Co-administration of VIOXX with rifampin 600 mg daily, a potent inducer of hepatic metabolism, produced an approximate 50% decrease in rofecoxib plasma concentrations.\\nDrug 1: Rifampin\\nDrug 2: VIOXX\\nInteraction: none\\n\\nSentence: Rifampin: Co-administration of VIOXX with rifampin 600 mg daily, a potent inducer of hepatic metabolism, produced an approximate 50% decrease in rofecoxib plasma concentrations.\\nDrug 1: Rifampin\\nDrug 2: rifampin\\nInteraction: none\\n\\nSentence: Rifampin: Co-administration of VIOXX with rifampin 600 mg daily, a potent inducer of hepatic metabolism, produced an approximate 50% decrease in rofecoxib plasma concentrations.\\nDrug 1: Rifampin\\nDrug 2: rofecoxib\\nInteraction: none\\n\\nSentence: Rifampin: Co-administration of VIOXX with rifampin 600 mg daily, a potent inducer of hepatic metabolism, produced an approximate 50% decrease in rofecoxib plasma concentrations.\\nDrug 1: VIOXX\\nDrug 2: rifampin\\nInteraction: mechanism\\n\\nSentence: Rifampin: Co-administration of VIOXX with rifampin 600 mg daily, a potent inducer of hepatic metabolism, produced an approximate 50% decrease in rofecoxib plasma concentrations.\\nDrug 1: VIOXX\\nDrug 2: rofecoxib\\nInteraction: none\\n\\nSentence: (See CLINICAL PHARMACOLOGY) Coadministration of Femara and tamoxifen 20 mg daily resulted in a reduction of letrozole plasma levels by 38% on average.\\nDrug1: Femara\\nDrug2: tamoxifen\\nInteraction:,  effect other mechanism none advice )  \n",
       "1462                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   ({'id': 'cmpl-4IU949UpdxinXS2xEoafOHHr3xzhl', 'object': 'text_completion', 'created': 1640311130, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      1863\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.65847224\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" none\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" none\": -0.65847224\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" none\"\n",
       "}]}, Sentence: Alpha-blockers: When Vardenafil 10 or 20 mg was given to healthy volunteers either simultaneously or 6 hours after a 10 mg dose of terazosin, significant hypotension developed in a substantial number of subjects.\\nDrug 1: Alpha-blockers\\nDrug 2: Vardenafil\\nInteraction: none\\n\\nSentence: Alpha-blockers: When Vardenafil 10 or 20 mg was given to healthy volunteers either simultaneously or 6 hours after a 10 mg dose of terazosin, significant hypotension developed in a substantial number of subjects.\\nDrug 1: Alpha-blockers\\nDrug 2: terazosin\\nInteraction: none\\n\\nSentence: Alpha-blockers: When Vardenafil 10 or 20 mg was given to healthy volunteers either simultaneously or 6 hours after a 10 mg dose of terazosin, significant hypotension developed in a substantial number of subjects.\\nDrug 1: Vardenafil\\nDrug 2: terazosin\\nInteraction: effect\\n\\nSentence: Cimetidine: In a study in healthy volunteers, a one-week course of cimetidine at 400 mg b.i.d. with a single 5 mg dose of isradipine on the sixth day showed an increase in isradipine mean peak plasma concentrations (36%) and significant increase in area under the curve (50%).\\nDrug 1: Cimetidine\\nDrug 2: cimetidine\\nInteraction: none\\n\\nSentence: Cimetidine: In a study in healthy volunteers, a one-week course of cimetidine at 400 mg b.i.d. with a single 5 mg dose of isradipine on the sixth day showed an increase in isradipine mean peak plasma concentrations (36%) and significant increase in area under the curve (50%).\\nDrug 1: Cimetidine\\nDrug 2: isradipine\\nInteraction: none\\n\\nSentence: In vivo studies: Nitrates: The blood pressure lowering effects of sublingual nitrates (0.4 mg) taken 1 and 4 hours after vardenafil and increases in heart rate when taken at 1, 4 and 8 hours were potentiated by a 20 mg dose of Vardenafil in healthy middle-aged subjects.\\nDrug1: nitrates\\nDrug2: vardenafil\\nInteraction:,  effect other mechanism none advice )  \n",
       "1501  ({'id': 'cmpl-4IU94DzxLKaC4SBCHFkpddeik1b1h', 'object': 'text_completion', 'created': 1640311130, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      3687\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.009376137\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" mechanism\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" mechanism\": -0.009376137\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" mechanism\"\n",
       "}]}, Sentence: Agents that are CYP3A4 inhibitors that have been found, or are expected, to increase plasma levels of EQUETROTM are the following: Acetazolamide, azole antifungals, cimetidine, clarithromycin(1), dalfopristin, danazol, delavirdine, diltiazem, erythromycin(1), fluoxetine, fluvoxamine, grapefruit juice, isoniazid, itraconazole, ketoconazole, loratadine, nefazodone, niacinamide, nicotinamide, protease inhibitors, propoxyphene, quinine, quinupristin, troleandomycin, valproate(1), verapamil, zileuton.\\nDrug 1: EQUETROTM\\nDrug 2: Acetazolamide\\nInteraction: mechanism\\n\\nSentence: Agents that are CYP3A4 inhibitors that have been found, or are expected, to increase plasma levels of EQUETROTM are the following: Acetazolamide, azole antifungals, cimetidine, clarithromycin(1), dalfopristin, danazol, delavirdine, diltiazem, erythromycin(1), fluoxetine, fluvoxamine, grapefruit juice, isoniazid, itraconazole, ketoconazole, loratadine, nefazodone, niacinamide, nicotinamide, protease inhibitors, propoxyphene, quinine, quinupristin, troleandomycin, valproate(1), verapamil, zileuton.\\nDrug 1: EQUETROTM\\nDrug 2: azole antifungals\\nInteraction: mechanism\\n\\nSentence: Agents that are CYP3A4 inhibitors that have been found, or are expected, to increase plasma levels of EQUETROTM are the following: Acetazolamide, azole antifungals, cimetidine, clarithromycin(1), dalfopristin, danazol, delavirdine, diltiazem, erythromycin(1), fluoxetine, fluvoxamine, grapefruit juice, isoniazid, itraconazole, ketoconazole, loratadine, nefazodone, niacinamide, nicotinamide, protease inhibitors, propoxyphene, quinine, quinupristin, troleandomycin, valproate(1), verapamil, zileuton.\\nDrug 1: EQUETROTM\\nDrug 2: cimetidine\\nInteraction: mechanism\\n\\nSentence: Agents that are CYP3A4 inhibitors that have been found, or are expected, to increase plasma levels of EQUETROTM are the following: Acetazolamide, azole antifungals, cimetidine, clarithromycin(1), dalfopristin, danazol, delavirdine, diltiazem, erythromycin(1), fluoxetine, fluvoxamine, grapefruit juice, isoniazid, itraconazole, ketoconazole, loratadine, nefazodone, niacinamide, nicotinamide, protease inhibitors, propoxyphene, quinine, quinupristin, troleandomycin, valproate(1), verapamil, zileuton.\\nDrug 1: EQUETROTM\\nDrug 2: clarithromycin\\nInteraction: mechanism\\n\\nSentence: Agents that are CYP3A4 inhibitors that have been found, or are expected, to increase plasma levels of EQUETROTM are the following: Acetazolamide, azole antifungals, cimetidine, clarithromycin(1), dalfopristin, danazol, delavirdine, diltiazem, erythromycin(1), fluoxetine, fluvoxamine, grapefruit juice, isoniazid, itraconazole, ketoconazole, loratadine, nefazodone, niacinamide, nicotinamide, protease inhibitors, propoxyphene, quinine, quinupristin, troleandomycin, valproate(1), verapamil, zileuton.\\nDrug 1: EQUETROTM\\nDrug 2: dalfopristin\\nInteraction: mechanism\\n\\nSentence: Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.\\nDrug1: EQUETROTM\\nDrug2: nortriptyline\\nInteraction:,  effect other mechanism none advice )  \n",
       "1558                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     ({'id': 'cmpl-4IU95CQN5l9BvOQfemmEHSZDf1L7x', 'object': 'text_completion', 'created': 1640311131, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      1446\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.34936067\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" mechanism\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" mechanism\": -0.34936067\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" mechanism\"\n",
       "}]}, Sentence: Co-administration of TIKOSYN with verapamil resulted in increases in dofetilide peak plasma levels of 42%, although overall exposure to dofetilide was not significantly increased.\\nDrug 1: TIKOSYN\\nDrug 2: verapamil\\nInteraction: mechanism\\n\\nSentence: Co-administration of TIKOSYN with verapamil resulted in increases in dofetilide peak plasma levels of 42%, although overall exposure to dofetilide was not significantly increased.\\nDrug 1: TIKOSYN\\nDrug 2: dofetilide\\nInteraction: none\\n\\nSentence: Co-administration of TIKOSYN with verapamil resulted in increases in dofetilide peak plasma levels of 42%, although overall exposure to dofetilide was not significantly increased.\\nDrug 1: TIKOSYN\\nDrug 2: dofetilide\\nInteraction: none\\n\\nSentence: Co-administration of TIKOSYN with verapamil resulted in increases in dofetilide peak plasma levels of 42%, although overall exposure to dofetilide was not significantly increased.\\nDrug 1: verapamil\\nDrug 2: dofetilide\\nInteraction: none\\n\\nSentence: Co-administration of TIKOSYN with verapamil resulted in increases in dofetilide peak plasma levels of 42%, although overall exposure to dofetilide was not significantly increased.\\nDrug 1: verapamil\\nDrug 2: dofetilide\\nInteraction: none\\n\\nSentence: Co-administration of anastrozole and tamoxifen resulted in a reduction of anastrozole plasma levels by 27% compared with those achieved with anastrozole alone.\\nDrug1: anastrozole\\nDrug2: tamoxifen\\nInteraction:,  effect other mechanism none advice )  \n",
       "1490    ({'id': 'cmpl-4IU951QrcyXDzJ44AaK4gLYs0nqnv', 'object': 'text_completion', 'created': 1640311131, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      3683\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.0077295625\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" mechanism\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" mechanism\": -0.0077295625\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" mechanism\"\n",
       "}]}, Sentence: Agents that are CYP3A4 inhibitors that have been found, or are expected, to increase plasma levels of EQUETROTM are the following: Acetazolamide, azole antifungals, cimetidine, clarithromycin(1), dalfopristin, danazol, delavirdine, diltiazem, erythromycin(1), fluoxetine, fluvoxamine, grapefruit juice, isoniazid, itraconazole, ketoconazole, loratadine, nefazodone, niacinamide, nicotinamide, protease inhibitors, propoxyphene, quinine, quinupristin, troleandomycin, valproate(1), verapamil, zileuton.\\nDrug 1: EQUETROTM\\nDrug 2: Acetazolamide\\nInteraction: mechanism\\n\\nSentence: Agents that are CYP3A4 inhibitors that have been found, or are expected, to increase plasma levels of EQUETROTM are the following: Acetazolamide, azole antifungals, cimetidine, clarithromycin(1), dalfopristin, danazol, delavirdine, diltiazem, erythromycin(1), fluoxetine, fluvoxamine, grapefruit juice, isoniazid, itraconazole, ketoconazole, loratadine, nefazodone, niacinamide, nicotinamide, protease inhibitors, propoxyphene, quinine, quinupristin, troleandomycin, valproate(1), verapamil, zileuton.\\nDrug 1: EQUETROTM\\nDrug 2: azole antifungals\\nInteraction: mechanism\\n\\nSentence: Agents that are CYP3A4 inhibitors that have been found, or are expected, to increase plasma levels of EQUETROTM are the following: Acetazolamide, azole antifungals, cimetidine, clarithromycin(1), dalfopristin, danazol, delavirdine, diltiazem, erythromycin(1), fluoxetine, fluvoxamine, grapefruit juice, isoniazid, itraconazole, ketoconazole, loratadine, nefazodone, niacinamide, nicotinamide, protease inhibitors, propoxyphene, quinine, quinupristin, troleandomycin, valproate(1), verapamil, zileuton.\\nDrug 1: EQUETROTM\\nDrug 2: cimetidine\\nInteraction: mechanism\\n\\nSentence: Agents that are CYP3A4 inhibitors that have been found, or are expected, to increase plasma levels of EQUETROTM are the following: Acetazolamide, azole antifungals, cimetidine, clarithromycin(1), dalfopristin, danazol, delavirdine, diltiazem, erythromycin(1), fluoxetine, fluvoxamine, grapefruit juice, isoniazid, itraconazole, ketoconazole, loratadine, nefazodone, niacinamide, nicotinamide, protease inhibitors, propoxyphene, quinine, quinupristin, troleandomycin, valproate(1), verapamil, zileuton.\\nDrug 1: EQUETROTM\\nDrug 2: clarithromycin\\nInteraction: mechanism\\n\\nSentence: Agents that are CYP3A4 inhibitors that have been found, or are expected, to increase plasma levels of EQUETROTM are the following: Acetazolamide, azole antifungals, cimetidine, clarithromycin(1), dalfopristin, danazol, delavirdine, diltiazem, erythromycin(1), fluoxetine, fluvoxamine, grapefruit juice, isoniazid, itraconazole, ketoconazole, loratadine, nefazodone, niacinamide, nicotinamide, protease inhibitors, propoxyphene, quinine, quinupristin, troleandomycin, valproate(1), verapamil, zileuton.\\nDrug 1: EQUETROTM\\nDrug 2: dalfopristin\\nInteraction: mechanism\\n\\nSentence: Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.\\nDrug1: EQUETROTM\\nDrug2: felbamate\\nInteraction:,  effect other mechanism none advice )  \n",
       "1493    ({'id': 'cmpl-4IU96ayh7tt8DLK8TaK3YdPQoeMcZ', 'object': 'text_completion', 'created': 1640311132, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      3685\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.010059679\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" mechanism\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" mechanism\": -0.010059679\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" mechanism\"\n",
       "}]}, Sentence: Agents that are CYP3A4 inhibitors that have been found, or are expected, to increase plasma levels of EQUETROTM are the following: Acetazolamide, azole antifungals, cimetidine, clarithromycin(1), dalfopristin, danazol, delavirdine, diltiazem, erythromycin(1), fluoxetine, fluvoxamine, grapefruit juice, isoniazid, itraconazole, ketoconazole, loratadine, nefazodone, niacinamide, nicotinamide, protease inhibitors, propoxyphene, quinine, quinupristin, troleandomycin, valproate(1), verapamil, zileuton.\\nDrug 1: EQUETROTM\\nDrug 2: Acetazolamide\\nInteraction: mechanism\\n\\nSentence: Agents that are CYP3A4 inhibitors that have been found, or are expected, to increase plasma levels of EQUETROTM are the following: Acetazolamide, azole antifungals, cimetidine, clarithromycin(1), dalfopristin, danazol, delavirdine, diltiazem, erythromycin(1), fluoxetine, fluvoxamine, grapefruit juice, isoniazid, itraconazole, ketoconazole, loratadine, nefazodone, niacinamide, nicotinamide, protease inhibitors, propoxyphene, quinine, quinupristin, troleandomycin, valproate(1), verapamil, zileuton.\\nDrug 1: EQUETROTM\\nDrug 2: azole antifungals\\nInteraction: mechanism\\n\\nSentence: Agents that are CYP3A4 inhibitors that have been found, or are expected, to increase plasma levels of EQUETROTM are the following: Acetazolamide, azole antifungals, cimetidine, clarithromycin(1), dalfopristin, danazol, delavirdine, diltiazem, erythromycin(1), fluoxetine, fluvoxamine, grapefruit juice, isoniazid, itraconazole, ketoconazole, loratadine, nefazodone, niacinamide, nicotinamide, protease inhibitors, propoxyphene, quinine, quinupristin, troleandomycin, valproate(1), verapamil, zileuton.\\nDrug 1: EQUETROTM\\nDrug 2: cimetidine\\nInteraction: mechanism\\n\\nSentence: Agents that are CYP3A4 inhibitors that have been found, or are expected, to increase plasma levels of EQUETROTM are the following: Acetazolamide, azole antifungals, cimetidine, clarithromycin(1), dalfopristin, danazol, delavirdine, diltiazem, erythromycin(1), fluoxetine, fluvoxamine, grapefruit juice, isoniazid, itraconazole, ketoconazole, loratadine, nefazodone, niacinamide, nicotinamide, protease inhibitors, propoxyphene, quinine, quinupristin, troleandomycin, valproate(1), verapamil, zileuton.\\nDrug 1: EQUETROTM\\nDrug 2: clarithromycin\\nInteraction: mechanism\\n\\nSentence: Agents that are CYP3A4 inhibitors that have been found, or are expected, to increase plasma levels of EQUETROTM are the following: Acetazolamide, azole antifungals, cimetidine, clarithromycin(1), dalfopristin, danazol, delavirdine, diltiazem, erythromycin(1), fluoxetine, fluvoxamine, grapefruit juice, isoniazid, itraconazole, ketoconazole, loratadine, nefazodone, niacinamide, nicotinamide, protease inhibitors, propoxyphene, quinine, quinupristin, troleandomycin, valproate(1), verapamil, zileuton.\\nDrug 1: EQUETROTM\\nDrug 2: dalfopristin\\nInteraction: mechanism\\n\\nSentence: Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.\\nDrug1: EQUETROTM\\nDrug2: haloperidol\\nInteraction:,  effect other mechanism none advice )  \n",
       "1319                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             ({'id': 'cmpl-4IU96vH6rN9gevBy0fZ76Qf3L6VL7', 'object': 'text_completion', 'created': 1640311132, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      830\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.51959467\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" none\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" none\": -0.51959467\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" none\"\n",
       "}]}, Sentence: Phenytoin: Amphetamines may delay intestinal absorption of phenytoin;\\nDrug 1: Phenytoin\\nDrug 2: Amphetamines\\nInteraction: none\\n\\nSentence: Phenytoin: Amphetamines may delay intestinal absorption of phenytoin;\\nDrug 1: Phenytoin\\nDrug 2: phenytoin\\nInteraction: none\\n\\nSentence: Phenytoin: Amphetamines may delay intestinal absorption of phenytoin;\\nDrug 1: Amphetamines\\nDrug 2: phenytoin\\nInteraction: mechanism\\n\\nSentence: Phenytoin: Amphetamines may delay intestinal absorption of phenytoin;\\nDrug 1: Phenytoin\\nDrug 2: Amphetamines\\nInteraction: none\\n\\nSentence: Phenytoin: Amphetamines may delay intestinal absorption of phenytoin;\\nDrug 1: Phenytoin\\nDrug 2: phenytoin\\nInteraction: none\\n\\nSentence: Phenobarbital: Amphetamines may delay intestinal absorption of phenobarbital;\\nDrug1: Amphetamines\\nDrug2: phenobarbital\\nInteraction:,  effect other mechanism none advice )  \n",
       "1312                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            ({'id': 'cmpl-4IU97xpRZl62zbq8GzYBoqiYzdEqi', 'object': 'text_completion', 'created': 1640311133, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      1440\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.5518371\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" none\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" none\": -0.5518371\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" none\"\n",
       "}]}, Sentence: Concurrent administration of cimetidine and tricyclic antidepressants can produce clinically significant increases in the plasma levels of the tricyclic antidepressants.\\nDrug 1: cimetidine\\nDrug 2: tricyclic antidepressants\\nInteraction: mechanism\\n\\nSentence: Concurrent administration of cimetidine and tricyclic antidepressants can produce clinically significant increases in the plasma levels of the tricyclic antidepressants.\\nDrug 1: cimetidine\\nDrug 2: tricyclic antidepressants\\nInteraction: none\\n\\nSentence: Concurrent administration of cimetidine and tricyclic antidepressants can produce clinically significant increases in the plasma levels of the tricyclic antidepressants.\\nDrug 1: tricyclic antidepressants\\nDrug 2: tricyclic antidepressants\\nInteraction: none\\n\\nSentence: Aspirin: In normal volunteers, a small decrease in diflunisal levels was observed when multiple doses of diflunisal and aspirin were administered concomitantly.\\nDrug 1: Aspirin\\nDrug 2: diflunisal\\nInteraction: none\\n\\nSentence: Aspirin: In normal volunteers, a small decrease in diflunisal levels was observed when multiple doses of diflunisal and aspirin were administered concomitantly.\\nDrug 1: Aspirin\\nDrug 2: diflunisal\\nInteraction: none\\n\\nSentence: Concomitant administration of Norpace and quinidine resulted in slight increases in plasma disopyramide levels and slight decreases in plasma quinidine levels.\\nDrug1: Norpace\\nDrug2: quinidine\\nInteraction:,  effect other mechanism none advice )  \n",
       "1337                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     ({'id': 'cmpl-4IU97EaM8RxtCedc0syOs1DwFspOH', 'object': 'text_completion', 'created': 1640311133, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      2166\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.38207775\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" mechanism\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" mechanism\": -0.38207775\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" mechanism\"\n",
       "}]}, Sentence: Midazolam: Aprepitant increased the AUC of midazolam, a sensitive CYP3A4 substrate, by 2.3-fold on Day 1 and 3.3-fold on Day 5, when a single oral dose of midazolam 2 mg was coadministered on Day 1 and Day 5 of a regimen of Aprepitant 125 mg on Day 1 and 80 mg/day on Days 2 through 5.\\nDrug 1: Midazolam\\nDrug 2: Aprepitant\\nInteraction: none\\n\\nSentence: Midazolam: Aprepitant increased the AUC of midazolam, a sensitive CYP3A4 substrate, by 2.3-fold on Day 1 and 3.3-fold on Day 5, when a single oral dose of midazolam 2 mg was coadministered on Day 1 and Day 5 of a regimen of Aprepitant 125 mg on Day 1 and 80 mg/day on Days 2 through 5.\\nDrug 1: Midazolam\\nDrug 2: midazolam\\nInteraction: none\\n\\nSentence: Midazolam: Aprepitant increased the AUC of midazolam, a sensitive CYP3A4 substrate, by 2.3-fold on Day 1 and 3.3-fold on Day 5, when a single oral dose of midazolam 2 mg was coadministered on Day 1 and Day 5 of a regimen of Aprepitant 125 mg on Day 1 and 80 mg/day on Days 2 through 5.\\nDrug 1: Midazolam\\nDrug 2: midazolam\\nInteraction: none\\n\\nSentence: Midazolam: Aprepitant increased the AUC of midazolam, a sensitive CYP3A4 substrate, by 2.3-fold on Day 1 and 3.3-fold on Day 5, when a single oral dose of midazolam 2 mg was coadministered on Day 1 and Day 5 of a regimen of Aprepitant 125 mg on Day 1 and 80 mg/day on Days 2 through 5.\\nDrug 1: Midazolam\\nDrug 2: Aprepitant\\nInteraction: none\\n\\nSentence: Midazolam: Aprepitant increased the AUC of midazolam, a sensitive CYP3A4 substrate, by 2.3-fold on Day 1 and 3.3-fold on Day 5, when a single oral dose of midazolam 2 mg was coadministered on Day 1 and Day 5 of a regimen of Aprepitant 125 mg on Day 1 and 80 mg/day on Days 2 through 5.\\nDrug 1: Aprepitant\\nDrug 2: midazolam\\nInteraction: mechanism\\n\\nSentence: Tolbutamide: Aprepitant, when given as 125 mg on Day 1 and 80 mg/day on Days 2 and 3, decreased the AUC of tolbutamide (a CYP2C9 substrate) by 23% on Day 4, 28% on Day 8, and 15% on Day 15, when a single dose of tolbutamide 500 mg was admini,stered orally prior to the administration of the 3-day regimen of Aprepitant and on Days 4,8, and 15.\\nDrug1: tolbutamide\\nDrug2: Aprepitant\\nInteraction:,  effect other mechanism none advice )  \n",
       "923                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    ({'id': 'cmpl-4IU97Zckx8zCpplAn1dtPrJQFpkZ5', 'object': 'text_completion', 'created': 1640311133, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      2309\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.016930854\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" none\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" none\": -0.016930854\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" none\"\n",
       "}]}, Sentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: platelet inhibitors\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: acetylsalicylic acid\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: NSAIDs\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: ketorolac tromethamine\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: dipyridamole\\nInteraction: none\\n\\nSentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug1: perchlorate\\nDrug2: iodine-containing compounds\\nInteraction:,  effect other mechanism none advice )  \n",
       "667                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                ({'id': 'cmpl-4IU98qfuRfakuOkwgX00eq8UNh0J5', 'object': 'text_completion', 'created': 1640311134, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      2311\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.0077649434\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" none\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" none\": -0.0077649434\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" none\"\n",
       "}]}, Sentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: phenytoin\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: glyburide\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: ranitidine\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: omeprazole\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: estrogens\\nInteraction: none\\n\\nSentence: Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.\\nDrug1: clofibrate\\nDrug2: 5-fluorouracil\\nInteraction:,  effect other mechanism none advice )  \n",
       "625                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   ({'id': 'cmpl-4IU98zNfhWZpI0MvZ3EuT6IYpEVa5', 'object': 'text_completion', 'created': 1640311134, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      2310\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.009621164\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" none\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" none\": -0.009621164\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" none\"\n",
       "}]}, Sentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: phenytoin\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: glyburide\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: ranitidine\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: omeprazole\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: estrogens\\nInteraction: none\\n\\nSentence: Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.\\nDrug1: androgens\\nDrug2: 5-fluorouracil\\nInteraction:,  effect other mechanism none advice )  \n",
       "907                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           ({'id': 'cmpl-4IU99kPBLDyKN1UOFeNNypq2zma6t', 'object': 'text_completion', 'created': 1640311135, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      2302\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.006533926\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" none\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" none\": -0.006533926\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" none\"\n",
       "}]}, Sentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: platelet inhibitors\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: acetylsalicylic acid\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: NSAIDs\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: ketorolac tromethamine\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: dipyridamole\\nInteraction: none\\n\\nSentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug1: thiocyanate\\nDrug2: somatostatin analogs\\nInteraction:,  effect other mechanism none advice )  \n",
       "455                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        ({'id': 'cmpl-4IU99dF53nQQiwGDPcvAQAQzGWwRW', 'object': 'text_completion', 'created': 1640311135, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      1615\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.0058703576\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" none\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" none\": -0.0058703576\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" none\"\n",
       "}]}, Sentence: Potassium-sparing diuretics (e.g., spironolactone, triamterene, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.\\nDrug 1: Potassium-sparing diuretics\\nDrug 2: spironolactone\\nInteraction: none\\n\\nSentence: Potassium-sparing diuretics (e.g., spironolactone, triamterene, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.\\nDrug 1: Potassium-sparing diuretics\\nDrug 2: triamterene\\nInteraction: none\\n\\nSentence: Potassium-sparing diuretics (e.g., spironolactone, triamterene, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.\\nDrug 1: Potassium-sparing diuretics\\nDrug 2: amiloride\\nInteraction: none\\n\\nSentence: Potassium-sparing diuretics (e.g., spironolactone, triamterene, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.\\nDrug 1: Potassium-sparing diuretics\\nDrug 2: potassium\\nInteraction: none\\n\\nSentence: Potassium-sparing diuretics (e.g., spironolactone, triamterene, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium.\\nDrug 1: Potassium-sparing diuretics\\nDrug 2: potassium\\nInteraction: none\\n\\nSentence: Potassium-sparing diuretics (spironolactone, amiloride, triamterene, and others) or potassium supplements can increase the risk of hyperkalemia.\\nDrug1: spironolactone\\nDrug2: triamterene\\nInteraction:,  effect other mechanism none advice )  \n",
       "416                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                ({'id': 'cmpl-4IU99he0VU11QodZAUW8DiCY9o7NV', 'object': 'text_completion', 'created': 1640311135, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      1477\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.21885142\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" effect\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" effect\": -0.21885142\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" effect\"\n",
       "}]}, Sentence: Effect of Other Drugs on the Pharmacokinetics of Clonazepam: Literature reports suggest that ranitidine, an agent that decreases stomach acidity, does not greatly alter clonazepam pharmacokinetics.\\nDrug 1: Clonazepam\\nDrug 2: ranitidine\\nInteraction: none\\n\\nSentence: Effect of Other Drugs on the Pharmacokinetics of Clonazepam: Literature reports suggest that ranitidine, an agent that decreases stomach acidity, does not greatly alter clonazepam pharmacokinetics.\\nDrug 1: Clonazepam\\nDrug 2: clonazepam\\nInteraction: none\\n\\nSentence: Effect of Other Drugs on the Pharmacokinetics of Clonazepam: Literature reports suggest that ranitidine, an agent that decreases stomach acidity, does not greatly alter clonazepam pharmacokinetics.\\nDrug 1: ranitidine\\nDrug 2: clonazepam\\nInteraction: none\\n\\nSentence: It has been reported that results of studies in animals indicate that dopamine-induced ventricular arrhythmias during anesthesia can be reversed by propranolol.\\nDrug 1: dopamine\\nDrug 2: propranolol\\nInteraction: effect\\n\\nSentence: Inhibitors Of Endogenous Prostaglandin Synthesis It has been reported that indomethacin may reduce the antihypertensive effect of captopril, especially in cases of low renin hypertension.\\nDrug 1: indomethacin\\nDrug 2: captopril\\nInteraction: effect\\n\\nSentence: MAO Inhibitors: Studies in animals demonstrate that the acute toxicity of bupropion is enhanced by the MAO inhibitor phenelzine .\\nDrug1: MAO Inhibitors\\nDrug2: MAO inhibitor\\nInteraction:,  effect other mechanism none advice )  \n",
       "834                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         ({'id': 'cmpl-4IU9AXHttEIhxyCl0VaDbSoqUXfEY', 'object': 'text_completion', 'created': 1640311136, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      2288\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.014599491\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" none\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" none\": -0.014599491\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" none\"\n",
       "}]}, Sentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: platelet inhibitors\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: acetylsalicylic acid\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: NSAIDs\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: ketorolac tromethamine\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: dipyridamole\\nInteraction: none\\n\\nSentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug1: amiodarone\\nDrug2: heparin\\nInteraction:,  effect other mechanism none advice )  \n",
       "727                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  ({'id': 'cmpl-4IU9ADaMxwnvo7rXTTymAWUE4RPzN', 'object': 'text_completion', 'created': 1640311136, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      2311\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.009043714\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" none\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" none\": -0.009043714\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" none\"\n",
       "}]}, Sentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: phenytoin\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: glyburide\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: ranitidine\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: omeprazole\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: estrogens\\nInteraction: none\\n\\nSentence: Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.\\nDrug1: glucocorticoids\\nDrug2: tamoxifen\\nInteraction:,  effect other mechanism none advice )  \n",
       "734                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                ({'id': 'cmpl-4IU9A6R9U2rtrsdNzYBwHSjD2jD9a', 'object': 'text_completion', 'created': 1640311136, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      2313\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.010498385\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" none\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" none\": -0.010498385\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" none\"\n",
       "}]}, Sentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: phenytoin\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: glyburide\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: ranitidine\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: omeprazole\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: estrogens\\nInteraction: none\\n\\nSentence: Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.\\nDrug1: meclofenamic acid\\nDrug2: tamoxifen\\nInteraction:,  effect other mechanism none advice )  \n",
       "607                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 ({'id': 'cmpl-4IU9BGNEyARjAezyBtdi8zBkj7qKl', 'object': 'text_completion', 'created': 1640311137, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      1388\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.5496055\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" none\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" none\": -0.5496055\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" none\"\n",
       "}]}, Sentence: Substances that are potent inhibitors of CYP3A4 activity (eg, ketoconazole and itraconazole) decrease gefitinib metabolism and increase gefitinib plasma concentrations.\\nDrug 1: ketoconazole\\nDrug 2: itraconazole\\nInteraction: none\\n\\nSentence: Substances that are potent inhibitors of CYP3A4 activity (eg, ketoconazole and itraconazole) decrease gefitinib metabolism and increase gefitinib plasma concentrations.\\nDrug 1: ketoconazole\\nDrug 2: gefitinib\\nInteraction: mechanism\\n\\nSentence: Substances that are potent inhibitors of CYP3A4 activity (eg, ketoconazole and itraconazole) decrease gefitinib metabolism and increase gefitinib plasma concentrations.\\nDrug 1: ketoconazole\\nDrug 2: gefitinib\\nInteraction: mechanism\\n\\nSentence: Substances that are potent inhibitors of CYP3A4 activity (eg, ketoconazole and itraconazole) decrease gefitinib metabolism and increase gefitinib plasma concentrations.\\nDrug 1: itraconazole\\nDrug 2: gefitinib\\nInteraction: mechanism\\n\\nSentence: Substances that are potent inhibitors of CYP3A4 activity (eg, ketoconazole and itraconazole) decrease gefitinib metabolism and increase gefitinib plasma concentrations.\\nDrug 1: itraconazole\\nDrug 2: gefitinib\\nInteraction: mechanism\\n\\nSentence: Fluconazole and Ketoconazole: Ketoconazole and fluconazole are predominantly CYP 3A4 and 2C9 inhibitors, respectively.\\nDrug1: Fluconazole\\nDrug2: Ketoconazole\\nInteraction:,  effect other mechanism none advice )  \n",
       "763                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             ({'id': 'cmpl-4IU9Bw4Hw5B3lgovBcHGqF82Q5JzJ', 'object': 'text_completion', 'created': 1640311137, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      2316\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.009735515\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" none\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" none\": -0.009735515\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" none\"\n",
       "}]}, Sentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: platelet inhibitors\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: acetylsalicylic acid\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: NSAIDs\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: ketorolac tromethamine\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: dipyridamole\\nInteraction: none\\n\\nSentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug1: aminoglutethimide\\nDrug2: b-adrenergic blocking agents\\nInteraction:,  effect other mechanism none advice )  \n",
       "780                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            ({'id': 'cmpl-4IU9BdsGngWSIW1avM7L9u7ExhCkA', 'object': 'text_completion', 'created': 1640311137, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      2301\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.018152107\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" none\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" none\": -0.018152107\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" none\"\n",
       "}]}, Sentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: platelet inhibitors\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: acetylsalicylic acid\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: NSAIDs\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: ketorolac tromethamine\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: dipyridamole\\nInteraction: none\\n\\nSentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug1: aminoglutethimide\\nDrug2: nitroprusside\\nInteraction:,  effect other mechanism none advice )  \n",
       "841                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  ({'id': 'cmpl-4IU9CmOdUVa93JE9cOWlhSgRCoJG6', 'object': 'text_completion', 'created': 1640311138, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      2295\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.010840391\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" none\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" none\": -0.010840391\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" none\"\n",
       "}]}, Sentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: platelet inhibitors\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: acetylsalicylic acid\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: NSAIDs\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: ketorolac tromethamine\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: dipyridamole\\nInteraction: none\\n\\nSentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug1: amiodarone\\nDrug2: metoclopramide\\nInteraction:,  effect other mechanism none advice )  \n",
       "915                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                ({'id': 'cmpl-4IU9ChpUnEgo3jCvVPuZHdpuFbErh', 'object': 'text_completion', 'created': 1640311138, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      2297\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.008588092\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" none\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" none\": -0.008588092\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" none\"\n",
       "}]}, Sentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: platelet inhibitors\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: acetylsalicylic acid\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: NSAIDs\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: ketorolac tromethamine\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: dipyridamole\\nInteraction: none\\n\\nSentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug1: perchlorate\\nDrug2: chloral hydrate\\nInteraction:,  effect other mechanism none advice )  \n",
       "655                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  ({'id': 'cmpl-4IU9DkFX2HXIfVOUUVDit262U5rk8', 'object': 'text_completion', 'created': 1640311139, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      2309\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.0067363116\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" none\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" none\": -0.0067363116\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" none\"\n",
       "}]}, Sentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: phenytoin\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: glyburide\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: ranitidine\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: omeprazole\\nInteraction: none\\n\\nSentence: Other Drugs: In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides) and theophylline did not affect the pharmacokinetics of TIKOSYN.\\nDrug 1: amlodipine\\nDrug 2: estrogens\\nInteraction: none\\n\\nSentence: Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.\\nDrug1: asparaginase\\nDrug2: furosemide\\nInteraction:,  effect other mechanism none advice )  \n",
       "494                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      ({'id': 'cmpl-4IU9Dl953O2IbXYfvA3hWcI0EnrHq', 'object': 'text_completion', 'created': 1640311139, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      2319\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.04596935\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" advice\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" advice\": -0.04596935\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" advice\"\n",
       "}]}, Sentence: Therefore, co-administration of clozapine with other drugs that are metabolized by this isozyme, including antidepressants, phenothiazines, carbamazepine, and Type 1C antiarrhythmics (e.g., propafenone, flecainide and encainide), or that inhibit this enzyme (e.g., quinidine), should be approached with caution.\\nDrug 1: clozapine\\nDrug 2: antidepressants\\nInteraction: advice\\n\\nSentence: Therefore, co-administration of clozapine with other drugs that are metabolized by this isozyme, including antidepressants, phenothiazines, carbamazepine, and Type 1C antiarrhythmics (e.g., propafenone, flecainide and encainide), or that inhibit this enzyme (e.g., quinidine), should be approached with caution.\\nDrug 1: clozapine\\nDrug 2: phenothiazines\\nInteraction: advice\\n\\nSentence: Therefore, co-administration of clozapine with other drugs that are metabolized by this isozyme, including antidepressants, phenothiazines, carbamazepine, and Type 1C antiarrhythmics (e.g., propafenone, flecainide and encainide), or that inhibit this enzyme (e.g., quinidine), should be approached with caution.\\nDrug 1: clozapine\\nDrug 2: carbamazepine\\nInteraction: advice\\n\\nSentence: Therefore, co-administration of clozapine with other drugs that are metabolized by this isozyme, including antidepressants, phenothiazines, carbamazepine, and Type 1C antiarrhythmics (e.g., propafenone, flecainide and encainide), or that inhibit this enzyme (e.g., quinidine), should be approached with caution.\\nDrug 1: clozapine\\nDrug 2: Type 1C antiarrhythmics\\nInteraction: advice\\n\\nSentence: Therefore, co-administration of clozapine with other drugs that are metabolized by this isozyme, including antidepressants, phenothiazines, carbamazepine, and Type 1C antiarrhythmics (e.g., propafenone, flecainide and encainide), or that inhibit this enzyme (e.g., quinidine), should be approached with caution.\\nDrug 1: clozapine\\nDrug 2: propafenone\\nInteraction: advice\\n\\nSentence: Therefore, co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme, including other antidepressants, phenothiazines, carbamazepine, and Type 1C antiarrhythmics (eg, propafenone, flecainide, and encainide), or that inhibit this enzyme (eg, quinidine), should be approached with caution.\\nDrug1: carbamazepine\\nDrug2: encainide\\nInteraction:,  effect other mechanism none advice )  \n",
       "426                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            ({'id': 'cmpl-4IU9DYBwrOHQAo9fi2YoYYdlgKRbj', 'object': 'text_completion', 'created': 1640311139, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      1217\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.1201114\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" none\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" none\": -0.1201114\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" none\"\n",
       "}]}, Sentence: Accordingly, careful patient monitoring and dose adjustment of metformin is recommended in patients concomitantly taking cephalexin and metformin.\\nDrug 1: metformin\\nDrug 2: cephalexin\\nInteraction: none\\n\\nSentence: Accordingly, careful patient monitoring and dose adjustment of metformin is recommended in patients concomitantly taking cephalexin and metformin.\\nDrug 1: metformin\\nDrug 2: metformin\\nInteraction: none\\n\\nSentence: Accordingly, careful patient monitoring and dose adjustment of metformin is recommended in patients concomitantly taking cephalexin and metformin.\\nDrug 1: cephalexin\\nDrug 2: metformin\\nInteraction: advice\\n\\nSentence: In order to avoid lithium intoxication, lithium plasma levels should be monitored closely.\\nDrug 1: lithium\\nDrug 2: lithium\\nInteraction: none\\n\\nSentence: Therefore, cyclosporine serum levels should be monitored and appropriate cyclosporine dosage adjustments made when these drugs are used concomitantly.\\nDrug 1: cyclosporine\\nDrug 2: cyclosporine\\nInteraction: none\\n\\nSentence: Nevertheless, plasma lithium levels should be monitored with appropriate adjustment to the lithium dose in accordance with standard clinical practice.\\nDrug1: lithium\\nDrug2: lithium\\nInteraction:,  effect other mechanism none advice )  \n",
       "977                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 ({'id': 'cmpl-4IU9EwSY1AiunNfQMutmQtffU1og3', 'object': 'text_completion', 'created': 1640311140, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      2296\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.017196171\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" none\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" none\": -0.017196171\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" none\"\n",
       "}]}, Sentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: platelet inhibitors\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: acetylsalicylic acid\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: NSAIDs\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: ketorolac tromethamine\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: dipyridamole\\nInteraction: none\\n\\nSentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug1: antithyroid drugs\\nDrug2: levodopa\\nInteraction:,  effect other mechanism none advice )  \n",
       "896                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       ({'id': 'cmpl-4IU9EiF24Ml657eCSWyrgBNwTg54e', 'object': 'text_completion', 'created': 1640311140, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      2290\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.012775228\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" none\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" none\": -0.012775228\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" none\"\n",
       "}]}, Sentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: platelet inhibitors\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: acetylsalicylic acid\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: NSAIDs\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: ketorolac tromethamine\\nInteraction: none\\n\\nSentence: These agents include medications such as: anticoagulants, platelet inhibitors including acetylsalicylic acid, sali-cylates, NSAIDs (including ketorolac tromethamine), dipyridamole, or sulfinpyrazone.\\nDrug 1: anticoagulants\\nDrug 2: dipyridamole\\nInteraction: none\\n\\nSentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nDrug1: thiocyanate\\nDrug2: levodopa\\nInteraction:,  effect other mechanism none advice )  \n",
       "1591                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              ({'id': 'cmpl-4IU9Ece9q4A4f37TAnysWAPGtwMxm', 'object': 'text_completion', 'created': 1640311140, 'model': 'davinci:2020-05-03', 'choices': [{\n",
       "  \"finish_reason\": \"length\",\n",
       "  \"index\": 0,\n",
       "  \"logprobs\": {\n",
       "    \"text_offset\": [\n",
       "      2382\n",
       "    ],\n",
       "    \"token_logprobs\": [\n",
       "      -0.4127358\n",
       "    ],\n",
       "    \"tokens\": [\n",
       "      \" none\"\n",
       "    ],\n",
       "    \"top_logprobs\": [\n",
       "      {\n",
       "        \" none\": -0.4127358\n",
       "      }\n",
       "    ]\n",
       "  },\n",
       "  \"text\": \" none\"\n",
       "}]}, Sentence: If desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/hypnotics, careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines (e.g., chlordiazepoxide or diazepam) are additive.\\nDrug 1: desipramine hydrochloride\\nDrug 2: psychotropic agents\\nInteraction: effect\\n\\nSentence: If desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/hypnotics, careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines (e.g., chlordiazepoxide or diazepam) are additive.\\nDrug 1: desipramine hydrochloride\\nDrug 2: tranquilizers\\nInteraction: effect\\n\\nSentence: If desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/hypnotics, careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines (e.g., chlordiazepoxide or diazepam) are additive.\\nDrug 1: desipramine hydrochloride\\nDrug 2: sedative\\nInteraction: effect\\n\\nSentence: If desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/hypnotics, careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines (e.g., chlordiazepoxide or diazepam) are additive.\\nDrug 1: desipramine hydrochloride\\nDrug 2: hypnotics\\nInteraction: effect\\n\\nSentence: If desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/hypnotics, careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines (e.g., chlordiazepoxide or diazepam) are additive.\\nDrug 1: desipramine hydrochloride\\nDrug 2: desipramine\\nInteraction: none\\n\\nSentence: Since Zarontin (ethosuximide) may interact with concurrently administered antiepileptic drugs, periodic serum level determinations of these drugs may be necessary (eg, ethosuximide may elevate phenytoin serum levels and valproic acid has been reported to both increase and decrease ethosuximide levels).\\nDrug1: Zarontin\\nDrug2: antiepileptic drugs\\nInteraction:,  effect other mechanism none advice )  "
      ]
     },
     "execution_count": 32,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 300,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(dict_items([('Recommendation', 0), ('No Interaction', 1), ('Metabolic Mechanism ', 2), ('Effect Alteration', 3), ('Unspecified', 4)]),\n",
       " dict_values([0, 1, 2, 3, 4]))"
      ]
     },
     "execution_count": 300,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "unique_label_dict.items(), unique_label_dict.values()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 301,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>index</th>\n",
       "      <th>sentence</th>\n",
       "      <th>label</th>\n",
       "      <th>doc</th>\n",
       "      <th>split</th>\n",
       "      <th>entity1</th>\n",
       "      <th>entity2</th>\n",
       "      <th>prompts</th>\n",
       "      <th>empty_prompts</th>\n",
       "      <th>labels</th>\n",
       "      <th>unique_labels</th>\n",
       "      <th>test_ready_prompt</th>\n",
       "      <th>gpt3_output_ddi_test_prompts_random_33.5.50.perm_4.natural</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ddi_test_prompts_random_33.5.50.perm_4.natural</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>No Interaction</th>\n",
       "      <td>44</td>\n",
       "      <td>44</td>\n",
       "      <td>44</td>\n",
       "      <td>44</td>\n",
       "      <td>44</td>\n",
       "      <td>44</td>\n",
       "      <td>44</td>\n",
       "      <td>44</td>\n",
       "      <td>44</td>\n",
       "      <td>44</td>\n",
       "      <td>44</td>\n",
       "      <td>44</td>\n",
       "      <td>44</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Recommendation</th>\n",
       "      <td>4</td>\n",
       "      <td>4</td>\n",
       "      <td>4</td>\n",
       "      <td>4</td>\n",
       "      <td>4</td>\n",
       "      <td>4</td>\n",
       "      <td>4</td>\n",
       "      <td>4</td>\n",
       "      <td>4</td>\n",
       "      <td>4</td>\n",
       "      <td>4</td>\n",
       "      <td>4</td>\n",
       "      <td>4</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                index  sentence  label  doc  \\\n",
       "ddi_test_prompts_random_33.5.50.perm_4.natural                                \n",
       "No Interaction                                     44        44     44   44   \n",
       "Recommendation                                      4         4      4    4   \n",
       "\n",
       "                                                split  entity1  entity2  \\\n",
       "ddi_test_prompts_random_33.5.50.perm_4.natural                            \n",
       "No Interaction                                     44       44       44   \n",
       "Recommendation                                      4        4        4   \n",
       "\n",
       "                                                prompts  empty_prompts  \\\n",
       "ddi_test_prompts_random_33.5.50.perm_4.natural                           \n",
       "No Interaction                                       44             44   \n",
       "Recommendation                                        4              4   \n",
       "\n",
       "                                                labels  unique_labels  \\\n",
       "ddi_test_prompts_random_33.5.50.perm_4.natural                          \n",
       "No Interaction                                      44             44   \n",
       "Recommendation                                       4              4   \n",
       "\n",
       "                                                test_ready_prompt  \\\n",
       "ddi_test_prompts_random_33.5.50.perm_4.natural                      \n",
       "No Interaction                                                 44   \n",
       "Recommendation                                                  4   \n",
       "\n",
       "                                                gpt3_output_ddi_test_prompts_random_33.5.50.perm_4.natural  \n",
       "ddi_test_prompts_random_33.5.50.perm_4.natural                                                              \n",
       "No Interaction                                                                                          44  \n",
       "Recommendation                                                                                           4  "
      ]
     },
     "execution_count": 301,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.groupby(filename_root).count()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 148,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>index</th>\n",
       "      <th>sentence</th>\n",
       "      <th>label</th>\n",
       "      <th>doc</th>\n",
       "      <th>split</th>\n",
       "      <th>entity1</th>\n",
       "      <th>entity2</th>\n",
       "      <th>prompts</th>\n",
       "      <th>empty_prompts</th>\n",
       "      <th>unique_labels</th>\n",
       "      <th>test_ready_prompt</th>\n",
       "      <th>ddi_test_prompts_random_21.5.50.perm_4.natural</th>\n",
       "      <th>gpt3_output_ddi_test_prompts_random_21.5.50.perm_4.natural</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>labels</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>Effect Alteration</th>\n",
       "      <td>12</td>\n",
       "      <td>12</td>\n",
       "      <td>12</td>\n",
       "      <td>12</td>\n",
       "      <td>12</td>\n",
       "      <td>12</td>\n",
       "      <td>12</td>\n",
       "      <td>12</td>\n",
       "      <td>12</td>\n",
       "      <td>12</td>\n",
       "      <td>12</td>\n",
       "      <td>12</td>\n",
       "      <td>12</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Metabolic Mechanism</th>\n",
       "      <td>11</td>\n",
       "      <td>11</td>\n",
       "      <td>11</td>\n",
       "      <td>11</td>\n",
       "      <td>11</td>\n",
       "      <td>11</td>\n",
       "      <td>11</td>\n",
       "      <td>11</td>\n",
       "      <td>11</td>\n",
       "      <td>11</td>\n",
       "      <td>11</td>\n",
       "      <td>11</td>\n",
       "      <td>11</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>No Interaction</th>\n",
       "      <td>19</td>\n",
       "      <td>19</td>\n",
       "      <td>19</td>\n",
       "      <td>19</td>\n",
       "      <td>19</td>\n",
       "      <td>19</td>\n",
       "      <td>19</td>\n",
       "      <td>19</td>\n",
       "      <td>19</td>\n",
       "      <td>19</td>\n",
       "      <td>19</td>\n",
       "      <td>19</td>\n",
       "      <td>19</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Recommendation</th>\n",
       "      <td>5</td>\n",
       "      <td>5</td>\n",
       "      <td>5</td>\n",
       "      <td>5</td>\n",
       "      <td>5</td>\n",
       "      <td>5</td>\n",
       "      <td>5</td>\n",
       "      <td>5</td>\n",
       "      <td>5</td>\n",
       "      <td>5</td>\n",
       "      <td>5</td>\n",
       "      <td>5</td>\n",
       "      <td>5</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Unspecified</th>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                      index  sentence  label  doc  split  entity1  entity2  \\\n",
       "labels                                                                       \n",
       "Effect Alteration        12        12     12   12     12       12       12   \n",
       "Metabolic Mechanism      11        11     11   11     11       11       11   \n",
       "No Interaction           19        19     19   19     19       19       19   \n",
       "Recommendation            5         5      5    5      5        5        5   \n",
       "Unspecified               1         1      1    1      1        1        1   \n",
       "\n",
       "                      prompts  empty_prompts  unique_labels  \\\n",
       "labels                                                        \n",
       "Effect Alteration          12             12             12   \n",
       "Metabolic Mechanism        11             11             11   \n",
       "No Interaction             19             19             19   \n",
       "Recommendation              5              5              5   \n",
       "Unspecified                 1              1              1   \n",
       "\n",
       "                      test_ready_prompt  \\\n",
       "labels                                    \n",
       "Effect Alteration                    12   \n",
       "Metabolic Mechanism                  11   \n",
       "No Interaction                       19   \n",
       "Recommendation                        5   \n",
       "Unspecified                           1   \n",
       "\n",
       "                      ddi_test_prompts_random_21.5.50.perm_4.natural  \\\n",
       "labels                                                                 \n",
       "Effect Alteration                                                 12   \n",
       "Metabolic Mechanism                                               11   \n",
       "No Interaction                                                    19   \n",
       "Recommendation                                                     5   \n",
       "Unspecified                                                        1   \n",
       "\n",
       "                      gpt3_output_ddi_test_prompts_random_21.5.50.perm_4.natural  \n",
       "labels                                                                            \n",
       "Effect Alteration                                                             12  \n",
       "Metabolic Mechanism                                                           11  \n",
       "No Interaction                                                                19  \n",
       "Recommendation                                                                 5  \n",
       "Unspecified                                                                    1  "
      ]
     },
     "execution_count": 148,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.groupby('labels').count()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 133,
   "metadata": {},
   "outputs": [],
   "source": [
    "mea_df = df[['sentence',filename_root,'labels','test_ready_prompt']]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 134,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>sentence</th>\n",
       "      <th>ddi_test_prompts_random_33.5.50.perm_4.natural</th>\n",
       "      <th>labels</th>\n",
       "      <th>test_ready_prompt</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>4386</th>\n",
       "      <td>The concomitant use of H2 blockers or proton pump inhibitors with SPRYCEL is not recommended.</td>\n",
       "      <td>Recommendation</td>\n",
       "      <td>Recommendation</td>\n",
       "      <td>Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: The concomitant use of H2 blockers or proton pump inhibitors with SPRYCEL is not recommended.\\nHow do  drugs proton pump inhibitors and SPRYCEL interact based on the previous sentence?\\nInteraction:</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17780</th>\n",
       "      <td>MAO inhibitors should be used with caution in patients receiving hydralazine.</td>\n",
       "      <td>No Interaction</td>\n",
       "      <td>Recommendation</td>\n",
       "      <td>Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: MAO inhibitors should be used with caution in patients receiving hydralazine.\\nHow do  drugs MAO inhibitors and hydralazine interact based on the previous sentence?\\nInteraction:</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9530</th>\n",
       "      <td>Cyclosporine, tacrolimus and digoxin concentrations should be monitored at the initiation of Itraconazole therapy and frequently thereafter, and the dose of these three drug products adjusted appropriately.</td>\n",
       "      <td>Recommendation</td>\n",
       "      <td>Recommendation</td>\n",
       "      <td>Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Cyclosporine, tacrolimus and digoxin concentrations should be monitored at the initiation of Itraconazole therapy and frequently thereafter, and the dose of these three drug products adjusted appropriately.\\nHow do  drugs Cyclosporine and Itraconazole interact based on the previous sentence?\\nInteraction:</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19325</th>\n",
       "      <td>There is insufficient experience to assess the safety and efficacy of ORENCIA administered concurrently with anakinra, and therefore such use is not recommended.</td>\n",
       "      <td>No Interaction</td>\n",
       "      <td>Recommendation</td>\n",
       "      <td>Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: There is insufficient experience to assess the safety and efficacy of ORENCIA administered concurrently with anakinra, and therefore such use is not recommended.\\nHow do  drugs ORENCIA and anakinra interact based on the previous sentence?\\nInteraction:</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14414</th>\n",
       "      <td>Coadministration of alosetron and strong CYP3A4 inhibitors, such as clarithromycin, telithromycin, protease inhibitors, voriconazole, and itraconazole has not been evaluated but should be undertaken with caution because of similar potential drug interactions.</td>\n",
       "      <td>No Interaction</td>\n",
       "      <td>Recommendation</td>\n",
       "      <td>Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Coadministration of alosetron and strong CYP3A4 inhibitors, such as clarithromycin, telithromycin, protease inhibitors, voriconazole, and itraconazole has not been evaluated but should be undertaken with caution because of similar potential drug interactions.\\nHow do  drugs alosetron and telithromycin interact based on the previous sentence?\\nInteraction:</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>930</th>\n",
       "      <td>Concurrent use of butorphanol with central nervous system depressants (e.g., alcohol, barbiturates, tranquilizers, and antihistamines) may result in increased central nervous system depressant effects.</td>\n",
       "      <td>No Interaction</td>\n",
       "      <td>Effect Alteration</td>\n",
       "      <td>Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Concurrent use of butorphanol with central nervous system depressants (e.g., alcohol, barbiturates, tranquilizers, and antihistamines) may result in increased central nervous system depressant effects.\\nHow do  drugs butorphanol and antihistamines interact based on the previous sentence?\\nInteraction:</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19162</th>\n",
       "      <td>When atropine and pralidoxime are used together, the signs of atropinization (flushing, mydriasis, tachycardia, dryness of the mouth and nose) may occur earlier than might be expected than when atropine is used alone because pralidoxime may potentiate the effect of atropine.</td>\n",
       "      <td>No Interaction</td>\n",
       "      <td>Effect Alteration</td>\n",
       "      <td>Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: When atropine and pralidoxime are used together, the signs of atropinization (flushing, mydriasis, tachycardia, dryness of the mouth and nose) may occur earlier than might be expected than when atropine is used alone because pralidoxime may potentiate the effect of atropine.\\nHow do  drugs atropine and pralidoxime interact based on the previous sentence?\\nInteraction:</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10039</th>\n",
       "      <td>Lithium: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ACE inhibitors during therapy with lithium.</td>\n",
       "      <td>Recommendation</td>\n",
       "      <td>Effect Alteration</td>\n",
       "      <td>Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Lithium: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ACE inhibitors during therapy with lithium.\\nHow do  drugs ACE inhibitors and lithium interact based on the previous sentence?\\nInteraction:</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12858</th>\n",
       "      <td>The actions of the benzodiazepines may be potentiated by barbiturates, narcotics, phenothiazines, monoamine oxidase inhibitors or other antidepressants.</td>\n",
       "      <td>No Interaction</td>\n",
       "      <td>Effect Alteration</td>\n",
       "      <td>Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: The actions of the benzodiazepines may be potentiated by barbiturates, narcotics, phenothiazines, monoamine oxidase inhibitors or other antidepressants.\\nHow do  drugs benzodiazepines and antidepressants interact based on the previous sentence?\\nInteraction:</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21838</th>\n",
       "      <td>In an analysis of the supraventricular arrhythmia and DIAMOND patient populations, the concomitant administration of verapamil with dofetilide was associated with a higher occurrence of torsade de pointes.</td>\n",
       "      <td>Recommendation</td>\n",
       "      <td>Effect Alteration</td>\n",
       "      <td>Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: In an analysis of the supraventricular arrhythmia and DIAMOND patient populations, the concomitant administration of verapamil with dofetilide was associated with a higher occurrence of torsade de pointes.\\nHow do  drugs verapamil and dofetilide interact based on the previous sentence?\\nInteraction:</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17981</th>\n",
       "      <td>Patients receiving other narcotic analgesics, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with hydrocodone and acetaminophen tablets may exhibit an additive CNS depression.</td>\n",
       "      <td>No Interaction</td>\n",
       "      <td>Effect Alteration</td>\n",
       "      <td>Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Patients receiving other narcotic analgesics, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with hydrocodone and acetaminophen tablets may exhibit an additive CNS depression.\\nHow do  drugs alcohol and hydrocodone interact based on the previous sentence?\\nInteraction:</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2563</th>\n",
       "      <td>Concomitant administration of diflunisal and acetaminophen in dogs, but not in rats, at approximately 2 times the recommended maximum human therapeutic dose of each (40 to 52 mg/kg/day of diflunisal/acetaminophen) resulted in greater gastrointestinal toxicity than when either drug was administered alone.</td>\n",
       "      <td>No Interaction</td>\n",
       "      <td>Effect Alteration</td>\n",
       "      <td>Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Concomitant administration of diflunisal and acetaminophen in dogs, but not in rats, at approximately 2 times the recommended maximum human therapeutic dose of each (40 to 52 mg/kg/day of diflunisal/acetaminophen) resulted in greater gastrointestinal toxicity than when either drug was administered alone.\\nHow do  drugs diflunisal and acetaminophen interact based on the previous sentence?\\nInteraction:</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>643</th>\n",
       "      <td>Several tricyclic antidepressants have been reported to block the pharmacologic effects of guanethidine, clonidine, or similar agents, and such an effect may be anticipated with CMI because of its structural similarity to other tricyclic antidepressants.</td>\n",
       "      <td>No Interaction</td>\n",
       "      <td>Effect Alteration</td>\n",
       "      <td>Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Several tricyclic antidepressants have been reported to block the pharmacologic effects of guanethidine, clonidine, or similar agents, and such an effect may be anticipated with CMI because of its structural similarity to other tricyclic antidepressants.\\nHow do  drugs tricyclic antidepressants and guanethidine interact based on the previous sentence?\\nInteraction:</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3227</th>\n",
       "      <td>The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension.</td>\n",
       "      <td>No Interaction</td>\n",
       "      <td>Effect Alteration</td>\n",
       "      <td>Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension.\\nHow do  drugs norepinephrine and monoamine oxidase inhibitors interact based on the previous sentence?\\nInteraction:</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12582</th>\n",
       "      <td>Anticoagulants: Combination hormonal contraceptives may increase or decrease the effects of coumarin derivatives.</td>\n",
       "      <td>No Interaction</td>\n",
       "      <td>Effect Alteration</td>\n",
       "      <td>Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Anticoagulants: Combination hormonal contraceptives may increase or decrease the effects of coumarin derivatives.\\nHow do  drugs hormonal contraceptives and coumarin derivatives interact based on the previous sentence?\\nInteraction:</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8035</th>\n",
       "      <td>Ergotamine: Concurrent use of erythromycin and ergotamine or dihydroergotamine has been associated in some patients with acute ergot toxicity characterized by severe peripheral vasospasm and dysesthesia.</td>\n",
       "      <td>No Interaction</td>\n",
       "      <td>Effect Alteration</td>\n",
       "      <td>Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Ergotamine: Concurrent use of erythromycin and ergotamine or dihydroergotamine has been associated in some patients with acute ergot toxicity characterized by severe peripheral vasospasm and dysesthesia.\\nHow do  drugs erythromycin and ergotamine interact based on the previous sentence?\\nInteraction:</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>929</th>\n",
       "      <td>Concurrent use of butorphanol with central nervous system depressants (e.g., alcohol, barbiturates, tranquilizers, and antihistamines) may result in increased central nervous system depressant effects.</td>\n",
       "      <td>No Interaction</td>\n",
       "      <td>Effect Alteration</td>\n",
       "      <td>Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Concurrent use of butorphanol with central nervous system depressants (e.g., alcohol, barbiturates, tranquilizers, and antihistamines) may result in increased central nervous system depressant effects.\\nHow do  drugs butorphanol and tranquilizers interact based on the previous sentence?\\nInteraction:</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21139</th>\n",
       "      <td>Chlorpropamide: Chlorpropamides plasma half-life may be prolonged by allopurinol, since allopurinol and chlorpropamide may compete for excretion in the renal tubule.</td>\n",
       "      <td>No Interaction</td>\n",
       "      <td>Metabolic Mechanism</td>\n",
       "      <td>Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Chlorpropamide: Chlorpropamides plasma half-life may be prolonged by allopurinol, since allopurinol and chlorpropamide may compete for excretion in the renal tubule.\\nHow do  drugs allopurinol and chlorpropamide interact based on the previous sentence?\\nInteraction:</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4216</th>\n",
       "      <td>Drugs that induce hepatic enzymes such as phenobarbital, phenytoin and rifampin may increase the clearance of corticosteroids and may require increases in corticosteroid dose to achieve the desired response.</td>\n",
       "      <td>No Interaction</td>\n",
       "      <td>Metabolic Mechanism</td>\n",
       "      <td>Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Drugs that induce hepatic enzymes such as phenobarbital, phenytoin and rifampin may increase the clearance of corticosteroids and may require increases in corticosteroid dose to achieve the desired response.\\nHow do  drugs rifampin and corticosteroids interact based on the previous sentence?\\nInteraction:</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14400</th>\n",
       "      <td>(See CLINICAL PHARMACOLOGY) Coadministration of Femara and tamoxifen 20 mg daily resulted in a reduction of letrozole plasma levels by 38% on average.</td>\n",
       "      <td>No Interaction</td>\n",
       "      <td>Metabolic Mechanism</td>\n",
       "      <td>Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: (See CLINICAL PHARMACOLOGY) Coadministration of Femara and tamoxifen 20 mg daily resulted in a reduction of letrozole plasma levels by 38% on average.\\nHow do  drugs Femara and tamoxifen interact based on the previous sentence?\\nInteraction:</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14502</th>\n",
       "      <td>In vivo studies: Nitrates: The blood pressure lowering effects of sublingual nitrates (0.4 mg) taken 1 and 4 hours after vardenafil and increases in heart rate when taken at 1, 4 and 8 hours were potentiated by a 20 mg dose of Vardenafil in healthy middle-aged subjects.</td>\n",
       "      <td>No Interaction</td>\n",
       "      <td>Metabolic Mechanism</td>\n",
       "      <td>Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: In vivo studies: Nitrates: The blood pressure lowering effects of sublingual nitrates (0.4 mg) taken 1 and 4 hours after vardenafil and increases in heart rate when taken at 1, 4 and 8 hours were potentiated by a 20 mg dose of Vardenafil in healthy middle-aged subjects.\\nHow do  drugs nitrates and vardenafil interact based on the previous sentence?\\nInteraction:</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15384</th>\n",
       "      <td>Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.</td>\n",
       "      <td>No Interaction</td>\n",
       "      <td>Metabolic Mechanism</td>\n",
       "      <td>Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.\\nHow do  drugs EQUETROTM and nortriptyline interact based on the previous sentence?\\nInteraction:</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21031</th>\n",
       "      <td>Co-administration of anastrozole and tamoxifen resulted in a reduction of anastrozole plasma levels by 27% compared with those achieved with anastrozole alone.</td>\n",
       "      <td>No Interaction</td>\n",
       "      <td>Metabolic Mechanism</td>\n",
       "      <td>Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Co-administration of anastrozole and tamoxifen resulted in a reduction of anastrozole plasma levels by 27% compared with those achieved with anastrozole alone.\\nHow do  drugs anastrozole and tamoxifen interact based on the previous sentence?\\nInteraction:</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15373</th>\n",
       "      <td>Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.</td>\n",
       "      <td>No Interaction</td>\n",
       "      <td>Metabolic Mechanism</td>\n",
       "      <td>Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.\\nHow do  drugs EQUETROTM and felbamate interact based on the previous sentence?\\nInteraction:</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15376</th>\n",
       "      <td>Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.</td>\n",
       "      <td>No Interaction</td>\n",
       "      <td>Metabolic Mechanism</td>\n",
       "      <td>Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.\\nHow do  drugs EQUETROTM and haloperidol interact based on the previous sentence?\\nInteraction:</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6252</th>\n",
       "      <td>Phenobarbital: Amphetamines may delay intestinal absorption of phenobarbital;</td>\n",
       "      <td>No Interaction</td>\n",
       "      <td>Metabolic Mechanism</td>\n",
       "      <td>Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Phenobarbital: Amphetamines may delay intestinal absorption of phenobarbital;\\nHow do  drugs Amphetamines and phenobarbital interact based on the previous sentence?\\nInteraction:</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5648</th>\n",
       "      <td>Concomitant administration of Norpace and quinidine resulted in slight increases in plasma disopyramide levels and slight decreases in plasma quinidine levels.</td>\n",
       "      <td>No Interaction</td>\n",
       "      <td>Metabolic Mechanism</td>\n",
       "      <td>Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Concomitant administration of Norpace and quinidine resulted in slight increases in plasma disopyramide levels and slight decreases in plasma quinidine levels.\\nHow do  drugs Norpace and quinidine interact based on the previous sentence?\\nInteraction:</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7549</th>\n",
       "      <td>Tolbutamide: Aprepitant, when given as 125 mg on Day 1 and 80 mg/day on Days 2 and 3, decreased the AUC of tolbutamide (a CYP2C9 substrate) by 23% on Day 4, 28% on Day 8, and 15% on Day 15, when a single dose of tolbutamide 500 mg was admini,stered orally prior to the administration of the 3-day regimen of Aprepitant and on Days 4,8, and 15.</td>\n",
       "      <td>No Interaction</td>\n",
       "      <td>Metabolic Mechanism</td>\n",
       "      <td>Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Tolbutamide: Aprepitant, when given as 125 mg on Day 1 and 80 mg/day on Days 2 and 3, decreased the AUC of tolbutamide (a CYP2C9 substrate) by 23% on Day 4, 28% on Day 8, and 15% on Day 15, when a single dose of tolbutamide 500 mg was admini,stered orally prior to the administration of the 3-day regimen of Aprepitant and on Days 4,8, and 15.\\nHow do  drugs tolbutamide and Aprepitant interact based on the previous sentence?\\nInteraction:</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1772</th>\n",
       "      <td>Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.</td>\n",
       "      <td>No Interaction</td>\n",
       "      <td>No Interaction</td>\n",
       "      <td>Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nHow do  drugs perchlorate and iodine-containing compounds interact based on the previous sentence?\\nInteraction:</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1516</th>\n",
       "      <td>Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.</td>\n",
       "      <td>No Interaction</td>\n",
       "      <td>No Interaction</td>\n",
       "      <td>Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.\\nHow do  drugs clofibrate and 5-fluorouracil interact based on the previous sentence?\\nInteraction:</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1474</th>\n",
       "      <td>Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.</td>\n",
       "      <td>No Interaction</td>\n",
       "      <td>No Interaction</td>\n",
       "      <td>Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.\\nHow do  drugs androgens and 5-fluorouracil interact based on the previous sentence?\\nInteraction:</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1756</th>\n",
       "      <td>Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.</td>\n",
       "      <td>No Interaction</td>\n",
       "      <td>No Interaction</td>\n",
       "      <td>Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nHow do  drugs thiocyanate and somatostatin analogs interact based on the previous sentence?\\nInteraction:</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>438</th>\n",
       "      <td>Potassium-sparing diuretics (spironolactone, amiloride, triamterene, and others) or potassium supplements can increase the risk of hyperkalemia.</td>\n",
       "      <td>No Interaction</td>\n",
       "      <td>No Interaction</td>\n",
       "      <td>Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Potassium-sparing diuretics (spironolactone, amiloride, triamterene, and others) or potassium supplements can increase the risk of hyperkalemia.\\nHow do  drugs spironolactone and triamterene interact based on the previous sentence?\\nInteraction:</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>195</th>\n",
       "      <td>MAO Inhibitors: Studies in animals demonstrate that the acute toxicity of bupropion is enhanced by the MAO inhibitor phenelzine .</td>\n",
       "      <td>No Interaction</td>\n",
       "      <td>No Interaction</td>\n",
       "      <td>Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: MAO Inhibitors: Studies in animals demonstrate that the acute toxicity of bupropion is enhanced by the MAO inhibitor phenelzine .\\nHow do  drugs MAO Inhibitors and MAO inhibitor interact based on the previous sentence?\\nInteraction:</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1683</th>\n",
       "      <td>Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.</td>\n",
       "      <td>No Interaction</td>\n",
       "      <td>No Interaction</td>\n",
       "      <td>Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nHow do  drugs amiodarone and heparin interact based on the previous sentence?\\nInteraction:</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1576</th>\n",
       "      <td>Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.</td>\n",
       "      <td>No Interaction</td>\n",
       "      <td>No Interaction</td>\n",
       "      <td>Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.\\nHow do  drugs glucocorticoids and tamoxifen interact based on the previous sentence?\\nInteraction:</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1583</th>\n",
       "      <td>Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.</td>\n",
       "      <td>No Interaction</td>\n",
       "      <td>No Interaction</td>\n",
       "      <td>Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.\\nHow do  drugs meclofenamic acid and tamoxifen interact based on the previous sentence?\\nInteraction:</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1298</th>\n",
       "      <td>Fluconazole and Ketoconazole: Ketoconazole and fluconazole are predominantly CYP 3A4 and 2C9 inhibitors, respectively.</td>\n",
       "      <td>No Interaction</td>\n",
       "      <td>No Interaction</td>\n",
       "      <td>Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Fluconazole and Ketoconazole: Ketoconazole and fluconazole are predominantly CYP 3A4 and 2C9 inhibitors, respectively.\\nHow do  drugs Fluconazole and Ketoconazole interact based on the previous sentence?\\nInteraction:</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1612</th>\n",
       "      <td>Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.</td>\n",
       "      <td>No Interaction</td>\n",
       "      <td>No Interaction</td>\n",
       "      <td>Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nHow do  drugs aminoglutethimide and b-adrenergic blocking agents interact based on the previous sentence?\\nInteraction:</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1629</th>\n",
       "      <td>Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.</td>\n",
       "      <td>No Interaction</td>\n",
       "      <td>No Interaction</td>\n",
       "      <td>Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nHow do  drugs aminoglutethimide and nitroprusside interact based on the previous sentence?\\nInteraction:</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1690</th>\n",
       "      <td>Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.</td>\n",
       "      <td>No Interaction</td>\n",
       "      <td>No Interaction</td>\n",
       "      <td>Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nHow do  drugs amiodarone and metoclopramide interact based on the previous sentence?\\nInteraction:</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1764</th>\n",
       "      <td>Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.</td>\n",
       "      <td>No Interaction</td>\n",
       "      <td>No Interaction</td>\n",
       "      <td>Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nHow do  drugs perchlorate and chloral hydrate interact based on the previous sentence?\\nInteraction:</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1504</th>\n",
       "      <td>Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.</td>\n",
       "      <td>No Interaction</td>\n",
       "      <td>No Interaction</td>\n",
       "      <td>Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.\\nHow do  drugs asparaginase and furosemide interact based on the previous sentence?\\nInteraction:</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>611</th>\n",
       "      <td>Therefore, co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme, including other antidepressants, phenothiazines, carbamazepine, and Type 1C antiarrhythmics (eg, propafenone, flecainide, and encainide), or that inhibit this enzyme (eg, quinidine), should be approached with caution.</td>\n",
       "      <td>No Interaction</td>\n",
       "      <td>No Interaction</td>\n",
       "      <td>Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Therefore, co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme, including other antidepressants, phenothiazines, carbamazepine, and Type 1C antiarrhythmics (eg, propafenone, flecainide, and encainide), or that inhibit this enzyme (eg, quinidine), should be approached with caution.\\nHow do  drugs carbamazepine and encainide interact based on the previous sentence?\\nInteraction:</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>283</th>\n",
       "      <td>Nevertheless, plasma lithium levels should be monitored with appropriate adjustment to the lithium dose in accordance with standard clinical practice.</td>\n",
       "      <td>No Interaction</td>\n",
       "      <td>No Interaction</td>\n",
       "      <td>Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Nevertheless, plasma lithium levels should be monitored with appropriate adjustment to the lithium dose in accordance with standard clinical practice.\\nHow do  drugs lithium and lithium interact based on the previous sentence?\\nInteraction:</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1826</th>\n",
       "      <td>Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.</td>\n",
       "      <td>No Interaction</td>\n",
       "      <td>No Interaction</td>\n",
       "      <td>Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nHow do  drugs antithyroid drugs and levodopa interact based on the previous sentence?\\nInteraction:</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1745</th>\n",
       "      <td>Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.</td>\n",
       "      <td>No Interaction</td>\n",
       "      <td>No Interaction</td>\n",
       "      <td>Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nHow do  drugs thiocyanate and levodopa interact based on the previous sentence?\\nInteraction:</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6697</th>\n",
       "      <td>Since Zarontin (ethosuximide) may interact with concurrently administered antiepileptic drugs, periodic serum level determinations of these drugs may be necessary (eg, ethosuximide may elevate phenytoin serum levels and valproic acid has been reported to both increase and decrease ethosuximide levels).</td>\n",
       "      <td>No Interaction</td>\n",
       "      <td>Unspecified</td>\n",
       "      <td>Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Since Zarontin (ethosuximide) may interact with concurrently administered antiepileptic drugs, periodic serum level determinations of these drugs may be necessary (eg, ethosuximide may elevate phenytoin serum levels and valproic acid has been reported to both increase and decrease ethosuximide levels).\\nHow do  drugs Zarontin and antiepileptic drugs interact based on the previous sentence?\\nInteraction:</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               sentence  \\\n",
       "4386                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      The concomitant use of H2 blockers or proton pump inhibitors with SPRYCEL is not recommended.   \n",
       "17780                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     MAO inhibitors should be used with caution in patients receiving hydralazine.   \n",
       "9530                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Cyclosporine, tacrolimus and digoxin concentrations should be monitored at the initiation of Itraconazole therapy and frequently thereafter, and the dose of these three drug products adjusted appropriately.   \n",
       "19325                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 There is insufficient experience to assess the safety and efficacy of ORENCIA administered concurrently with anakinra, and therefore such use is not recommended.   \n",
       "14414                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Coadministration of alosetron and strong CYP3A4 inhibitors, such as clarithromycin, telithromycin, protease inhibitors, voriconazole, and itraconazole has not been evaluated but should be undertaken with caution because of similar potential drug interactions.   \n",
       "930                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Concurrent use of butorphanol with central nervous system depressants (e.g., alcohol, barbiturates, tranquilizers, and antihistamines) may result in increased central nervous system depressant effects.   \n",
       "19162                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               When atropine and pralidoxime are used together, the signs of atropinization (flushing, mydriasis, tachycardia, dryness of the mouth and nose) may occur earlier than might be expected than when atropine is used alone because pralidoxime may potentiate the effect of atropine.   \n",
       "10039                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Lithium: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ACE inhibitors during therapy with lithium.   \n",
       "12858                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          The actions of the benzodiazepines may be potentiated by barbiturates, narcotics, phenothiazines, monoamine oxidase inhibitors or other antidepressants.   \n",
       "21838                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     In an analysis of the supraventricular arrhythmia and DIAMOND patient populations, the concomitant administration of verapamil with dofetilide was associated with a higher occurrence of torsade de pointes.   \n",
       "17981                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Patients receiving other narcotic analgesics, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with hydrocodone and acetaminophen tablets may exhibit an additive CNS depression.   \n",
       "2563                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Concomitant administration of diflunisal and acetaminophen in dogs, but not in rats, at approximately 2 times the recommended maximum human therapeutic dose of each (40 to 52 mg/kg/day of diflunisal/acetaminophen) resulted in greater gastrointestinal toxicity than when either drug was administered alone.   \n",
       "643                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Several tricyclic antidepressants have been reported to block the pharmacologic effects of guanethidine, clonidine, or similar agents, and such an effect may be anticipated with CMI because of its structural similarity to other tricyclic antidepressants.   \n",
       "3227                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension.   \n",
       "12582                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Anticoagulants: Combination hormonal contraceptives may increase or decrease the effects of coumarin derivatives.   \n",
       "8035                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Ergotamine: Concurrent use of erythromycin and ergotamine or dihydroergotamine has been associated in some patients with acute ergot toxicity characterized by severe peripheral vasospasm and dysesthesia.   \n",
       "929                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Concurrent use of butorphanol with central nervous system depressants (e.g., alcohol, barbiturates, tranquilizers, and antihistamines) may result in increased central nervous system depressant effects.   \n",
       "21139                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Chlorpropamide: Chlorpropamides plasma half-life may be prolonged by allopurinol, since allopurinol and chlorpropamide may compete for excretion in the renal tubule.   \n",
       "4216                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Drugs that induce hepatic enzymes such as phenobarbital, phenytoin and rifampin may increase the clearance of corticosteroids and may require increases in corticosteroid dose to achieve the desired response.   \n",
       "14400                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            (See CLINICAL PHARMACOLOGY) Coadministration of Femara and tamoxifen 20 mg daily resulted in a reduction of letrozole plasma levels by 38% on average.   \n",
       "14502                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    In vivo studies: Nitrates: The blood pressure lowering effects of sublingual nitrates (0.4 mg) taken 1 and 4 hours after vardenafil and increases in heart rate when taken at 1, 4 and 8 hours were potentiated by a 20 mg dose of Vardenafil in healthy middle-aged subjects.   \n",
       "15384                                                                                                         Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.   \n",
       "21031                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Co-administration of anastrozole and tamoxifen resulted in a reduction of anastrozole plasma levels by 27% compared with those achieved with anastrozole alone.   \n",
       "15373                                                                                                         Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.   \n",
       "15376                                                                                                         Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.   \n",
       "6252                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Phenobarbital: Amphetamines may delay intestinal absorption of phenobarbital;   \n",
       "5648                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Concomitant administration of Norpace and quinidine resulted in slight increases in plasma disopyramide levels and slight decreases in plasma quinidine levels.   \n",
       "7549                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Tolbutamide: Aprepitant, when given as 125 mg on Day 1 and 80 mg/day on Days 2 and 3, decreased the AUC of tolbutamide (a CYP2C9 substrate) by 23% on Day 4, 28% on Day 8, and 15% on Day 15, when a single dose of tolbutamide 500 mg was admini,stered orally prior to the administration of the 3-day regimen of Aprepitant and on Days 4,8, and 15.   \n",
       "1772   Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.   \n",
       "1516                                                                                                                                                                                                                                                                                                                                                                                                                               Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.   \n",
       "1474                                                                                                                                                                                                                                                                                                                                                                                                                               Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.   \n",
       "1756   Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.   \n",
       "438                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Potassium-sparing diuretics (spironolactone, amiloride, triamterene, and others) or potassium supplements can increase the risk of hyperkalemia.   \n",
       "195                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   MAO Inhibitors: Studies in animals demonstrate that the acute toxicity of bupropion is enhanced by the MAO inhibitor phenelzine .   \n",
       "1683   Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.   \n",
       "1576                                                                                                                                                                                                                                                                                                                                                                                                                               Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.   \n",
       "1583                                                                                                                                                                                                                                                                                                                                                                                                                               Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.   \n",
       "1298                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Fluconazole and Ketoconazole: Ketoconazole and fluconazole are predominantly CYP 3A4 and 2C9 inhibitors, respectively.   \n",
       "1612   Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.   \n",
       "1629   Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.   \n",
       "1690   Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.   \n",
       "1764   Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.   \n",
       "1504                                                                                                                                                                                                                                                                                                                                                                                                                               Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.   \n",
       "611                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Therefore, co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme, including other antidepressants, phenothiazines, carbamazepine, and Type 1C antiarrhythmics (eg, propafenone, flecainide, and encainide), or that inhibit this enzyme (eg, quinidine), should be approached with caution.   \n",
       "283                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Nevertheless, plasma lithium levels should be monitored with appropriate adjustment to the lithium dose in accordance with standard clinical practice.   \n",
       "1826   Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.   \n",
       "1745   Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.   \n",
       "6697                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Since Zarontin (ethosuximide) may interact with concurrently administered antiepileptic drugs, periodic serum level determinations of these drugs may be necessary (eg, ethosuximide may elevate phenytoin serum levels and valproic acid has been reported to both increase and decrease ethosuximide levels).   \n",
       "\n",
       "      ddi_test_prompts_random_33.5.50.perm_4.natural                labels  \\\n",
       "4386                                  Recommendation        Recommendation   \n",
       "17780                                 No Interaction        Recommendation   \n",
       "9530                                  Recommendation        Recommendation   \n",
       "19325                                 No Interaction        Recommendation   \n",
       "14414                                 No Interaction        Recommendation   \n",
       "930                                   No Interaction     Effect Alteration   \n",
       "19162                                 No Interaction     Effect Alteration   \n",
       "10039                                 Recommendation     Effect Alteration   \n",
       "12858                                 No Interaction     Effect Alteration   \n",
       "21838                                 Recommendation     Effect Alteration   \n",
       "17981                                 No Interaction     Effect Alteration   \n",
       "2563                                  No Interaction     Effect Alteration   \n",
       "643                                   No Interaction     Effect Alteration   \n",
       "3227                                  No Interaction     Effect Alteration   \n",
       "12582                                 No Interaction     Effect Alteration   \n",
       "8035                                  No Interaction     Effect Alteration   \n",
       "929                                   No Interaction     Effect Alteration   \n",
       "21139                                 No Interaction  Metabolic Mechanism    \n",
       "4216                                  No Interaction  Metabolic Mechanism    \n",
       "14400                                 No Interaction  Metabolic Mechanism    \n",
       "14502                                 No Interaction  Metabolic Mechanism    \n",
       "15384                                 No Interaction  Metabolic Mechanism    \n",
       "21031                                 No Interaction  Metabolic Mechanism    \n",
       "15373                                 No Interaction  Metabolic Mechanism    \n",
       "15376                                 No Interaction  Metabolic Mechanism    \n",
       "6252                                  No Interaction  Metabolic Mechanism    \n",
       "5648                                  No Interaction  Metabolic Mechanism    \n",
       "7549                                  No Interaction  Metabolic Mechanism    \n",
       "1772                                  No Interaction        No Interaction   \n",
       "1516                                  No Interaction        No Interaction   \n",
       "1474                                  No Interaction        No Interaction   \n",
       "1756                                  No Interaction        No Interaction   \n",
       "438                                   No Interaction        No Interaction   \n",
       "195                                   No Interaction        No Interaction   \n",
       "1683                                  No Interaction        No Interaction   \n",
       "1576                                  No Interaction        No Interaction   \n",
       "1583                                  No Interaction        No Interaction   \n",
       "1298                                  No Interaction        No Interaction   \n",
       "1612                                  No Interaction        No Interaction   \n",
       "1629                                  No Interaction        No Interaction   \n",
       "1690                                  No Interaction        No Interaction   \n",
       "1764                                  No Interaction        No Interaction   \n",
       "1504                                  No Interaction        No Interaction   \n",
       "611                                   No Interaction        No Interaction   \n",
       "283                                   No Interaction        No Interaction   \n",
       "1826                                  No Interaction        No Interaction   \n",
       "1745                                  No Interaction        No Interaction   \n",
       "6697                                  No Interaction           Unspecified   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          test_ready_prompt  \n",
       "4386                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: The concomitant use of H2 blockers or proton pump inhibitors with SPRYCEL is not recommended.\\nHow do  drugs proton pump inhibitors and SPRYCEL interact based on the previous sentence?\\nInteraction:  \n",
       "17780                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: MAO inhibitors should be used with caution in patients receiving hydralazine.\\nHow do  drugs MAO inhibitors and hydralazine interact based on the previous sentence?\\nInteraction:  \n",
       "9530                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Cyclosporine, tacrolimus and digoxin concentrations should be monitored at the initiation of Itraconazole therapy and frequently thereafter, and the dose of these three drug products adjusted appropriately.\\nHow do  drugs Cyclosporine and Itraconazole interact based on the previous sentence?\\nInteraction:  \n",
       "19325                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: There is insufficient experience to assess the safety and efficacy of ORENCIA administered concurrently with anakinra, and therefore such use is not recommended.\\nHow do  drugs ORENCIA and anakinra interact based on the previous sentence?\\nInteraction:  \n",
       "14414                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Coadministration of alosetron and strong CYP3A4 inhibitors, such as clarithromycin, telithromycin, protease inhibitors, voriconazole, and itraconazole has not been evaluated but should be undertaken with caution because of similar potential drug interactions.\\nHow do  drugs alosetron and telithromycin interact based on the previous sentence?\\nInteraction:  \n",
       "930                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Concurrent use of butorphanol with central nervous system depressants (e.g., alcohol, barbiturates, tranquilizers, and antihistamines) may result in increased central nervous system depressant effects.\\nHow do  drugs butorphanol and antihistamines interact based on the previous sentence?\\nInteraction:  \n",
       "19162                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: When atropine and pralidoxime are used together, the signs of atropinization (flushing, mydriasis, tachycardia, dryness of the mouth and nose) may occur earlier than might be expected than when atropine is used alone because pralidoxime may potentiate the effect of atropine.\\nHow do  drugs atropine and pralidoxime interact based on the previous sentence?\\nInteraction:  \n",
       "10039                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Lithium: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ACE inhibitors during therapy with lithium.\\nHow do  drugs ACE inhibitors and lithium interact based on the previous sentence?\\nInteraction:  \n",
       "12858                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: The actions of the benzodiazepines may be potentiated by barbiturates, narcotics, phenothiazines, monoamine oxidase inhibitors or other antidepressants.\\nHow do  drugs benzodiazepines and antidepressants interact based on the previous sentence?\\nInteraction:  \n",
       "21838                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: In an analysis of the supraventricular arrhythmia and DIAMOND patient populations, the concomitant administration of verapamil with dofetilide was associated with a higher occurrence of torsade de pointes.\\nHow do  drugs verapamil and dofetilide interact based on the previous sentence?\\nInteraction:  \n",
       "17981                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Patients receiving other narcotic analgesics, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with hydrocodone and acetaminophen tablets may exhibit an additive CNS depression.\\nHow do  drugs alcohol and hydrocodone interact based on the previous sentence?\\nInteraction:  \n",
       "2563                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Concomitant administration of diflunisal and acetaminophen in dogs, but not in rats, at approximately 2 times the recommended maximum human therapeutic dose of each (40 to 52 mg/kg/day of diflunisal/acetaminophen) resulted in greater gastrointestinal toxicity than when either drug was administered alone.\\nHow do  drugs diflunisal and acetaminophen interact based on the previous sentence?\\nInteraction:  \n",
       "643                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Several tricyclic antidepressants have been reported to block the pharmacologic effects of guanethidine, clonidine, or similar agents, and such an effect may be anticipated with CMI because of its structural similarity to other tricyclic antidepressants.\\nHow do  drugs tricyclic antidepressants and guanethidine interact based on the previous sentence?\\nInteraction:  \n",
       "3227                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension.\\nHow do  drugs norepinephrine and monoamine oxidase inhibitors interact based on the previous sentence?\\nInteraction:  \n",
       "12582                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Anticoagulants: Combination hormonal contraceptives may increase or decrease the effects of coumarin derivatives.\\nHow do  drugs hormonal contraceptives and coumarin derivatives interact based on the previous sentence?\\nInteraction:  \n",
       "8035                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Ergotamine: Concurrent use of erythromycin and ergotamine or dihydroergotamine has been associated in some patients with acute ergot toxicity characterized by severe peripheral vasospasm and dysesthesia.\\nHow do  drugs erythromycin and ergotamine interact based on the previous sentence?\\nInteraction:  \n",
       "929                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Concurrent use of butorphanol with central nervous system depressants (e.g., alcohol, barbiturates, tranquilizers, and antihistamines) may result in increased central nervous system depressant effects.\\nHow do  drugs butorphanol and tranquilizers interact based on the previous sentence?\\nInteraction:  \n",
       "21139                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Chlorpropamide: Chlorpropamides plasma half-life may be prolonged by allopurinol, since allopurinol and chlorpropamide may compete for excretion in the renal tubule.\\nHow do  drugs allopurinol and chlorpropamide interact based on the previous sentence?\\nInteraction:  \n",
       "4216                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Drugs that induce hepatic enzymes such as phenobarbital, phenytoin and rifampin may increase the clearance of corticosteroids and may require increases in corticosteroid dose to achieve the desired response.\\nHow do  drugs rifampin and corticosteroids interact based on the previous sentence?\\nInteraction:  \n",
       "14400                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: (See CLINICAL PHARMACOLOGY) Coadministration of Femara and tamoxifen 20 mg daily resulted in a reduction of letrozole plasma levels by 38% on average.\\nHow do  drugs Femara and tamoxifen interact based on the previous sentence?\\nInteraction:  \n",
       "14502                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: In vivo studies: Nitrates: The blood pressure lowering effects of sublingual nitrates (0.4 mg) taken 1 and 4 hours after vardenafil and increases in heart rate when taken at 1, 4 and 8 hours were potentiated by a 20 mg dose of Vardenafil in healthy middle-aged subjects.\\nHow do  drugs nitrates and vardenafil interact based on the previous sentence?\\nInteraction:  \n",
       "15384                                                                                                                                Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.\\nHow do  drugs EQUETROTM and nortriptyline interact based on the previous sentence?\\nInteraction:  \n",
       "21031                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Co-administration of anastrozole and tamoxifen resulted in a reduction of anastrozole plasma levels by 27% compared with those achieved with anastrozole alone.\\nHow do  drugs anastrozole and tamoxifen interact based on the previous sentence?\\nInteraction:  \n",
       "15373                                                                                                                                    Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.\\nHow do  drugs EQUETROTM and felbamate interact based on the previous sentence?\\nInteraction:  \n",
       "15376                                                                                                                                  Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Agents that have been found, or are expected to have decreased plasma levels in the presence of EQUETROTM due to induction of CYP enzymes are the following: Acetaminophen, alprazolam, amitriptyline, bupropion, buspirone, citalopram, clobazam, clonazepam, clozapine, cyclosporin, delavirdine, desipramine, diazepam, dicumarol, doxycycline, ethosuximide, felbamate, felodipine, glucocorticoids, haloperidol, itraconazole, lamotrigine, levothyroxine, lorazepam, methadone, midazolam, mirtazapine, nortriptyline, olanzapine, oral contraceptives(3), oxcarbazepine, Phenytoin(4), praziquantel, protease inhibitors, quetiapine, risperidone, theophylline, topiramate, tiagabine, tramadol, triazolam, valproate, warfarin(5) , ziprasidone, and zonisamide.\\nHow do  drugs EQUETROTM and haloperidol interact based on the previous sentence?\\nInteraction:  \n",
       "6252                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Phenobarbital: Amphetamines may delay intestinal absorption of phenobarbital;\\nHow do  drugs Amphetamines and phenobarbital interact based on the previous sentence?\\nInteraction:  \n",
       "5648                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Concomitant administration of Norpace and quinidine resulted in slight increases in plasma disopyramide levels and slight decreases in plasma quinidine levels.\\nHow do  drugs Norpace and quinidine interact based on the previous sentence?\\nInteraction:  \n",
       "7549                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Tolbutamide: Aprepitant, when given as 125 mg on Day 1 and 80 mg/day on Days 2 and 3, decreased the AUC of tolbutamide (a CYP2C9 substrate) by 23% on Day 4, 28% on Day 8, and 15% on Day 15, when a single dose of tolbutamide 500 mg was admini,stered orally prior to the administration of the 3-day regimen of Aprepitant and on Days 4,8, and 15.\\nHow do  drugs tolbutamide and Aprepitant interact based on the previous sentence?\\nInteraction:  \n",
       "1772          Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nHow do  drugs perchlorate and iodine-containing compounds interact based on the previous sentence?\\nInteraction:  \n",
       "1516                                                                                                                                                                                                                                                                                                                                                                                                                                                    Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.\\nHow do  drugs clofibrate and 5-fluorouracil interact based on the previous sentence?\\nInteraction:  \n",
       "1474                                                                                                                                                                                                                                                                                                                                                                                                                                                     Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.\\nHow do  drugs androgens and 5-fluorouracil interact based on the previous sentence?\\nInteraction:  \n",
       "1756                 Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nHow do  drugs thiocyanate and somatostatin analogs interact based on the previous sentence?\\nInteraction:  \n",
       "438                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Potassium-sparing diuretics (spironolactone, amiloride, triamterene, and others) or potassium supplements can increase the risk of hyperkalemia.\\nHow do  drugs spironolactone and triamterene interact based on the previous sentence?\\nInteraction:  \n",
       "195                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: MAO Inhibitors: Studies in animals demonstrate that the acute toxicity of bupropion is enhanced by the MAO inhibitor phenelzine .\\nHow do  drugs MAO Inhibitors and MAO inhibitor interact based on the previous sentence?\\nInteraction:  \n",
       "1683                               Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nHow do  drugs amiodarone and heparin interact based on the previous sentence?\\nInteraction:  \n",
       "1576                                                                                                                                                                                                                                                                                                                                                                                                                                                    Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.\\nHow do  drugs glucocorticoids and tamoxifen interact based on the previous sentence?\\nInteraction:  \n",
       "1583                                                                                                                                                                                                                                                                                                                                                                                                                                                  Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.\\nHow do  drugs meclofenamic acid and tamoxifen interact based on the previous sentence?\\nInteraction:  \n",
       "1298                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Fluconazole and Ketoconazole: Ketoconazole and fluconazole are predominantly CYP 3A4 and 2C9 inhibitors, respectively.\\nHow do  drugs Fluconazole and Ketoconazole interact based on the previous sentence?\\nInteraction:  \n",
       "1612   Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nHow do  drugs aminoglutethimide and b-adrenergic blocking agents interact based on the previous sentence?\\nInteraction:  \n",
       "1629                  Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nHow do  drugs aminoglutethimide and nitroprusside interact based on the previous sentence?\\nInteraction:  \n",
       "1690                        Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nHow do  drugs amiodarone and metoclopramide interact based on the previous sentence?\\nInteraction:  \n",
       "1764                      Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nHow do  drugs perchlorate and chloral hydrate interact based on the previous sentence?\\nInteraction:  \n",
       "1504                                                                                                                                                                                                                                                                                                                                                                                                                                                      Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Binding to Serum Proteins: The following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins: androgens and related anabolic hormones, asparaginase, clofibrate, estrogens and estrogen-containing compounds, 5-fluorouracil, furosemide, glucocorticoids, meclofenamic acid, mefenamic acid, methadone, perphenazine, phenylbutazone, phenytoin, salicylates, tamoxifen.\\nHow do  drugs asparaginase and furosemide interact based on the previous sentence?\\nInteraction:  \n",
       "611                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Therefore, co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme, including other antidepressants, phenothiazines, carbamazepine, and Type 1C antiarrhythmics (eg, propafenone, flecainide, and encainide), or that inhibit this enzyme (eg, quinidine), should be approached with caution.\\nHow do  drugs carbamazepine and encainide interact based on the previous sentence?\\nInteraction:  \n",
       "283                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Nevertheless, plasma lithium levels should be monitored with appropriate adjustment to the lithium dose in accordance with standard clinical practice.\\nHow do  drugs lithium and lithium interact based on the previous sentence?\\nInteraction:  \n",
       "1826                       Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nHow do  drugs antithyroid drugs and levodopa interact based on the previous sentence?\\nInteraction:  \n",
       "1745                             Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Thyroid Physiology: The following agents may alter thyroid hormone or TSH levels, generally by effects on thyroid hormone synthesis, secretion, distribution, metabolism, hormone action, or elimination, or altered TSH secretion: aminoglutethimide, p-aminosalicylic acid, amiodarone, androgens and related anabolic hormones, complex anions (thiocyanate, perchlorate, pertechnetate), antithyroid drugs, b-adrenergic blocking agents, carbamazepine, chloral hydrate, diazepam, dopamine and dopamine agonists, ethionamide, glucocorticoids, heparin, hepatic enzyme inducers, insulin, iodinated cholestographic agents, iodine-containing compounds, levodopa, lovastatin, lithium, 6-mercaptopurine, metoclopramide, mitotane, nitroprusside, phenobarbital, phenytoin, resorcinol, rifampin, somatostatin analogs, sulfonamides, sulfonylureas, thiazide diuretics.\\nHow do  drugs thiocyanate and levodopa interact based on the previous sentence?\\nInteraction:  \n",
       "6697                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\\nHow do drugs Bentiromide and Pronestyl interact based on the previous sentence?\\nInteraction: Unspecified\\n\\nSentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \\nHow do drugs clindamycin and gentamicin interact based on the previous sentence?\\nInteraction: Effect Alteration\\n\\nSentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\\nHow do drugs procarbazine and mechlorethamine interact based on the previous sentence?\\nInteraction: No Interaction\\n\\nSentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\\nHow do drugs VIOXX and warfarin interact based on the previous sentence?\\nInteraction: Recommendation\\n\\nSentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\\nHow do drugs bosentan and cyclosporine A interact based on the previous sentence?\\nInteraction: Metabolic Mechanism \\n\\nSentence: Since Zarontin (ethosuximide) may interact with concurrently administered antiepileptic drugs, periodic serum level determinations of these drugs may be necessary (eg, ethosuximide may elevate phenytoin serum levels and valproic acid has been reported to both increase and decrease ethosuximide levels).\\nHow do  drugs Zarontin and antiepileptic drugs interact based on the previous sentence?\\nInteraction:  "
      ]
     },
     "execution_count": 134,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "mea_df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 135,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).\n",
      "How do drugs Bentiromide and Pronestyl interact based on the previous sentence?\n",
      "Interaction: Unspecified\n",
      "\n",
      "Sentence: Combinations of clindamycin and gentamicin were indifferent for 16 and synergistic for 11 of the resistant strains. \n",
      "How do drugs clindamycin and gentamicin interact based on the previous sentence?\n",
      "Interaction: Effect Alteration\n",
      "\n",
      "Sentence: However, in a well-controlled study of patients with lymphoma on combination therapy, allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide, doxorubicin, bleomycin, procarbazine and/or mechlorethamine.\n",
      "How do drugs procarbazine and mechlorethamine interact based on the previous sentence?\n",
      "Interaction: No Interaction\n",
      "\n",
      "Sentence: Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing VIOXX therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding complications.\n",
      "How do drugs VIOXX and warfarin interact based on the previous sentence?\n",
      "Interaction: Recommendation\n",
      "\n",
      "Sentence: Steady-state bosentan plasma concentrations were 3- to 4-fold higher than in the absence of cyclosporine A.\n",
      "How do drugs bosentan and cyclosporine A interact based on the previous sentence?\n",
      "Interaction: Metabolic Mechanism \n",
      "\n",
      "Sentence: MAO inhibitors should be used with caution in patients receiving hydralazine.\n",
      "How do  drugs MAO inhibitors and hydralazine interact based on the previous sentence?\n",
      "Interaction:\n"
     ]
    }
   ],
   "source": [
    "print(mea_df[mea_df['labels'] != mea_df[filename_root]].test_ready_prompt.values[0])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 92,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Sentence: Topical papaverine was used as a direct therapeutic action to manage vasospasm in a total of 11 patients .\n",
      "Drugs: papaverine\n",
      "\n",
      "Sentence: In summary , the chick embryo provides a reliable and simple experimental animal model of coniine - induced arthrogryposis .\n",
      "Drugs: coniine\n",
      "\n",
      "Sentence: Her QT interval returned to normal upon withdrawal of ketoconazole .\n",
      "Drugs: ketoconazole\n",
      "\n",
      "Sentence: Sodium bicarbonate alleviates penile pain induced by intracavernous injections for erectile dysfunction .\n",
      "Drugs: sodium bicarbonate\n",
      "\n",
      "Sentence: We report a patient in whom hypersensitivity to carbamazepine presented with generalized erythroderma , a severe leukemoid reaction , eosinophilia , hyponatremia , and renal failure .\n",
      "Drugs: carbamazepine\n",
      "\n",
      "Sentence: Plasma was tested for amphetamine and the cocaine metabolite benzoylecgonine using enzyme - mediated immunoassay methodology .\n",
      "Drugs:\n"
     ]
    }
   ],
   "source": [
    "print(df.test_ready_prompt.values[0])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 93,
   "metadata": {},
   "outputs": [],
   "source": [
    "full_dev = pickle.load(open('../data/bc5cdr_chemical_test_prompts_full_dev_random_33.5., ','rb'))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 94,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "processed 116741 tokens with 5347 phrases; found: 5470 phrases; correct: 5114.\n",
      "accuracy:  99.34%; (non-O)\n",
      "accuracy:  99.34%; precision:  93.49%; recall:  95.64%; FB1:  94.55%\n",
      "                X: precision:  93.49%; recall:  95.64%; FB1:  94.55%  5470\n",
      "(93.49177330895795, 95.64241630821022, 94.55486733844874)\n"
     ]
    }
   ],
   "source": [
    "conlleval_eval(full_dev.ner_seq,full_dev.bio_preds)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 95,
   "metadata": {},
   "outputs": [],
   "source": [
    "subset_with_predictions = full_dev.merge(df[['sents']],on='sents',how='inner')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 96,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "processed 5156 tokens with 218 phrases; found: 220 phrases; correct: 213.\n",
      "accuracy:  99.59%; (non-O)\n",
      "accuracy:  99.59%; precision:  96.82%; recall:  97.71%; FB1:  97.26%\n",
      "                X: precision:  96.82%; recall:  97.71%; FB1:  97.26%  220\n",
      "(96.81818181818181, 97.70642201834863, 97.26027397260275)\n"
     ]
    }
   ],
   "source": [
    "conlleval_eval(subset_with_predictions.ner_seq,subset_with_predictions.bio_preds)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 76,
   "metadata": {},
   "outputs": [],
   "source": [
    "def run_gpt3(engine, prompt, logit_bias_text, sep):\n",
    "    #constrain potential output to tokens in test sentence using logit bias\n",
    "    logit_biases = {}\n",
    "    tokens = tokenizer.encode(logit_bias_text)\n",
    "    for token in tokens:\n",
    "        logit_biases[token] = .1\n",
    "    \n",
    "    sep_token = tokenizer.encode(sep)\n",
    "    logit_biases[sep_token[0]] = .1           \n",
    "    \n",
    "    #use API to generate completion\n",
    "    sample = openai.Completion.create(engine=engine,\n",
    "                                      prompt=prompt,\n",
    "                                      max_tokens=10,\n",
    "                                      temperature=0,\n",
    "                                      logit_bias = logit_biases,\n",
    "                                      presence_penalty=-0.001,\n",
    "                                      stop=[\"\\n\", \"<|endoftext|>\"])\n",
    "    return sample"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "scispacy",
   "language": "python",
   "name": "scispacy"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.4"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
